書籍詳細

I. 本書の特色とその利用法

P.42 掲載の参考文献

• ・Leucocyte Typing VII, edited by Mason, D. et al, Oxford University Press, Oxford, 2002.

• ・Leucocyte Typing VI, edited by Kishimoto, T. et al, Garland Publishing Inc., New York, 1998.

• ・Leucocyte Typing V, edited by Schlossman, S. F. et al, Oxford University Press, Oxford, 1995.

• ・Leucocyte Typing IV, edited by Knapp, W. et al, Oxford University Press, Oxford, 1989.

• ・Leucocyte Typing III, edited by McMichael, A. J. et al, Oxford University Press, Oxford, 1987.

• ・Leucocyte Typing II, edited by Reinherz, E. L. et al, Springer-Verlag, Berlin, 1986.

• ・Leucocyte Typing, edited by Bernard, A. et al, Springer-Verlag, Berlin, 1984.

P.47 掲載の参考文献

• 1) Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP:Structure and function of the CD1 family of MHC-like cell surface proteins.Immunol Rev 147:5, 1995.
  pubmed

• 2) Calabi F, Yung Yu C, Bilsland CAG, Milstein C:In Immunogenetics of the mayor histocompatibility complex De, (eds Srivastava R, Ram B, Tyle P), VCH Publishers, New York, pp215-243, 1991.

• 3) Crispe IN, Mehal WZ:Strange brew:T cells in the liver. Immunol Today 17:522, 1996.

• 4) Melian A, Beckman EM, Porcelli SA, Brenner MB:Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol 8:82, 1996.

• 5) Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR:CD1 recognition by mouse NK1+T lymphocytes.Science 268:863, 1995.d

• 6) Martin LH, Calabi F, Milstein C:Isolation of CD1 genes:a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci USA 83:9154, 1986.

• 7) Salamone MC, Fainboim L:Intracellular expression of CD1 molecules on PHA-activated normal T lymphocytes. Immunol Lett 33:61, 1992.
  pubmed

• 8) Salamone MC, Roisman FR, Santiago J, Satz ML, Fainboim L:Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression. Dis Markers 8:265, 1990.
  pubmed

• 9) Woolfson A, Milstein C:Alternative splicing generates secretory isoforms of human CD1. Proc Natl Acad Sci USA 91:6683, 1994.
  pubmed

• 10) Yu CY, Milstein C:A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J 8:3727, 1989.
  pubmed

P.48 掲載の参考文献

• 1) Balk SP, Burke S, Polischuk JE, Frantz ME, Yang L, Porcelli S, Colgan SP, Blumberg RS:Beta-2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265:259-262, 1994.
  pubmed

• 2) Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A:Athymic precursor to NK T cell lineage. Science 296:553-555, 2002.

• 3) Bradbury A, Milstein C, Kozak CA:Chromosomal localization of Cd1d genes in the mouse. Somat Cell Molec Genet 17:93-96, 1991.
  pubmed

• 4) Driessen C, Bryant RA, Lennon-Dumenil AM, Villadangos JA, Bryant PW, Shi GP, Chapman HA, Ploegh HL:Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J Cell Biol 147:775-790, 1999.
  pubmed

• 5) Honey K, Benlagha K, Beers C, Forbush K, Teyton L, Kleijmeer M J, Rudensky AY, Bendelac A:Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immun 3:1069-1074, 2002.

• 6) Jayawardena-Wolf J, Benlagha K, Chiu Y-H, Mehr R, Bendelac A:CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897-908, 2001.
  pubmed

• 7) MacDonald HR:T before NK. Science 296:481-482, 2002.
  pubmed

• 8) Nieuwenhuis EES, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS:CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 8:588-593, 2002.
  pubmed

• 9) Park S-H, Bendelac A:CD1-restricted T-cell responses and microbial infection. Nature 406:788-792, 2000.
  pubmed

• 10) Pellicci DG, Hammond KJL, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI:A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1 (-) CD4 (+) CD1d-dependent precursor stage. J Exp Med 195:835-844, 2002.

• 11) Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M:Glycolipid antigen processing for presentation by CD1d molecules. Science 291:664-667, 2001.
  pubmed

• 12) Riese RJ, Shi G-P, Villadangos J, Stetson D, Driessen C, Lennon-Dumenil A-M, Chu C-L, Naumov Y, Behar SM, Ploegh H, Locksley R, Chapman HA:Regulation of CD1 function and NK1.1+T cell selection and maturation by cathepsin S. Immunity 15:909-919, 2001.
  pubmed

• 13) Shi F-D, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL, Wilson SB, Sarvetnick N:Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Nat Acad Sci USA 98:6777-6782, 2001.
  pubmed

• 14) Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB:CD1-dependent dendritic cell instruction. Nat Immun 3:1163-1168, 2002.

• 15) Zeng Z-H, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA:Crystal structure of mouse CD1:an MHC-like fold with a large hydrophobic binding groove. Science 277:339-345, 1997.

P.50 掲載の参考文献

• 1) Albertson DG, Fishpool R, Sherrington P, Nacheva E, Milstein C:Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes:assignment of the human thymocyte CD1 antigen genes to chromosome 1. EMBO J 7:2801-2805, 1988.
  pubmed

• 2) Park S-H, Bendelac A:CD1-restricted T-cell responses and microbial infection. Nature 406:788-792, 2000.
  pubmed

• 3) Yu CY, Milstein C:A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J 8:3727-3732, 1989.
  pubmed

P.52 掲載の参考文献

• 1) Bell GM, Imboden JB:CD2 and the regulation of T cell anergy. J Immunol 155:2805, 1995.
  pubmed

• 2) Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ:The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol 7:579, 1989.

• 3) Moingeon P, Chang HC, Sayre PH, Clayton LK, Alcover A, Gardner P, Reinherz EL:The structural biology of CD2. Immunol Rev 111:111, 1989.
  pubmed

• 4) Arulanandam AR, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL:A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2:divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439, 1993.
  pubmed

• 5) Aversa GG, Bishop GA, Suranyi MG, Hall BM:RPA-2.10:an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation. Transplant Proc 19:277, 1987.

• 6) Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL:CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 175:353, 1992.
  pubmed

• 7) Dustin ML, Sanders ME, Shaw S, Springer TA:Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J Exp Med 165:677, 1987.
  pubmed

• 8) Dustin ML, Sanders ME, Shaw S, Springer TA:Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J Exp Med 165:677, 1987.
  pubmed

• 9) Filatov AV, Bachurin PS, Markova NA, Surnakova NE:Apanel of monoclonal antibodies against human lymphocyte antigens. Eksp Onkol 11:28, 1989.

• 10) Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE:Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805, 1992.

• 11) Kato K, Koyanagi M, Okada H, Takanashi T, Wong YW, Williams AF, Okumura K, Yagita H:CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241, 1992.

• 12) Schraven B, Wild M, Kirchgessner H, Siebert B, Wallich R, Henning S, Samstag Y, Meuer SC:Alterations of CD2 association with T cell receptor signaling molecules in 'CD2 unresponsive' human T lymphocytes. Eur J Immunol 23:119, 1993.

• 13) Warren HS, Altin JG, Waldron JC, Kinnear BF, Parish CR:A carbohydrate structure associated with CD15 (Lewis x) on myeloid cells is a novel ligand for human CD2. J Immunol 156:2866, 1996.
  pubmed

P.56 掲載の参考文献

• 1) van den Elsen P, Shepley BA, Borst J, Coligan JE, Markham AF, Orkin S, Terhorst C:Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex. Nature 312 (5993):413-418, 1984.

• 2) Tunnacliffe A, Sims JE, Rabbitts TH:T3 delta pre-mRNA is transcribed from a non-TATA promoter and is alternatively spliced in human T cells. EMBO J 5 (6):1245-1252, 1986.

• 3) Gold DP, Clevers H, Alarcon B, Dunlap S, Novotny J, Williams AF, Terhorst C:Evolutionary relation-ship between the T3 chains of the T-cell receptor complex and the immunoglobulin supergene family. Proc Natl Acad Sci USA 84 (21):7649-7653, 1987.

• 4) van den Elsen P, Georgopoulos K, Shepley BA, Orkin S, Terhorst C:Exon/intron organization of the genes coding for the delta chains of the human and murine T-cell receptor/T3 complex. Proc Natl Acad Sci USA 83 (9):2944-2948, 1986.
  pubmed

• 5) van den Elsen P, Shepley BA, Cho M, Terhorst C:Isolation and characterization of a cDNA clone encoding the murine homologue of the human 20K T3/T-cell receptor glycoprotein. Nature 314 (6011):542-544, 1985.
  pubmed

• 6) Tunnacliffe A, Buluwela L, Rabbitts TH:Physical linkage of three CD3 genes on human chromosome ll. EMBO J 6 (10):2953-2957, 1987.

P.57 掲載の参考文献

• 1) Gil D, Schamel WW, Montoya M, Sanchez-Madrid F, Alarcon B:Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 109 (7):901-912, 2002.

• 2) Stanners J, Kabouridis PS, McGuire KL, Tsoukas CD:Interaction between G proteins and tyrosine kinases upon T cell receptor. CD3-mediated signaling. J Biol Chem 270 (51):30635-30642, 1995.
  pubmed

• 3) Soudais C, de Villartay JP, Le Deist F, Fischer A, Lisowska-Grospierre B:Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet 3 (1):77-81, 1993.

• 4) Gold DP, Clevers H, Alarcon B, Dunlap S, Novotny J, Williams AF, Terhorst C:Evolutionary relation-ship between the T3 chains of the T-cell receptor complex and the immunoglobulin supergene family. Proc Natl Acad Sci USA 84 (21):7649-7653, 1987.

• 5) Clevers HC, Dunlap S, Wileman TE, Terhorst C:Human CD3-epsilon gene contains three miniexons and is transcribed from a non-TATA promoter. Proc Natl Acad Sci USA 85 (21):8156-8160, 1988.
  pubmed

• 6) Gold DP, Puck JM, Pettey CL, Cho M, Coligan J, Woody JN, Terhorst C:Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature 321 (6068):431-434, 1986.

• 7) van den Elsen P, Shepley BA, Cho M, Terhorst C:Isolation and characterization of a cDNA clone encoding the murine homologue of the human 20K T3/T-cell receptor glycoprotein. Nature 314 (6011):542-544, 1985.
  pubmed

• 8) Thoenes G, Soudais C, le Deist F, Griscelli C, Fischer A, Lisowska-Grospierre B:Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient. J Biol Chem 267 (1):487-493, 1992.

P.59 掲載の参考文献

• 1) Center DM, Kornfeld H, Cruikshank WW:Interleukin 16 and its function as a CD4 ligand. Immunol Today 17:476, 1996.
  pubmed

• 2) Gaubin M, Autiero M, Houlgatte R, Basmaciogullari S, Auffray C, Piatier-Tonneau D:Molecular basis of T lymphocyte CD4 antigen functions. Eur J Clin Chem Clin Biochem 34:723, 1996.

• 3) Kisielow P, von Boehmer H:Development and selection of T cells:facts and puzzles. Adv Immunol 58:87, 1995.
  pubmed

• 4) Mazerolles F, Auffray C, Fischer A:Down regulation of T-cell adhesion by CD4. Hum Immunol 31:40, 1991.
  pubmed

• 5) Sattentau QJ, Weiss RA:The CD4 antigen:physiological ligand and HIV receptor. Cell 52:631, 1988.
  pubmed

• 6) Autiero M, Cammarota G, Friedlein A, Zulauf M, Chiappetta G, Dragone V, Guardiola J:A17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Eur J Immunol 25:1461, 1995.

• 7) Brady RL, Dodson EJ, Dodson GG, Lange G, Davis SJ, Williams AF, Barclay AN:Crystal structure of domains 3 and 4 of rat CD4:relation to the NH2-terminal domains. Science 260:979, 1993.

• 8) Moir S, Perreault J, Poulin L:Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4. J Virol 70:8019, 1996.
  pubmed

• 9) Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai XP, Xuong NH, Axel R, Sweet RW, et al:Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348:419, 1990.
  pubmed

• 10) Sakihama T, Smolyar A, Reinherz EL:Oligomerization of CD4 is required for stable binding to class ll major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gP120. Proc Natl Acad Sci USA 92:6444, 1995.

• 11) Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC:Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348:411, 1990.
  pubmed

• 12) Zhang X, Piatier-Tonneau D, Auffray C, Murali R, Mahapatra A, Zhang F, Maier CC, Saragovi H, Greene MI:Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation. Nat Biotechnol 14:472-475, 1996.

P.62 掲載の参考文献

• 1) Kipps TJ:The CD5 B cell. Adv Immunol 47:117, 1988.

• 2) Resnick D, Pearson A, Krieger M:The SRCR superfamily:a family reminiscent of the Ig superfamily. Trends Biochem Sci 19:5, 1993.

• 3) Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F:Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 148:1287, 1992.

• 4) Alberola-Ila J, Places L, Lozano F, Vives J:Association of an activation inducible serine kinase activity with CD5. J Immunol 151:4423, 1993.
  pubmed

• 5) Antin JH, Emerson SG, Martin P, Gadol N, Ault KA:Leu-1+ (CD5+) Bcells. A major lymphoid subpopulation in human fetal spleen:phenotypic and functional studies. J Immunol 136:505, 1985.

• 6) Bergui L, Tesio L, Schena M, Riva M, Malavasi F, Schulz T, Marchisio PC, Caligaris-Cappio F:CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells. Eur J Immunol 18:89, 1988.

• 7) Beyers AD, Spruyt LL, Williams AF:Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci USA 89:2945, 1992.
  pubmed

• 8) Biancone L, Bowen MA, Lim A, Aruffo A, Andres G, Stamenkovic I:Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med 184:811, 1996.
  pubmed

• 9) Bierer BE, Burakoff SJ, Smith BR:A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation. Blood 73:1359, 1989.
  pubmed

• 10) Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S:CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274:1906, 1996.

• 11) Calvo J, Sole J, Simarro M, Vives J, Lozano F:Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD5 gene. Tissue Antigens 47:257, 1996.
  pubmed

• 12) Ceuppens JL, Baroja ML:Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase bound OKT3. J Immzanol 137:1816, 1986.

• 13) Davies AA, Ley SC, Crumpton MJ:CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc Natl Acad Sci USA 89:6368,1992.

• 14) Dennehy KM, Broszeit R, Garnett D, Durrheim GA, Spruyt LL, Beyers AD:Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur. J Immunol 27:679, 1997.
  pubmed

• 15) Gary-Gouy H, Lang V, Sarun S, Boumsell L, Bismuth G:In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+thymocytes. J Immunol 159:3739, 1997.
  pubmed

• 16) Jones NH, Clabby ML, Dialynas DP, Huang HJ, Herzenberg LA, Strominger JL:Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 323:346, 1986.
  pubmed

• 17) Lankester AC, van Schijndel GM, Cordell JL, van Noesel CJ, van Lier RA:CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 24:812, 1994.

• 18) Ledbetter JA, Parsons M, Martin PJ, Hansen JA, Rabinovitch PS, June CH:Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules:effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol 137:3299, 1986.
  pubmed

• 19) Nishimura Y, Bierer BE, Burakoff SJ:Expression of CD5 regulates responsiveness to IL-1. J Immunol 141:3438, 1988.
  pubmed

• 20) Raab M, Yamamoto M, Rudd CE:The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p561ck. Mol Cell Biol 14:2862, 1994.

• 21) Reinherz EL, Kung PC, Goldstein G, Schlossman SF:Amonoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312, 1979.

• 22) Simarro M, Pelassy C, Calvo J, Places L, Aussel C, Lozano F:The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and-independent diacylglycerol production. J Immunol 159:4307, 1997.
  pubmed

• 23) Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Muller W, Killeen N, Rajewsky K:Arole for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535, 1995.

• 24) Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K:The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351:662, 1991.

• 25) Vandenberghe P, Ceuppens JL:Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth:evidence for signal transduction through CD5. Eur J Immunol 21:251, 1991.
  pubmed

P.64 掲載の参考文献

• 1) Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA, Bajorath J:CD6-ligand interac-tions:aparadigm for SRCR domain function? Immunol Today 18:498, 1997.

• 2) Aruffo A, Melnick MB, Linsley PS, Seed B:The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J Exp Med 174:949, 1991.
  pubmed

• 3) Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, et al:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181:2213, 1995.

• 4) Bowen MA, Whitney GS, Neubauer M, Starling GC, Palmer D, Zhang J, Nowak NJ, Shows TB, Aruffo A:Structure and chromosomal location of the human CD6 gene:detection of five human CD6 isoforms. J Immunol 158:1149, 1997.
  pubmed

• 5) Gangemi RM, Swack JA, Gaviria DM, Romain PL:Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. J Immunol 143:2439, 1989.

• 6) Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A, Haynes BF:Identification and characterization of a 100-kD Iigand for CD6 on human thymic epithelial cells. J Exp Med 181:1563, 1995.

• 7) Robinson WH, Neuman de Vegvar HE, Prohaska SS, Rhee JW, Parnes JR:Human CD6 possesses a large, alternatively spliced cytoplasmic domain. Eur J Immunol 25:2765, 1995.
  pubmed

• 8) Starling GC, Whitney GS, Siadak AW, Llewellyn MB, Bowen MA, Farr AG, Aruffo AA:Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur J Immunol 26:738, 1996.
  pubmed

• 9) Wee S, Wang WC, Farr AG, Nelson AJ, Patel DD, Haynes BF, Linsley PS, Aruffo A:Characterization of a CD6 ligand (s) expressed on human-and murine-derived cell lines and murine lymphoid tissues. Cell Immunol 158:353, 1994.
  pubmed

• 10) Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A:The membrane-proximalscavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J Biol Chem 270:18187, 1995.
  pubmed

P.66 掲載の参考文献

• 1) Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC:Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem 275 (5):3431-3437, 2000.

• 2) Slentz-Kesler KA, Hale LP, Kaufman RE:Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 47 (3):327-340, 1998.
  pubmed

• 3) Lee DM, Schanberg LE, Fleenor DE, Seldin MF, Haynes BF, Kaufman RE:The mouse CD7 gene:identification of a new element common to the human CD7 and mouse Thy-1 promoters. Immunogenetics 44 (2):108-114, 1996.

• 4) Aruffo A, Seed B:Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J 6 (11):3313-3316, 1987.
  pubmed

• 5) Osada S, Utsumi KR, Ueda R, Akao Y, Tsuge I, Nishida K, Okada J, Matsuoka H, Takahashi T:Assignment of a gene coding for a human T-cell antigen with a molecular weight of 40,000 daltons to chromosome 17. Cytogenet Cell Genet 47 (1-2):8-10, 1988.

• 6) Ware RE, Scearce RM, Dietz MA, Starmer CF, Palker TJ, Haynes BF:Characterization of the surface topography and putative tertiary structure of the human CD7 molecule. J Immunol 143 (11):3632-3640, 1989.
  pubmed

• 7) Yoshikawa K, Seto M, Ueda R, Obata Y, Notake K, Yokochi T, Takahashi T:Molecular cloning of the gene coding for the human T cell differentiation antigen CD7. Immunogenetics 33 (5-6):352-360, 1991.

• 8) Schanberg LE, Fleenor DE, Kurtzberg J, Haynes BF, Kaufman RE:Isolation and characterization of the genomic human CD7 gene:structural similarity with the murine Thy-1 gene. Proc Natl Acad Sci USA 88 (2):603-607, 1991.
  pubmed

• 9) Baker E, Sandrin MS, Garson OM, Sutherland GR, McKenzie IF, Webber LM:Localization of the cell surface antigen CD7 by chromosomal in situ hybridization. Immunogenetics 31 (5-6):412-413, 1990.

P.68 掲載の参考文献

• 1) Kieffer LJ, Greally JM, Landres I, Nag S, Nakajima Y, Kohwi-Shigematsu T, Kavathas PB:Identifica-tion of a candidate regulatory region in the human CD8 gene complex by colocalization of DNase I hypersensitive sites and matrix attachment regions which bind SATB1 and GATA-3. J Immunol 168 (8):3915-3922, 2002.

• 1) Kieffer LJ, Greally JM, Landres I, Nag S, Nakajima Y, Kohwi-Shigematsu T, Kavathas PB:Identifica-tion of a candidate regulatory region in the human CD8 gene complex by colocalization of DNase I hypersensitive sites and matrix attachment regions which bind SATB1 and GATA-3. J Immunol 168 (8):3915-3922, 2002.

• 2) Sukhatme VP, Sizer KC, Vollmer AC, Hunkapiller T, Parnes JR:The T cell differentiation antigen Leu-2/T8 is homologous to immunoglobulin and T cell receptor variable regions. Cell 40 (3):591-597, 1985.

• 2) DiSanto JP, Smith D, de Bruin D, Lacy E, Flomenberg N:Transcriptional diversity at the duplicated human CD8 beta loci. Eur J Immunol 23 (2):320-326, 1993.
  pubmed

• 3) Tunnacliffe A, Kefford R, Milstein C, Forster A, Rabbitts TH:Sequence and evolution of the human T-cell antigen receptor beta-chain genes. Proc Natl Acad Sci USA 82 (15):5068-5072, 1985.

• 3) Littman DR, Thomas Y, Maddon PJ, Chess L, Axel R:The isolation and sequence of the gene encoding T8:amolecule defining functional classes of T lymphocytes. Cell 40 (2):237-246, 1985.

• 4) Nakayama K, Tokito S, Okumura K, Nakauchi H:Structure and expression of the gene encoding CD8 alpha chain (Leu-2/T8). Immunogenetics 30 (5):393-397, 1989.
  pubmed

• 4) Shiue L, Gorman SD, Parnes JR:Asecond chain of human CD8 is expressed on peripheral blood lymphocytes. J Exp Med 168 (6):1993-2005, 1988.

• 5) Norment AM, Lonberg N, Lacy E, Littman DR:Alternatively spliced mRNA encodes a secreted form of human CD8 alpha. Characterization of the human CD8 alpha gene. J Immunol 142 (9):3312-3319, 1989.

• 5) DiSanto JP, Knowles RW, Flomenberg N:The human Lyt-3 molecule requires CD8 for cell surface expression. EMBO J 7 (11):3465-3470, 1988.
  pubmed

• 6) Nakayama K, Kawachi Y, Tokito S, Minami N, Yamamoto R, Imai T, Gachelin G, Nakauchi H:Recent duplication of the two human CD8 beta-chain genes. J Immunol 148 (6):1919-1927, 1992.

• 6) Norment AM, Littman DR:A second subunit of CD8 is expressed in human T cells. EMBO J 7 (11):3433-3439, 1988.

• 7) Giblin P, Ledbetter JA, Kavathas P:Asecreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing. Proc Natl Acad Sci USA 86 (3):998-1002, 1989.

• 8) Nakayama K, Kawachi Y, Tokito S, Minami N, Yamamoto R, Imai T, Gachelin G, Nakauchi H:Recent duplication of the two human CD8 beta-chain genes. J Immunol 148 (6):1919-1927, 1992.

P.70 掲載の参考文献

• 1) Rubinstein E, Boucheix C, Worthington RE, Carroll RC:Anti-platelet antibody interactions with Fc gamma receptor. Semin Thromb Hemost 21:10, 1995.
  pubmed

• 2) Wright MD, Tomlinson MG:The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588, 1994.
  pubmed

• 3) Berditchevski F, Zutter MM, Hemler ME:Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 7:193, 1996.
  pubmed

• 4) Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J, Uzan G:Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem 266:117, 1991.
  pubmed

• 5) Ikeyama S, Koyama M, Yamaoka M, Sasada R, Miyake M:Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177:1231, 1993.

• 6) Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E:Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 13:2322, 1994.
  pubmed

• 7) Lanza F, Wolf D, Fox CF, Kieffer N, Seyer JM, Fried VA, Coughlin SR, Phillips DR, Jennings LK:cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins. J Biol Chem 266:10638, 1991.
  pubmed

• 8) Le Naour F, Prenant M, Francastel C, Rubinstein E, Uzan G, Boucheix C:Transcriptional regulation of the human CD9 gene:characterization of the 5'-flanking region. Oncogene 13:481, 1996
  pubmed

• 9) Loffler S, Lottspeich F, Lanza F, Azorsa DO, ter Meulen V, Schneider-Schaulies J:CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol 71:42, 1997.

• 10) Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM, Burstein SA, Kincade PW:Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87:2252, 1996.
  pubmed

• 11) Rubinstein E, Le Naour F, Billard M, Prenant M, Boucheix C:CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol 24:3005, 1994.
  pubmed

• 12) Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C:CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 26:2657, 1996.
  pubmed

• 13) Seehafer JG, Tang SC, Slupsky JR, Shaw AR:The functional glycoprotein CD9 is variably acylated:localization of the variably acylated region to a membrane-associated peptide containing the binding site for the agonistic monoclonal antibody 50H.19. Biochim Biophys Acta 957:399, 1988.

• 14) Shaw AR, Domanska A, Mak A, Gilchrist A, Dobler K, Visser L, Poppema S, Fliegel L, Letarte M, Willett BJ:Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem 270:24092, 1995.

• 15) Tai XG, Yashiro Y, Abe R, Toyooka K, Wood CR, Morris J, Long A, Ono S, Kobayashi M, Hamaoka T, Neben S, Fujiwara H:Arole for CD9 molecules in T cell activation. J Exp Med 184:753, 1996.

• 16) Willett BJ, Hosie MJ, Jarrett O, Neil JC:Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 81:228, 1994.
  pubmed

P.72 掲載の参考文献

• 1) Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y, Mukai K:Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 33 (8):806-811, 2002.
  pubmed

• 2) Navarrete Santos A, Wulfanger J, Helbing G, Blosz T, Langner J, Riemann D:Two C-terminal cysteines are necessary for proper folding of the peptidase neprilysin/CD10. Biochem Biophys Res Commun 295 (2):423-427, 2002.
  pubmed

• 3) Cutrona G, Tasso P, Dono M, Roncella S, Ulivi M, Carpaneto EM, Fontana V, Comis M, Morabito F, Spinelli M, Frascella E, Boffa LC, Basso G, Pistoia V, Ferrarini M:CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer 86 (11):1776-1785, 2002.
  pubmed

• 4) Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K:Stromal expression of CD10 in invasive breast carcinoma:anew predictor of clinical outcome. Virchows Arch 440 (6):589-593, 2002.

• 5) Inguimbert N, Coric P, Poras H, Meudal H, Teffot F, Fournie-Zaluski MC, Roques BP:Toward an optimal joint recognition of the S1' subsites of endothelin converting enzyme-1 (ECE-1), angiotensin converting enzyme (ACE), and neutral endopeptidase (NEP). J Med Chem 45 (7):1477-1486, 2002.
  pubmed

• 6) Haouas H, Morello D, Lavenu A, Billard M, Jasmin C, Boucheix C:Characterization of the 5' region of the CD10/neutral endopeptidase 24.11 gene. Biochem Biophys Res Commun 207 (3):933-942, 1995.
  pubmed

• 7) Malfroy B, Kuang WJ, Seeburg PH, Mason AJ, Schofield PR:Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 229 (1):206-210, 1988.
  pubmed

• 8) Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J, Reinherz EL:Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci USA 85 (13):4819-4823, 1988.
  pubmed

• 9) D'Adamio L, Shipp MA, Masteller EL, Reinherz EL:Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11):multiple miniexons and separate 5' untranslated regions. Proc Natl Acad Sci USA 86 (18):7103-7107, 1989.
  pubmed

• 10) Shipp MA, Vijayaraghavan J, Schmidt EV, Masteller EL, D'Adamio L, Hersh LB, Reinherz EL:Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enke-phalinase"):direct evidence by cDNA transfection analysis. Proc Nlatl Acad Sci USA 86 (1):297-301, 1989.

• 11) Barker PE, Shipp MA, D'Adamio L, Masteller EL, Reinherz EL:The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27). J Immunol 142 (1):283-287, 1989.
  pubmed

• 12) Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinherz EL:CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88 (23):10662-10666, 1991.
  pubmed

P.75 掲載の参考文献

• 1) Bergelson JM, Hemler ME:Integrin-ligand binding. Do integrins use a 'MIDAS touch' to grasp an Asp? Curr Biol 5:615, 1995.
  pubmed

• 2) Hogg N, Landis RC, Bates PA, Stanley P, Randi AM:The sticking point:how integrins bind to their ligands. Trends Cell Biol 4:379-382, 1994.

• 3) Lub M, van Kooyk Y, Figdor CG:Ins and outs of LFA-1. Immunol Today 16:479, 1995.
  pubmed

• 4) Martz E:Leukocyte function-associated antigen one (LFA-1). Encyclopedia of Immunology, 2nd ed, (eds Ivan M Roitt, Peter J Delves), Academic Press, London, 1997.

• 5) Parsons JT:Integrin-mediated signalling:regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 8:146, 1996.
  pubmed

• 6) Petty HR, Todd RF 3d:Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996.

• 7) Sanchez-Mateos P, Cabanas C, Sanchez-Madrid F:Regulation of integrin function. Semin Cancer Biol 7:99, 1996.

• 8) Springer TA:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76:301, 1994.
  pubmed

• 9) Stewart M, Thiel M, Hogg N:Leukocyte integrins. Curr Opin Cell Biol 7:690, 1995.
  pubmed

• 10) Dustin ML, Springer TA:T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619, 1989.
  pubmed

• 11) Larson RS, Corbi AL, Berman L, Springer T:Primary structure of the leukocyte function-associated molecule-1 alpha subunit:an integrin with an embedded domain defining a protein superfamily.J Cell Biol 108:703, 1989.
  pubmed

• 12) Lee JO, Bankston LA, Arnaout MA and Liddington RC:Two conformations of the integrin A-domain (I-domain):apathway for activation? Strncture 3:1333, 1995.

• 13) Qu A, Leahy DJ:Crystal structure of the I-domain from the CD11a/CD18 (LFA-I, alpha L beta 2) integrin. Proc Natl Acad Sci USA 92:10277, 1995.
  pubmed

• 14) Qu A, Leahy DJ:The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure 4:931, 1996.
  pubmed

• 15) Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJ, Duncan G, Wakeham A, Shahinian A, van der Heiden A, Bachmann MF, Ohashi PS, Mak TW, Hickstein DD:LFA-1-deficient mice show normal CTL responses to virus but fail to relect immunogenic tumor. J Exp Med 183:1415, 1996.

• 16) Springer TA:Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci USA 94:65, 1997.

P.78 掲載の参考文献

• 1) Arnaout MA:Leukocyte adhesion molecules deficiency:its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 114:145, 1990.
  pubmed

• 2) Petty HR, Todd RF:Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996.
  pubmed

• 3) Springer TA:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76:301, 1994.
  pubmed

• 4) Stewart M, Thiel M, Hogg N:Leukocyte integrins. Curr Opin Cell Biol 7:690, 1995.
  pubmed

• 5) Arnaout MA, Gupta SK, Pierce MW, Tenen DG:Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3). J Cell Biol 106:2153, 1988.
  pubmed

• 6) Corbi AL, Kishimoto TK, Miller LJ, Springer TA:The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem 263:12403, 1988.

• 7) Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN:A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis:ahomeostatic mechanism in inflammation. Immunity 5:653, 1996.
  pubmed

• 8) Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA:The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 120:1031, 1993.

• 9) Lee JO, Rieu P, Arnaout MA, Liddington R:Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80:631, 1995.
  pubmed

• 10) Michishita M, Videm V, Arnaout MA:A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 72:857, 1993.
  pubmed

• 11) Springer TA:Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci USA 94:65, 1997.

P.80 掲載の参考文献

• 1) Corbi AL:In 'Leukocyte Integrins:structure, expression and function'. Springer (Heidelberg, Ger-many)/RG. Landes (Gergetown, Texas) Ed, 1996.

• 2) Petty HR, Todd RF:Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996.
  pubmed

• 3) Springer TA:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76:301, 1994.
  pubmed

• 4) Stewart M, Thiel M, Hogg N:Leukocyte integrins. Curr Opin Cell Biol 7:690, 1995.
  pubmed

• 5) Corbi AL, Miller LJ, O'Connor K, Larson RS, Springer TA:cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p150, 95. EMBO J 6:4023, 1987.
  pubmed

• 6) Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN:A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis:a homeostatic mechanism in inflammation. Immunity 5:653, 1996.
  pubmed

• 7) Lopez-Rodriguez C, Chen HM, Tenen DG, Corbi AL:Identification of Sp1-binding sites in the CD11c (p150, 95 alpha) and CD11a (LFA-1 alpha) integrin subunit promoters and their involvement in the tissue-specific expression of CD11c. Eur J Immunol 25:3496, 1995.
  pubmed

• 8) Lopez-Rodriguez C, Kluin-Nelemans HC, Corbi AL:AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J Immunol 156:3780, 1996.

• 9) Noti JD, Reinemann BC, Petrus MN:Spl binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol 16:2940, 1996.

• 10) Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA:A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit:the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150, 95 molecule. J Exp Med 158:1785,1983.

• 11) Springer TA:Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci USA 94:65, 1997.

P.81 掲載の参考文献

• 1) Bernard A:In Leukocyte Typing, (eds Bernard A, et al), Springer-Verlag, Berlin, p82, 1984.

• 2) Knapp W:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, p781, 1989.

• 3) Marinov J, Koubek K, Stary J:Expression of CDw12 and CD17 cell surface antigens on leukemic cells from patients with blood malignancies. Folia Biol (Praha) 39:124, 1993.
  pubmed

• 4) Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J Jr:Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75:198, 1990.
  pubmed

• 5) Stain C, Stockinger H, Scharf M, Jager U, Gossinger H, Lechner K, Bettelheim P:Human blood basophils display a unique phenotype including activation linked membrane structures. Blood 70:1872, 1987.
  pubmed

• 6) van der Schoot CE, et al:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp868-876, 1989.

P.82 掲載の参考文献

• 1) Ashmun RA, Holmes KV, Shapiro LH, et al:In Leukocyte Typing III (ed771-774)

• 2) Larsen SL, Pedersen LO, Buus S, Stryhn A:Tcell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 184:183-189, 1996

• 3) Look AT, Ashmun RA, Shapiro LH, Peiper SC:Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 83:1299-1307, 1989.
  pubmed

• 4) Olsen J, Cowell GM, Konigshofer E, Danielsen EM, Moller J, Laustsen L, Hansen OC, Welinder KG, Engberg J, Hunziker W, et al:Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett 238:307-314, 1988.
  pubmed

• 5) Semenza G:Anchoring and biosynthesis of stalked brush border membrane proteins:glycosidases and peptidases of enterocytes and renal tubuli. Annu Rev Cell Biol 2:255-313, 1986.
  pubmed

• 6) Soderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Moller E:CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 67:6576-6585, 1993.
  pubmed

• 7) Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E:Cytomegalovirus-induced CD13-specific autoimmunity-a possible cause of chronic graft-vs-host disease. Transplantation 61:600-609, 1996.
  pubmed

• 8) Weber M, Uguccioni M, Baggiolini M, Clark-Lewis I, Dahinden CA:Deletion of the NH2-terminal residue converts monocyte chemotactic protein I from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 183:681-685, 1996.

• 9) Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV:Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422, 1992.
  pubmed

P.85 掲載の参考文献

• 1) Bazil V, Strominger JL:Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567, 1991.
  pubmed

• 2) Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger JL, Kostka W, Hilgert I:Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 16:1583, 1986.
  pubmed

• 3) Bufler P, Stiegler G, Schuchmann M, Hess S, Kruger C, Stelter F, Eckerskorn C, Schutt C, Engelmann H:Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 25:604, 1995.
  pubmed

• 4) Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ:Murine CD14 gene expression in vivo:extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 181:857, 1995.
  pubmed

• 5) Ferrero E, Goyert SM:Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucleic Acids Res 16:4173, 1988.
  pubmed

• 6) Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM:The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239:497, 1988.
  pubmed

• 7) Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattison AC:Biochemistry and expression of myelomonocytic antigens. J Immunol 137:3909, 1986.
  pubmed

• 8) Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD:Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269, 1994.
  pubmed

• 9) Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM:The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141:547, 1988.

• 10) Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM:Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407, 1996.
  pubmed

• 11) Haziot A, Tsuberi BZ, Goyert SM:Neutrophil CD14:biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 150:5556, 1993.
  pubmed

• 12) Haziot A, Katz I, Jiao D, Rong G-W, Goyert SM:Functional epitopes of CD14. White cell differentiation antigens. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp782-784, 1995.

• 13) Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P:Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 23:2144, 1993.
  pubmed

• 14) Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, Calandra T:Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 171:639, 1995.
  pubmed

• 15) Pugin J, Ulevitch RJ, Tobias PS:Activation of endothelial cells by endotoxin:direct versus indirect pathways and the role of CD14. Prog Clin Biol Res 392:369, 1994.

• 16) Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC:CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431, 1990.
  pubmed

• 17) Wurfel MM, Hailman E, Wright SD:Soluble CD14 acts as a shuttle in the neutralization of lipopolysac-charide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181:1743, 1995.

• 18) Yu B, Hailman E, Wright SD:Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.J Clin Invest 99:315, 1997.
  pubmed

P.87 掲載の参考文献

• 1) Liu Y, Zhu X, Zhuang H, Lin H, Wu Q, Jiang G, Gu Y, Luo D, Luo X:Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma. Zhonghua Bing Li Xue Za Zhi 31 (3):227-230, 2002.

• 2) Richmond LJ, Alcorn MJ, Pearson C, Cameron G, Thomas T, Eaves CJ, Eaves AC, Holyoake TL:CML leukapheresis products can be enriched for CD34 (+) cells and simultaneously depleted of CD15 (+) cells using a simple Ab cocktail. Cytotherapy 4 (5):407-413, 2002.
  pubmed

• 3) Parrens M, Vergier B, Fitoussi O, Lahet C, Belleannee G, Marit G, Dubus P, De Mascarel A, Delfau-Larue MH, Merlio JP:Sequential Development of Hodgkin's Disease and CD30+Diffuse Large B-Cell Lymphoma in a Patient With MALT-Type Lymphoma:Evidence of Different Clonal Origin of Single Microdissected Reed-Sternberg Cells. Am J Surg Pathol 26 (12):1634-1642, 2002.

• 4) Marchini G, Lonne-Rahm S, Agerberth B, Gudmundsson GH:The newborn infant is protected by an innate antimicrobial barrier:peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol 147 (6):1127-1134, 2002.
  pubmed

• 5) Reyes-Botella C, Montes MJ, Vallecillo-Capilla MF, Olivares EG, Ruiz C:Antigenic phenotype of cultured human osteoblast-like cells. Cell Physiol Biochem 12 (5-6):359-364, 2002.

• 6) Paquet P, Pierard GE:Differential pathomechanisms of epidermal necrolytic blistering diseases. Int J Mol Med 10 (6):695-699, 2002.
  pubmed

• 7) Aldinucci D, Poletto D, Nanni P, Degan M, Rupolo M, Pinto A, Gattei V:CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts. Exp Hematol 30 (11):1283-1292, 2002.
  pubmed

• 8) Cavazza A, Rossi G, Agostini L, Facciolongo N, De Marco L, Putrino I, Gardini G:Mesotelioma a piccole cellule della pleura:descrizione di un caso. Pathologica 94 (5):247-252, 2002. (Italian)
  pubmed

• 9) Zu Y, Gangi MD, Yang GC:Ultrafast Papanicolaou stain and cell-transfer technique enhance cytologic diagnosis of Hodgkin lymphoma. Diagn Cytopathol 27 (5):308-311, 2002.
  pubmed

• 10) Lim MS, Beaty M, Sorbara L, Cheng RZ, Pittaluga S, Raffeld M, Jaffe ES:T-cell/histiocyte-rich large B-cell lymphoma:aheterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 26 (11):1458-1466, 2002.

• 11) Laack E, Nikbakht H, Peters A, Kugler C, Jasiewicz Y, Edler L, Brummer J, Schumacher U, Hossfeld DK:Expression of CEACAM1 in adenocarcinoma of the lung:a factor of independent prognostic significance. J Clin Oncol 20 (21):4279-4284, 2002.
  pubmed

• 12) Naranjo TA, Matutes El E, Martinez JJ, Font Ferre L, Domingo A, Princep RB, Usach TS:Prolymphocytic leukaemia and Hodgkin's lymphoma. Eur J Haematol 69 (3):182-184, 2002.
  pubmed

• 13) Mata-Greenwood E, Cuendet M, Sher D, Gustin D, Stock W, Pezzuto JM:Brusatol-mediated induction of leukemic cell differentiation and G (1) arrest is associated with down-regulation of c-myc. Leukemia 16 (11):2275-2284, 2002.

• 14) Hedvat CV, Hegde A, Chaganti RS, Chen B, Qin J, Filippa DA, Nimer SD, Teruya-Feldstein J:Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum Pathol 33 (10):968-974, 2002.

• 15) Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O, Iwakiri R, Hayashi T, Sakamaki H, Murai Y, Tohyama K, Tomoyasu S, Nonaka Y, Mori M, Dan K, Yoshida Y:Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 (12):3887-3896, 2002.
  pubmed

• 16) Januszkiewicz A, Lore K, Essen P, Andersson B, McNurlan MA, Garlick PJ, Ringden O, Andersson J, Wernerman J:Response of in vivo protein synthesis in T lymphocytes and leucocytes to an endotoxin challenge in healthy volunteers. Clin Exp Immunol 130 (2):263-270, 2002.

• 17) Reiman T, Clarke ML, Dabbagh L, Vsianska M, Coupland RW, Belch AR, Baldwin SA, Young JD, Cass CE, Mackey JR:Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leuk Lymphoma 43 (7):1435-1440, 2002.
  pubmed

• 18) Gervasi MT, Chaiworapongsa T, Naccasha N, Pacora P, Berman S, Maymon E, Kim JC, Kim YM, Yoshimatsu J, Espinoza J, Romero R:Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 11 (3):171-175, 2002.
  pubmed

• 19) Heller DS, Haefner HK, Hameed M, Lieberman RW:Vulvar hidradenitis suppurativa. Immunohisto-chemical evaluation of apocrine and eccrine involvement. J Reprod Med 47 (9):695-700, 2002.

• 20) Cheng G, Marotte LR, Mai JK, Ashwell KW:Early development of the hypothalamus of a wallaby (Macropus eugenii). J Comp Neurol 453 (2):199-215, 2002.
  pubmed

P.90 掲載の参考文献

• 1) Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M:Cell activation and cellular-cellular interactions during hemodialysis:effect of dialyzer membrane. Int J Artif Organs 25 (6):529-537, 2002.
  pubmed

• 2) Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W, Reymond MA:Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103 (1):68-78, 2002.
  pubmed

• 3) Suzuki A, Yamakawa M, Tsukamoto M:The adhesion molecules, 1-selectin and sialyl lewis x, relate to the formation of the follicular dendritic cell-lymphocyte cluster in the mantle zone. Immunol Lett 79 (3):181-187, 2001.

• 4) Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V:Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 38 (3):394-398, 2001.
  pubmed

• 5) Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S, Reinhold U:CD4 (+) CD7 (-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome. J Am Acad Dermatol 44 (3):456-461, 2001.
  pubmed

• 6) Stammberger U, Hamacher J, Hillinger S, Schmid RA:sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation. J Thorac Cardiovasc Surg 120 (6):1078-1084, 2000.
  pubmed

• 7) Ishida H, Koyama I, Sawada T, Murakami T, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S, Toma H, Agishi T:Sialyl Lewis (x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation:CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantation. Transplantation 69 (10):2208-2211, 2000.
  pubmed

• 8) Obayashi Y, Fujita J, Nishiyama T, Yoshinouchi T, Kamei.T, Yamadori I, Hojo S, Ohtsuki Y, Hirashima M, Takahara J:Role of carbohydrate antigens sialyl Lewis (a) (CA19-9) in bronchoalveolar Iavage in patients with pulmonary fibrosis. Respiration 67 (2):146-152, 2000.
  pubmed

• 9) Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T:Clinical utility of monitoring sialyl Lewis (x) (CD15s) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation. Transplant Proc 32 (2):265-268, 2000. (No abstract available)

• 10) Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T:Clinical utility of monitoring sialyl Lewis (X) (CD15S) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation. Transplantation 69 (1):59-63, 2000.
  pubmed

• 11) Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T:Monitoring sialyl lewis x (CD15s) on peripheral lymphocytes for the diagnosis of acute rejection. Nephrol Dial Transplant 15 (2):286-287, 2000. (No abstract available)

• 12) Wimazal F, Ghannadan M, Muller MR, End A, Willheim M, Meidlinger P, Schernthaner GH, Jordan JH, Hagen W, Agis H, Sperr WR, Czerwenka K, Lechner K, Valent P:Expression of homing receptors and related molecules on human mast cells and basophils:a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques. Tissue Antigens 54 (5):499-507, 1999.
  pubmed

• 13) Sirolli V, Ballone E, Amoroso L, Di Liberato L, Di Mascio R, Capelli P, Albertazzi A, Bonomini M:Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis:effects of different synthetic membranes. Int J Artif Organs 22 (8):536-542, 1999.
  pubmed

• 14) Koller M, Aringer M, Kiener H, Erlacher L, Machold K, Eberl G, Studnicka-Benke A, Graninger W, Smolen J:Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis. Ann Rheum Dis 58 (11):709-712, 1999.
  pubmed

• 15) Scala E, Russo G, Cadoni S, Narducci MG, Girardelli CR, De Pita O, Puddu P:Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7-T helper lymphocytes expansion. J Invest Dermatol 113 (4):622-627, 1999.
  pubmed

• 16) Bonomini M, Sirolli V, Settefrati N, Stuard S, Tropea F, Di Liberato L, Tetta C, Albertazzi A:Surface antigen expression and platelet neutrophil interactions in haemodialysis. Blood Purif 17 (2-3):107-117, 1999.

• 17) Weston BW, Hiller KM, Mayben JP, Manousos G, Nelson CM, Klein MB, Goodman JL:A cloned CD15s-negative variant of HL60 cells is deficient in expression of FUT7 and does not adhere to cytokine-stimulated endothelial cells. Eur J Haematol 63 (1):42-49, 1999.

• 18) Chute JP, Saini AA, Kampen RL, Wells MR, Davis TA:A comparative study of the cell cycle status and primitive cell adhesion molecule profile of human CD34+cells cultured in stroma-free versus porcine microvascular endothelial cell cultures. Exp Hematol 27 (2):370-379, 1999.
  pubmed

• 19) Kwiatkowski P, Artrip JH, Edwards NM, Lietz K, Tugulea S, Michler RE, McKenzie IF, Sandrin MS, Itescu S:High-level porcine endothelial cell expression of alpha (1, 2)-fucosyltransferase reduces human monocyte adhesion and activation. Transplantation 67 (2):219-226, 1999. (discussion 193-194)

• 20) Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW:Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest 103 (3):407-412, 1999.
  pubmed

P.92 掲載の参考文献

• 1) Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG:Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc gamma R III and anti body-dependent cellular toxicity. J Biol Chem 277 (30):26733-26740, 2002.

• 2) Heusohn F, Wirries G, Schmidt RE, Gessner JE:The Pmed1 gene promoter of human Fc gamma R IIIA can function as a NK/T cell-specific restriction element, which involves binding of Spl transcription factor. J Immunol 168 (6):2857-2864, 2002.

• 3) Gessner JE, Grussenmeyer T, Dumbsky M, Schmidt RE:Separate promoters from proximal and medial control regions contribute to the natural killer cell-specific transcription of the human Fc gamma R III-A (CD16-A) receptor gene. J Biol Chem 271 (48):30755-30764, 1996.

• 4) Gessner JE, Grussenmeyer T, Kolanus W, Schmidt RE:The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J Biol Chem 270 (3):1350-1361, 1995.

• 5) Morcos M, Hansch GM, Schonermark M, Ellwanger S, Harle M, Heckl-Ostreicher B:Human glomerular mesangial cells express CD16 and may be stimulated via this receptor. Kidney Int 46 (6):1627-1634, 1994.
  pubmed

• 6) Simmons D, Seed B:The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 333 (6173):568-570, 1988.
  pubmed

• 7) Ravetch JV, Perussia B:Alternative membrane forms of Fc gamma R III (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 170 (2):481-497, 1989.
  pubmed

• 8) Scallon BJ, Scigliano E, Freedman VH, Miedel MC, Pan YC, Unkeless JC, Kochan JP:A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinostol-glycan-an-chored forms. Proc Natl Acad Sci USA 86 (13):5079-5083, 1989.

• 9) Peltz GA, Grundy HO, Lebo RV, Yssel H, Barsh GS, Moore KW:Human Fc gamma R III:cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc Natl Acad Sci USA 86 (3):1013-1017, 1989.

• 10) Le Coniat M, Kinet JP, Berger R:The human genes for the alpha and gamma subunits of the mast cell receptor for immunoglobulin E are located on human chromosome band 1q23. Immunogenetics 32 (3):183-186, 1990.
  pubmed

• 11) Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV:Organization of the human and mouse low-affinity Fc gamma R genes:duplication and recombination. Science 248 (4956):732-735, 1990.
  pubmed

• 12) Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF:Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 87 (6):2274-2278, 1990.
  pubmed

P.94 掲載の参考文献

• 1) Fossati G, Moots RJ, Bucknall RC, Edwards SW:Differential role of neutrophil Fcgamma receptor III B (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum 46 (5):1351-1361, 2002.

• 2) Davoine F, Lavigne S, Chakir J, Ferland C, Boulay ME, Laviolette M:Expression of Fc gamma R III (CD16) on human peripheral blood eosinophils increases in allergic conditions. J Allergy Clin Immunol 109 (3):463-469, 2002.

• 3) Gessner JE, Grussenmeyer T, Dumbsky M, Schmidt RE:Separate promoters from proximal and medial control regions contribute to the natural killer cell-specific transcription of the human Fc gamma R III-A (CD16-A) receptor gene. J Biol Chem 271 (48):30755-30764, 1996.

• 4) Gessner JE, Grussenmeyer T, Kolanus W, Schmidt RE:The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J Biol Chem 270 (3):1350-1361, 1995.

• 5) Ravetch JV, Perussia B:Alternative membrane forms of Fc gamma Rm (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitu-tions. J Exp Med 170 (2):481-497, 1989.

• 6) Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV:Organization of the human and mouse low-affinity Fc gamma R genes:duplication and recombination. Science 248 (4956):732-735, 1990.
  pubmed

P.96 掲載の参考文献

• 1) Iwabuchi K, Nagaoka I:Cellular functions and signal transduction through glycosignaling domain:lactosylceramide mediated superoxide generation from neutrophils. Tanpakushitsu Kakusan Koso 47 (4 Suppl):357-364, 2002. (Japanese)

• 2) Inokuchi J, Kabayama K, Uemura S, Igarashi Y:Biological significance of lactosylceramide branching and domain formation:glycosphingolipids govern gene expression. Tanpakushitsu Kakusan Koso 47 (4 Suppl):371-378, 2002. (Japanese)

• 3) Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH:Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide mediated mechanism. J Biol Chem 278 (3):2043-2050, 2003.

• 4) Eto Y, Meier C, Herschkowitz NN:Chemical compositions of brain and myelin in two patients with multiple sulphatase deficiency (a variant form of metachromatic leukodystrophy). J Neurochem 27 (5):1071-1076, 1976.
  pubmed

• 5) Iwabuchi K, Nagaoka I:Lactosylceramide-enriched glycosphingolipid signaling domain mediates super-oxide generation from human neutrophils. Blood 100 (4):1454-1464, 2002.

• 6) Plo I, Lehne G, Beckstrom KJ, Maestre N, Bettaieb A, Laurent G, Lautier D:Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KGIa cells. Mol Pharmacol 62 (2):304-312, 2002.

• 7) Choudhury A, Dominguez M, Puri V, Sharma DK, Narita K, Wheatley CL, Marks DL, Pagano RE:Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J Clin Invest 109 (12):1541-1550, 2002.

• 8) Veldman RJ, Klappe K, Hinrichs J, Hummel I, van der Schaaf G, Sietsma H, Kok JW:Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J 16 (9):1111-1113, 2002.
  pubmed

• 9) Yokohama A, Tsukamoto N, Hatsumi N, Suto M, Akiba T, Uchiumi H, Maehara T, Matsushima T, Karasawa M, Murakami H, Shinonome S, Saito H, Nojima Y:Acute basophilic leukemia lacking basophil-specific antigens:the importance of cytokine receptor expression in differential diagnosis. Int J Hematol 75 (3):309-313, 2002.
  pubmed

• 10) Hahn PY, Limper AH:Pneumocystis carinii beta-glucan induces release of macrophage inflammatory protein-2 from primary rat alveolar epithelial cells via a receptor distinct from CD11b/CD18. J Eukaryot Microbiol (Suppl):157S, 2001.

• 11) Conboy JC, McReynolds KD, Gervay-Hague J, Saavedra SS:Quantitative measurements of recom-binant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers. J Am Chem Soc 124 (6):968-977, 2002.

• 12) Whitfield PD, Nelson P, Sharp PC, Bindloss CA, Dean C, Ravenscroft EM, Fong BA, Fietz MJ, Hopwood JJ, Meikle PJ:Correlation among genotype, phenotype, and biochemical markers in Gaucher disease:implications for the prediction of disease severity. Mol Genet Metab 75 (1):46-55, 2002.
  pubmed

• 13) Yeh LH, Kinsey AM, Chatterjee S, Alevriadou BR:Lactosylceramide mediates shear-induced endo-thelial superoxide production and intercellular adhesion molecule-1 expression. J Vasc Res 38 (6):551-559, 2001.

• 14) Iwamoto T, Fukumoto S, Kanaoka K, Sakai E, Shibata M, Fukumoto E, Inokuchi J, Takamiya K, Furukawa K, Kato Y, Mizuno A:Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-kappa B ligand. J Biol Chem 276 (49):46031-46038, 2001.

• 15) Puri V, Watanabe R, Singh RD, Dominguez M, Brown JC, Wheatley CL, Marks DL, Pagano RE:Clathrin-dependent and-independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J Cell Biol 154 (3):535-547, 2001.
  pubmed

• 16) Kabayama K, Ito N, Honke K, Igarashi Y, Inokuchi J:Suppression of integrin expression and tumor-genicity by sulfation of lactosylceramide in 3LL Lewis lung carcinoma cells. J Biol Chem 276 (29):26777-26783, 2001.

• 17) Sun X, Marks DL, Park WD, Wheatley CL, Puri V, O'Brien JF, Kraft DL, Lundquist PA, Patterson MC, Pagano RE, Snow K:Niemann-Pick C variant detection by altered sphingolipid trafficking and correla-tion with mutations within a specific domain of NPC1. Am J Hum Genet 68 (6):1361-1372, 2001.

• 18) Hulkova H, Cervenkova M, Ledvinova J, Tochackova M, Hrebicek M, Poupetova H, Befekadu A, Berna L, Paton BC, Harzer K, Boor A, Smid F, Elleder M:A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 10 (9):927-940, 2001.
  pubmed

• 19) Ardail D, Popa I, Alcantara K, Pons A, Zanetta JP, Louisot P, Thomas L, Portoukalian J:Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria. FEBS Lett 488 (3):160-164, 2001.
  pubmed

• 20) Ciopraga J, Angstrom J, Bergstrom J, Larsson T, Karlsson N, Motas C, Gozia O, Teneberg S:Isolectins from Solanum tuberosum with different detailed carbohydrate binding specificities:unexpected recogni-tion of lactosylceramide by N-acetyllactosamine-binding lectins. J Biochem (Tokyo) 128 (5):855-867, 2000.

• 21) Symington FW:CDw17:aneutrophil glycolipid antigen regulated by activation. J Immunol 142:2784, 1989.

• 22) Symington FW, Bernstein ID, Hakomori S:Monoclonal antibody specific for lactosylceramide. J Biol Chem 259:6008, 1984.
  pubmed

• 23) Willheim M, Agis H, Sperr WR, Koller M, Bankl HC, Kiener H, Fritsch G, Fureder W, Spittler A, Graninger W, et al:Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit. J Immunol Methods 182:115, 1995.

P.99 掲載の参考文献

• 1) Anderson DC, Springer TA:Leukocyte adhesion deficiency:an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Annu Rev Med 38:175, 1987.
  pubmed

• 2) Springer TA:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76:301, 1994.
  pubmed

• 3) Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA:Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150, 95 g1ycoproteins cause leukocyte adhesion deficiency. Cell 50:193, 1987.

• 4) Kishimoto TK, O'Connor K, Lee A, Roberts TM, Springer TA:Cloning of the beta subunit of the leukocyte adhesion proteins:homology to an extracellular matrix receptor defines a novel supergene family. Cell 48:681, 1987.

• 5) Law SK, Gagnon J, Hildreth JE, Wells CE, Willis AC, Wong AJ:The primary structure of the beta-subunit of the cell surface adhesion glycoproteins LFA-1, CR3 and p150, 95 and its relationship to the fibronectin receptor. EMBO J 6:915, 1987.

• 6) Weitzman JB, Wells CE, Wright AH, Clark PA, Law SK:The gene organisation of the human beta 2 integrin subunit (CD18). FEBS Lett 294:97, 1991.
  pubmed

• 7) Wilson RW, Ballantyne CM, Smith CW, Montgomery C, Bradley A, O'Brien WE, Beaudet AL:Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol 151:1571, 1993.

P.101 掲載の参考文献

• 1) Tedder TF, Zhou LJ, Engel P:The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 15:437, 1994
  pubmed

• 2) Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841, 1992.

• 3) Carter RH, Fearon DT:CD19:lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105, 1992.

• 4) Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT:The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol 147:3663, 1991.
  pubmed

• 5) Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF:Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39, 1995.
  pubmed

• 6) Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT:Intersection of the complement and immune systems:a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173:55, 1991.

• 7) Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF:B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 131:244, 1983.

• 8) Pezzutto A, Dorken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA:CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol 138:2793, 1987.

• 9) Rickert RC, Rajewsky K, Roes J:Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352, 1995.

• 10) Sato S, Steeber DA, Tedder TF:The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92:11558, 1995.
  pubmed

• 11) Steeber DA, Green NE, Sato S, Tedder TF:Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol 157:1096, 1996.

• 12) Tedder TF, Isaacs CM:Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 143:712, 1989.
  pubmed

• 13) Tuveson DA, Carter RH, Soltoff SP, Fearon DT:CD190f B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986, 1993.
  pubmed

• 14) Weng WK, Jarvis L, LeBien TW:Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 269:32514, 1994.

• 15) Zhou LJ, Smith HM, Waldschmidt TJ, Schwarting R, Daley J, Tedder TF:Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol Cell Biol 14:3884, 1994.
  pubmed

P.103 掲載の参考文献

• 1) Kanzaki M, Lindorfer MA, Garrison JC, Kojima I:Activation of the calcium-permeable cation channel CD20 by alpha subunits of the Gi protein. J Biol Chem 272 (23):14733-14739, 1997.

• 2) Szepetowski P, Perucca-Lostanlen D, Gaudray P:Mapping genes according to their amplification status in tumor cells:contribution to the map of 11q13. Genomics 16 (3):745-750, 1993.

• 3) Stamenkovic I, Seed B:Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1, Bp35), a type III integral membrane protein. J Exp Med 167 (6):1975-1980, 1988.

• 4) Tedder TF, Klejman G, Schlossman SF, Saito H:Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J Immunol 142 (7):2560-2568, 1989.

• 5) Einfeld DA, Brown JP, Valentine MA, Clark EA, Ledbetter JA:Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 7 (3):711-717, 1988.

• 6) Tedder TF, Streuli M, Schlossman SF, Saito H:Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci USA 85 (1):208-212, 1988.

P.105 掲載の参考文献

• 1) Cooper NR, Moore MD, Nemerow GR:Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu Rev Immunol 6:85, 1988.

• 2) Fearon DT:The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. Curr Opin Immunol 5:341, 1993.
  pubmed

• 3) Carel JC, Myones BL, Frazier B, Holers VM:Structural requirements for C3d, g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem 265:12293, 1990.
  pubmed

• 4) Knowles DM 2d, Tolidjian B, Marboe CC, Mittler RS, Talle MA, Goldstein G:Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues. Blood 63:886, 1984.

• 5) Ling NR, Brown B, Hardie D:Synergy test for recognition of epitopes on soluble proteins;its application in the study of CD21 and CD23 antigens and their respective antibodies. J Immunol Methods 173:11, 1994.

• 6) Nadler LM, Stashenko P, Hardy R, van Agthoven A, Terhorst C, Schlossman SF:Characterization of a human B cell-specific antigen (B2) distinct from. J Immunol 126:1941, 1981.

• 7) Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Xu JW, Jones JF, Gelfand EW:Activation of human thymocytes after infection by EBV. J Immunol 154:1440, 1995.
  pubmed

• 8) Petzer AL, Schulz TF, Stauder R, Eigentler A, Myones BL, Dierich MP:Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion. Immunology 63:47, 1988.
  pubmed

• 9) Tedder TF, Clement LT, Cooper MD:Expression of C3d receptors during human B cell differentiation:immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133:678, 1984.

P.107 掲載の参考文献

• 1) Campbell MA, Klinman NR:Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase IC. Eur J Immunol 25:1573, 1995.

• 2) Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT:A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242, 1995.

• 3) Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM:HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136:4470, 1986.

• 4) Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF:The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunol 150:4719, 1993.

• 5) Engel P, Wagner N, Miller AS, Tedder TF:Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med 181:1581, 1995.
  pubmed

• 6) Law CL, Torres RM, Sundberg HA, Parkhouse RM, Brannan CI, Copeland NG, Jenkins NA, Clark EA:Organization of the murine CD22 locus. Mapping to chromosome 7 and characterization of two alleles. J Immunol 151:175, 1993.
  pubmed

• 7) Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA:CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci USA 90:3236, 1993.
  pubmed

• 8) Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC:CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7:133, 1997.
  pubmed

• 9) Powell LD, Varki A:1-type lectins. J Biol Chem 270:14243, 1995.

• 10) Stamenkovic I, Seed B:The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 345:74, 1990.

• 11) Tuscano JM, Engel P, Tedder TF, Agarwal A, Kehrl JH:Involvement of p72syk kinase, p53/561yn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur J Immunol 26:1246, 1996.

• 12) Wilson GL, Fox CH, Fauci AS, Kehrl JH:cDNA cloning of the B cell membrane protein CD22:a mediator of B-B cell interactions. J Exp Med 173:137, 1991.

• 13) Wilson GL, Najfeld V, Kozlow E, Menniger J, Ward D, Kehrl JH:Genomic structure and chromosomal mapping of the human CD22 gene. J Immunol 150:5013, 1993.

P.109 掲載の参考文献

• 1) Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M:The low-affinity receptor for IgE. Immunol Rev 125:77, 1992.
  pubmed

• 2) Lamers MC, Yu P:Regulation of IgE synthesis. Lessons from the study of IgE transgenic and CD23-deficient mice. Immunol Rev 148:71, 1995.

• 3) Ludin C, Hofstetter H, Sarfati M, Levy CA, Suter U, Alaimo D, Kilchherr E, Frost H, Delespesse G:Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor. EMBO J 6:109, 1987.
  pubmed

• 4) Kikutani H, Inui S, Sato R, Barsumian EL, Owaki H, Yamasaki K, Kaisho T, Uchibayashi N, Hardy RR, Hirano T, et al:Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell 47:657, 1986.
  pubmed

• 5) Flores-Romo L, Shields J, Humbert Y, Graber P, Aubry JP, Gauchat JF, Ayala G, Allet B, Chavez M, Bazin H, et al:Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261:1038, 1993.

• 6) Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY:CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505, 1992.
  pubmed

• 7) Armant M, Ishihara H, Rubio M:Delespesse G, Sarfati M:Regulation of cytokine production by soluble CD23:costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J Exp Med 180:1005, 1994.
  pubmed

• 8) Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, et al:CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3:119, 1995.
  pubmed

• 9) Plater-Zyberk C, Bonnefoy JY:Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat Med 1:781, 1995.
  pubmed

• 10) Yu P, Kosco-Vilbois M, Richards M, Kohler G, Lamers MC:Negative feedback regulation of IgE synthesis by murine CD23. Nature 369:753, 1994.

• 11) Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S, et al:The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 91:6835, 1994.
  pubmed

P.111 掲載の参考文献

• 1) Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P:CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89:3385, 1997.
  pubmed

• 2) Bruce J, Symington FW, McKearn TJ, Sprent J:Amonoclonal antibody discriminating between subsets of T and B cells. J Immunol 127:2496, 1981.

• 3) Chappel MS, Hough MR, Mittel A, Takei F, Kay R, Humphries RK:Cross-linking the murine heat-stable antigen induces apoptosis in B cell precursors and suppresses the anti-CD40-induced proliferation of mature resting B lymphocytes. J Exp Med 184:1638, 1996.

• 4) Fischer GF, Majdic O, Gadd S, Knapp W:Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol 144:638, 1990.
  pubmed

• 5) Hahne M, Wenger RH, Vestweber D, Nielsen PJ:The heat-stable antigen can alter very late antigen 4-mediated adhesion.J Exp Med 179:1391, 1994.
  pubmed

• 6) Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K:Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173:1213, 1991.

• 7) Hough MR, Chappel MS, Sauvageau G, Takei F, Kay R, Humphries RK:Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen. J Immunol 156:479, 1996.

• 8) Hough MR, Takei F, Humphries RK, Kay R:Defective development of thymocytes overexpressing the costimulatory molecule, heat-stable antigen. J Exp Med 179:177, 1994.
  pubmed

• 9) Jackson D, Waibel R, Weber E, Bell J, Stahel RA:CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res 52:5264, 1992.

• 10) Kadmon G, Eckert M, Sammar M, Schachner M, Altevogt P:Nectadrin, the heat-stable antigen, is a cell adhesion molecule. J Cell Biol 118:1245, 1992.
  pubmed

• 11) Kay R, Rosten PM, Humphries RK:CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 147:1412, 1991.

• 12) Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr:Heat-stable antigen is a co-stimulatory molecule for CD4 T cell growth. J Exp Med 175:437, 1992.

• 13) Sammar M, Aigner S, Hubbe M, Schirrmacher V, Schachner M, Vestweber D, Altevogt P:Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol 6:1027, 1994.
  pubmed

P.114 掲載の参考文献

• 1) Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Nakamura M, Takeshita T:The common gamma-chain for multiple cytokine receptors. Adv Immunol 59:225, 1995.
  pubmed

• 2) Tanaka Y, Tozawa H, Hayami M, Sugamura K, Hinuma Y:Distinct reactivities of four monoclonal antibodies with human interleukin 2 receptor. Microbiol Immunol 29:959, 1985.
  pubmed

• 3) Taniguchi T, Minami Y:The IL-2/IL-2 receptor system:acurrent overview. Cell 73:5, 1993.

• 4) Uchiyama T, Broder S, Waldmann TA:Amonoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells.1. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126:1393, 1981.

• 5) Uchiyama T, Nelson DL, Fleisher TA, Waldmann TA:Amonoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. ll. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol 126:1398, 1981.

• 6) Urdal DL, March CJ, Gillis S, Larsen A, Dower SK:Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line. Proc Natl Acad Sci USA 81:6481, 1984.

• 7) Waldmann TA:The interleukin-2 receptor. J Biol Chem 266:2681, 1991.
  pubmed

• 8) Cosman D, Cerretti DP, Larsen A, Park L, March C, Dower S, Gillis S, Urdal D:Cloning, sequence and expression of human interleukin-2 receptor. Nature 312:768, 1984.
  pubmed

• 9) Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldmann TA, et al:Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626, 1984.
  pubmed

• 10) Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T:Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311:631, 1984.
  pubmed

• 11) Uchiyama T, Broder S, Waldmann TA:Amonoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells.1. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126:1393, 1981.

P.116 掲載の参考文献

• 1) Morimoto C, Schlossman SF:CD26, a key costimulatory molecule on CD4 memory T cells. Immunologist 2:4, 1994.

• 2) Fleischer B:CD26:asurface protease involved in T-cell activation. Immunol Today 15:180, 1994.

• 3) Yaron A, Naider F:Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28:31, 1993.
  pubmed

• 4) Stein H, Schwarting R, Niedobitek G:In Leucocyte typing IV, (eds Knapp W, et al), Oxford University Press, p412, 1989.

• 5) Hegen M, Niedobitek G, Klein CE, Stein H, Fleischer B:The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 144:2908, 1990.

• 6) Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C:Cloning and functional expression of the T cell activation antigen CD26. J Immunol 149:481, 1992.

• 7) Hegen M, Camerini D, Fleischer B:Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell Immunol 146:249, 1993.

• 8) Abbott CA, Baker E, Sutherland GR, McCaughan GW:Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40:331, 1994.
  pubmed

• 9) Bohm SK, Gum JR Jr, Erickson RH, Hicks JW, Kim YS:Human dipeptidyl peptidase IV gene pro-moter:tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J 311:835, 1995.

• 10) Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C:Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466, 1993.

• 11) Bauvois B:Acollagen-binding glycoprotein on the surface of mouse fibroblasts is identified as di-peptidyl peptidase IV. Biochem J 252:723, 1988.

• 12) Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C:Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 147:2514, 1991.

• 13) Oravecz T, Roderiquez G, Koffi J, Wang J, Ditto M, Bou-Habib DC, Lusso P, Norcross MA:CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat Med 1:919, 1995.

• 14) Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C:Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156:1349, 1996.

P.118 掲載の参考文献

• 1) Hintzen RQ, de Jong R, Lens SM, van Lier RA:CD27:marker and mediator of T-cell activation? Immunol Today 15:307, 1994.
  pubmed

• 2) Akiba H, Nakano H, Nishinaka S, et al:CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappa B and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappa B-inducing kinase. J Biol Chem 273 (21):13353-13358, 1998.
  pubmed

• 3) Agematsu K, Kobata T, Sugita K, Hirose T, Schlossman SF, Morimoto C:Direct cellular communications between CD45RO and CD45RA T cell subsets via CD27/CD70. J Immunol 154:3627, 1995.
  pubmed

• 4) Bigler RD, Bushkin Y, Chiorazzi N:S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol 141:21, 1988.
  pubmed

• 5) Camerini D, Walz G, Loenen WA, Borst J, Seed B:The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 147:3165, 1991.

• 6) Gravestein LA, van Ewijk W, Ossendorp F, Borst J:CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development. J Exp Med 184:675, 1996.
  pubmed

• 7) Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF:CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses:enhancement of plasma cell differentiation by CD27 signaling. J Immunol 159:2652, 1997.

• 8) Kobata T, Agematsu K, Kameoka J, Schlossman SF, Morimoto C:CD27 is a signal-transducing molecule involved in CD45RA+naive T cell costimulation. J Immunol 153:5422, 1994.
  pubmed

• 9) Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C:CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci USA 92:11249, 1995.

• 10) Loenen WA, De Vries E, Gravestein LA, Hintzen RQ, Van Lier RA, Borst J:The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol 22:447, 1992.

• 11) Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF:CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 94:6346, 1997.

• 12) Sugita K, Torimoto Y, Nojima Y, Daley JF, Schlossman SF, Morimoto C:The IA4 molecule (CD27) is involved in T cell activation. J Immunol 147:1477, 1991.

• 13) van Lier RA, Borst J, Vroom TM, Klein H, Van Mourik P, Zeijlemaker WP, Melief CJ:Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 139:1589, 1987.
  pubmed

P.120 掲載の参考文献

• 1) June CH, Bluestone JA, Nadler LM, Thompson CB:The B7 and CD28 receptor families. Immunol Today 15:321, 1994.
  pubmed

• 2) June CH, Ledbetter JA, Linsley PS, Thompson CB:Role of the CD28 receptor in T-cell activation. Immunol Today 11:211, 1990.

• 3) Linsley PS, Ledbetter JA:The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993.

• 4) Aruffo A, Seed B:Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci USA 84:8573, 1987.
  pubmed

• 5) Hansen JA, Martin PJ, Nowinski RC:Monoclonal antibodies identifying a novel T-cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10:247-260, 1980.

• 6) Ledbetter JA, Martin PJ, Spooner CE, Wofsy D, Tsu TT, Beatty PG, Gladstone P:Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J Immunol 135:2331, 1985.
  pubmed

• 7) Lee KP, Taylor C, Petryniak B, Turka LA, June CH, Thompson CB:The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J Immunol 145:344, 1990.
  pubmed

• 8) Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW:Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609, 1993.
  pubmed

• 9) Weiss A, Manger B, Imboden J:Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J Immunol 137:819, 1986.

P.122 掲載の参考文献

• 1) Brakebusch C, Hirsch E, Potocnik A, et al:Genetic analysis of beta 1 integrin function:confirmed, new and revised roles for a crucial family of cell adhesion molecules. J Cell Sci 110 (Pt 23):2895-2904, 1997.

• 2) Hemler ME:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu Rev Immunol 8:365-400, 1990.
  pubmed

• 3) Hynes RO:Integrins:versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
  pubmed

• 4) Schwartz MA, Schaller MD, Ginsberg MH:Integrins:emerging paradigms of signal transduction. Ann Rev Cell Dev Biol 11:549-599, 1995.

• 5) Argraves WS, Suzuki S, Thompson K, et al:Amino acid sequence of the human fibronectin receptor. J Cell Biol 105:1183-1190, 1987.
  pubmed

• 6) Balzac F, Berkin AM, Koteliansky VE, et al:Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit. J Cell Biol 121:171-178, 1993.

• 7) Belkin AM, Zhidkova NI, Balzac F, et al:Beta 1 D integrin displaces the beta 1 A isoform in striated muscles:localization at junctional structures and signaling potential in nonmuscle cells. J Cell Biol 132:211-226, 1996.132:211-226, 1996.

• 8) Bossy B, Bossy-Wetzel NI, Reichardt LF:Characterization of the integrin alpha 8 subunit:anew integrin beta 1-associated subunit, which is prominently expressed on azons and on cells in contact with basal laminae in chick embryos. EMBO J 10:2375-2385, 1991.

• 9) Holers VM, Ruff TG, Parks DL, et al:Molecular cloning of a murine fibronectin receptor and its expression during inflammmation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J Exp Med 169:1589-1605, 1989.

• 10) Languino LR, Ruoslahti E:An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J Biol Chem 267:7116-7120, 1992.
  pubmed

• 11) Leung-Hagesteijin C, Fitz-Gibbon L, Coppolino MG, et al:Reglation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379:91-96, 1996.

• 12) Loftus JC, O'Toole TE, Plow FE, et al:A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 249:915-918, 1990.

• 13) Luque A, Gomez M, Puzon M, et al:Activated confomations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel reglatory region (355-425) of the common beta 1 chain. J Biol Chem 271:11067-11075, 1996.

• 14) Rowin ME, Whatley RE, Yednock T, et al:Intracellular calcium requirement for beta 1 integrin activation. J Cell Physiol 175:193-202, 1998.

• 15) Ruegg C, Ferrando R, Pytela R, et al:Sequence and tissue distribution of the integrin alpha 9 subunit, anovel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol 123:1289-1297, 1993.

• 16) Shimizu Y, Mobley JL, Finkelstein LD, et al:Arole for phosphatidyl inositol 3-kinase in the regulation of beta 1 integrin activity by the CD2 antigen. J Cell Biol 131:1867-1880, 1995.

• 17) Takada Y, Puzon W:Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J Biol Chem 268:17597-17601, 1993.
  pubmed

• 18) Tamkun JW, DeSimone DW, Fonda D, et al:Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46:271-282, 1986.
  pubmed

• 19) Tanaka Y, Adams DH, Hubsher S, et al:T-cell adhesion induced by proteoglycan-immobilized cytokine MIP. Nature 361:79-82, 1993.

• 20) Ziober BL, Vu MP, Walch N, et al:Altenative extracellular and cytoplasmic domains of the integrin 7 subunit are differentially expressed during development. J Biol Chem 268:36773-26783, 1993.

P.125 掲載の参考文献

• 1) Del Prete G, Maggi E, Pizzolo G, Romagnani S:CD30, Th2 cytokines and HIV infection:acomplex and fascinating link. Immunol Today 16:76, 1995.

• 2) Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H:CD30 (Ki-1) molecule:a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1,1995.
  pubmed

• 3) de Bruin PC, Gruss HJ, van der Valk P, Willemze R, Meijer CJ:CD30 expression in normal and neoplastic lymphoid tissue:biological aspects and clinical implications. Leukemia 9:1620, 1995.
  pubmed

• 4) Agrawal B, Reddish M, Longenecker BM:CD30 expression on human CD8+T cells isolated from peripheral blood lymphocytes of normal donors. J Immunol 157:3229, 1996.
  pubmed

• 5) Aizawa S, Nakano H, Ishida T, Horie R, Nagai M, Ito K, Yagita H, Okumura K, Inoue J, Watanabe T:Tumor necrosis factor receptor-associated factor (TRAF) 5and TRAF2 are involved in CD30-mediated NF kappa B activation. J Biol Chem 272:2042, 1997.

• 6) Aizawa S, Satoh H, Horie R, Ito K, Choi SH, Takeuchi H, Watanabe T:Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene. Gene 182:155, 1996.

• 7) Alzona M, Jack HM, Fisher RI, Ellis TM:1L-12 activates IFN-gamma production through the preferential activation of CD30+T cells. J Immunol 154:9, 1995.

• 8) Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger JM, Mak TW:Impaired negative selection of T cells in Hodgkin's disease antigen. Cell 84:551, 1996.
  pubmed

• 9) Ansieau S, Scheffrahn I;Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hubinger G, Kieff E, Herrmann F, Leutz A, Gruss HJ:Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2. Proc Natl Acad Sci USA 93:14053, 1996.
  pubmed

• 10) Biswas P, Smith CA, Goletti D, Hardy EC, Jackson RW, Fauci AS:Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2:587, 1995.
  pubmed

• 11) Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER:Structure and expression of murine CD30 and its role in cytokine production. J Immunol 156:442, 1996.
  pubmed

• 12) Del Prete G, De Carli M, D'Elios MM, Daniel KC, Almerigogna F, Alderson M, Smith CA, Thomas E, Romagnani S:CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 182:1655, 1995.

• 13) Duckett CS, Gedrich RW, Gilfillan MC, Thompson CB:Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol 17:1535, 1997.
  pubmed

• 14) Gedrich RW, Gilfillan MC, Duckett CS, Van Dongen JL, Thompson CB:CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 271:12852, 1996.
  pubmed

• 15) Hamann D, Hilkens CM, Grogan JL, Lens SM, Kapsenberg ML, Yazdanbakhsh M, van Lier RA:CD30 expression does not discriminate between human Th1-and Th2-type T cells. J Immunol 156:1387, 1996.

• 16) Horie R, Ito K, Tatewaki M, Nagai M, Aizawa S, Higashihara M, Ishida T, Inoue J, Takizawa H, Watanabe T:A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Blood 88:2422, 1996.

• 17) Lee SY, Park CG, Choi Y:Tcell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 183:669, 1996.

• 18) Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM:Primary effusion lymphoma:a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88:645, 1996.
  pubmed

• 19) Wiley SR, Goodwin RG, Smith CA:Reverse signaling via CD30 ligand. J Immunol 157:3635, 1996.
  pubmed

P.127 掲載の参考文献

• 1) DeLisser HM, Newman PJ, Albelda SM:Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15:490, 1994.
  pubmed

• 2) Muller WA:Migration of leukocytes across the vascular intima:molecules and mechanisms trends in cardiovasc. Trends Cardiovasc Med 5:15-20, 1995.
  pubmed

• 3) Newman PJ:The biology of PECAM-1. J Clin Invest 99:3, 1997.
  pubmed

• 4) Baldwin HS, Shen HM, Yan HC, DeLisser HM, Chung A, Mickanin C, Trask T, Kirschbaum NE, Newman PJ, Albelda SM, et al:Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31):alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120:2539, 1994.
  pubmed

• 5) Berman ME, Muller WA:Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 154:299, 1995.
  pubmed

• 6) DeLisser HM, Christofidou-Solomidou M, Strieter RM, .Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM:Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671, 1997.

• 7) Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ:Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter:identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89:1260, 1997.
  pubmed

• 8) Jackson DE, Ward CM, Wang R, Newman PJ:The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1-and integrin-mediated cellular signaling. J Biol Chem 272:6986, 1997.
  pubmed

• 9) Kirschbaum NE, Gumina RJ, Newman PJ:Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84:4028, 1994,

• 10) Liao F, Ali J, Greene T, Muller WA:Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 185:1349, 1997.
  pubmed

• 11) Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA:Migration of monocytes across endo-thelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182:1337, 1995.

• 12) Muller WA, Ratti CM, McDonnell SL, Cohn ZA:Ahuman endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170:399, 1989.

• 13) Muller WA, Weigl SA, Deng X, Phillips DM:PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449, 1993.
  pubmed

• 14) Newman PJ, Berndt MC, Gorski J, White GC 2d, Lyman S, Paddock C, Muller WA:PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219, 1990.

• 15) Newman PJ, Hillery CA, Albrecht R, Parise LV, Berndt MC, Mazurov AV, Dunlop LC, Zhang J, Rittenhouse SE:Activation-dependent changes in human platelet PECAM-1:phosphorylation, cyto-skeletal association, and surface membrane redistribution. J Cell Biol 119:239, 1992.

• 16) Simmons DL, Walker C, Power C, Pigott R:Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 171:2147, 1990.
  pubmed

• 17) Stockinger H, Gadd SJ, Eher R, Maldic O, Schreiber W, Kasinrerk W, Strass B, Schnabl E, Knapp W:Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145:3889, 1990.

• 18) Sun QH, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ:Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 271:11090, 1996.
  pubmed

• 19) Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S:CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.J Exp Med 176:245, 1992.
  pubmed

P.129 掲載の参考文献

• 1) McKenzie SE:Humanized mouse models of FcR clearance in immune platelet disorders. Blood Rev 16 (1):3-5, 2002.
  pubmed

• 2) Karassa FB, Trikalinos TA, Ioannidis JP:Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis:ameta-analysis. Arthritis Rheum 46 (6):1563-1571, 2002.

• 3) Barabe F, Rollet-Labelle E, Gilbert C, Fernandes MJ, Naccache SN, Naccache PH:Early events in the activation of Fc gamma R II A in human neutrophils:stimulated insolubilization, translocation to detergent-resistant domains, and degradation of Fc gamma R II A. J Immunol 168 (8):4042-4049, 2002.

• 4) Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, Bacino D, Dietz M, Hogue R, Koelsch G, Nightingale L, Shaver T, Abdou NI, Albert DA, Carson C, Petri M, Treadwell EL, James JA, Harley JB:Genome scan of human systemic lupus erythematosus:evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 95 (25):14869-14874, 1998.
  pubmed

• 5) Stengelin S, Stamenkovic I, Seed B:Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J 7 (4):1053-1059, 1988.
  pubmed

• 6) Hibbs ML, Bonadonna L, Scott BM, McKenzie IF, Hogarth PM:Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci USA 85 (7):2240-2244, 1988.
  pubmed

• 7) Seki T:Identification of multiple isoforms of the low-affinity human IgG Fc receptor. Immunogenetics 30 (1):5-12, 1989.
  pubmed

• 8) Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV:Organization of the human and mouse low-affinity Fc gamma R genes:duplication and recombination. Science 248 (4956):732-735, 1990.
  pubmed

P.131 掲載の参考文献

• 1) Andrews RG, Torok-Storb B, Bernstein ID:Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies. Blood 62:124-132, 1983.
  pubmed

• 2) Andrews RG, Singer JW, Bernstein ID:Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721-1731, 1989.
  pubmed

• 3) Caron PC, Jurcic JG, Scott AM, Finn RD, Divgi CR, Graham MC, Jureidini IM, Sgouros G, Tyson D, Old LJ, et al:Aphase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia:specific targeting without immunogenicity. Blood 83:1760-1768, 1994.

• 4) Freeman SD, Kelm S, Barber EK, Crocker PR:Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85:2005-2012, 1995.
  pubmed

• 5) Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF:Amonoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 8:521-534, 1984.

• 6) Peiper SC, Andrews RG:CD33 cluster workshop report. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF) , Oxford University Press, pp837-840, 1995.

• 7) Peiper SC, Ashmun RA, Look AT:Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen. Blood 72:314-321, 1988.
  pubmed

• 8) Robertson MJ, Soiffer RJ, Freedman AS, Rabinowe SL, Anderson KC, Ervin TJ, Murray C, Dear K, Griffin JD, Nadler LM, et al:Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis:clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia. Blood 79:2229-2236, 1992.
  pubmed

• 9) Simmons D, Seed B:Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J Immunol 141:2797-2800, 1988.
  pubmed

• 10) Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, et al:Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316:1111-1117, 1987.
  pubmed

• 11) Tchilian EZ, Beverley PC, Young BD, Watt SM:Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen. Blood 83:3188-3198, 1994.
  pubmed

• 12) Thomas R, Lipsky PE:Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 153:4016-4028, 1994.
  pubmed

P.134 掲載の参考文献

• 1) Krause DS, Fackler MJ, Civin CI, May WS:CD34:structure, biology, and clinical utility. Blood 87:1, 1996.
  pubmed

• 2) Sutherland DR, Keating A:The CD34 antigen:structure, biology, and potential clinical applications. J Hematother 1:115, 1992.
  pubmed

• 3) Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA:Binding of L-selectin to the vascular sialomucin CD34. Science 262:436, 1993.

• 4) Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH:Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984.

• 5) Fackler MJ, Krause DS, Smith OM, Civin CI, May WS:Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040, 1995.

• 6) Gaudernack G, Egeland, T:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp861-864.1995.

• 7) Huyhn A, Dommergues M, Izac B, Croisille L, Katz A, Vainchenker W, Coulombel L:Characterization of hematopoietic progenitors from human yolk sacs and embryos. Blood 86:4474, 1995.
  pubmed

• 8) Lin G, Finger E, Gutierrez-Ramos JC:Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol 25:1508, 1995.

• 9) Nakamura Y, Komano H, Nakauchi H:Two alternative forms of cDNA encoding CD34. Exp Hematol 21:236, 1993.
  pubmed

• 10) Perrotti D, Bellon T, Trotta R, Martinez R, Calabretta B:Acell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. Blood 88:3336, 1996.

• 11) Sato N, Sawada K, Koizumi K, Tarumi T, Ieko M, Yasukouchi T, Yamaguchi M, Takahashi TA, Sekiguchi S, Koike T:In vitro expansion of human peripheral blood CD34+cells. Blood 82:3600, 1993.
  pubmed

• 12) Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG:Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 12:788, 1992.
  pubmed

• 13) Suda J, Sudo T, Ito M, Ohno N, Yamaguchi Y, Suda T:Two types of murine CD34 mRNA generated by alternative splicing. Blood 79:2288, 1992.
  pubmed

• 14) Sutherland DR, Abdullah KM, Cyopick P, Mellors A:Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica. J Immunol 148:1458, 1992.
  pubmed

• 15) Tavian M, Coulombel L, Luton D, Clemente HS, Dieterlen-Lievre F, Peault B:Aorta-associated CD34+hematopoietic cells in the early human embryo. Blood 87:67, 1996.
  pubmed

• 16) Tindle RW, Nichols RA, Chan L, Campana D, Catovsky D, Birnie GD:A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res 9:1, 1985.
  pubmed

P.136 掲載の参考文献

• 1) Ahearn JM, Fearon DT:Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46:183, 1989.
  pubmed

• 2) Hourcade D, Holers VM, Atkinson JP:The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381, 1989.
  pubmed

• 3) Moore FD Jr:Therapeutic regulation of the complement system in acute injury states. Adv Immunol 56:267, 1994.
  pubmed

• 4) Ross GD, Medof ME:Membrane complement receptors specific for bound fragments of C3. Adv Immunol 37:217, 1985.
  pubmed

• 5) Taylor RP, Ferguson PJ:Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation. J Hematother 4:357, 1995.
  pubmed

• 6) Birmingham DJ, Logar CM, Shen XP, Chen W:The baboon erythrocyte complement receptor is a glycophosphatidylinositol-linked protein encoded by a homologue of the human CR1-like genetic element. J Immunol 157:2586, 1996.
  pubmed

• 7) Changelian PS, Jack RM, Collins LA, Fearon DT:PMA induces the ligand-independent internalization of CR1 on human neutrophils. J Immunol 134:1851, 1985.
  pubmed

• 8) Kalli KR, Hsu PH, Bartow TJ, Ahearn JM, Matsumoto AK, Klickstein LB, Fearon DT:Mapping of the C3b-binding site of CR1 and construction of a (CR1) 2-F (ab') 2chimeric complement inhibitor. J Exp Med 174:1451, 1991.

• 9) Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP:Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor;CD35) by substitution mutagenesis. J Bio Chem 269:13273, 1994.

• 10) Mathew JM, Naziruddin B, Duffy B, Krych M, Mohanakumar T:Functional analysis of complement receptor 1 using a new monoclonal antibody, KuN241. Hybridoma 14:29, 1995.
  pubmed

• 11) Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD:Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93:3357, 1996.

• 12) Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP:The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med 173:1159, 1991.
  pubmed

• 13) Nickells MW, Subramanian VB, Clemenza L, Atkinson JP:Identification of complement receptor type 1-related proteins on primate erythrocytes. J Immunol 154:2829, 1995.
  pubmed

• 14) O'Shea JJ, Brown EJ, Seligmann BE, Metcalf JA, Frank MM, Gallin JI:Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol 134:2580, 1985.
  pubmed

• 15) Reist CJ, Liang HY, Denny D, Martin EN, Scheld WM, Taylor RP:Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur J Immunol 24:2018, 1994.

• 16) Tausk FA, McCutchan A, Spechko P, Schreiber RD, Gigli I:Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 78:977, 1986.
  pubmed

P.138 掲載の参考文献

• 1) Daviet L, McGregor JL:Functional roles of membrane glycoprotein CD36. Platelets 7:117-124, 1996.
  pubmed

• 2) Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA:Membrane glyco-protein CD36:a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80:1105, 1992.

• 3) Krieger M, Herz J:Structures and functions of multiligand lipoprotein receptors:macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601, 1994.
  pubmed

• 4) Savill J, Fadok V, Henson P, Haslett C:Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131, 1993.
  pubmed

• 5) Armesilla AL, Vega MA:Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 269:18985, 1994
  pubmed

• 6) Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M:Analysis of CD36 binding domains:ligand specificity controlled by dephosphorylation of an ectodomain. Science 262:1436, 1993.

• 7) Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA:CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11811, 1993.
  pubmed

• 8) Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS:Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA. 88:7844, 1991.
  pubmed

• 9) Konig H, Pfisterer P, Corcoran LM, Wirth T:Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev 9:1598, 1995.

• 10) Tang Y, Taylor KT, Sobieski DA, Medved ES, Lipsky RH:Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. J Biol Chem 269:6011, 1994.
  pubmed

• 11) Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K:Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 83:392, 1994.
  pubmed

P.140 掲載の参考文献

• 1) Wright MD, Tomlinson MG:The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588, 1994.
  pubmed

• 2) Angelisova P, Hilgert I, Horejsi V:Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249, 1994.
  pubmed

• 3) Classon BJ, Williams AF, Willis AC, Seed B, Stamenkovic I:The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 172:1007, 1990.
  pubmed

• 4) Ledbetter JA, Shu G, Clark EA:In Leucocyte Typing III, (eds McMichael A, et al), Oxford University Press, pp339-340, 1987.

• 5) Link MP, Bindl J, Meeker TC, Carswell C, Doss CA, Warnke RA, Levy R:A unique antigen on mature B cells defined by a monoclonal antibody. J Immunol 137:3013, 1986.

• 6) Schwartz-Albiez R, Dorken B, Hofmann W, Moldenhauer G:The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein. J Immunol 140:905, 1988.

• 7) Sidorenko SP, Vetrova EP, Yurchenko OV, Berdova AG, Shlapatskaya LN, Gluzman DF:Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasma 39:3, 1992.
  pubmed

• 8) Virtaneva KI, Angelisova P, Baumruker T, Horejsi V, Nevanlinna H, Schroder J:The genes for CD37, CD53, and R2, all members of a novel gene family, are located on different chromosomes. Immunogenetics 37:461, 1993.
  pubmed

P.142 掲載の参考文献

• 1) Ferrero E, Malavasi F:The metamorphosis of a molecule:from soluble enzyme to the leukocyte receptor CD38. J Leukoc Biol 65:151, 1999.

• 2) Lund F, Solvason N, Grimaldi JC, Parkhouse RM, Howard M:Murine CD38:an immunoregulatory ectoenzyme. Immunol Today 16:469, 1995.
  pubmed

• 3) Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K:Human CD38:aglycoprotein in search of a function. Immunol Today 15:95, 1994.

• 4) Mehta K, Shahid U, Malavasi F:Human CD38, a cell-surface protein with multiple functions. FASEB J 10:1408, 1996.
  pubmed

• 5) Shubinsky G, Schlesinger M:The CD38 lymphocyte differentiation marker:new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 7:315, 1997.
  pubmed

• 6) Aarhus R, Graeff RM, Dickey DM, Walseth TF, Lee HC:ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem 270:30327, 1995.
  pubmed

• 7) Cesano A, Visonneau S, Deaglio S, Malavasi F, Santoli D:Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells. J Immunol 160:1106, 1998.
  pubmed

• 8) Cockayne DA, Muchamuel T, Grimaldi JC, Muller-Steffner H, Randall TD, Lund FE, Murray R, Schuber F, Howard MC:Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood 92:1324, 1998.
  pubmed

• 9) Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F:Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 160:395, 1998.

• 10) Deterre P, Gelman L, Gary-Gouy H, Arrieumerlou C, Berthelier V, Tixier JM, Ktorza S, Goding J, Schmitt C, Bismuth G:Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J Immunol 157:1381, 1996.

• 11) Ferrero E, Malavasi F:Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes:extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol 159:3858, 1997.
  pubmed

• 12) Ferrero E, Saccucci F, Malavasi F:The human CD38 gene:polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 49:597, 1999.

• 13) Funaro A, Reinis M, Trubiani O, Santi S, Di Primio R, Malavasi F:CD38 functions are regulated through an internalization step. J Immunol 160:2238, 1998.
  pubmed

• 14) Hoshino S, Kukimoto I, Kontani K, Inoue S, Kanda Y, Malavasi F, Katada T:Mapping of the catalytic and epitopic sites of human CD38/NAD-glycohydrolase to a functional domain in the carboxyl terminus. J Immunol 158:741, 1997.
  pubmed

• 15) Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, Walseth TF, Lee HC:Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262:1056, 1993.
  pubmed

• 16) Ikehata F, Satoh J, Nata K, Tohgo A, Nakazawa T, Kato I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H:Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin-dependent diabetes patients. J Clin Invest 102:395, 1998.
  pubmed

• 17) Kato I, Yamamoto Y, Fujimura M, Noguchi N, Takasawa S, Okamoto H:CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose,[Ca2+]i, and insulin secretion. J Biol Chem 274:1869, 1999.
  pubmed

• 18) Kitanaka A, Suzuki T, Ito C, Nishigaki H, Coustan-Smith E, Tanaka T, Kubota Y, Campana D:CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J Immunol 162:1952, 1999.
  pubmed

• 19) Kontani K, Nishina H, Ohoka Y, Takahashi K, Katada T:NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J Biol Chem 268:16895, 1993.
  pubmed

• 20) Mallone R, Ferrua S, Morra M, Zocchi E, Mehta K, Notarangelo LD, Malavasi F:Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia. J Clin Invest 101:2821, 1998.

• 21) Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F:CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J 12:581, 1998.

• 22) Nata K, Takamura T, Karasawa T, Kumagai T, Hashioka W, Tohgo A, Yonekura H, Takasawa S, Nakamura S, Okamoto H:Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase):organization, nucleotide sequence and alternative splicing. Gene 186:285, 1997.
  pubmed

• 23) Prasad GS, McRee DE, Stura EA, Levitt DG, Lee HC, Stout CD:Crystal structure of Aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38. Nat Struct Biol 3:957, 1996.
  pubmed

• 24) States DJ, Walseth TF, Lee HC:Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38. Trends Biochem Sci 17:495, 1992.
  pubmed

P.144 掲載の参考文献

• 1) Kaneider NC, Egger P, Dunzendorfer S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ:Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition:effects on Rho-GTPase and adenosine nucleotide metabolism. Arterioscler Thromb Vasc Biol 22 (6):894-900, 2002.
  pubmed

• 2) Kittel A, Garrido M, Varga G:Localization of NTPDasel/CD39 in normal and transformed human pancreas. J Histochem Cytochem 50 (4):549-556, 2002.
  pubmed

• 3) Adrian K, Bernhard MK, Breitinger HG, Ogilvie A:Expression of purinergic receptors (ionotropic P2Xl-7 and metabotropic P2Yl-11) during myeloid differentiation of HL60 cells. Biochim Biophys Acta 1492 (1):127-138, 2000.
  pubmed

• 4) Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC:CD39 modulates endothelial cell activation and apoptosis. Mol Med 6 (7):591-603, 2000.
  pubmed

• 5) Matsumoto M, Sakurai Y, Kokubo T, Yagi H, Makita K, Matsui T, Titani K, Fujimura Y, Narita N:The cDNA cloning of human placental ecto-ATP diphosphohydrolases I and II. FEBS Lett 453 (3):335-340, 1999.
  pubmed

• 6) Gray IC, Fallowfield J, Ford S, Nobile C, Volpi EV, Spurr NK:An integrated physical and genetic map spanning chromosome band 10q24. Genomics 43 (1):85-88, 1997.
  pubmed

• 7) Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH:Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185 (1):153-163, 1997.
  pubmed

• 8) Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC:Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271 (51):33116-33122, 1996.
  pubmed

• 9) Malis2ewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C, et al:The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153 (8):3574-3583, 1994.

P.146 掲載の参考文献

• 1) Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi Jp, Van Kooten C, Liu YJ, Rousset F, Saeland S:The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922, 1994.
  pubmed

• 2) Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ:Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617, 1996.
  pubmed

• 3) Gordon J:CD40 and its ligand:central players in B lymphocyte survival, growth, and differentiation. Blood Rev 9:53-56, 1995.

• 4) Gordon J, Katira A, Holder M, MacDonald I, Pound J:Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens. Cell Mol Biol (Noisy-le-grand) 40:1-13, 1994.

• 5) Clark EA, Ledbetter JA:Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83:4494-4498, 1986.

• 6) Goldstein MD, Watts TH:Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J Immunol 157:2837-2843, 1996.
  pubmed

• 7) Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlmann P:A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20:23-28, 1985.

P.148 掲載の参考文献

• 1) Porter JC, Hogg N:Integrins take partners:cross-talk between integrins and other membrane receptors. Trends Cell Biol 8 (10):390-396, 1998.
  pubmed

• 2) Naik UP, Parise LV:Structure and function of platelet alpha llb beta 3. Curr Opin Hematol 4 (5):317-322, 1997.

• 3) Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horej si V, Shattil SJ, Watson SP:Differential role of glycolipid-enriched membrane domains in glycoprotein VI-and integrin-mediated phospholipase C gamma 2 regulation in platelets. Biochem J 364 (Pt 3):755-765, 2002.

• 4) Kato A, Kawamata N, Tamayose K, Egashira M, Miura R, Fujimura T, Murayama K, Oshimi K:Ancient ubiquitous protein I binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin alpha subunits that plays a crucial role in the inside-out signaling of alpha IIb beta 3. J Biol Chem 277 (32):28934-28941, 2002.

• 5) Hantgan RR, Stahle MC, Jerome WG, Nagaswami C, Weisel JW:Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of Gp IIb/IIIa structure. Thromb Haemost 87 (5):910-917, 2002.

• 6) Barry WT, Boudignon-Proudhon C, Shock DD, McFadden A, Weiss JM, Sondek J, Parise LV:Molecular basis of CIB binding to the integrin alpha IIb cytoplasmic domain. J Biol Chem 277 (32):28877-28883, 2002.

• 7) Bertoni A, Tadokoro S, Eto K, Pampori N, Parise LV, White GC, Shattil SJ:Relationships between Rap1b, affinity modulation of integrin alpha IIb beta 3, and the actin cytoskeleton. J Biol Chem 277 (28):25715-25721, 2002.
  pubmed

• 8) Ndoko S, Poujol C, Combrie R, Nurden A, Nurden P:Paradoxical platelet activation was not observed on dissociation of abciximab from Gp IIb-IIIa complexes. Thromb Haemost 87 (2):317-322, 2002.
  pubmed

• 9) Kasirer-Friede A, Ware J, Leng L, Marchese P, Ruggeri ZM, Shattil SJ:Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIb beta 3. J Biol Chem 277 (14):11949-11956, 2002.
  pubmed

• 10) Derrick JM, Shattil SJ, Poncz M, Gruppo RA, Gartner TK:Distinct domains of alpha IIb beta 3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alpha IIb beta 3 interacting peptide. Thromb Haemost 86 (3):894-901, 2001.

• 11) Yan B, Smith JW:Mechanism of integrin activation by disulfide bond reduction. Biochemistry 40 (30):8861-8867, 2001.
  pubmed

• 12) Longhurst CM, White MM, Wilkinson DA, Jennings LK:ACD9, alpha IIb beta 3, integrin-associated protein, and GPIb/V/IX complex on the surface of human platelets is influenced by alpha IIb beta 3 conformational states. Eur J Biochem 263 (1):104-111, 1999.

• 13) Basani RB, Vilaire G, Shattil SJ, Kolodziej MA, Bennett JS, Poncz M:Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of alpha IIb:demonstration of the importance of calcium-binding domains in the conformation of alpha IIb beta 3. Blood 88 (1):167-173, 1996.
  pubmed

• 14) Ozawa K, Takahashi M, Sobue K:Phase specific association of heterotrimeric GTP-binding proteins with the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. FEBS Lett 382 (1-2):159-163, 1996.

• 15) Bray PF, Rosa JP, Johnston GI, Shiu DT, Cook RG, Lau C, Kan YW, McEver RP, Shuman MA:Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest 80 (6):1812-1817, 1987.
  pubmed

• 16) Uzan G, Frachet P, Lajmanovich A, Prandini MH, Denarier E, Duperray A, Loftus J, Ginsberg M, Plow E, Marguerie G:cDNA clones for human platelet GPIIb corresponding to mRNA from megakaryocytes and HEL cells. Evidence for an extensive homology to other Arg-Gly-Asp adhesion receptors. Eur J Biochem 171 (1-2):87-93, 1988.

• 17) Prandini MH, Denarier E, Frachet P, Uzan G, Marguerie G:Isolation of the human platelet glycoprotein IIb gene and characterization of the 5'flanking region. Biochem Biophys Res Commzan 156 (1):595-601, 1988.
  pubmed

• 18) Loftus JC, Plow EF, Frelinger AL 3rd, D'Souza SE, Dixon D, Lacy J, Sorge J, Ginsberg MH:Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci USA 84 (20):7114-7118, 1987.
  pubmed

• 19) Poncz M, Eisman R, Heidenreich R, Silver SM, Vilaire G, Surrey S, Schwartz E, Bennett JS:Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 262 (18):8476-8482, 1987.

• 20) Bray PF, Leung CS, Shuman MA:Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs. J Biol Chem 265 (17):9587-9590, 1990.
  pubmed

P.150 掲載の参考文献

• 1) Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF:Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 70:304, 1982.
  pubmed

• 2) Fox JE, Aggerbeck LP, Berndt MC:Structure of the glycoprotein Ib. IX complex from platelet membranes. J Biol Chem 263:4882, 1988.
  pubmed

• 3) Hickey MJ, Williams SA, Roth GJ:Human platelet glycoprotein IX:an adhesive prototype of leucinerich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 86:6773, 1989.
  pubmed

• 4) Muszbek L, Laposata M:Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J Biol Chem 264:9716, 1989.
  pubmed

• 5) Nurden AT, Dupuis D, Kunicki TJ, Caen JP:Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 67:1431, 1981.
  pubmed

• 6) Schick PK, Walker J:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87:1377, 1996.
  pubmed

• 7) Wicki AN, Clemetson KJ:The glycoprotein Ib complex of human blood platelets. Eur J Biochem 163:43, 1987.
  pubmed

• 8) Wright SD, Michaelides K, Johnson DJ, West NC, Tuddenham EG:Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 81:2339, 1993.
  pubmed

P.151 掲載の参考文献

• 1) Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF:Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 70:304, 1982.
  pubmed

• 2) Fox JE, Aggerbeck LP, Berndt MC:Structure of the glycoprotein Ib.IX complex from platelet membranes. J Biol Chem 263:4882, 1988.
  pubmed

• 3) Kuijpers RW, Ouwehand WH, Bleeker PM, Christie D, von dem Borne AE:Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 79:283, 1992.

• 4) Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ:Cloning of the alpha chain of human platelet glycoprotein Ib:atransmembrane protein with homology to leucine-rich alpha 2-91ycoprotein. Proc Natl Acad Sci USA 84:5615, 1987.

• 5) Miller JL, Castella A:Platelet-type von Willebrand's disease:characterization of a new bleeding disorder. Blood 60:790, 1982.
  pubmed

• 6) Muszbek L, Laposata M:Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J Biol Chem 264:9716, 1989.
  pubmed

• 7) Nurden AT, Dupuis D, Kunicki TJ, Caen Jp:Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 67:1431, 1981.
  pubmed

• 8) Schick PK, Walker J:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87:1377, 1996.
  pubmed

• 9) Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma Jp, Vicic WJ, Rogers J:Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 306:326, 1982.
  pubmed

P.153 掲載の参考文献

• 1) Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF:Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 70:304, 1982.
  pubmed

• 2) Fox JE, Aggerbeck LP, Berndt MC:Structure of the glycoprotein Ib. IX complex from platelet membranes. J Biol Chem 263:4882, 1988.
  pubmed

• 3) Kunishima S, Lopez JA, Kobayashi S, Imai N, Kamiya T, Saito H, Naoe T:Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alphabeta disulfide linkage in a family with giant Platelet disorder. Blood 89:2404, 1997.

• 4) Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ:The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 85:2135, 1988.
  pubmed

• 5) Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA:Identification of a mutation in a GATA binding site of the platelet glycoprotein Ib beta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 271:22076, 1996.

• 6) Muszbek L, Laposata M:Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J Biol Chem 264:9716, 1989.
  pubmed

• 7) Nurden AT, Dupuis D, Kunicki TJ, Caen JP:Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 67:1431, 1981.
  pubmed

• 8) Schick PK, Walker J:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87:1377, 1996.
  pubmed

P.154 掲載の参考文献

• 1) Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF:Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 70:304, 1982.
  pubmed

• 2) Dong JF, Sae-Tung G, Lopez JA:Role of glycoprotein V in the formation of the platelet high-affinity thrombin-bindlng site. Blood 89:4355, 1997.

• 3) Hickey MJ, Hagen FS, Yagi M, Roth GJ:Human platelet glycoprotein V:characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci USA 90:8327, 1993.
  pubmed

• 4) Lanza F, Morales M, de La Salle C, Cazenave JP, Clemetson KJ, Shimomura T, Phillips DR:Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 268:20801, 1993.

• 5) Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JE:Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IXcomplex requires the presence of its three subunits. J Biol Chem 267:12851, 1992.
  pubmed

• 6) Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE:Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 267:364, 1992.

P.156 掲載の参考文献

• 1) Alvarado M, Klassen C, Cerny J, Horejsi V, Schmidt RE:MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation. Eur J Immunol 25:1051, 1995.
  pubmed

• 2) Bazil V, Brandt J, Tsukamoto A, Hoffman R:Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes. Blood 86:502, 1995.
  pubmed

• 3) Cyster JG, Shotton DM, Williams AF:The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J 10:893, 1991.

• 4) Kudo S, Fukuda M:Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation. J Biol Chem 270:13298, 1995.
  pubmed

• 5) Manjunath N, Johnson RS, Staunton DE, Pasqualini R, Ardman B:Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J Immunol 151:1528, 1993.
  pubmed

• 6) Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ:Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med 165:1383, 1987.

• 7) Nong YH, Remold-O'Donnell E, LeBien TW, Remold HG:Amonoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J Exp Med 170:259, 1989.

• 8) Pallant A, Eskenazi A, Mattei MG, Fournier RE, Carlsson SR, Fukuda M, Frelinger JG:Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 86:1328, 1989.
  pubmed

• 9) Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ:CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354:233, 1991.
  pubmed

• 10) Schmid K, Hediger MA, Brossmer R, Collins JH, Haupt H, Marti T, Offner GD, Schaller J, Takagaki K, Walsh MT, et al:Amino acid sequence of human plasma galactoglycoprotein:identity with the extracellular region of CD43 (sialophorin). Proc Natl Acad Sci USA 89:663, 1992.
  pubmed

• 11) Shelley CS, Remold-O'Donnell E, Rosen FS, Whitehead AS:Structure of the human sialophorin (CD43) gene. Identification of features atypical of genes encoding integral membrane proteins. Biochem J 270:569, 1990.
  pubmed

P.158 掲載の参考文献

• 1) Haynes BF, Liao HX, Patton KL:The transmembrane hyaluronate receptor (CD44):multiple functions, multiple forms. Cancer Cells 3:347, 1991.
  pubmed

• 2) Lesley J, Hyman R, Kincade PW:CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993.
  pubmed

• 3) Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B:CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990.
  pubmed

• 4) Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I:Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199, 1996.
  pubmed

• 5) Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC:A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1063, 1989.
  pubmed

• 6) Kalomiris EL, Bourguignon LY:Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem 264:8113, 1989.

• 7) Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW:Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419, 1995.
  pubmed

• 8) Kohda D, Morton CJ, Parkar AA, Hatanaka H, Inagaki FM, Campbell ID, Day AJ:Solution structure of the link module:ahyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86:767, 1996.
  pubmed

• 9) Mikecz K, Brennan FR, Kim JH, Glant TT:Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1:558, 1995.
  pubmed

• 10) Miyake K, Underhill CB, Lesley J, Kincade PW:Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69, 1990.
  pubmed

• 11) Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI:Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160, 1992.
  pubmed

• 12) Stamenkovic I, Amiot M, Pesando JM, Seed B:A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057, 1989.

P.160 掲載の参考文献

• 1) Haynes BF, Liao HX, Patton KL:The transmembrane hyaluronate receptor (CD44):multiple functions, multiple forms. Cancer Cells 3:347, 1991.
  pubmed

• 2) Lesley J, Hyman R, Kincade PW:CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993.
  pubmed

• 3) Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I:Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199, 1996.
  pubmed

• 4) Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A:CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687, 1995.
  pubmed

• 5) Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N:Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673, 1995.

• 6) Levesque MC, Haynes BF:In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557, 1996.
  pubmed

• 7) Liao HX, Levesque MC, Patton K, Bergamo B, Jones D, Moody MA, Telen MJ, Haynes BF:Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 151:6490, 1993.
  pubmed

• 8) Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U:Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71, 1994.
  pubmed

• 9) Terpe HJ, Koopmann R, Imhof BA, Gunthert U:Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas:CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 174:89, 1994.
  pubmed

P.162 掲載の参考文献

• 1) Barclay AN, McCall MN:CD45;from alloantigen to mapping of restricted epitopes using recombinant soluble CD45 isoforms. Biochem Soc Trans 20:161, 1992.
  pubmed

• 2) Trowbridge IS, Thomas ML:CD45:an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12:85, 1993.

• 3) Beverley PCL:In Production and Use of Monoclonal Antibodies in Transplantation Immunology. In Transplantation and Clinical Immunology XI, (eds Touraine JL, et al), Excerpta Medica, Amsterdam, pp87-94, 1980.

• 4) Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, et al:Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice. Cell 74:143, 1993.
  pubmed

• 5) Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF:The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 134:1508, 1985.
  pubmed

• 6) Okumura M, Matthews RJ, Robb B, Litman GW, Bork P, Thomas ML:Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J Immunol 157:1569, 1996.
  pubmed

• 7) Perillo NL, Pace KE, Seilhamer JJ, Baum LG:Apoptosis of T cells mediated by galectin-1. Nature 378:736, 1995.
  pubmed

• 8) Pingel JT, Thomas ML:Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055, 1989.

• 9) Pulido R, Cebrian M, Acevedo A, de Landazuri MO, Sanchez-Madrid F:Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J Immunol 140:3851, 1988.

• 10) Roach T, Slater S, Koval M, White L, McFarland EC, Okumura M, Thomas M, Brown E:CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol 7:408, 1997.

• 11) Terry LA, Brown MH, Beverley PC:The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology 64:331, 1988.
  pubmed

• 12) Tonks NK, Charbonneau H, Diltz CD, Fischer EH, Walsh KA:Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemist 27:8695, 1988.

• 13) Zapata JM, Pulido R, Acevedo A, Sanchez-Madrid F, de Landazuri MO:Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages. J Immunol 152:3852, 1994.

P.164 掲載の参考文献

• ・Cobbold S, Hale G, Waldmann H:In Leukocyte Typing III, (eds McMichael AJ, et al), Oxford University Press, p789, 1987.

• ・Streuli M, Morimoto C, Schreiber M, et al:J Immunol 141:3910, 1988.

P.165 掲載の参考文献

• ・Warnke RA, Gatter KC, Falini B, et al:New Engl J Med 309:1275, 1983.
  pubmed

• ・Pulido R, Cebrian M, Acevedo A, et al:J Immunol 140:3851, 1988.

• ・Streuli M, Morimoto C, Schreiber M, et al:J Immunol 141:3910, 1988.

P.167 掲載の参考文献

• ・Smith SH, Brown MH, Rowe D, et al:Immunology 58:63, 1986.
  pubmed

• ・Streuli M, Morimoto C, Schreiber M, et al:J Immunol 141:3910, 1988.

P.168 掲載の参考文献

• 1) Gerlier D, Varior-Krishnan G, Devaux P:CD46-mediated measles virus entry:a first key to host-range specificity. Trends Microbiol 3:338, 1995.
  pubmed

• 2) Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP:Control of the complement system. Adv Immunol 61:201, 1996.
  pubmed

• 3) Liszewski MK, Post TW, Atkinson JP:Membrane co-factor protein (MCP or CD46):newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9:431, 1991.
  pubmed

• 4) Vanderpuye OA, Labarrere CA, McIntyre JA:The complement system in human reproduction. Am J Reprod Immunol 27:145, 1992.
  pubmed

• 5) Cho SW, Oglesby TJ, Hsi BL, Adams EM, Atkinson JP:Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay. Clin Exp Immunol 83:257, 1991.
  pubmed

• 6) Hsi BL, Yeh CJ, Fenichel P, Samson M, Grivaux C:Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen. Am J Reprod Immunol Microbiol 18:21, 1988.
  pubmed

• 7) Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S:Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem 270:15148, 1995.
  pubmed

• 8) Johnstone RW, Russell SM, Loveland BE, McKenzie IF:Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol 30:1231, 1993.
  pubmed

• 9) Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE:Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228, 1996.
  pubmed

• 10) Kitamura M, Namiki M, Matsumiya K, Tanaka K, Matsumoto M, Hara T, Kiyohara H, Okabe M, Okuyama A, Seya T:Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralizing activity. Immunology 84:626, 1995.
  pubmed

• 11) Liszewski MK, Tedja I, Atkinson JP:Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 269:10776, 1994.
  pubmed

• 12) Lublin DM, Liszewski MK, Post TW, Arce MA, Le Beau MM, Rebentisch MB, Lemons LS, Seya T, Atkinson JP:Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med 168:181, 1988.
  pubmed

• 13) Milland J, Christiansen D, Thorley BR, McKenzie IF, Loveland BE:Translation is enhanced after silent nucleotide substitutions in A+T-rich sequences of the coding region of CD46 cDNA. Eur J Biochem 238:221, 1996.

• 14) Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D:Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025, 1993.

• 15) Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP:Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149:129, 1996.
  pubmed

• 16) Okabe M, Nagira M, Kawai Y, Matzno S, Mimura T, Mayumi T:A human sperm antigen possibly involved in binding and/or fusion with zona-free hamster eggs. Fertil Steril 54:1121, 1990.
  pubmed

• 17) Okada N, Liszewski MK, Atkinson JP, Caparon M:Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci USA 92:2489, 1995.

• 18) Pesando JM, Hoffman P, Abed M:Antibody-induced antigenic modulation is antigen dependent:characterization of 22 proteins on a malignant human B cell line. J Immunol 137:3689, 1986.

• 19) Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP:Membrane cofactor protein of the complement system:alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174:93, 1991.
  pubmed

• 20) Purcell DF, McKenzie IF, Lublin DM, Johnson PM, Atkinson Jp, Oglesby TJ, Deacon NJ:The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology 70:155, 1990.
  pubmed

• 21) Russell SM, Sparrow RL, McKenzie IF, Purcell DF:Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 22:1513, 1992.
  pubmed

• 22) Seya T, Hara T, Matsumoto M, Akedo H:Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol 145:238, 1990.
  pubmed

• 23) Seya T, Turner JR, Atkinson Jp:Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 163:837, 1986.
  pubmed

• 24) Sparrow RL, McKenzie IF:Hu Ly-m5:aunique antigen physically associated with HLA molecules. Hum Immunol 7:1, 1983.

• 25) Stern PL, Beresford N, Thompson S, Johnson PM, Webb PD, Hole N:Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody. J Immunol 137:1604, 1986.
  pubmed

• 26) Thorley BR, Milland J, Christiansen D, Lanteri MB, McInnes B, Moeller I, Rivailler P, Horvat B, Rabourdin-Combe C, Gerlier D, McKenzie IF, Loveland BE:Transgenic expression of a CD46 (membrane cofactor protein) minigene:studies of xenotransplantation and measles virus infection. Eur J Immunol 27:726, 1997.

P.171 掲載の参考文献

• 1) Anstee DJ, Spring FA:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp233-234, 1995.

• 2) Brown E, Hooper L, Ho T, Gresham H:Integrin-associated protein:a50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111:2785, 1990.

• 3) Campbell IG, Freemont PS, Foulkes W, Trowsdale J:An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 52:5416, 1992.
  pubmed

• 4) Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA:Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271:21, 1996.

• 5) Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ:Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795, 1996.
  pubmed

• 6) Lindberg FP, Lublin DM, Telen MJ, Veile RA, Miller YE, Donis-Keller H, Brown EJ:Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem 269:1567, 1994.

• 7) Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJ:Isolation and characterization of CD47 glycoprotein:a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J 304:525, 1994.
  pubmed

• 8) Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ:In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci 108:3419, 1995.
  pubmed

P.172 掲載の参考文献

• 1) Arvieux J, Jefferies WA, Paterson DJ, Williams AF, Green JR:Monoclonal antibodies against a rat leucocyte antigen block antigen-induced T-cell responses via an effect on accessory cells. Immunology 58:337, 1986.
  pubmed

• 2) Del Porto P, Mami-Chouaib F, Bruneau JM, Jitsukawa S, Dumas J, Harnois M, Hercend T:TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1. J Exp Med 173:1339, 1991.

• 3) Flament C, Bellagha K, Rosenthal-Allieri A, Chouaib S, Mami-Chouaib F:CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells. Hum Immunol 46:82, 1996.

• 4) Garnett D, Barclay AN, Carmo AM, Beyers AD:The association of the protein tyrosine kinases p561ck and p60fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Eur J Immunol 23:2540, 1993.

• 5) Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, Jonveaux P, Vu T, Bazarbachi A, Carosella ED, Sigaux F, Socie G:Aplastic anemia and paroxysmal nocturnal hemoglobinuria:search for a pathogenetic link. Blood 85:1354, 1995.
  pubmed

• 6) Kingsmore SF, Souryal CA, Watson ML, Patel DD, Seldin MF:Physical and genetic linkage of the genes encoding Ly-9 and CD48 on mouse and human chromosomes 1. Immunogenetics 42:59, 1995.
  pubmed

• 7) Korinek V, Stefanova I, Angelisova P, Hilgert I, Horejsi V:The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1. Immunogenetics 33:108, 1991.

• 8) Mami-Chouaib F, Del Porto P, Delorme D, Hercend T:Further evidence for a gamma/delta T cell receptor-mediated TCT.1/CD48 recognition. J Immunol 147:2864, 1991.
  pubmed

• 9) Mami-Chouaib F, Miossec C, Del Porto P, Flament C, Triebel F, Hercend T:Tcell target 1 (TCT.1):a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes. J Exp Med 172:1071, 1990.

• 10) Sandrin MS, Henning MM, Lo MF, Baker E, Sutherland GR, McKenzie IF:Isolation and characterization of cDNA clones for Humly9:the human homologue of mouse Ly9. Immunogenetics 43:13, 1996.
  pubmed

• 11) Sandrin MS, Mouhtouris E, Vaughan HA, Warren HS, Parish CR:CD48 is a low affinity ligand for human CD2. J Immunol 151:4606, 1993.
  pubmed

• 12) Staunton DE, Fisher RC, LeBeau MM, Lawrence JB, Barton DE, Francke U, Dustin M, Thorley-Lawson DA:Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23. J Exp Med 169:1087, 1989.
  pubmed

• 13) Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H:GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991.
  pubmed

• 14) Thorley-Lawson DA, Ianelli C, Klaman LD, Staunton D, Yokoyama S:Function of CD48 and its regulation by Epstein-Barr virus. Biochem Soc Trans 21:976, 1993.
  pubmed

• 15) Vaughan HA, Henning MM, Purcell DF, McKenzie IF, Sandrin MS:The isolation of cDNA clones for CD48. Immunogenetics 33:113, 1991.
  pubmed

• 16) van der Merwe PA, McNamee PN, Davies EA, Barclay AN, Davis SJ:Topology of the CD2-CD48 cell-adhesion molecule complex:implications for antigen recognition by T cells. Curr Biol 5:74, 1995.

P.174 掲載の参考文献

• 1) Briesewitz R, Epstein MR, Marcantonio EE:Expression of native and truncated forms of the human integrin alpha 1 subunit. J Biol Chem 268 (4):2989-2996, 1993.
  pubmed

P.176 掲載の参考文献

• 1) Dickeson SK, Santoro SA:Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci 54 (6):556-566, 1998.
  pubmed

• 2) Takada Y, Kamata T, Irie A, Puzon-McLaughlin W, Zhang XP:Structural basis of integrin-mediated signal transduction. Matrix Biol 16 (4):143-151, 1997. PMID:9402003[PubMed-indexed for MEDLINE]

• 3) Moroi M, Jung SM:Platelet receptors for collagen. Thromb Haemost 78 (1):439-444, 1997.
  pubmed

• 4) Nishiya T, Kainoh M, Murata M, Handa M, Ikeda Y:Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions:specific synergy of receptor-ligand interactions. Blood 100 (1):136-142, 2002.
  pubmed

• 5) Sashiyama H, Shino Y, Sakao S, Shimada H, Kobayashi S, Ochiai T, Shirasawa H:Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. Cancer Lett 177 (1):21-28, 2002.
  pubmed

• 6) Meleady P, Clynes M:Bromodeoxyuridine induces integrin expression at transcriptional (alpha 2 subunit) and post-transcriptional (beta1 subunit) levels, and alters the adhesive properties of two human lung tumour cell lines. Cell Commun Adhes 8 (1):45-59, 2001.

• 7) Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA:Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIPI. Proc Natl Acad Sci USA 97 (18):10026-10031, 2000.

• 8) Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, Jensen B, Madsen HO, Ryder LP, Svejgaard A, Malling HJ, Skov PS, Poulsen LK:CXC chemokine receptor 3 expression on CD34 (+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor:chemotax-is and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 96 (4):1230-1238, 2000.

• 9) Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K:Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol 162 (7):4285-4292, 1999.
  pubmed

• 10) Porter JC, Hogg N:Integrins take partners:cross-talk between integrins and other membrane receptors. Trends Cell Biol 8 (10):390-396, 1998.
  pubmed

• 11) Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M:Angiogenesis promoted by vascular endothelial growth factor:regulation through alphal betal and alpha2 betal integrins. Proc Natl Acad Sci USA 94 (25):13612-13617, 1997.

• 12) Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ:Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318 (6045):470-472, 1985.
  pubmed

• 13) Takada Y, Hemler ME:The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa):homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 109 (1):397-407, 1989.
  pubmed

• 14) Jaspers M, Marynen P, Aly MS, Cuppens H, Hilliker C, Cassiman JJ:Localization of the gene encoding the alpha 2 subunit of the human VLA-2 receptor to chromosome 5q23-31. Somat Cell Mol Genet 17 (5):505-511, 1991.
  pubmed

P.178 掲載の参考文献

• 1) Fornaro M, Languino LR:Alternatively spliced variants:a new view of the integrin cytoplasmic domain. Matrix Biol 16 (4):185-193, 1997.
  pubmed

• 2) Hirosaki T, Mizushima H, Tsubota Y, Moriyama K, Miyazaki K:Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion and migration by laminin-5. J Biol Chem 275 (29):22495-22502, 2000.
  pubmed

• 3) Jones SD, van der Flier A, Sonnenberg A:Genomic organization of the human alpha 3 integrin subunit gene. Biochem Biophys Res Commun 248 (3):896-898, 1998.
  pubmed

• 4) de Melker AA, Sterk LM, Delwel GO, Fles DL, Daams H, Weening JJ, Sonnenberg A:The A and B variants of the alpha 3 integrin subunit:tissue distribution and functional characterization. Lab Invest 76 (4):547-563, 1997.

• 5) Bosman FT:Integrins:cell adhesives and modulators of cell function. Histochem J 25 (7):469-477, 1993. (Review)
  pubmed

• 6) Tsuji T, Hakomori S, Osawa T:Identification of human galactoprotein b3, an oncogenic transformation-induced membrane glycoprotein, as VLA-3 alpha subunit:the primary structure of human integrin alpha 3. J Biochem (Tokyo) 109 (4):659-665, 1991.
  pubmed

• 7) Takada Y, Murphy E, Pil P, Chen C, Ginsberg MH, Hemler ME:Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J Cell Biol 115 (1):257-266, 1991.
  pubmed

P.179 掲載の参考文献

• 1) Porter JC, Hogg N:Integrins take partners:cross-talk between integrins and other membrane receptors. Trends Cell Biol 8 (10):390-396, 1998.
  pubmed

• 2) Oostendorp RA, Dormer P:VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma 24 (5-6):423-435, 1997.

• 3) Humphries MJ, Sheridan J, Mould AP, Newham P:Mechanisms of VCAM-1 and fibronectin binding to integrin alpha 4 beta 1:implications for integrin function and rational drug design. Ciba Found Symp 189:177-191, discussion 191-199, 1995.

• 4) de Bruyn KM, Rangarajan S, Reedquist KA, Figdor CG, Bos JL:The small GTPase Rapl is required for Mn (2+)-and antibody-induced LFA-1-and VLA-4-mediated cell adhesion. J Biol Chem 277 (33):29468-29476, 2002.

• 5) Crook MF, Southgate KM, Newby AC:Both ICAM-1-and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein. J Vasc Res 39 (3):221-229, 2002.
  pubmed

• 6) Decker S, van Valen F, Vischer P:Adhesion of osteosarcoma cells to the 70-kDa core region of thrombospondin-1 is mediated by the alpha 4 beta 1 integrin. Biochem Biophys Res Commun 293 (1):86-92, 2002.

• 7) Garcia-Gila M, Lopez-Martin EM, Garcia-Pardo A:Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors. Clin Exp Immunol 127 (3):455-462, 2002.
  pubmed

• 8) Till KJ, Lin K, Zuzel M, Cawley JC:The chemokine receptor CCR7 and alpha 4 integrin are important for migration of chronic Iymphocytic leukemia cells into lymph nodes. Blood 99 (8):2977-2984, 2002.

• 9) Boyce JA, Mellor EA, Perkins B, Lim YC, Luscinskas FW:Human mast cell progenitors use alpha 4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 99 (8):2890-2896, 2002.
  pubmed

• 10) Giet O, Van Bockstaele DR, Di Stefano I, Huygen S, Greimers R, Beguin Y, Gothot A:Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood 99 (6):2023-2031, 2002.
  pubmed

• 11) Hyduk SJ, Cybulsky MI:Alpha 4 integrin signaling activates phosphatidylinositol 3-kinase and stimulates T cell adhesion to intercellular adhesion molecule-1 to a similar extent as CD3, but induces a distinct rearrangement of the actin cytoskeleton. J Immunol 168 (2):696-704, 2002.
  pubmed

• 12) Szabo M, McIntyre BW:Identification of two variants of the human integrin alpha 4 subunit. Mol Immunol 32 (17-18):1453-1454, 1995. (No abstract available)

• 13) Pujades C, Teixido J, Bazzoni G, Hemler ME:Integrin alpha 4 cysteines 278 and 717 modulate VLA-4 ligand binding and also contribute to alpha 4/180 formation. Biochem J 313 (Pt 3):899-908, 1996.

• 14) Takada Y, Elices MJ, Crouse C, Hemler ME:The primary structure of the alpha 4 subunit of VLA-4:homology to other integrins and a possible cell-cell adhesion function. EMBO J 8 (5):1361-1368, 1989.

• 15) Rosen GD, Birkenmeier TM, Dean DC:Characterization of the alpha 4 integrin gene promoter. Proc Natl Acad Sci USA 88 (10):4094-4098, 1991.
  pubmed

• 16) Fernandez-Ruiz E, Pardo-Manuel de Villena F, Rubio MA, Corbi AL, Rodriguez de Cordoba S, Sanchez-Madrid F:Mapping of the human VLA-alpha 4 gene to chromosome 2q31-q32. Eur J Immunol 22 (2):587-590, 1992.
  pubmed

• 17) Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA:The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128:1243, 1995.
  pubmed

• 18) Arroyo AG, Yang JT, Rayburn H, Hynes RO:Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell 85:997, 1996.
  pubmed

• 19) Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, Weissman IL, Hamann A, Butcher EC:Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185, 1993.

• 20) Ennis E, Isberg RR, Shimizu Y:Very late antigen 4-dependent adhesion and costimulation of resting human T cells by the bacterial beta 1 integrin ligand invasin. J Exp Med 177:207, 1993.

• 21) Maguire JE, Danahey KM, Burkly LC, van Seventer GA:T cell receptor-and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells. J Exp Med 182:2079, 1995.

• 22) Masumoto A, Hemler ME:Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4:distinct effects on adhesion to CS1/fibronectin. J Cell Biol 123:245, 1993.
  pubmed

• 23) Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer S, Garcia-Pardo A, Lobb R, Hemler ME, Sanchez-Madrid F:Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes. J Biol Chem 266:10241, 1991.
  pubmed

• 24) Schweighoffer T, Tanaka Y, Tidswell M, Erle DJ, Horgan KJ, Luce GE, Lazarovits AI, Buck D, Shaw S:Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+memory T cells with Hallmarks of gut-trophism. J Immunol 151:717, 1993.

P.182 掲載の参考文献

• 1) Porter JC, Hogg N:Integrins take partners:cross-talk between integrins and other membrane receptors. Trends Cell Biol 8 (10):390-396, 1998.
  pubmed

• 2) Coulombel L, Auffray I, Gaugler MH, Rosemblatt M:Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol 97 (1-2):13-21, 1997.

• 3) Ruoslahti E:Integrin signaling and matrix assembly. Tumour Biol 17 (2):117-124, 1996.
  pubmed

• 4) Su JM, Gui L, Zhou YP, Zha XL:Expression of focal adhesion kinase and alpha 5 and beta 1 integrins in carcinomas and its clinical significance. World J Gastroenterol 8 (4):613-618, 2002.

• 5) Klein S, de Fougerolles AR, Blaikie P, Khan L, Pepe A, Green CD, Koteliansky V, Giancotti FG:Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol 22 (16):5912-5922, 2002.
  pubmed

• 6) Pulai JI, Del Carlo M Jr, Loeser RF:The alpha 5 beta 1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum 46 (6):1528-1535, 2002.
  pubmed

• 7) Nesti LJ, Caterson EJ, Wang M, Chang R, Chapovsky F, Hoek JB, Tuan RS:TGF-beta 1-stimulated osteoblasts require intracellular calcium signaling for enhanced alpha 5 integrin expression. Ann N Y Acad Sci 961:178-182, 2002.
  pubmed

• 8) Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, Hynes RO:Central roles of alpha 5 beta 1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 22 (6):927-933, 2002.
  pubmed

• 9) Mould AP, Askari JA, Barton S, Kline AD, McEwan PA, Craig SE, Humphries MJ:Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain. J Biol Chem 277 (22):19800-19805, 2002.
  pubmed

• 10) Giet O, Van Bockstaele DR, Di Stefano I, Huygen S, Greimers R, Beguin Y, Gothot A:Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood 99 (6):2023-2031, 2002.
  pubmed

• 11) El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, Laplantine E, Geerts D, Georges-Labouesse E, Sonnenberg A, Aumailley M:The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha 5 and alpha 6 subunits. Matrix Biol 21 (2):207-214, 2002.

• 12) Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY:An alternative processing of integrin alpha (v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 277 (9):7377-7385, 2002.
  pubmed

• 13) Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E:Amino acid sequence of the human fibronectin receptor. J Cell Biol 105 (3):1183-1190, 1987.
  pubmed

• 14) Argraves WS, Pytela R, Suzuki S, Millan JL, Pierschbacher MD, Ruoslahti E:cDNA sequences from the alpha subunit of the fibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide. J Biol Chem 261 (28):12922-12924, 1986.

• 15) Wayner EA, Carter WG, Piotrowicz RS, Kunicki TJ:The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix:preparation of monoclonal antibodies tothe fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 107 (5):1881-1891, 1988.

• 16) Sosnoski DM, Emanuel BS, Hawkins AL, van Tuinen P, Ledbetter DH, Nussbaum RL, Kaos FT, Schwartz E, Phillips D, Bennett JS, et al:Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest 81 (6):1993-1998, 1988.
  pubmed

• 17) Fitzgerald LA, Poncz M, Steiner B, Rall SC Jr, Bennett JS, Phillips DR:Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glyco-protein IIb. Biochemistry 26 (25):8158-8165, 1987.

P.184 掲載の参考文献

• 1) Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM:Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation:asurvival mechanism for carcinoma cells. J Cell Biol 158 (1):165-174, 2002.

• 2) Davis TL, Buerger F, Cress AE:Differential regulation of a novel variant of the alpha (6) integrin, alpha (6p). Cell Growth Differ 13 (3):107-113, 2002.
  pubmed

• 3) El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, Laplantine E, Geerts D, Georges-Labouesse E, Sonnenberg A, Aumailley M:The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha 5 and alpha 6 subunits. Matrix Biol 21 (2):207-214, 2002.

• 4) Sashiyama H, Shino Y, Sakao S, Shimada H, Kobayashi S, Ochiai T, Shirasawa H:Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. Cancer Lett 177 (1):21-28, 2002.
  pubmed

• 5) Schottelndreier H, Potter BV, Mayr GW, Guse AH:Mechanisms involved in alpha 6 beta1-integrin-mediated Ca (2+) signalling. Cell Signal 13 (12):895-899, 2001.

• 6) Davis TL, Rabinovitz I, Futscher BW, Schnolzer M, Burger F, Liu Y, Kulesz-Martin M, Cress AE:Identification of a novel structural variant of the alpha 6 integrin. J Biol Chem 276 (28):26099-26106, 2001.
  pubmed

• 7) Ruzzi L, Gagnoux-Palacios L, Pinola M, Belli S, Meneguzzi G, D'Alessio M, Zambruno G:A homozygous mutation in the integrin alpha 6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest 99 (12):2826-2831, 1997.

• 8) Hogervorst F, Kuikman I, van Kessel AG, Sonnenberg A:Molecular cloning of the human alpha 6 integrin subunit. Alternative splicing of alpha 6 mRNA and chromosomal localization of the alpha 6 and beta 4 genes. Eur J Biochem 199 (2):425-433, 1991.
  pubmed

• 9) Tamura RN, Rozzo C, Starr L, Chambers J, Reichardt LF, Cooper HM, Quaranta V:Epithelial integrin alpha 6 beta 4:complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol 111 (4):1593-1604, 1990.
  pubmed

• 10) Tamura RN, Cooper HM, Collo G, Quaranta V:Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc Natl Acad Sci USA 88 (22):10183-10187, 1991.
  pubmed

• 11) Starr L, Quaranta V:An efficient and reliable method for cloning PCR-amplification products:a survey of point mutations in integrin cDNA. Biotechniques 13 (4):612-618, 1992.
  pubmed

P.186 掲載の参考文献

• 1) Acevedo A, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Gonzalez-Amaro R, Sanchez-Madrid F:Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 143:774-783, 1993.
  pubmed

• 2) Campanero MR, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Hernandez-Caselles T, Craig A, Pulido R, Sanchez-Madrid F:ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 123:1007-1016, 1993.
  pubmed

• 3) Fawcett J, Holness CL, Needham LA, Turley H, Gatter KC, Mason DY, Simmons DL:Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360:481-484, 1992.
  pubmed

• 4) Hernandez-Caselles T, Rubio G, Campanero MR, del Pozo MA, Muro M, Sanchez-Madrid F, Aparicio P:ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. Eur J Immunol 23:2799-2806, 1993.
  pubmed

• 5) Juan M, Vinas O, Pino-Otin MR, Places L, Martinez-Caceres E, Barcelo JJ, Miralles A, Vilella R, de la Fuente MA, Vives J, et al:CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56ick in Jurkat T cell line. J Exp Med 179:1747-1756, 1994.

• 6) Van der Vieren M, Le Trong H, Wood CL, Moore PF, St John T, Staunton DE, Gallatin WM:Anovel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity 3:683-690, 1995.

• 7) Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St John T, Gallatin WM:Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature 360:485-488, 1992.
  pubmed

• 8) de Fougerolles AR, Springer TA:Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 175:185-190, 1992.
  pubmed

• 9) de Fougerolles AR, Qin X, Springer TA:Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 179:619-629, 1994.
  pubmed

• 10) del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F:Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extrace1-lular matrix. Involvement of cAMP signaling pathway. J Cell Biol 131:495-508, 1995.

P.188 掲載の参考文献

• 1) Sajid M, Stouffer GA:The role of alpha (v) beta 3 integrins in vascular healing. Thromb Haemost 87 (2):187-193, 2002.

• 2) Porter JC, Hogg N:Integrins take partners:cross-talk between integrins and other membrane receptors. Trends Cell Biol 8 (10):390-396, 1998.
  pubmed

• 3) Horton MA:The alpha v beta 3 integrin "vitronectin receptor". Int J Biochem Cell Biol 29 (5):721-725, 1997.
  pubmed

• 4) Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B, Hensler M:Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis 19 (5):427-436, 2002.

• 5) Nejjari M, Hafdi Z, Gouysse G, Fiorentino M, Beatrix O, Dumortier J, Pourreyron C, Barozzi C, D'errico A, Grigioni WF, Scoazec JY:Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma:an in vivo and in vitro study. Hepatology 36 (2):418-426, 2002.

• 6) Rezaee M, Penta K, Quertermous T:Dell mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha (v) beta (3). Am J Physiol Heart Circ Physiol 282 (5):H1924-H1932, 2002.

• 7) Pilch J, Habermann R, Felding-Habermann B:Unique ability of integrin alpha (v) beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 277 (24):21930-21938, 2002.
  pubmed

• 8) Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS:Overexpression of alpha (v) beta 6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 23 (2):237-244, 2002.

• 9) Chettab K, Zibara K, Belaiba SR, McGregor JL:Acute hyperglycaemia induces changes in the transcription levels of 4 maj or genes in human endothelial cells:macroarrays-based expression analysis. Thromb Haemost 87 (1):141-148, 2002.
  pubmed

• 10) Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY:Processing of integrin alpha (v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277 (12):9749-9756, 2002..
  pubmed

• 11) Sims MA, Field SD, Barnes MR, Shaikh N, Ellington K, Murphy KE, Spurr N, Campbell DA:Cloning and characterisation of ITGAV, the genomic sequence for human cell adhesion protein (vitronectin) receptor alpha subunit, CD51. Cytogenet Cell Genet 89 (3-4):268-271, 2000.

• 12) Maeshima Y, Colorado PC, Kalluri R:Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275 (31):23745-23750, 2000.
  pubmed

• 13) Fernandez-Ruiz E, Pardo-Manuel de Villena F, Rodriguez de Cordoba S, Sanchez-Madrid F:Regional localization of the human vitronectin receptor alpha subunit gene (VNRA) to chromosome 2q31-> q32. Cytogenet Cell Genet 62 (1):26-28, 1993.
  pubmed

• 14) Donahue JP, Sugg N, Hawiger J:The integrin alpha v gene:identification and characterization of the promoter region. Biochim Biophys Acta 1219 (1):228-232, 1994.
  pubmed

• 15) Sosnoski DM, Emanuel BS, Hawkins AL, van Tuinen P, Ledbetter DH, Nussbaum RL, Kaos FT, Schwartz E, Phillips D, Bennett JS, et al:Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest 81 (6):1993-1998, 1988.
  pubmed

• 16) Fitzgerald LA, Poncz M, Steiner B, Rall SC Jr, Bennett JS, Phillips DR:Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glyco-protein IIb. Biochemistry 26 (25):8158-8165, 1987.

• 17) Suzuki S, Argraves WS, Arai H, Languino LR, Pierschbacher MD, Ruoslahti E:Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem 262 (29):14080-14085, 1987.
  pubmed

• 18) Suzuki S, Argraves WS, Pytela R, Arai H, Krusius T, Pierschbacher MD, Ruoslahti E:cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Nalt Sci USA 83 (22):8614-8618, 1986.

P.190 掲載の参考文献

• 1) Hale G, Phillips JM:Clinical trials with CAMPATH-1 and other monoclonal antibodies. Biochem Soc Trans 23:1057, 1995.
  pubmed

• 2) Hale G, Waldmann H:CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J Hematother 3:15, 1994.
  pubmed

• 3) Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H:The CAMPATH-1 antigen (CDw52). Tissue Antigens 35:118, 1990.
  pubmed

• 4) Kirchhoff C, Hale G:Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Mol Hum Reprod 2:177, 1996.
  pubmed

• 5) Hale G, Rye PD, Warford A, Lauder I, Brito-Babapulle A:The glycosylphosphatidylinositol-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa. J Reprod Immunol 23:189, 1993.
  pubmed

• 6) Kirchhoff C, Krull N, Pera I, Ivell R:Amajor mRNA of the human epididymal principal cells, HE5, encodes the leucocyte differentiation CDw52 antigen peptide backbone. Mol Repr Dev 34:11-15, 1992.

• 7) Riechmann L, Clark M, Waldmann H, Winter G:Reshaping human antibodies for therapy. Nature 332:323, 1988.
  pubmed

• 8) Treumann A, Lifely MR, Schneider P, Ferguson MA:Primary structure of CD52. J Biol Chem 270:6088, 1995.
  pubmed

• 9) Valentin H, Gelin C, Coulombel L, Zoccola D, Morizet J, Bernard A:The distribution of the CDW52 molecule on blood cells and characterization of its involvement in T cell activation. Transplantation 54:97, 1992.

• 10) Xia MQ, Hale G, Lifely MR, Ferguson MA, Campbell D, Packman L, Waldmann H:Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem J 293:633, 1993.
  pubmed

• 11) Xia MQ, Tone M, Packman L, Hale G, Waldmann H:Characterization of the CAMPATH-1 (CDw52) antigen:biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol 21:1677, 1991.
  pubmed

P.192 掲載の参考文献

• 1) Wright MD, Tomlinson MG:The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588, 1994.
  pubmed

• 2) Amiot M:Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins. J Immunol 145:4322, 1990.
  pubmed

• 3) Angelisova P, Hilgert I, Horejsi V:Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249, 1994.
  pubmed

• 4) Angelisova P, Vlcek C, Stefanova I, Lipoldova M, Horejsi V:The human leucocyte surface antigen CD53 is a protein structurally similar to the CD37 and MRC OX-44 antigens. Immunogenetics 32:281, 1990.

• 5) Bell GM, Seaman WE, Niemi EC, Imboden JB:The OX-44 molecule couples to signaling pathways and is associated with CD2on rat T lymphocytes and a natural killer cell line. J Exp Med 175:527, 1992.

• 6) Bosca L, Lazo PA:Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages. J Exp Med 179:1119, 1994.
  pubmed

• 7) Carmo AM, Wright MD:Association of the transmembrane 4 superfamily molecule CD53 with a tyrosine phosphatase activity. Eur J Immunol 25:2090,1995.
  pubmed

• 8) Mannion BA, Berditchevski F, Kraeft SK, Chen LB, Hemler ME:Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J Immunol 157:2039, 1996.
  pubmed

• 9) Mitnacht R, Tacke M, Hunig T:Expression of cell interaction molecules by immature rat thymocytes during passage through the CD4+8+compartment:developmental regulation and induction by T cell receptor engagement of CD2, CD5, CD28, CD11a, CD44 and CD53. Eur J Immunol 25:328, 1995.

• 10) Olweus J, Lund-Johansen F, Horejsi V:CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells. J Immunol 151:707, 1993.

• ll) Rasmussen AM, Blomhoff HK, Stokke T, Horejsi V, Smeland EB:Cross-linking of CD53 promotes activation of resting human B lymphocytes. J Immunol 153:4997, 1994

P.194 掲載の参考文献

• 1) Springer TA:Adhesion receptors of the immune system. Nature 346:425, 1990.
  pubmed

• 2) Dustin ML, Staunton DE, Springer TA:Supergene families meet in the immune system. Immunol Today 9:213, 1988.
  pubmed

• 3) Simmons D, Makgoba MW, Seed B:ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 331:624, 1988.4) Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V:Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545, 1987.

• 5) Medof ME, Lublin DM, Holers VM, Ayers DJ, Getty RR, Leykam JF, Atkinson JP, Tykocinski ML:Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 84:2007, 1987.
  pubmed

• 6) Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fuj ita T, Anstee DJ, Rosse W, Lublin DM:Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 149:2906, 1992.

• 7) Rothlein R, Dustin ML, Marlin SD, Springer TA:Ahuman intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137:1270, 1986.

• 8) Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA:Induction by IL 1 and interferon-gamma:tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245, 1986.

• 9) Tsujisaki M, Imai K, Hirata H, Hanzawa Y, Masuya J, Nakano T, Sugiyama T, Matsui M, Hinoda Y, Yachi A:Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 85:3, 1991.
  pubmed

• 10) Yamamura M, Hinoda Y, Sasaki S, Tsujisaki M, Oriuchi N, Endo K, Imai K:A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging. Jpn J Cancer Res 87:405, 1996.
  pubmed

P.196 掲載の参考文献

• 1) Garratty G:Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol Invest 24:213, 1995.
  pubmed

• 2) Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP:Control of the complement system. Adv Immunol 61:201, 1996.
  pubmed

• 3) Lublin DM, Atkinson JP:Decay-accelerating factor and membrane cofactor protein. Curr Top Microbiol Immunol 153:123, 1990.
  pubmed

• 4) Nicholson-Weller A, Wang CE:Structure and function of decay accelerating factor CD55. J Lab Clin Med 123:485, 1994.
  pubmed

• 5) Vanderpuye OA, Labarrere CA, McIntyre JA:The complement system in human reproduction. Am J Reprod Immunol 27:145, 1992.
  pubmed

• 6) Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW:Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903, 1995.
  pubmed

• 7) Brodbeck WG, Liu D, Sperry J, Mold C, Medof ME:Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J Immunol 156:2528, 1996.

• 8) Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V:Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545, 1987.
  pubmed

• 9) Clarkson NA, Kaufman R, Lublin DM, Ward T, Pipkin PA, Minor PD, Evans DJ, Almond JW:Characterization of the echovirus 7 receptor:domains of CD55 critical for virus binding. J Virol 69:5497, 1995.
  pubmed

• 10) Finberg RW, White W, Nicholson-Weller A:Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J Immunol 149:2055, 1992.
  pubmed

• 11) Hatanaka M, Seya T, Matsumoto M, Hara T, Nonaka M, Inoue N, Takeda J, Shimizu A:Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Biochem J 314:969, 1996.
  pubmed

• 12) Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K:The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol 70:5143, 1996.
  pubmed

• 13) Medof ME, Lublin DM, Holers VM, Ayers DJ, Getty RR, Leykam JF, Atkinson JP, Tykocinski ML:Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 84:2007, 1987.
  pubmed

• 14) Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP:Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149:129, 1996.
  pubmed

• 15) Pham T, Kaul A, Hart A, Goluszko P, Moulds J, Nowicki S, Lublin DM, Nowicki BJ:Dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect Immun 63:1663, 1995.
  pubmed

• 16) Post TW, Arce MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM:Structure of the gene for human complement protein decay accelerating factor. J Immunol 144:740, 1990.
  pubmed

• 17) Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD:Coxsackieviruses B1, B3, and B5 use decay accelerating as a receptor for cell attachment. J Virol 69:3873, 1995.
  pubmed

• 18) Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW, Shaw AS, Lublin DM:Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p561ck and p5gfyn 1. J Immunol 149:3535, 1992.

• 19) Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M:Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-1) and human cytomegalovirus (HCMV). J Immunol 155:4376, 1995.
  pubmed

• 20) Stoiber H, Pinter C, Siccardi AG, Clivio A, Dierich MP ;Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 183:307, 1996.
  pubmed

• 21) Telen MJ:Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria. Transfus Clin Biol 2:277, 1995.
  pubmed

• 22) Thomas DJ, Lublin DM:Identification of 5'-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 150:151, 1993.
  pubmed

• 23) Venneker GT, Das PK, Naafs B, Tigges AJ, Bos JD, Asghar SS:Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium. Br J Dermatol 131:237, 1994.
  pubmed

P.198 掲載の参考文献

• 1) Thiery JP, Duband JL, Rutishauser U, Edelman GM:Cell adhesion molecules in early chicken em-bryogenesis. Proc Natl A cad Sci USA 79:6737, 1982.

• 2) Rutishauser U, Grumet M, Edelman GM:Neural cell adhesion molecule mediates initial interactions between spinal cord neurons and muscle cells in culture. J Cell Biol 97:145, 1983.
  pubmed

• 3) Lanier LL, Testi R, Bindl J, Phillips JH:Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169:2233, 1989.
  pubmed

• 4) Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson MA, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J:Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin In vest 75:932, 1985.

• 5) Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman GM:Neural cell adhesion molecule:structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 236:799, 1987.
  pubmed

• 6) Barton CH, Dickson G, Gower HJ, Rowett LH, Putt W, Elsom V, Moore SE, Goridis C, Walsh FS:Complete sequence and in vitro expression of a tissue-specific phosphatidylinositol-linked N-CAM isoform from skeletal muscle. Development 104:165, 1988.
  pubmed

• 7) Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH:Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol 146:4421, 1991.
  pubmed

• 8) Hemperly JJ, DeGuglielmo JK, Reid RA:Characterization of cDNA clones defining variant forms of human neural cell adhesion molecule N-CAM. J Mol Neurosci 2:71, 1990.

• 9) Cremer H, Lange R, Christoph A, Plomann M, Vopper G, Roes J, Brown R, Baldwin S, Kraemer P, Scheff S, et al:Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 367:455, 1994.

P.200 掲載の参考文献

• 1) Schroder J, Nikinmaa B, Kavathas P, Herzenberg LA:Fluorescence-activated cell sorting of mouse-human hybrid cells aids in locating the gene for the Leu 7 (HNK-1) antigen to human chromosome II. Proc Nat Acad Sci USA 80:3421-3424, 1983.

• 2) Pruitt KD, Maglott DR:NCBI gene-centered resources. Nucleic Acids Res 29 (1):137-140, 2001.
  pubmed

• 3) Pruitt KD, Katz KS, Sicotte H, Maglott DR:Introducing RefSeq and LocusLink:curated human genome resources at the NCBI. Trends Genet 16 (1):44-47, 2000.
  pubmed

P.201 掲載の参考文献

• 1) Springer TA, Dustin ML, Kishimoto TK, Marlin SD:The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules:cell adhesion receptors of the immune system. Annu Rev Immunol 5:223, 1987.
  pubmed

• 2) Arulanandam AR, Kister A, McGregor MJ, Wyss DF, Wagner G, Reinherz EL:Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains. J Exp Med 180:1861, 1994.
  pubmed

• 3) Dustin ML, Selvaraj P, Mattaliano RJ, Springer TA:Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface. Nature 329:846, 1987.
  pubmed

• 4) Osborn L, Day ES, Miller GT, Karpusas M, Tizard R, Meuer SC, Hochman PS:Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2. J Exp Med 181:429, 1995.
  pubmed

• 5) Plunkett ML, Sanders ME, Selvaraj P, Dustin ML, Springer TA:Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3). J Exp Med 165:664, 1987.

• 6) Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA:Three distinct antigens associated with human T-lymphocyte-mediated cytolysis:LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 79:7489, 1982.

• 7) Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S:Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 140:1401, 1988.
  pubmed

• 8) Seed B:An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 329:840, 1987.
  pubmed

• 9) Semnani RT, Nutman TB, Hochman P, Shaw S, van Seventer GA:Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human 'naive' and 'memory' CD4+Tcells. J Exp Med 180:2125, 1994.

• 10) Wallner BP, Frey AZ, Tizard R, Mattaliano RJ, Hession C, Sanders ME, Dustin ML, Springer TA:Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein. J Exp Med 166:923, 1987.

P.203 掲載の参考文献

• 1) Davies A, Lachmann PJ:Membrane defence against complement lysis:the structure and biological properties of CD59. Immunol Res 12:258, 1993
  pubmed

• 2) Lachmann PJ:The control of homologous lysis. Immunol Today 12:312, 1991
  pubmed

• 3) Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP:Control of the complement system. Adv Immunol 61:201, 1996
  pubmed

• 4) Venneker GT, Asghar SS:CD59:a molecule involved in antigen presentation as well as downregulation of membrane attack complex. Exp Clin Immunogenet 9:33, 1992
  pubmed

• 5) Walsh LA, Tone M, Thiru S, Waldmann H:The CD59 antigen-a multifunctional molecule. Tissue Antigens 40:213, 1992.
  pubmed

• 6) Bickmore WA, Longbottom D, Oghene K, Fletcher JM, van Heyningen V:Colocalization of the human CD59 gene to IIp13 with the MIC11 cell surface antigen. Genomics 17:129, 1993.
  pubmed

• 7) Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS:Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149, 1997.
  pubmed

• 8) Cerny J, Stockinger H, Horejsi V:Noncovalent associations of T lymphocyte surface proteins. Eur J Immunol 26:2335, 1996.
  pubmed

• 9) Holguin MH, Martin CB, Eggett T, Parker CJ:Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter. J Immunol 157:1659, 1996.
  pubmed

• 10) Husler T, Lockert DH, Sims PJ:Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59. Biochemisdy 35:3263, 1996.
  pubmed

• 11) Kieffer B, Driscoll PC, Campbell ID, Willis AC, van der Merwe PA, Davis SJ:Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 33:4471, 1994.
  pubmed

• 12) Kroshus TJ, Bolman RM III, Dalmasso AP, Rollins SA, Guilmette ER, Williams BL, Squinto SP, Fodor WL:Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 61:1513, 1996.

• 13) Meri S, Waldmann H, Lachmann PJ:Distribution of protectin (CD59), acomplement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532, 1991.

• 14) Solomon KR, Rudd CE, Finberg RW:The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc Natl Acad Sci USA 93:6053, 1996.
  pubmed

• 15) Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M:Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-1) and human cytomegalovirus (HCMV). J Immunol 155:4376, 1995.
  pubmed

• 16) Venneker GT, Das PK, Meinardi MM, van Marle J, van Veen HA, Bos JD, Asghar SS:Glycosylphosphatidylinositol (GPI)-anchored membrane proteins are constitutively down-regulated in psoriatic skin. J Pathol 172:189, 1994.
  pubmed

• 17) Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S:Mapping the active site of CD59. J Exp Med 185:745, 1997.
  pubmed

• 18) van den Berg CW, Cinek T, Hallett MB, Horejsi V, Morgan BP:Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca (2+)-signaling competent. J Cell Biol 131:669, 1995.
  pubmed

• 19) van den Berg CW, Morgan BP:Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 152:4095, 1994.

P.205 掲載の参考文献

• 1) Fox DA, Millard JA, Kan L, Zeldes WS, Davis W, Higgs J, Emmrich F, Kinne RW:Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest 86:1124, 1990.
  pubmed

• 2) Fox DA, et al:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp399-401, 1995.

• 3) Hamann D, et al:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp401-403, 1995.

• 4) Kniep B, Flegel WA, Northoff H, Rieber EP:CDw60 glycolipid antigens of human leukocytes:structural characterization and cellular distribution. Blood 82:1776, 1993.
  pubmed

• 5) Kniep J, et al:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp362-364, 1989.

• 6) Rieber EP, Rank G:CDw60:a marker for human CD8+T helper cells. J Exp Med 179:1385, 1994.
  pubmed

• 7) Semnani RT, Nutman TB, Hochman P, Shaw S, van Seventer GA:Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human 'naive' and 'memory' CD4+Tcells.J Exp Med 180:2125, 1994.

P.206 掲載の参考文献

• 1) Fox DA, Millard JA, Kan L, Zeldes WS, Davis W, Higgs J, Emmrich F, Kinne RW:Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest 86:1124, 1990.
  pubmed

• 2) Fox DA, et al:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp399-401, 1995.

• 3) Hamann D, et al:In Leukocyte Typing V, eds Schlossman SF, et al), Oxford University Press, pp401-403, 1995.

• 4) Kniep B, Flegel WA, Northoff H, Rieber EP:CDw60 glycolipid antigens of human leukocytes:structural characterization and cellular distribution. Blood 82:1776, 1993.
  pubmed

• 5) Kniep J, et al:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp362-364, 1989.

• 6) Rieber EP, Rank G:CDw60:amarker for human CD8+T helper cells. J Exp Med 179:1385, 1994.

• 7) Semnani RT, Nutman TB, Hochman P, Shaw S, van Seventer GA:Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human 'naive' and 'memory' CD4+Tcells. J Exp Med 180:2125, 1994.

P.207 掲載の参考文献

• 1) Fox DA, Millard JA, Kan L, Zeldes WS, Davis W, Higgs J, Emmrich F, Kinne RW:Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest 86:1124, 1990.
  pubmed

• 2) Fox DA, et al:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp399-401, 1995.

• 3) Hamann D, et al:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp401-403, 1995.

• 4) Kniep B, Flegel WA, Northoff H, Rieber EP:CDw60 glycolipid antigens of human leukocytes:structural characterization and cellular distribution. Blood 82:1776, 1993.
  pubmed

• 5) Kniep J, et al:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp362-364, 1989.

• 6) Rieber EP, Rank G:CDw60:amarker for human CD8+T helper cells. J Exp Med 179:1385, 1994.

• 7) Semnani RT, Nutman TB, Hochman P, Shaw S, van Seventer GA:Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human 'naive' and 'memory' CD4+Tcells. J Exp Med 180:2125, 1994.

P.209 掲載の参考文献

• 1) Sajid M, Stouffer GA:The role of alpha (v) beta 3 integrins in vascular healing. Thromb Haemost 87 (2):187-193, 2002.

• 2) Trikha M, Timar J, Zacharek A, Nemeth JA, Cai Y, Dome B, Somlai B, Raso E, Ladanyi A, Honn KV:Role for beta3 integrins in human melanoma growth and survival. Int J Cancer 101 (2):156-167, 2002.
  pubmed

• 3) Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B, Hensler M:Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis 19 (5):427-436, 2002.

• 4) Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horejsi V, Shattil SJ, Watson SP:Differential role of glycolipid-enriched membrane domains in glycoprotein VI-and integrin-mediated phospholipase C gamma 2 regulation in platelets. Biochem J 364 (Pt 3):755-765, 2002.

• 5) Hantgan RR, Stahle MC, Jerome WG, Nagaswami C, Weisel JW:Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of Gp IIb/IIIa structure. Thromb Haemost 87 (5):910-917, 2002.

• 6) Jallu V, Meunier M, Brement M, Kaplan C:Anew platelet polymorphism Duv (a+), localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia. Blood 99 (12):4449-4456, 2002.

• 7) Bertoni A, Tadokoro S, Eto K, Pampori N, Parise LV, White GC, Shattil SJ:Relationships between Raplb, affinity modulation of integrin alpha IIb beta 3, and the actin cytoskeleton. J Biol Chem 277 (28):25715-25721, 2002.

• 8) Rezaee M, Penta K, Quertermous T:Dell mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha (v) beta (3). Am J Physiol Heart Circ Physiol 282 (5):H1924-H1932, 2002.

• 9) Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ:Coordinate interactions of Csk, Src, and Syk kinases with[alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 157 (2):265-275, 2002.

• 10) Pilch J, Habermann R, Felding-Habermann B:Unique ability of integrin alpha (v) beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 277 (24):21930-21938, 2002.
  pubmed

• 11) Simovich MJ, Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, Smith HK:Cellular location of proteins related to iron absorption and transport. Am J Hematol 69 (3):164-170, 2002.
  pubmed

• 12) Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS:Direct regulation of beta 3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol 16 (3):571-579, 2002.
  pubmed

• 13) Ndoko S, Poujol C, Combrie R, Nurden A, Nurden P:Paradoxical platelet activation was not observed on dissociation of abciximab from Gp IIb-IIIa complexes. Thromb Haemost 87 (2):317-322, 2002.
  pubmed

• 14) Kasirer-Friede A, Ware J, Leng L, Marchese P, Ruggeri ZM, Shattil SJ:Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIb beta 3. J Biol Chem 277 (14):11949-11956, 2002.
  pubmed

• 15) Morel-Kopp MC, Melchior C, Chen P, Ammerlaan W, Lecompte T, Kaplan C, Kieffer N:A naturally occurring point mutation in the beta 3 integrin MIDAS-like domain affects differently alpha v beta 3 and alpha IIIb beta 3 receptor function. Thromb Haemost 86 (6):1425-1434, 2001.

• 16) Dicker IB, Pedicord DL, Seiffert DA, Jamieson GA, Greco NJ:Both the high affinity thrombin receptor (GPIb-IX-V) and GP IIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Thromb Haemost 86 (4):1065-1069, 2001.

• 17) Derrick JM, Shattil SJ, Poncz M, Gruppo RA, Gartner TK:Distinct domains of alpha IIb beta 3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alpha IIb beta 3 interacting peptide. Thromb Haemost 86 (3):894-901, 2001.

• 18) Maeshima Y, Colorado PC, Kalluri R:Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275 (31):23745-23750, 2000.
  pubmed

• 19) Longhurst CM, White MM, Wilkinson DA, Jennings LK:ACD9, alpha llb beta 3, integrin-associated protein, and GP Ib/V/IX complex on the surface of human platelets is influenced by alpha llb beta 3 conformational states. Eur J Biochem 263 (1):104-111, 1999.

• 20) Villa-Garcia M, Li L, Riely G, Bray PF:Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene. Blood 83 (3):668-676, 1994.
  pubmed

P.212 掲載の参考文献

• 1) Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, Picker LJ, Butcher EC:The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 174:1461, 1991.
  pubmed

• 2) Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr:Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238, 1987.
  pubmed

• 3) Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B:Endothelial leukocyte adhesion molecule 1:an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160, 1989.
  pubmed

• 4) Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J:Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells:endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77:2266, 1991.
  pubmed

• 5) Cotran RS, Gimbrone MA Jr, Bevnacqua MP, Mendrick DL, Pober JS:Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 164:661, 1986.

• 6) Groves RW, Allen MH, Barker JN, Haskard DO, MacDonald DM:Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 124:117, 1991.
  pubmed

• 7) Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ:Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 64:313, 1991.
  pubmed

• 8) Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ:Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517, 1995.
  pubmed

• 9) Lawrence MB, Springer TA:Neutrophils roll on E-selectin. J Immunol 151:6338, 1993.

• 10) Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr:Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680, 1986.
  pubmed

• 11) Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B:Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250:1132, 1990.
  pubmed

P.214 掲載の参考文献

• 1) Chen A, Engel P, Tedder TF:Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 182:519, 1995.

• 2) Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, Tedder TF:Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J Immunol 145:576, 1990.
  pubmed

• 3) Migaki GI, Kahn J, Kishimoto TK:Mutational analysis of the membrane-proximal cleavage site of L-selectin:relaxed sequence specificity surrounding the cleavage site. J Exp Med 182:549, 1995.

• 4) Spertini O, Freedman AS, Belvin MP, Penta AC, Griffin JD, Tedder TF:Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 5:300, 1991.
  pubmed

• 5) Spertini O, Luscinskas FW, Gimbrone MA Jr, Tedder TF:Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions. J Exp Med 175:1789, 1992.
  pubmed

• 6) Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA Jr, Tedder TF:Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 147:2565, 1991.

• 7) Tedder TF, Isaacs CM, Ernst TJ, Demetri GD, Adler DA, Disteche CM:Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins. J Exp Med 170:123, 1989.
  pubmed

• 8) Tedder TF, Matsuyama T, Rothstein D, Schlossman SF, Morimoto C:Human antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation. Eur J Immunol 20:1351, 1990.
  pubmed

• 9) Tedder TF, Penta AC, Levine HB, Freedman AS:Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 144:532, 1990.
  pubmed

P.216 掲載の参考文献

• 1) McEver RP, Moore KL, Cummings RD:Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 270:11025, 1995.
  pubmed

• 2) Varki A:Selectin ligands. Proc Natl Acad Sci USA 91:7390, 1994.
  pubmed

• 3) Crovello CS, Furie BC, Furie B:Histidine phosphorylation of P-selectin upon stimulation of human platelets:a novel pathway for activation-dependent signal transduction. Cell 82:279, 1995.
  pubmed

• 4) Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH:Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273:252, 1996.
  pubmed

• 5) Frenette PS, Johnson RC, Hynes RO, Wagner DD:Platelets roll on stimulated endothelium in vivo:an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92:7450, 1995.
  pubmed

• 6) Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD:Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell 84:563, 1996.

• 7) Fujimoto T, Stroud E, Whatley RE, Prescott SM, Muszbek L, Laposata M, McEver RP:P-selectin is acylated with palmitic acid and stearic acid at cysteine 766 through a thioester linkage. J Biol Chem 268:11394, 1993.
  pubmed

• 8) Johnston GI, Cook RG, McEver RP:Cloning of GMP-140, a granule membrane protein of platelets and endothelium:sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56:1033, 1989.
  pubmed

• 9) Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD:Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74:541, 1993.

• 10) Norman KE, Moore KL, McEver RP, Ley K:Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand. Blood 86:4417, 1995.

• 11) Pan J, McEver RP:Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family. J Biol Chem 270:23077, 1995.

• 12) Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B, et al:Expression clohing of a functional glycoprotein ligand for P-selectin. Cell 75:1179, 1993.

P.218 掲載の参考文献

• 1) Berditchevski F, Bazzoni G, Hemler ME:Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 270:17784, 1995.
  pubmed

• 2) Berditchevski F, Tolias KF, Wong K, Carpenter CL, Hemler ME:A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J Biol Chem 272:2595, 1997.
  pubmed

• 3) Berditchevski F, Zutter MM, Hemler ME:Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 7:193, 1996.
  pubmed

• 4) Hotta H, Miyamoto H, Hara I, Takahashi N, Homma M:Genomic structure of the ME491/CD63 antigen gene and functional analysis of the 5'-flanking regulatory sequences. Biochem Biophys Res Commun 185:436, 1992.
  pubmed

• 5) Kitani S, Berenstein E, Mergenhagen S, Tempst P, Siraganian RP:Acell surface glycoprotein of rat basophilic leukemia cells close to the high affinity IgE receptor (Fc epsilon RI). Similarity to human melanoma differentiation antigen ME491. J Biol Chem 266:1903, 1991.

• 6) Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC:CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266:3239, 1991.
  pubmed

• 7) Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ:Studies with a monoclonal antibody against activated platelets:evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70:838, Stars, 1987.

• 8) Nishikata H, Oliver C, Mergenhagen SE, Siraganian RP:The rat mast cell antigen AD1 (homologue to human CD63 or melanoma antigen ME491) is expressed in other cells in culture. J Immunol 149:862, 1992.
  pubmed

• 9) Radford KJ, Mallesch J, Hersey P:Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 62:631, 1995.
  pubmed

• 10) Radford KJ, Thorne RF, Hersey P:CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochenz Biophys Res Commun 222:13, 1996.
  pubmed

• 11) Radford KJ, Thorne RF, Hersey P:Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158:3353, 19971.

• 12) Sikora LK, Pinto A, Demetrick DJ, Dixon WT, Urbanski SJ, Temple W, Jerry LM:Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes. Int J Cancer 39:138, 1987.
  pubmed

• 13) Takahashi N, Hotta H, Homma M:Activation and suppression of a cryptic promoter in the intron of the human melanoma-associated ME491 antigen gene. Jpn J Cancer Res 82:1239, 1991.
  pubmed

• 14) Vischer UM, Wagner DD:CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184, 1993.
  pubmed

P.220 掲載の参考文献

• 1) Hulett MD, Hogarth PM:Molecular basis of Fc receptor function. Adv Immunol 57:1, 1994.
  pubmed

• 2) Van de Winkel JGJ, Capel PJA (eds):Human IgG Fc Receptors. RG Landes Company, Austin, TX, USA, 1996.

• 3) van de Winkel JG, Capel PJ:Human IgG Fc receptor heterogeneity:molecular aspects and clinical implications. Immunol Today 14:215, 1993.
  pubmed

• 4) Anderson CL, Guyre PM, Whitin JC, Ryan DH, Looney RJ, Fanger MW:Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem 261:12856, 1986.

• 5) Dougherty GJ, Selvendran Y, Murdoch S, Palmer DG, Hogg N:The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol 17:1453, 1987.
  pubmed

• 6) Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM:Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol 157:541, 1996.
  pubmed

• 7) Olweus J, Terstappen LW, Thompson PA, Lund-Johansen F:Expression and function of receptors for tem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood 88:1594, 1996.

• 8) van Vugt MJ, Heijnen AF, Capel PJ, Park SY, Ra C, Saito T, Verbeek JS, van de Winkel JG:FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo. Blood 87:3593, 1996.

• 9) van Vugt MJ, van den Herik-Oudijk IE, van de Winkle JG:Binding of PE-CY5 conjugates to the human high-affinity receptor for IgG. Blood 88:2358, 1996.

P.222 掲載の参考文献

• 1) Bengtson P, Lundblad A, Larson G, Pahlsson P:Polymorphonuclear leukocytes from individuals carrying the G329A mutation in the alpha 1, 3-fucosyltransferase VII gene (FUT7) roll on E-and P-selectins. J Immunol 169 (7):3940-3946, 2002.

• 2) Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, Zimmermann M, Ludwig WD, Janka-Schaub G, Schrappe M, Harbott J:Infant acute lymphoblastic leukemia-combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 16 (9):1685-1690, 2002.
  pubmed

• 3) Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I:The immunophenotype of 325 adult acute leukemias:relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol. 117 (3):380-389, 2002.
  pubmed

• 4) Bengtson P, Larson C, Lundblad A, Larson G, Pahlsson P:Identification of a missense mutation (G329A;Arg (110)->GLN) in the human FUT7 gene. J Biol Chem 276 (34):31575-31582, 2001.

• 5) Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Loffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Volkers B, Aydemir U, Fonatsch C, Gokbuget N, Thiel E, Hoelzer D:Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia:results of the German multicenter trials GMALL 03/87 and 04/89. Blood 92 (6):1898-1909, 1998.

• 6) Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, Ludwig W, Loffler H, Buchner T, Wormann B, Hiddemann W, Bohlander SK:MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t (10;11):both rearrangements are associated with a poor prognosis. Blood 91 (12):4662-4667, 1998.
  pubmed

• 7) Oehler L, Majdic O, Pickl WF, Stockl J, Riedl E, Drach J, Rappersberger K, Geissler K, Knapp W:Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med 187 (7):1019-1028, 1998.
  pubmed

P.225 掲載の参考文献

• 1) Virji M, Watt SM, Barker S, Makepeace K, Doyonnas R:The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 22:929, 1996

• 2) Svenberg T, Hammarstrom S, Zeromski J:Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues. Clin Exp Immunol 36:436, 1979.
  pubmed

• 3) Audette M, Buchegger F, Schreyer M, Mach JP:Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Mol Immunol 24:1177, 1987.
  pubmed

• 4) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J Clin Lab Anal 5:344, 1991.
  pubmed

• 5) Barnett TR, Kretschmer A, Austen DA, Goebel SJ, Hart JT, Elting JJ, Kamarck ME:Carcinoembryonic antigens:alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family. J Cell Biol 108:267, 1989.
  pubmed

• 6) Rojas M, Fuks A, Stanners CP:Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2 (+)-dependent intercellular adhesion molecule. Cell Growth Differ 1:527, 1990.
  pubmed

• 7) Hauck W, Nedellec P, Turbide C, Stanners CP, Barnett TR, Beauchemin N:Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas. Eur J Biochem 223:529, 1994.
  pubmed

• 8) Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C:Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 90:10744, 1993.
  pubmed

• 9) Stocks SC, Kerr MA:Stimulation of neutrophil adhesion by antibodies recognizing CD15 (Le (X) ) and CD15-expressing carcinoembryonic antigen-related glycoprotein NCA-160. Biochem J 288:23, 1992.

• 10) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
  pubmed

• 11) Skubitz KM, Campbell KD, Skubitz AP:CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J Leukoc Biol 60:106, 1996.
  pubmed

• 12) Kuijpers TW, Hoogerwerf M, van der Laan LJ, Nagel G, van der Schoot CE, Grunert F, Roos D:CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells.J Cell Biol 118:457, 1992.
  pubmed

P.226 掲載の参考文献

• 1) Buchegger F, Schreyer M, Carrel S, Mach JP:Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD. Int J Cancer 33:643, 1984.
  pubmed

• 2) Arakawa F, Kuroki M, Misumi Y, Oikawa S, Nakazato H, Matsuoka Y:Characterization of a cDNA clone encoding a new species of the nonspecific cross-reacting antigen (NCA), amember of the CEA gene family. Biochem Biophys Res Commun 166:1063, 1990.

• 3) Berling B, Kolbinger F, Grunert F, Thompson JA, Brombacher F, Buchegger F, von Kleist S, Zimmermann W:Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res 50:6534, 1990.
  pubmed

• 4) Oikawa S, Inuzuka C, Kuroki M, Arakawa F, Matsuoka Y, Kosaki G, Nakazato H:Aspecific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W272 and NCA, is mediated by N-domains. J Biol Chem 266:7995, 1991.

• 5) Lund-Johansen F, Olweus J, Symington FW, Arli A, Thompson JS, Vilella R, Skubitz K, Horejsi V:Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphos-phatidylinositol-anchored antigens. Eur J Immunol 23:2782, 1993.

• 6) Kuijpers TW, van der Schoot CE, Hoogerwerf M, Roos D:Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation. J Immunol 151:4934, 1993.
  pubmed

• 7) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
  pubmed

• 8) Skubitz KM, Campbell KD, Skubitz AP:CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J Leuleoc Biol 60:106, 1996.
  pubmed

• 9) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biologyand clinical perspectives. J Clin Lab Anal 5:344, 1991.

P.228 掲載の参考文献

• 1) Kleist S von, Chavanel G, Burtin P:Identification of an antigen from normal human tissue that cross-reacts with the carcinoembryonic antigen. Proc Natl Acad Sci USA 69:2492, 1972.

• 2) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J Clin Lab Anal 5:344, 1991.
  pubmed

• 3) Audette M, Buchegger F, Schreyer M, Mach JP:Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Mol Immunol 24:1177, 1987.
  pubmed

• 4) Tawaragi Y, Oikawa S, Matsuoka Y, Kosaki G, Nakazato H:Primary structure of nonspecific cross-reacting antigen (NCA) , a member of carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequence. Biochem Biophys Res Commun 150:89, 1988.

• 5) Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H:Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface:homophilic and heterophilic adhesion. Biochem Biophys Res Commun 164:39, 1989.

• 6) Leusch HG, Hefta SA, Drzeniek Z, Hummel K, Markos-Pusztai Z, Wagener C:Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett 261:405, 1990.
  pubmed

• 7) Kuijpers TW, Hoogerwerf M, van der Laan LJ, Nagel G, van der Schoot CE, Grunert F, Roos D:CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endo-thelial cells. J Cell Biol 118:457, 1992.

• 8) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
  pubmed

• 9) Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius HJ, Lotan R:Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55:2191, 1995.
  pubmed

• 10) Skubitz KM, Campbell KD, Skubitz AP:CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J Leukoc Biol 60:106, 1996.
  pubmed

P.229 掲載の参考文献

• 1) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J Clin Lab Anal 5:344, 1991.
  pubmed

• 2) Kuroki M, Arakawa F, Matsuo Y, Oikawa S, Misumi Y, Nakazato H, Matsuoka Y:Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. J Biol Chem 266:11810, 1991.
  pubmed

• 3) Nagel G, Grunert F, Kuijpers TW, Watt SM, Thompson J, Zimmermann W:Genomic organization, splice variants and expression of CGM1, a CD66-related member of the carcinoembryonic antigen gene family. Eur J Biochem 214:27, 1993.
  pubmed

• 4) Skubitz KM, Campbell KD, Ahmed K, Skubitz AP:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J Immunol 155:5382, 1995.
  pubmed

• 5) Skubitz KM, Campbell KD, Skubitz AP:CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J Leuleoc Biol 60:106, 1996.
  pubmed

• 6) Chen T, Gotschlich EC:CGMla antigen of neutrophils, a receptor of gonococcal opacity proteins. Proc Natl Acad Sci USA 93:14851, 1996.
  pubmed

P.230 掲載の参考文献

• 1) Shively JE, Beatty JD:CEA-related antigens:molecular biology and clinical significance. Crit Rev Oncol Hematol 2:355, 1985.
  pubmed

• 2) Gold P, Freedman SO:Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques.J Exp Med 121:439-462, 1965.
  pubmed

• 3) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives.J Clin Lab Anal 5:344, 1991.
  pubmed

• 4) Oikawa S, Nakazato H, Kosaki G:Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Commun 142:511, 1987.
  pubmed

• 5) Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP:Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57:327, 1989.
  pubmed

• 6) Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H:Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface:homophilic and heterophilic adhesion. Biochem Biophys Res Commun 164:39, 1989.

• 7) Leusch HG, Hefta SA, Drzeniek Z, Hummel K, Markos-Pusztai Z, Wagener C:Escerichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett 261:405, 1990.

• 8) Chen CJ, Li LJ, Maruya A, Shively JE:In vitro and in vivo footprint analysis of the promoter ofcarcinoembryonic antigen in colon carcinoma cells:effects of interferon gamma treatment. Cancer Res 55:3873, 1995.

• 9) Gangopadhyay A, Bajenova O, Kelly TM, Thomas P:Carcinoembryonic antigen induces cytokine expression in Kuppfer cells:implications for hepatic metastasis from colorectal cancer. Cancer Res 56:4805, 1996.
  pubmed

P.231 掲載の参考文献

• 1) Tatarinov YS:Trophoblast-specific beta1-glycoprotein as a marker for pregnancy and malignancies. Gynecol Obstet Invest 9:65, 1978.
  pubmed

• 2) Thompson JA, Grunert F, Zimmermann W:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J Clin Lab Anal 5:344, 1991.
  pubmed

• 3) Watanabe S, Chou JY:Human pregnancy-specific beta 1-glycoprotein:anew member of the carcinoembryonic antigen gene family. Biochem Biophys Res Commun 152:762, 1988.

• 4) Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H:Apregnancy-specific beta 1-glycoprotein, a CEA gene family member, expressed in a human promyelocytic leukemia cell line, HL 60:structures of protein, mRNA and gene. Biochem Biopdys Res Commun 163:1021, 1989.

• 5) Barnett TR, Pickle W 2d, Elting JJ:Characterization of two new members of the pregnancy-specific beta 1-glycoprotein family from the myeloid cell line KG-1 and suggestion of two distinct classes of transcription unit. Biochemistry 29:10213, 1990.

• 6) Teglund S, Olsen A, Khan WN, Frangsmyr L, Hammarstrom S:The pregnancy-specific glycoprotein (PSG) gene cluster on human chromosome 19:fine structure of the ll PSG genes and identification of 6new genes forming a third subgroup within the carcinoembryonic antigen (CEA) family. Genomics 23:669, 1994.

P.233 掲載の参考文献

• 1) Cordell JL, Falini B, Flenghi L, Jones DB, Pileri S, Radzun HJ, Wilkins BS:In Leukocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp925-927, 1995.

• 2) Davey FR, Cordell JL, Erber WN, Pulford KA, Gatter KC, Mason DY:Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol 41:753, 1988.
  pubmed

• 3) Fukuda M:Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266:21327, 1991.
  pubmed

• 4) Holness CL, Simmons DL:Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81:1607, 1993.
  pubmed

• 5) Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY:KP1:a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42:414, 1989.
  pubmed

• 6) Pulford KA, Sipos A, Cordell JL, Stross WP, Mason DY:Distribution of the CD68 macrophage/myeloid associated antigen. 1nt Immunol 2:973, 1990.

• 7) Rabinowitz SS, Gordon S:Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 174:827, 1991.
  pubmed

• 8) Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D:The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580, 1995.
  pubmed

• 9) Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D:Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low densitylipoprotein. Proc Natl Acad Sci USA 93:14833, 1996.

• 10) Stockinger H:In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp841-843, 1989.

• 11) Strobl H, Scheinecker C, Csmarits B, Majdic O, Knapp W:Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol 90:774, 1995.
  pubmed

P.235 掲載の参考文献

• 1) Sanchez-Madrid F:In Leukocyte Typing V, (eds Schlossman, et al), Oxford University Press, pp1123-1124, 1995.

• 2) Testi R, D'Ambrosio D, De Maria R, Santoni A:The CD69 receptor:amultipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15:479, 1994.
  pubmed

• 3) Cebrian M, Yague E, Rincon M, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F:Triggering of Tcell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 168:1621, 1988.

• 4) Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips JH:Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167:1572, 1988.
  pubmed

• 5) Lopez-Cabrera M, Munoz E, Blazquez MV, Ursa MA, Santis AG, Sanchez-Madrid F:Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J Biol Chem 270:21545, 1995.

• 6) Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F:Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 178:537, 1993.

• 7) Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E, Moretta L:CD69-mediated pathway of lymphocyte activation:anti-CD69 monoclonal antibodies trig-er the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med 174:1393, 1991.

• 8) Santis AG, Lopez-Cabrera M, Sanchez-Madrid F, Proudfoot N:Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur J Immunol 25:2142, 1995.

• 9) Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A:CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med 172:701, 1990.
  pubmed

P.237 掲載の参考文献

• 1) Kobayashi N, Nagumo H, Agematsu K:IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction. Clin Exp Immunol 129 (3):446-452, 2002.
  pubmed

• 2) Groth C, Drager R, Warnatz K, Wolff-Vorbeck G, Schmidt S, Eibel H, Schlesier M, Peter HH:Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 129 (1):133-139, 2002.
  pubmed

• 3) Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach Jp, Rimner A, Huang H, Schulz JB, Ohgaki H, Aguzzi A, Rammensee HG, Weller M:Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 62 (9):2592-2599, 2002.
  pubmed

• 4) Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA:Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 15 (5):801-812, 2001.

• 5) Yang FC, Agematsu K, Nakazawa T, Mori T, Ito S, Kobata T, Morimoto C, Komiyama A:CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology 88 (2):289-293, 1996.
  pubmed

• 6) Goodwin RG, Alderson MR, Smith CA, Armitage RJ, VandenBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, et al:Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73 (3):447-456, 1993.
  pubmed

• 7) Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA:Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 152 (4):1762-1773, 1994.
  pubmed

• 8) Bowman MR, Crimmins MA, Yetz-Aldape J, Kriz R, Kelleher K, Herrmann S:The cloning of CD70 and its identification as the ligand for CD27. J Immunol 152 (4):1756-1761, 1994.
  pubmed

• 9) Brown GR, Meek K, Nishioka Y, Thiele DL:CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+T lymphocytes. J Immunol 154 (8):3686-3695, 1995.
  pubmed

• 10) Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C:CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci USA 92 (24):11249-11253, 1995.

• 11) Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG:Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+with a high content of reactive histiocytes). Histopathology 16 (4):383-391, 1990.
  pubmed

P.238 掲載の参考文献

• 1) Hentze MW, Kuhn LC:Molecular control of vertebrate iron metabolism:mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175, 1996.
  pubmed

• 2) Trowbridge IS, Collawn JF, Hopkins CR:Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol 9:129, 1993.
  pubmed

• 3) Barclay AN, Birkeland ML, Brown MH, Beyers BD, Davis SJ, Somoza C, Williams AF:In The Leucocyte Antigen Facts Book, (eds Barclay AN, et al), Academic Press, London, pp258-259, 1993.

• 4) Goding JW, Burns GF:Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells. J Immunol 127:1256, 1981.

• 5) Goding JW, Harris AW:Subunit structure of cell surface proteins:disulfide bonding in antigen receptors, Ly-2/3 antigens, and transferrin receptors of murine T and B lymphocytes. Proc Natl Acad Sci USA 78:4530, 1981.

• 6) Israeli RS, Powell CT, Fair WR, Heston WD:Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53:227, 1993.
  pubmed

• 7) Jamroz RC, Gasdaska JR, Bradfield JY, Law JH:Transferrin in a cockroach:molecular cloning, characterization, and suppression by juvenile hormone. Proc Natl Acad Sci USA 90:1320, 1993.

• 8) Kuhn LC, McClelland A, Ruddle FH:Gene transfer, expression, and molecular cloning of the human transferrin receptor gene. Cell 37:95, 1984.
  pubmed

• 9) Pytowski B, Judge TW, McGraw TE:An internalization motif is created in the cytoplasmic domain of the transferrin receptor by substitution of a tyrosine at the first position of a predicted tight turn. J Biol Chem 270:9067, 1995.
  pubmed

• 10) Ruoslahti E, Pierschbacher MD:New perspectives in cell adhesion:RGD and integrins. Science 238:491, 1987.
  pubmed

• 11) Schneider C, Owen MJ, Banville D, Williams JG:Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature 311:675, 1984.
  pubmed

• 12) Schneider C, Sutherland R, Newman R, Greaves M:Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J Biol Chem 257:8516, 1982.
  pubmed

• 13) Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M:Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci USA 78:4515, 1981.
  pubmed

• 14) Trowbridge IS, Omary MB:Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78:3039, 1981.
  pubmed

• 15) van Driel IR, Stearne PA, Grego B, Simpson RJ, Goding JW:The receptor for transferrin on murine myeloma cells:one-step purification based on its physiology, and partial amino acid sequence. J Immunol 133:3220, 1984.
  pubmed

P.240 掲載の参考文献

• 1) Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA:Large-scale concatenation cDNA sequencing. Genome Res 7 (4):353-358, 1997.

• 2) Von Hoegen I, Nakayama E, Parnes JR:Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA.J Immunol 144 (12):4870-4877, 1990.

• 3) Von Hoegen I, Hsieh CL, Scharting R, Francke U, Parnes JR:Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9. Eur J Immunol 21 (6):1425-1431, 1991.
  pubmed

• 4) Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K:The B-cell surface protein CD72/Lyb-2is the ligand for CD5. Natblre 351 (6328):662-665, 1991.

P.242 掲載の参考文献

• 1) Zimmermann H:5'-Nucleotidase:molecular structure and functional aspects. Biochem J 285:345, 1992.
  pubmed

• 2) Thomson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, Klemens MR, Massaia M, Lucas AH:Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositolanchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73). Tissue Antigens 35:9, 1990.3) Airas L, Salmi M, Jalkanen S:Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol 151:4228, 1993.

• 4) Thompson LF, Ruedi JM, O'Connor RD, Bastian JF:Ecto-5'-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5'-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol 137:2496, 1986.

• 5) Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL:Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome:evidence of CD8 cell immaturity. J Immunol 135:1778, 1985.
  pubmed

• 6) Barcos M, Pollard C, Thompson LF, Stoll H, Evans RL:Ecto-5'-Nucleotidase (E5'-NT, 27.2, CD73), 27.1, Leu13, CD28 and LAM-1 (Leu8) Antigens in Mycosis Fungoides (MF). Leuk Lymphoma 6:503-512, 1992.

• 7) Thompson LF:Ecto-5'-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells. J Immunol 134:3794, 1985.

• 8) Thompson LF, Ruedi JM, Glass A, Low MG, Lucas AH:Antibodies to 5'-nucleotidase (CD73) , a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J Immunol 143:1815, 1989.

• 9) Gutensohn W, Resta R, Misumi Y, Ikehara Y, Thompson LF:Ecto-5'-nucleotidase activity is not required for T cell activation through CD73. Cell Immunol 161:213, 1995.
  pubmed

• 10) Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S:CD73 is involved in lymphocyte binding to the endothelium:characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 182:1603, 1995.

• 11) Airas L, Jalkanen S:CD73 mediates adhesion of B cells to follicular dendritic cells. Blood 88:1755, 1996.
  pubmed

• 12) Airas L, Niemela J, Salmi M, Puurunen T, Smith DJ, Jalkanen S:Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol 136:421, 1997.
  pubmed

P.244 掲載の参考文献

• 1) Cresswell P:Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259, 1994.
  pubmed

• 2) Bakke O, Dobberstein B:MHC class H-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707, 1990.

• 3) Freisewinkel IM, Schenck K, Koch N:The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci USA 90:9703, 1993.
  pubmed

• 4) Ghosh P, Amaya M, Mellins E, Wiley DC:The structure of an intermediate in class II MHC maturation:CLIP bound to HLA-DR3. Nature 378:457, 1995.
  pubmed

• 5) Koch N, Moldenhauer G, Hofmann WJ, Moller P:Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J Immunol 147:2643, 1991.
  pubmed

• 6) Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA:Intracellular transport of class H MHC molecules directed by invariant chain. Nature 348:600, 1990.

• 7) Roche PA, Cresswell P:Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615, 1990.
  pubmed

• 8) Stockinger B, Pessara U, Lin RH, Habicht J, Grez M, Koch N:A role of la-associated invariant chains in antigen processing and presentation. Cell 56:683, 1989.

• 9) Strubin M, Long EO, Mach B:Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 47:619, 1986.
  pubmed

• 10) Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D:Mice lacking the MHC class II-associated invariant chain. Cell 72:635, 1993.
  pubmed

• 11) Wraight CJ, van Endert P, Moller P, Lipp J, Ling NR, MacLennan IC, Koch N, Moldenhauer G:Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem 265:5787, 1990.
  pubmed

P.246 掲載の参考文献

• 1) Schwartz-Albiez R, Moldenhauer G, Kuipers J, Moeller P, Funderud S, Bast B:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 580-586, 1995.

• 2) Gross HJ, Merling A, Moldenhauer G, Schwartz-Albiez R:Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. Blood 87:5113, 1996.

• 3) Bast BJ, Zhou LJ, Freeman GJ, Colley KJ, Ernst TJ, Munro JM, Tedder TF:The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2, 6-sialyltransferase. J Cell Biol 116:423-435, 1992.

• 4) Keppler OT, Moldenhauer G, Oppenlander M, Schwartz-Albiez R, Berger EG, Funderud S, Pawlita M:Human Golgi beta-galactoside alpha-2, 6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens. Eur J Immunol 22:2777-2781, 1992.
  pubmed

• 5) Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T:The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 66:1133, 1991.

P.247 掲載の参考文献

• 1) Kniep B, Muhlradt PF, Dorken B, Moldenhauer G, Vilella R, Schwartz-Albiez R:Monoclonal antibodies against the human lymphocyte differentiation antigen CD76 bind to gangliosides. FEBS Lett 261:347-349, 1990.
  pubmed

• 2) Schwartz-Albiez R, Moldenhauer G, Kuipers J, Moeller P, Funderud S, Bast B:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp580-586, 1995.

• 3) Keppler OT, Moldenhauer G, Oppenlander M, Schwartz-Albiez R, Berger EG, Funderud S, Pawlita M:Human Golgi beta-galactoside alpha-2, 6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens. Eur J Immunol 22:2777-2781, 1992.
  pubmed

• 4) Bast BJ, Zhou LJ, Freeman GJ, Colley KJ, Ernst TJ, Munro JM, Tedder TF:The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2, 6-sialyltransferase.J Cell Biol 116:423, 1992.

• 5) Gross HJ, Merling A, Moldenhauer G, Schwartz-Albiez R:Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neur-aminic acid. Blood 87:5113, 1996.

P.249 掲載の参考文献

• 1) Brodin NT, Dahmen J, Nilsson B, Messeter L, Martensson S, Heldrup J, Sjogren HO, Lundblad A:Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4 Glc beta-O and Gal alpha 1-4 Gal beta 1-4 GlcNAc beta-O residues:useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int J Cancer 42:185, 1988.

• 2) Fyfe G, Cebra-Thomas JA, Mustain E, Davie JM, Alley CD, Nahm MH:Subpopulations of B lymphocytes in germinal centers. J Immunol 139:2187, 1987.

• 3) Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M:Identification of a subset of normal B cells with a Burkitt's lymphoma. J Immunol 139:313, 1987.
  pubmed

• 4) Ito M, Suzuki E, Naiki M, Sendo F, Arai S:Carbohydrates as antigenic determinants of tumor associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system. Int J Cancer 34:689, 1984.

• 5) Maloney MD, Lingwood CA:CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits:implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.J Exp Med 180:191, 1994.

• 6) Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J:Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 53:5314, 1993.
  pubmed

• 7) Mangeney M, Richard Y, Coulaud D, Tursz T, Wiels J:CD77:an antigen of germinal center B cells entering apoptosis. Eur J Immunol 21:1131, 19918) Nudelman E, Kannagi R, Hakomori S, Parsons M, Lipinski M, Wiels J, Fellous M, Tursz T:Aglycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220:509, 1983.

• 9) O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson MP, Olsnes S, Sandvig K, Lindberg AA, Keusch GT:Shiga toxin:biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 180:65, 1992.

• 10) Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ:Monoclonal antibodies against Gal alpha 1-4 Gal beta 1-4 Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen:reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors. Int J Cancer 48:848, 1991.

• 11) Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD:Analysis of somatic mutation in five B cell subsets of human tonsi. J Exp Med 180:329, 1994.

• 12) Thorbecke GJ, Amin AR, Tsiagbe VK:Biology of germinal centers in lymphoid tissue. FASEB J 8:832, 1994.
  pubmed

• 13) Wiels J, Fellous M, Tursz T:Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci USA 78:6485, 1981.
  pubmed

P.250 掲載の参考文献

• 1) Drbal K, Angelisova P, Rasmussen AM, et al:The nature of the subset of MHC class II molecules carrying the CDw78 epitopes. Int Immunol 11:491-498, 1999.
  pubmed

• 2) Kikutani H, Kimura R, Nakamura H, et al:Expression and function of an early activation marker restricted to human B cells. J Immunol 136:4019, 1986.

• 3) Kikutani H, Nakamura H, Sato R, et al:Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody. J Immunol 136:4027, 1986.

• 4) Dorken B, Moller P, Pezzutto A, et al:B-cell antigens:CDw78. In Leukocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp122-123, 1989.

• 5) Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841-2850, 1992.

P.252 掲載の参考文献

• 1) Malone CS, Wall R:Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters. J Immunol 168 (7):3369-3375, 2002.

• 2) Koyama M, Ishihara K, Karasuyama H, Cordell JL, Iwamoto A, Nakamura T:CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated mu heavy chain. Int Immunol 9 (11):1767-1772, 1997.
  pubmed

• 3) Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA:Large-scale concatenation cDNA sequencing. Genome Res 7 (4):353-358, 1997.

• 4) Koyama M, Nakamura T, Higashihara M, Herren B, Kuwata S, Shibata Y, Okumura K, Kurokawa K:The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing. Immunol Lett 47 (3):151-156, 1995.
  pubmed

• 5) Ha H, Barnoski BL, Sun L, Emanuel BS, Burrows PD:Structure, chromosomal localization, and methylation pattern of the human mb-1 gene. J Immunol 152 (12):5749-5757, 1994.

• 6) Hashimoto S, Mohrenweiser HW, Gregersen PK, Chiorazzi N:Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79 alpha (Ig-alpha/mb-1) gene. Immunogenetics 40 (4):287-295, 1994.
  pubmed

• 7) Hashimoto S, Chiorazzi N, Gregersen PK:Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 32 (9):651-659, 1995.

• 8) Sakaguchi N, Kashiwamura S, Kimoto M, Thalmann P, Melchers F:Blymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J 7 (11):3457-3464, 1988.

• 9) Yu LM, Chang TW:Human mb-1 gene:complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. J Immunol 148 (2):633-637, 1992.

• 10) Flaswinkel H, Reth M:Molecular cloning of the Ig-alpha subunit of the human B-cell antigen receptor complex. Immunogenetics 36 (4):266-269, 1992.

• 11) Ha HJ, Kubagawa H, Burrows PD:Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene. J Immunol 148 (5):1526-1531, 1992.

• 12) Kristensen T, Lopez R, Prydz H:An estimate of the sequencing error frequency in the DNA sequence databases. DNA Swq 2 (6):343-346, 1992.

• 13) Leduc I, Preud'homme JL, Cogne M:Structure and expression of the mb-1 transcript in human lymphoid cells. Clin Exp Immunol 90 (1):141-146, 1992.

P.254 掲載の参考文献

• 1) Malone CS, Wall R:Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters. J Immunol 168 (7):3369-3375, 2002.

• 2) Nakazato S, Nomoto K, Kazahari K, Ono M:Physical linkage of the B29/lg-beta (CD79B) gene to the skeletal muscle, sodium-channel, and growth hormone genes in rat and human. Genomics 48 (3):363-368, 1998.

• 3) Bennani-Baiti IM, Cooke NE, Liebhaber SA:Physical linkage of the human growth hormone gene cluster and the CD79b (lg beta/B29) gene. Genomics 48 (2):258-264, 1998.

• 4) Koyama M, Ishihara K, Karasuyama H, Cordell JL, Iwamoto A, Nakamura T:CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated mu heavy chain. Int Immunol 9 (11):1767-1772, 1997.
  pubmed

• 5) Koyama M, Nakamura T, Higashihara M, Herren B, Kuwata S, Shibata Y, Okumura K, Kurokawa K:The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing. Immunol Lett 47 (3):151-156, 1995.
  pubmed

• 6) Thompson AA, Wood WJ Jr, Gilly MJ, Damore MA, Omori SA, Wall R:The promoter and 5'flanking sequences controlling human B29 gene expression. Blood 87 (2):666-673, 1996.
  pubmed

• 7) Wood WJ Jr, Thompson AA, Korenberg J, Chen XN, May W, Wall R, Denny CT:Isolation and chromosomal mapping of the human immunoglobulin-associated B29 gene (IGB). Genomics 16 (1):187-192, 1993.
  pubmed

• 8) Hashimoto S, Gregersen PK, Chiorazzi N:The human lg-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes. J Immunol 150 (2):491-498, 1993,

• 9) Hashimoto S, Chiorazzi N, Gregersen PK:The complete sequence of the human CD79b (Ig beta/B29) gene:identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism. Immunogenetics 40 (2):145-149, 1994.
  pubmed

• 10) Hashimoto S, Chiorazzi N, Gregersen PK:Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (lg-beta/B29) RNA transcripts in human B cells. Mol Immunol 32 (9):651-659, 1995.

• 11) Muller B, Cooper L, Terhorst C:Cloning and sequencing of the cDNA encoding the human homologue of the murine immunoglobulin-associated protein B29. Eur J Immunol 22 (6):1621-1625, 1992.
  pubmed

P.256 掲載の参考文献

• 1) Engel P, Wagner N, Tedder TF:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 682-684, 1995.

• 2) Freedman AS, Freeman G, Horowitz JC, Daley J, Nadler LM:B7, a B-cell-restricted antigen that identifies preactivated B cells. J Immunol 139:3260, 1987.

• 3) Freeman GJ, Disteche CM, Gribben JG, Adler DA, Freedman AS, Dougery J, Nadler LM:The gene for B7, a costimulatory signal for T-cell activation, maps to chromosomal region 3q13.3-3q21. Blood 79:489, 1992.

• 4) Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM:B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714, 1989.
  pubmed

• 5) Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM:Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 174:625, 1991.

• 6) Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS:Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4:535, 1996.
  pubmed

• 7) Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA:CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174:561, 1991.

• 8) Linsley PS, Clark EA, Ledbetter JA:T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 87:5031, 1990.

• 9) Yokochi T, Holly RD, Clark EA:Blymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 128:823, 1982.

P.257 掲載の参考文献

• 1) Levy S, Todd SC, Maecker HT:CD81 (TAPA-1):Amolecule involved in signal transduction and cell adhesion in the immune system. Ann Rev Immunol 16:89-109, 1998.

• 2) Andria ML, Hsieh CL, Oren R, Francke U, Levy S:Genomic organization and chromosomal localization of the TAPA-1 gene. J Immunol 147:1030, 1991.

• 3) Bradbury LE, Goldmacher VS, Tedder TF:The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J Immunol 151:2915, 1993.

• 4) Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex f human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841, 1992.

• 5) Bradbury L, Tedder TF:In Leucocyte Typing V, eds Schlossman SF, et al) , Oxford University Press, pp690-691, 1995.

• 6) Freedman A, Phifer JS, Svahn J:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp732-733, 1995.

• 7) Oren R, Takahashi S, Doss C, Levy R, Levy S:TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10:4007, 1990.
  pubmed

• 8) Schick MR, Nguyen VQ, Levy S:Anti-TAPA-1 antibodies induce protein tyrosine phosphorylation that is prevented by increasing intracellular thiol levels. J Immunol 151:1918, 1993.

• 9) Takahashi S, Doss C, Levy S, Levy R:TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 145:2207, 1990.
  pubmed

• 10) Tedder TF, Wagner N, Engel P:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, 1995.

• 11) Vaickus L, Levy R:Antiproliferative monoclonal antibodies:detection and initial characterization. J Immunol 135:1987, 1985.
  pubmed

P.259 掲載の参考文献

• 1) Wright MD, Tomlinson MG:The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588, 1994.
  pubmed

• 2) Hemler ME, Mannion BA, Berditchevski F:Association of TM4SF proteins with integrins:relevance to cancer.Biochim biophys Acta 1287:67, 1996.
  pubmed

• 3) Gaugitsch HW, Hofer E, Huber NE, Schnabl E, Baumruker T:Anew superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 21:377, 1991.

• 4) Gil ML, Vita N, Lebel-Binay S, Miloux B, Chalon P, Kaghad M, Marchiol-Fournigault C, Conjeaud H, Caput D, Ferrara P, et al:Amember of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer susceptible, B lymphocyte line. Cloning and preliminary functional studies. J Immunol 148:2826, 1992.

• 5) Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y, Yoshie O:Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation:altered glycosylation of C33 antigen. J Virol 66:1394, 1992.

• 6) Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, Nishimura M, Hinuma Y, Yoshie O:C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 149:2879, 1992.
  pubmed

• 7) Imai T, Yoshie O:C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD40r CD8 in T cells. J Immunol 151:6470, 1993.

• 8) Nojima Y, Hirose T, Tachibana K, Tanaka T, Shi L, Doshen J, Freeman GJ, Schlossman SF, Morimoto C:The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell Immunol 152:249, 1993.

• 9) Angelisova P, Hilgert I, Horejsi V:Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class H glycoproteins. Immunogenetics 39:249, 1994.

• 10) Mannion BA, Berditchevski F, Kraeft SK, Chen LB, Hemler ME:Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J Immunol 157:2039, 1996.
  pubmed

• 11) Imai T, Kakizaki M, Nishimura M, Yoshie O:Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J Immunol 155:1229, 1995.
  pubmed

• 12) Lebel-Binay S, Lagaudriere C, Fradelizi D, Conjeaud H:CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line. J Leukoc Biol 57:956, 1995.
  pubmed

• 13) Lebel-Binay S, Lagaudriere C, Fradelizi D, Conjeaud H:CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation.J Immunol 155:101, 1995.

• 14) Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC:KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884, 1995.

• 15) Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C:CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA DR and VLA integrins. Eur J Immunol 26:2657, 1996.

• 16) Lagaudriere-Gesbert C, Lebel-Binay S, Wiertz E, Ploegh HL, Fradelizi D, Conjeaud H:The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J Immunol 158:2790, 1997.

• 17) Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S:Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 157:2939, 1996.

• 18) Lebel-Binay S, Gil ML, Lagaudriere C, Miloux B, Marchiol-Fournigault C, Quillet-Mary A, Lopez M, Fradelizi D, Conjeaud H:Further characterization of CD82/IA4 antigen (type IIIsurface protein):an activation/differentiation marker of mononuclear cells. Cell Immunol 154:468, 1994.

P.260 掲載の参考文献

• 1) Egner W, Hart DN:The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells:possible heterogeneity in bone marrow dendritic cell populations. Immunology 85:611, 1995.
  pubmed

• 2) Engel P, Wagner N, Tedder TF:White Cell Differentiation Antigens. In Leukocyte Typing V, (eds Schlossman SF) , Oxford University Press, p693, 1995.

• 3) Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM:Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol 157:541, 1996.
  pubmed

• 4) Kozlow EJ, Wilson GL, Fox CH, Kehrl JH:Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81:454, 1993.
  pubmed

• 5) Weissman D, Li Y, Ananworanich J, Zhou LJ, Adelsberger J, Tedder TF, Baseler M, Fauci AS:Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 92:826, 1995.
  pubmed

• 6) Zhou LJ, Schwarting R, Smith HM, Tedder TF:Anovel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735, 1992.

• 7) Zhou LJ, Tedder TF:A distinct pattern of cytokine gene expression by human CD83+blood dendritic cells. Blood 86:3295, 1995.
  pubmed

• 8) Zhou LJ, Tedder TF:CD14+blood monocytes can differentiate into functionally mature CD83+den-dritic cells. Proc. Natl Acad Sci USA 93:2588, 1996.

• 9) Zhou LJ, Tedder TF:Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821, 1995.
  pubmed

P.262 掲載の参考文献

• 1) Engel P, Smith H, Tedder TF:Phenotypic analysis with the B-cell unknown panel mAb. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 607-620, 1995.

• 2) Engel P, Wagner N, Tedder TF:CDw84 workshop report. In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 699-700, 1995

P.264 掲載の参考文献

• 1) Engel P, Wagner R, Tedder TF:In Leucocyte typing V, (eds Schlossman SF, et al), Oxford University Press, pp 701-702, 1995.

• 2) Hirohashi N, Nakao M, Kubo K, Yamada A, Shichijo S, Hara A, Sagawa K, Itoh K:Anovel antigen (H47Ag) on human Iymphocytes involved in T cell activation. Cell Immunol 152:371, 1993.

• 3) Moldenhauer G, Schwarz-Albeiz R, Moller P:In Leucocyte typing V, (eds Schlossman SF, et al), Oxford University Press, pp 623-636, 1995.

• 4) Pulford K, Micklem K, Thomas J, Jones M, Mason DY:A72-kD B cell-associated surface glycoprotein expressed at high levels in hairy cell leukaemia and plasma cell neoplasms. Clin Exp Immunol 85:429, 1991.

• 5) Pulford K, Micklem KJ, Thomas J, Jones M, Law SK, Willis AC. et al:In Leucocyte typing V, (eds Schlossman SF, et al) , Oxford University Press, pp 702-703, 1995.

• 6) Wagner N, Engel P, Tedder TF:In Leucocyte typing V, (eds Schlossman SF, et al) , Oxford University Press, pp 636-642, 1995.

• 7) Nikolova M, Musette P, Bagot M, Boumsell L, Bensussan A:Engagement of ILT2/CD85j in Sezary syndrome cells inhibits their CD3/TCR signaling. Blood 100 (3):1019-1025, 2002.
  pubmed

• 8) Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, Ciccone E:Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 168 (1):207-215, 2002.

• 9) Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M:Acommon inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (11):1809-1818, 1997.

• 10) Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML:A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. immunity 7 (2):273-282, 1997.
  pubmed

• 11) Wagtmann N, Roj o S, Eichler E, Mohrenweiser H, Long EO:Anew human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7 (8):615-618, 1997. (No abstract available)

• 12) Samaridis J, Colonna M:Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells:structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27 (3):660-665, 1997.
  pubmed

• 13) Hirohashi N, Nakao M, Kubo K, Yamada A, Shichijo S, Hara A, Sagawa K, Itoh K:Anovel antigen (H47Ag) on human lymphocytes involved in T cell activation. Cell Immunol 152 (2):371-382, 1993

P.268 掲載の参考文献

• 1) Hathcock KS, Hodes RJ:Role of the CD 28-B7 costimulatory pathways in T cell-dependent B cell responses. Adv Immunol 62:131, 1996.

• 2) June CH, Bluestone JA, Nadler LM, Thompson CB:The B7 and CD28 receptor families. Immunol Today 15:321, 1994.
  pubmed

• 3) Lenschow DJ, Walunas TL, Bluestone JA:CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233, 1996.
  pubmed

• 4) Townsend SE, Su FW, Atherton JM, Allison JP:Specificity and longevity of antitumor immune responses induced by B 7-transfected tumors. Cancer Res 54:6477, 1994.

• 5) Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C:B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76, 1993.
  pubmed

• 6) Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH:B7-1 and B 7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303, 1997.

• 7) Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM:Cloning of B 7-2:a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909, 1993.

• 8) Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH:B7-1 and B 7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways:application to autoimmune disease therapy. Cell 80:707, 1995.

• 9) Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA:Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257:789, 1992.

• 10) Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R:Human B 7-1 (CD80) and B 7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793, 1994.

• 11) Prabhu Das MR, Zamvil SS, Borriello F, Weiner HL, Sharpe AH, Kuchroo VK:Reciprocal expression of co-stimulatory molecules, B 7-1 and B 7-2, on murine T cells following activation. Eur J Immunol 25:207, 1995.

• 12) Ronchese F, Hausmann B, Hubele S, Lane P:Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+Tcells and defective antibody production in vivo. J Exp Med 179:809, 1994.

• 13) Seino K, Azuma M, Bashuda H, Fukao K, Yagita H, Okumura K:CD86 (B70/B 7-2) on endothelial cells co-stimulates allogeneic CD4+T cells.lnt Immunol 7:1331, 1995.

• 14) Ueda Y, Levine BL, Huang ML, Freeman GJ, Nadler LM, June CH, Ward SG:Both CD28 ligands CD80 (B7-1) and CD86 (B 7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 7:957, 1995.

• 15) Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA:CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405, 1994.

P.270 掲載の参考文献

• 1) Dano K, Behrendt N, Brunner N, et al:The urokinase receptor:protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8:189-203, 1994.

• 2) Petty HR, Todd RF:3d Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996.

• 3) Vassalli JD:The urokinase receptor. Fibrinolysis 8:172-181, 1994.

• 4) Gadd SJ, Majdic O, Kasinrerk W, Stockinger H, Maurer D, Eher R, Knapp W:M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen. Clin Exp Immunol 80:252, 1990.
  pubmed

• 5) Gyetko MR, Sitrin RG, Fuller JA, Todd RF 3rd, Petty H, Standiford TJ:Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol 58:533, 1995.
  pubmed

• 6) Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Muller M, Schmitt M:Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Am J Pathol 150:1231, 1997.
  pubmed

• 7) Mizukami IF, Vinjamuri SD, Trochelman RD, Todd RF 3rd:Astructural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J Immunol 144:1841, 1990.

• 8) Schaefer BM, Stark HJ, Fusenig NE, Todd RF 3rd, Kramer MD:Differential expression of urokinase-type plasminogen activator (uPA) , its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system. Exp Cell Res 220:415, 1995.

• 9) Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA:Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994.
  pubmed

P.272 掲載の参考文献

• 1) Gerard C, Gerard N P:C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 12:775, 1994.
  pubmed

• 2) Oppermann:In Leukocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp 953-954, 1995.

• 3) Boulay F, Mery L, Tardif M, Brouchon L, Vignais P:Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30:2993, 1991.
  pubmed

• 4) Gerard NP, Gerard C:The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614, 1991.

• 5) Hopken UE, Lu B, Gerard NP, Gerard C:The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383:86, 1996.
  pubmed

• 6) Watanabe H, Kuraya M, Kasukawa R, Yanagisawa H, Yanagisawa M, Fujita T:Analysis of C5a receptor by monoclonal antibody. J Immunol Methods 185:19, 1995.

• 7) Ye RD, Boulay F:Structure and function of leukocyte chemoattractant receptors. Adv Pharmacol 39:221, 1997.
  pubmed

P.274 掲載の参考文献

• 1) Kerr MA:The structure and function of human IgA. Biochem J 271:285, 1990.
  pubmed

• 2) Shen L:Receptors for IgA on phagocytic cells. Immunol Res 11:273, 1992.
  pubmed

• 3) Morton HC, van Egmond M, van de Winkel JG:Structure and function of human IgA Fc receptors (Fc alpha R). Crit Rev Immunol 16:423, 1996.
  pubmed

• 4) Shen L, Lasser R, Fanger MW:My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J Immunol 143:4117, 1989.
  pubmed

• 5) Monteiro RC, Kubagawa H, Cooper MD:Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.J Exp Med 171:597, 1990.

• 6) Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L:Expression cloning of a human Fc receptor for IgA. J Exp Med 172:1665, 1990.

• 7) Monteiro RC, Cooper MD, Kubagawa H:Molecular heterogeneity of Fc alpha receptors detected byreceptor-specific monoclonal antibodies. J Immunol 148:1764, 1992.

• 8) Pfefferkorn LC, Yeaman GR:Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J Immunol 153:3228, 1994.
  pubmed

• 9) Morton HC, van den Herik-Oudij k IE, Vossebeld P, Snijders A, Verhoeven AJ, Capel PJ, van de Winkel JG:Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J Biol Chem 270:29781, 1995.

• 10) Patry C, Sibille Y, Lehuen A, Monteiro RC:Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 156:4442, 1996.
  pubmed

• 11) Morton HC, Schiel AE, Janssen SW, van de Winkel JG:Alternatively spliced forms of the human myeloid Fc alpha receptor (CD89) in neutrophils. Immunogenetics 43:246, 1996.
  pubmed

• 12) Carayannopoulos L, Hexham JM, Capra JD:Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between C alpha 2 and C alpha 3 in human IgA1.JEltp Med 183:1579, 1996.

P.276 掲載の参考文献

• 1) Cell surface Thy-1 (eds Reif AF, Schlesinger M), Marcel Dekker Inc, New York, 1989.

• 2) Craig W, Kay R, Cutler RL, Lansdorp PM:Expression of Thy-10n human hematopoietic progenitor cells. J Exp Med 177:1331, 1993.
  pubmed

• 3) Feng H, Zhao WQ, Bernard CC, Ng KT, Sedman G:Purified antichick Thy-11gG abolishes intermediate and long-term memory. Physiol Behav 53:215, 1993.

• 4) Mayani H, Lansdorp PM:Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 83:2410, 1994.
  pubmed

• 5) Nosten-Bertrand M, Errington ML, Murphy KP, Tokugawa Y, Barboni E, Kozlova E, Michalovich D, Morris RG, Silver J, Stewart CL, Bliss TV, Morris RJ:Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature 379:826, 1996.
  pubmed

• 6) Tiveron MC, Barboni E, Pliego Rivero FB, Gormley AM, Seeley PJ, Grosveld F, Morris R:Selective inhibition of neurite outgrowth on mature astrocytes by Thy-1 glycoprotein. Nature 355:745, 1992.
  pubmed

• 7) Tsukamoto AS, Reading C, Carella A, Frassoni F, Gorin C, LaPorte J, Negrin R, Blume K, Cunningham I, Deisseroth A, et al:Biological characterization of stem cell present in mobilized peripheral blood of CML patients. Bone Marrow Transplant 14:S25, 1994.
  pubmed

P.277 掲載の参考文献

• 1) May P, Reddy YK, Herz J:Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 277 (21):18736-18743, 2002.
  pubmed

• 2) Salicioni AM, Mizelle KS, Loukinova E, Mikhailenko I, Strickland DK, Gonias SL:The low density lipoprotein receptor-related protein mediates fibronectin catabolism and inhibits fibronectin accumulation on cell surfaces. J Biol Chem 277 (18):16160-16166, 2002.
  pubmed

• 3) Mettenburg JM, Webb DJ, Gonias SL:Distinct binding sites in the structure of alpha 2-macroglobulin mediate the interaction with beta-amyloid peptide and growth factors. J Biol Chem 277 (15):13338-13345, 2002.
  pubmed

• 4) Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, Ravichandran KS:Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptorrelated protein (LRP).1Biol Chem 277 (14):11772-11779, 2002.
  pubmed

• 5) Xu W, Takahashi Y, Sakashita T, Iwasaki T, Hattori H, Yoshimoto T:Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase. J Biol Chem 276 (39):36454-36459, 2001.
  pubmed

• 6) Kurdowska A, Alden SM, Noble JM, Stevens MD, Carr FK:Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2-macroglobulin complexes by human alveolar macro-phages. Cytokine 12 (7):1046-1053, 2000.

• 7) Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK:Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7 (13):4119-41127, 1988.

• 8) Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK:The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341 (6238):162-164, 1989.
  pubmed

• 9) Myklebost O, Arheden K, Rogne S, Geurts van Kessel A, Mandahl N, Herz J, Stanley K, Heim S, Mitelman F:The gene for the human putative apo E receptor is on chromosome 12 in the segment q 13-14.Genomics 5 (1):65-69, 1989.

• 10) Hilliker C, Van Leuven F, Van den Berghe H:Assignment of the gene coding for the alpha 2-macro globulin receptor to mouse chromosome 15 and to human chromosome 12q 13-q 14 by isotopic and nonisotopic in situ hybridization. Genomics 13 (2):472-474, 1992.

P.279 掲載の参考文献

• 1) Majdic O, Mai I, Pickl W F, Stockinger H, Knapp W:CDw92 (group 9) cluster workshop report. In Leukocyte Typing V. White cell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp 984-985, 1995.

• 1) Mai I, Pickl WF, Stockl J, Majdic O, Mellors A, De Smet W, et al:CD93 (group II) cluster workshop report. In Leukocyte Typing V. White cell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp 986-988, 1995.

• 2) Todd R:Myeloid antigens:section report. In Leukocyte Typing V. Whitecell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp769-770, 1995.

• 2) Todd R:Myeloid Antigens:Section report. In Leukocyte Typing V, Whitecell differentiation antigens, Vol 1, (eds Schlossman SF, et al), Oxford University Press, p769, 1995.

P.280 掲載の参考文献

• 1) Lopez-Botet M, Perez-Villar JJ, Carretero M, Rodriguez A, Melero I, Bellon T, Llano M, Navarro F:Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class Imolecules. Immunol Rev 155:165, 1997.

• 2) Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingari MC, Moretta L:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155:105, 1997.

• 3) Aramburu J, Balboa MA, Izquierdo M, Lopez-Botet M:Anovel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 147:714, 1991.

• 4) Brumbaugh KM, Perez-Villar JJ, Dick CJ, Schoon RA, Lopez-Botet M, Leibson PJ:Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 157:2804, 1996.

• 5) Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar JJ, Moretta L, Moretta A, Lopez-Botet M:The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27:563, 1997.

• 6) Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL:Molecular characterization of human CD94:atype H membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25:2433, 1995.

• 7) Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH:Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741, 1996.
  pubmed

• 8) Lopez-Botet M:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1437-1439, 1995.

• 9) Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, et al:Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 180:545, 1994.

• 10) Perez-Villar JJ, Carretero M, Navarro F, Melero I, Rodriguez A, Bottino C, Moretta A, Lopez-Botet M:Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 157:5367, 1996.

• 11) Perez-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lopez-Botet M:Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 154:5779, 1995.
  pubmed

• 12) Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL:CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5:163, 1996.

• 13) Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A:CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles:identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 26:2487, 1996.

P.283 掲載の参考文献

• 1) Krammer PH, Westendorp MO, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E:The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175-191, 1994.
  pubmed

• 2) Nagata S, Golstein P:The Fas death factor. Science 267:1449-1456, 1995.
  pubmed

• 3) Nishimura Y, Ishii A, Yonehara S:Expression and function of apoptosis antigen Fas on T lymphocytes in periphery and thymus. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, p1144, 1995.

• 4) Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S:The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
  pubmed

• 5) Rouvier E, Luciani MF, Golstein P:Fas involvement in Ca (2+)-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200, 1993.
  pubmed

• 6) Suda T, Takahashi T, Golstein P, Nagata S:Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993.
  pubmed

• 7) Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH:Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305, 1989.
  pubmed

• 8) Yonehara S, Ishii A, Yonehara M:Acell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989.

P.284 掲載の参考文献

• 1) Wang PL, O'Farrell S, Clayberger C, Krensky AM:Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J Immunol 148 (8):2600-2608, 1992.

P.285 掲載の参考文献

• 1) Pickl WF, Majdic O, Mai I, Gadd S, Knapp W:Overview of CD97. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp1151-1153, 1995.

• 2) Hamann J, Eichler W, Vogel B, Stortelers C, Hamann D, Horejsi V, van Lier RA:CD97 workshop panel report. In Leukocyte Typing VI, (eds Kishimoto T, Kikutani H, von dem Borne AE, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H) , Garland Publishing Inc, New York, p527, 1998.

• 3) Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O, Scherbaum WA, Dralle H, Hoang-Vu C:CD97:adedifferentiation marker in human thyroid carcinomas. Cancer Res 57:1798-1806, 1997.
  pubmed

• 4) Carver EA, Hamann J, Olsen AS, Stubbs L:Physical mapping of EMR1 and CD97 in human chromosome 19and assignment of Cd97 to mouse chromosome 8 suggest an ancient genomic duplication. Mamm Genome 10:1039-1040, 1999.

• 5) Eichler W, Aust G, Hamann D:Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac (F2). Scand J Immunol 39:111-115, 1994.
  pubmed

• 6) Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U, Kelly K:CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157:5438-5447, 1996.
  pubmed

• 7) Hamann J, Eichler W, Hamann D, Kerstens HM, Poddighe PJ, Hoovers JM, Hartmann E, Strauss M, van Lier RA:Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. J Immunol 155:1942-1950, 1995.
  pubmed

• 8) Hamann J, Hartmann E, van Lier RA:Structure of the human CD97 gene:exon shuffling has generated anew type of seven-span transmembrane molecule related to the secretin receptor superfamily. Genomics 32:144-147, 1996.

• 9) Hamann J, Stortelers C, Kiss-Toth E, Vogel B, Eichler W, van Lier RA:Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur J Immunol 28:1701-1707, 1998.
  pubmed

• 10) Hamann J, Vogel B, van Schijndel GM, van Lier RA:The seven-span transmembrane receptor CD97 has acellular ligand (CD55, DAF). J Exp Med 184:1185-1189, 1996.

• 11) Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP:Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum 42:650-658, 1999.
  pubmed

• 12) McKnight AJ, Gordon S:The EGF-TM7 family:unusual structures at the leukocyte surfqce. J Leukoc Biol 63:271-280, 1998.
  pubmed

• 13) Qian YM, Haino M, Kelly K, Song WC:Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Immunology 98:303-311, 1999.
  pubmed

P.287 掲載の参考文献

• 1) Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shdlhamer J, Mostowski HS, Thomas CA, Strominger JL, Fauci AS:Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409, 1981.
  pubmed

• 2) Ohgimoto S, Tabata N, Suga S, Nishio M, Ohta H, Tsurudome M, Komada H, Kawano M, Watanabe N, Ito Y:Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp 160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J Immunol 155:3585, 1995.

• 3) Freidman AW, Diaz LA Jr, Moore S, Schaller J, Fox DA:The human 4F2 antigen:evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol 154:253, 1994.

• 4) Bertran J, Magagnin S, Werner A, Markovich D, Biber J, Testar X, Zorzano A, Kuhn LC, Palacin M, Murer H:Stimulation of system y (+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes. Proc Natl Acad Sci USA 89:5606, 1992.
  pubmed

• 5) Lumadue JA, Glick AB, Ruddle FH:Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2. Proc Natl Acad Sci USA 84:9204, 1987.
  pubmed

• 6) Leiden JM, Yang LH, Morle GD, June CH, Lindsten T, Thompson CB, Karpinski B:The 4F2 heavy chain gene:amolecular model of inducible gene expression in human T cells. J Autoimmun 2:67, 1989.

• 7) Karpinski BA, Yang LH, Cacheris P, Morle GD, Leiden JM:The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol Cell Biol 9:2588, 1989.
  pubmed

• 8) Boumsell L:In Leucocyte Typing V, White cell differentiation antigens, eds Schlossman SF, et al), Oxford University Press, p280, 1995.

• 9) Wells RG, Lee WS, Kanai Y, Leiden JM, Hediger MA:The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J Biol Chem 267:15285, 1992.
  pubmed

• 10) Palacin M:Anew family of proteins (rBAT and 4F2hc) involved in cationic and zwitterionic amino acid transport:atale of two proteins in search of a transport function. J Exp Biol 196:123, 1994.

• 11) Bron C, Rousseaux M, Spiazzi AL, MacDonald HR:Structural homology between the human 4F2 antigen and a murine cell surface glycoprotein associated with lymphocyte activation. J Immunol 137:397, 1986.

• 12) Lindsten T, June CH, Thompson CB, Leiden JM:Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol Cell Biol 8:3820, 1988.

• 13) Gottesdiener KM, Karpinski BA, Lindsten T, Strominger JL, Jones N H, Thompson CB, Leiden JM:Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Mol Cell Biol 8:3809, 1988.

• 14) Parmacek MS, Karpinski BA, Gottesdiener KM, Thompson CB, Leiden JM:Structure, expression and regulation of the murine 4F2 heavy chain. Nucleic Acids Res 17:1915, 1989.
  pubmed

• 15) Francke U, Foellmer BE, Haynes BF:Chromosome mapping of human cell surface molecules:mono-clonal anti-human lymphocyte antibodies 4F2, A3D8, and A1G3 define antigens controlled by different regions of chromosome 11. Somatic Cell Genet 9:333, 1983.

P.289 掲載の参考文献

• 1) Matsumoto K, Yamamoto T:Pleomorphic hyalinizing angiectatic tumor of soft parts:Acase report and literature review. Pathol Int 52 (10):664-668, 2002.

• 2) Tayapiwatana C, Kasinrerk W:Construction and characterization of phage-displayed leukocyte surface molecule CD99. Appl Microbiol Biotechnol 60 (3):336-341, 2002.
  pubmed

• 3) Cavazza A, Rossi G, Agostini L, Facciolongo N, De Marco L, Putrino I, Gardini G:Mesotelioma a piccole cellule della pleura:descrizione di un caso. Pathologica 94 (5):247-252, 2002. (Italian)
  pubmed

• 4) Thomas De Montpreville V, Zemoura L, Dulmet E:Thymoma with epithelial micronodules and lymphoid hyperplasia:six cases of a rare and equivocal subtype. Ann Pathol 22 (3):177-182, 2002. (French)
  pubmed

• 5) Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM:Monophasic fibrous and poorly differentiated synovial sarcoma:immunohistochemical reassessment of 60 t (X;18) SYT-SSX)-positive cases. Am J Surg Pathol 26 (11):1434-1440, 2002.
  pubmed

• 6) Petkovic M, Zamolo G, Muhvic D, Coklo M, Stifter S, Antulov R:The first report of extraosseous Ewing's sarcoma in the rectovaginal septum. Tumon'88 (4):345-346, 2002.

• 7) Malpica A, Moran CA:Primitive neuroectodermal tumor of the cervix:aclinicopathologic and immunohistochemical study of two cases. Ann Diagn Pathol 6 (5):281-287, 2002.

• 8) Sebire NJ, Ramsay AD, Levitt G, Malone M, Risdon RA:Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy:retrospective review of clinical material. Pediatr Dev Pathol 5 (6):579-586, 2002.
  pubmed

• 9) Alberti I, Bernard G, Rouquette-Jazdanian AK, Pelassy C, Pourtein M, Aussel C, Bernard A:CD99 isoforms expression dictates T cell functional outcomes. FASEB J 16 (14):1946-1948, 2002.
  pubmed

• 10) Zamecnik M:Calcifying sclerosing tumor of the ovary:alate stage of sclerosing stromal tumor? Cesk Patol 38 (3):121-124, 2002.

• 11) Husek K, Vesely K:Extraorbital giant cell angiofibroma. Cesk Patol 38 (3):117-120, 2002.
  pubmed

• 12) Cavazza A, Gelli MC, Agostini L, Sgarbi G, De Marco L, Gardini G:Calcified pseudotumor of the pleura:description of a case. Pathologica 94 (4):201-205, 2002. Review. (Italian)
  pubmed

• 13) Shidham VB, Chivukula M, Gupta D, Rao RN, Komorowski R:Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. A rch Pathol Lab Med 126 (10):1189-1192, 2002.

• 14) Bongiovanni M, Viberti L, Pecchioni C, Papotti M, Thonhofer R, Hans Popper H, Sapino A:Steroid hormone receptor in pleural solitary fibrous tumours and CD34+progenitor stromal cells. J Pathol 198 (2):252-257, 2002.
  pubmed

• 15) Folpe AL, McKenney JK, Bridge JA, Weiss SW:Sclerosing rhabdomyosarcoma in adults:report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26 (9):1175-1183, 2002.
  pubmed

• 16) Raddaoui E, Donner LR, Panagopoulos I:Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma. Diagn Mol Pathol 11 (3):157-162, 2002.

• 17) Egger JF, Coindre JM, Benhattar J, Coucke P, Guillou L:Radiation-associated synovial sarcoma:clinicopathologic and molecular analysis of two cases. Mod Pathol 15 (9):998-1004, 2002.
  pubmed

• 18) Lee HJ, Kim E, Jee B, Hahn JH, Han K, Jung KC, Park SH, Lee H:Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells. Exp Mol Med 34 (3):177-183, 2002.

• 19) Jung KC, Park WS, Bae YM, Hahn JH, Hahn K, Lee H, Lee HW, Koo HJ, Shin HJ, Shin HS, Park YE, Park SH:Immunoreactivity of CD99 in stomach cancer. J Korean Med Sci 17 (4):483-489, 2002.

• 20) Movahedi-Lankarani S, Hruban RH, Westra WH, Klimstra DS:Primitive neuroectodermal tumors of the pancreas:areport of seven cases of a rare neoplasm. Am J Surg Pathol 26 (8):1040-1047, 2002.

P.291 掲載の参考文献

• 1) Gelin C, Aubrit F, Phalipon A, Raynal B, Cole S, Kaczorek M, Bernard A:The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 8 (11):3253-3259, 1989.

• 2) Banting GS, Pym B, Darling SM, Goodfellow PN:The MIC2 gene product:epitope mapping and structural prediction analysis define an integral membrane protein. Mol Immunol 26 (2):181-188, 1989.
  pubmed

P.292 掲載の参考文献

• 1) Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A, Boumsell L:Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 148:318, 1992.

• 2) Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ:Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 93:11780, 1996.
  pubmed

• 3) Herold C, Dastot H, Bensussan A, Boumsell L:In Leucocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp 288-289, 1995.

• 4) Herold C, Dastot H, Bismuth G, Bensussan A, Boumsell L:In Leucocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF), Oxford University Press, pp290-292, 1995.

• 5) Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L:CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 157 (12):5262-5268, 1996.

• 6) Herold C, Bismuth G, Bensussan A, Boumsell L:Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol 7:1, 1995.
  pubmed

P.293 掲載の参考文献

• 1) Gouttefangeas C, Schmid M, Boumsell L, Bensussan A:In Leukocyte Typing V, Vol 1, (eds Schlossman SF, et al), Oxford University Press, pp293-295, 1995.

• 2) Gouttefangeas C, Jacquot S, Meffre E, Schmid M, Boumsell L, Bensussan A:Differential proliferative responses in subsets of human CD28+cells delineated by BB27 mAb. Int Immunol 6:423, 1994.
  pubmed

• 3) Ruegg CL, Rivas A, Madani ND, Zeitung J, Laus R, Engleman EG:V7, a novel leukocyte surface protein that participates in T cell activation. H. Molecular cloning and characterization of the V7 gene. J Immunol 154:4434, 1995.

• 4) Russell GJ, Parker CM, Sood A, Mizoguchi E, Ebert EC, Bhan AK, Brenner MB:p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J Immunol 157:3366, 1996.
  pubmed

P.294 掲載の参考文献

• 1) Damle NK, Klussman K, Aruffo A:Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (1eukocyte function-associated antigen-1) , provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J Immunol 148:665, 1992.

• 2) Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA:ICAM-1 (CD54):acounter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111:3129, 1990.

• 3) Gahmberg CG, Nortamo P, Zimmermann D, Ruoslahti E:The human leukocyte-adhesion ligand, intercellular-adhesion molecule 2. Expression and characterization of the protein. Eur J Biochem 195:177, 1991.
  pubmed

• 4) Li R, Nortamo P, Kantor C, Kovanen P, Timonen T, Gahmberg CG:Aleukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J Biol Chem 268:21474, 1993.

• 5) Li R, Nortamo P, Valmu L, Tolvanen M, Huuskonen J, Kantor C, Gahmberg CG:A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J Biol Chem 268:17513, 1993.

• 6) Li R, Xie J, Kantor C, Koistinen V, Altieri DC, Nortamo P, Gahmberg CG:Apeptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J Cell Biol 129:1143, 1995.

• 7) Nortamo P, Li R, Renkonen R, Timonen T, Prieto J, Patarroyo M, Gahmberg CG:The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 21:2629, 1991.
  pubmed

• 8) Nortamo P, Salcedo R, Timonen T, Patarroyo M, Gahmberg CG:A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen. J Immunol 146:2530, 1991.

• 9) Renkonen R, Paavonen T, Nortamo P, Gahmberg CG:Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am J Pathol 140:763, 1992.
  pubmed

• 10) Staunton DE, Dustin ML, Springer TA:Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 339:61, 1989.
  pubmed

• 11) Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St John T, Gallatin WM:Cloning and characterization of a new intercellular adhesion molecule. Nature 360:485, 1992.
  pubmed

• 12) Xie J, Li R, Kotovuori P, Vermot-Desroches C, Wijdenes J, Arnaout MA, Nortamo P, Gahmberg CG:InterceUular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J Immunol 155:3619, 1995.

• 13) de Fougerolles AR, Stacker SA, Schwarting R, Springer TA:Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 174:253, 1991.
  pubmed

P.296 掲載の参考文献

• 1) Shaw SK, Brenner MB:The beta 7 integrins in mucosal homing and retention. Semin Immunol 7:335, 1995.
  pubmed

• 2) Benmerah A, Badrichani A, Ngohou K, Megarbane B, Begue B, Cerf-Bensussan N:Homotypic aggregation of CD103 (alpha E beta 7)+lymphocytes by an anti-CD103 antibody, HML-4. Eur J Immunol 24:2243, 1994.
  pubmed

• 3) Cepek KL, Parker CM, Madara JL, Brenner MB:Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells. J Immunol 150:3459, 1993.
  pubmed

• 4) Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, Brenner MB:Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372:190, 1994.

• 5) Cerf-Bensussan N, Guy-Grand D, Lisowska-Grospierre B, Griscelli C, Bhan AK:Amonoclonal antibody specific for rat intestinal lymphocytes. J Immunol 136:76, 1986.

• 6) Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C:Amonoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 17:1279, 1987.

• 7) Flenghi L, Spinozzi F, Stein H, Krushwitz M, Pileri S, Falini B:LF61:anew monoclonal antibody directed against a trimeric molecule (150kDa, 125kDa, 105kDa) associated with hairy cell leukemia. Br J Haematol 76:451, 1990.

• 8) Haury M, Kasahara Y, Schaal S, Bucy RP, Cooper MD:Intestinal T lymphocytes in the chicken express an integrin-like antigen. Eur J Immunol 23:313, 1993.
  pubmed

• 9) Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ:Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 25:852, 1995.
  pubmed

• 10) Kilshaw PJ, Murant SJ:Anew surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol 20:2201, 1990.

• 11) Kruschwitz M, Fritzsche G, Schwarting R, Micklem K, Mason DY, Falini B, Stein H:Ber-ACT8:new monoclonal antibody to the mucosa lymphocyte antigen. J Clin Pathol 44:636, 1991.

• 12) Micklem KJ, Dong Y, Willis A, Pulford KA, Visser L, Durkop H, Poppema S, Stein H, Mason DY:HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. Am J Pathol 139:1297, 1991.
  pubmed

• 13) Parker CM, Cepek KL, Russell GJ, Shaw SK, Posnett DN, Schwarting R, Brenner MB:Afamily of beta 7 integrins on human mucosal lymphocytes. Proc Natl Acad Sci USA 89:1924, 1992.

• 14) Russell GJ, Parker CM, Cepek KL, Mandelbrot DA, Sood A, Mizoguchi E, Ebert EC, Brenner MB, Bhan AK:Distinct structural and functional epitopes of the alpha E beta 7 integrin. Eur J Immunol 24:2832, 1994.
  pubmed

• 15) Sarnacki S, Begue B, Buc H, Le Deist F, Cerf-Bensussan N:Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur J Immunol 22:2887, 1992.
  pubmed

• 16) Schieferdecker HL, Ullrich R, Weiss-Breckwoldt AN, Schwarting R, Stein H, Riecken EO, Zeitz M:The HML-1 antigen of intestinal Iymphocytes is an activation antigen. J Immunol 144:2541, 1990.

• 17) Shaw SK, Cepek KL, Murphy EA, Russell GJ, Brenner MB, Parker CM:Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J Biol Chem 269:6016, 1994.
  pubmed

• 18) Smith TJ, Ducharme LA, Shaw SK, Parker CM, Brenner MB, Kilshaw PJ, Weis JH:Murine M290 integrin expression modulated by mast cell activation. Immunity 1:393, 1994.
  pubmed

• 19) Spencer J, Cerf-Bensussan N, Jarry A, Brousse N, Guy-Grand D, Krajewski AS, Isaacson PG:Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132:1, 1988.
  pubmed

P.298 掲載の参考文献

• 1) Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM:Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation:asurvival mechanism for carcinoma cells. J Cell Biol 158 (1):165-174, 2002.

• 2) Micheloni A, Falcioni R, Zambruno G, D'Alessio M:The human integrin beta 4B and beta 4C variants are not expressed in a tissue-specific manner. FEBS Lett 519 (1-3):238-239, 2002. (No abstract available)

• 3) Koster J, Kuikman I, Kreft M, Sonnenberg A:Two different mutations in the cytoplasmic domain of the integrin beta 4 subunit in nonlethal forms of epidermolysis bullosa prevent interaction of beta 4 with plectin. J Invest Dermatol 117 (6):1405-1411, 2001.
  pubmed

• 4) Chettab K, Zibara K, Belaiba SR, McGregor JL:Acute hyperglycaemia induces changes in the transcription levels of 4 major genes in human endothelial cells:macroarrays-based expression analysis. Thromb Haemost 87 (1):141-148, 2002.
  pubmed

• 5) Sashiyama H, Shino Y, Sakao S, Shimada H, Kobayashi S, Ochiai T, Shirasawa H:Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. Cancer Lett 177 (1):21-28, 2002.
  pubmed

• 6) Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM:Activation of phosphoinositide 3-OH kinase by the alpha 6 beta 4 integrin promotes carcinoma invasion. Cell 91 (7):949-960, 1997.
  pubmed

• 7) van Leusden MR, Kuikman I, Sonnenberg A:The unique cytoplasmic domain of the human integrin variant beta 4E is produced by partial retention of intronic sequences. Biochem Biophys Res Commun 235 (3):826-830, 1997.

• 8) Pulkkinen L, Kurtz K, Xu Y, Bruckner-Tuderman L, Uitto J:Genomic organization of the integrin beta 4gene (ITGB4):ahomozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab In vest 76 (6):823-833, 1997.

• 9) Vidal F, Aberdam D, Miquel C, Christiano AM, Pulkkinen L, Uitto J, Ortonne JP, Meneguzzi G:Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 10 (2):229-234, 1995.
  pubmed

• 10) Hogervorst F, Kuikman I, von dem Borne AE, Sonnenberg A:Cloning and sequence analysis of beta-4cDNA:an integrin subunit that contains a unique 118 kd cytoplasmic domain. EMBO J 9 (3):765-770, 1990.

• 11) Suzuki S, Naitoh Y:Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells. EMBO J 9 (3):757-763, 1990.
  pubmed

• 12) Hogervorst F, Kuikman I, van Kessel AG, Sonnenberg A:Molecular cloning of the human alpha 6 integrin subunit. Alternative splicing of alpha 6 mRNA and chromosomal localization of the alpha 6 and beta 4 genes. Eur J Biochem 199 (2):425-433, 1991.
  pubmed

• 13) Tamura RN, Rozzo C, Starr L, Chambers J, Reichardt LF, Cooper HM, Quaranta V:Epithelial integrin alpha 6 beta 4:complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol 111 (4):1593-1604, 1990.
  pubmed

P.300 掲載の参考文献

• 1) Letarte M, Greaves A, Vera S:In Leukocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1756-1759, 1995.

• 2) Bellon T, Corbi A, Lastres P, Cales C, Cebrian M, Vera S, Cheifetz S, Massague J, Letarte M, Bernabeu C:Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 23:2340, 1993.
  pubmed

• 3) Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M:Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267:19027, 1992.

• 4) Gougos A, Letarte M:Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.J Immunol 141:1925, 1988.
  pubmed

• 5) Gougos A, Letarte M:Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361, 1990.
  pubmed

• 6) Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C:Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 133:1109, 1996.
  pubmed

• 7) Lastres P, Martin-Perez J, Langa C, Bernabeu C:Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin. Biochem J 301:765, 1994.
  pubmed

• 8) McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al:Endoglin, a TGF--beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345, 1994.
  pubmed

• 9) Quackenbush EJ, Letarte M:Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134:1276, 1985.
  pubmed

• 10) Rokhlin OW, Cohen MB, Kubagawa H, Letarte M, Cooper MD:Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 154:4456, 1995.
  pubmed

P.301 掲載の参考文献

• 1) Ochi H, Masuda J, Gimbrone MA:Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity. Eur J Immunol 32 (7):1821-1831, 2002.
  pubmed

• 2) Crook MF, Southgate KM, Newby AC:Both ICAM-1-and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein. J Vasc Res 39 (3):221-229, 2002.
  pubmed

• 3) Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, Sanchez-Madrid F:Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Ce33 Biol 157 (7):1233-1245, 2002.

• 4) Ahmad M, Zhang Y, Zhang Y, Papharalambus C, Alexander RW:Role of isoprenylcysteine carboxyl methyltransferase in tumor necrosis factor-alpha stimulation of expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 22 (5):759-764, 2002.

• 5) Raab M, Daxecker H, Pavlovic V, Griesmacher A, Mueller MM:Quantification of the influence of mycophenolic acid on the release of endothelial adhesion molecules. Clin Chim Acta 320 (1-2):89-94, 2002.

• 6) Bluher M, Unger R, Rassoul F, Richter V, Paschke R:Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type H diabetes. Diabetologia 45 (2):210-216, 2002.
  pubmed

• 7) Boyce JA, Mellor EA, Perkins B, Lim YC, Luscinskas FW:Human mast cell progenitors use alpha 4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 99 (8):2890-2896, 2002.
  pubmed

• 8) Peng DQ, Zhao SP, Li YF, Li J, Zhou HN:Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta 319 (1):19-26, 2002.

• 9) Mukherjee TK, Dinh H, Chaudhuri G, Nathan L:Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells:implications in atherosclerosis. Proc Natl Acad Sci USA 99 (6):4055-4060, 2002.
  pubmed

• 10) Matsumoto K, Sera Y, Miyake S, Ueki Y:Serum levels of adhesion molecules correlate with insulin resistance. A therosclerosis 161 (1):243-244, 2002. (No abstract available)

• 11) Fischer DC, Winkler M, Ruck P, Poth D, Kemp B, Rath W:Localization and quantification of adhesion molecule expression in the lower uterine segment during premature labor. J Perinat Med 29 (6):497-505, 2001.
  pubmed

• 12) Wang JH, Pepinsky RB, Stehle T, Liu JH, Karpusas M, Browning B, Osborn L:The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1):acyclic peptide based on the domain 1 C-D Ioop can inhibit VCAM-1-alpha 4 integrin interaction. Proc Natl Acad Sci USA 92 (12):5714-5718, 1995.

• 13) Jones EY, Harlos K, Bottomley MJ, Robinson RC, Driscoll PC, Edwards RM, Clements JM, Dudgeon TJ, Stuart DI:Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature 373 (6514):539-544, 1995.
  pubmed

• 14) Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R:Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (6):1203-1211, 1989.
  pubmed

• 15) Cybulsky MI, Fries JW, Williams AJ, Sultan P, Eddy R, Byers M, Shows T, Gimbrone MA Jr, Collins T:Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAMl gene. Proc Natl Acad Sci USA 88 (17):7859-7863, 1991.

• 16) Polte T, Newman W, Raghunathan G, Gopal TV:Structural and functional studies of full-length vascular cell adhesion molecule-1:internal duplication and homology to several adhesion proteins. DNA Cell Biol 10 (5):349-357, 1991.
  pubmed

• 17) Hession C, Tizard R, Vassallo C, Schiffer SB, Goff D, Moy P, Chi-Rosso G, Luhowskyj S, Lobb R, Osborn L:Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1) J Biol Chem 266 (11):6682-6685, 1991.
  pubmed

P.303 掲載の参考文献

• 1) Fukuda M:Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficklng. J Biol Chem 266:21327, 1991.
  pubmed

• 2) Dahlgren C, Carlsson SR, Karlsson A, Lundqvist H, Sjolin C:The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils. Biochem/ 311:667, 1995.
  pubmed

• 3) Lippincott-Schwartz J, Fambrough DM:Lysosomal membrane dynamics:structure and interorganellar movement of a major lysosomal membrane glycoprotein. J Cell Biol 102:1593, 1986.

• 4) Sawada R, Jardine KA, Fukuda M:The genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2.5'-flanking sequence of lamp-2 gene and comparison of exon organization in two genes. J Biol Chem 268:9014, 1993.

• 5) Silverstein RL, Febbraio M:Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood 80:1470, 1992.
  pubmed

P.305 掲載の参考文献

• 1) Fukuda M:Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266:21327, 1991.
  pubmed

• 2) Dahlgren C, Carlsson SR, Karlsson A, Lundqvist H, Sjolin C:The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils. Biochem J 311:667, 1995.
  pubmed

• 3) Lippincott-Schwartz J, Fambrough DM:Lysosomal membrane dynamics:structure and interorganellar movement of a major lysosomal membrane glycoprotein. J Cell Biol 102:1593, 1986.

• 4) Sawada R, Jardine KA, Fukuda M:The genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2.5'flanking sequence of lamp-2 gene and comparison of exon organization in two genes. J Biol Chem 268:9014, 1993.

• 5) Silverstein RL, Febbraio M:Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood 80:1470, 1992.
  pubmed

P.306 掲載の参考文献

• 1) Klickstein LB, Springer TA:CDw108 cluster report. In Leukocyte Typing V, (eds Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF) , Oxford University Press, p1477, 1995.

• 2) Bobolis KA, Lande WM, Telen MJ:Biochemical study of possible mechanisms of acquired loss of JMH antigen expression. Transfusion 31:46S, 1991.

• 3) Kubo K:ヒト活性化リンパ球に存在する新しいPIアンカー型蛋白 (Phosphatidylinositol anchored protein) の性状. J Kurume Med Assoc 12:1051-1060, 1991.

• 4) Bobolis KA, Moulds JJ, Telen MJ:Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein. Blood 79:1574-1581, 1992.
  pubmed

• 5) Daniels GL, Knowles RW:Amonoclonal antibody to the high frequency red cell antigen JMH. J Immunogenet 9:57-59, 1982.

• 6) Daniels GL, Knowles RW:Further analysis of the monoclonal antibody H8 demonstrating a JMH-related specificity. J Immunogenet 10:257-258, 1983.
  pubmed

• 7) Mudad R, Rao N, Angelisova P, Horejsi V, Telen MJ:Evidence that CDw108 membrane protein bears the JMH blood group antigen. Transfusion (Paris) 35:566-570, 1995.

• 8) Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ:JMH variants:serologic, clinical, and biochemical analyses in two cases. Transfusion (Paris) 35:925-930, 1995.

P.307 掲載の参考文献

• 1) Schuh AC, Watkins NA, Nguyen Q, Harmer NJ, Lin M, Prosper JY, Campbell K, Sutherland DR, Metcalfe P, Horsfall W, Ouwehand WH:Atyrosine 703 serine polymorphism of CD109 defines the Gov Platelet alloantigens. Blood 99 (5):1692-1698, 2002.

• 2) Lin M, Sutherland DR, Horsfall W, Totty N, Yeo E, Nayar R, Wu XF, Schuh AC:Cell surface antigen CD109 is a novel member of the alpha (2) macroglobulin/C3, C4, C5 family of thioester-containing proteins. Blood 99 (5):1683-1691, 2002.
  pubmed

• 3) Berry JE, Murphy CM, Smith GA, Ranasinghe E, Finberg R, Walton J, Brown J, Navarrete C, Metcalfe P, Ouwehand WH:Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 110 (3):735-742, 2000.

• 4) Murray LJ, Bruno E, Uchida N, Hoffman R, Nayar R, Yeo EL, Schuh AC, Sutherland DR:CD109 is expressed on a subpopulation of CD34+cells enriched in hematopoietic stem and progenitor cells. Exp Hematol 27 (8):1282-1294, 1999.
  pubmed

• 5) Solomon KR, Mallory MA, Finberg RW:Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells. Biochem J 334 (Pt 2):325-333, 1998.

• 6) Kelton JG, Smith JW, Horsewood P, Warner MN, Warkentin TE, Finberg RW, Hayward CP:ABH antigens on human platelets:expression on the glycosyl phosphatidylinositol-anchored protein CD109. J Lab Clin Med 132 (2):142-148, 1998.
  pubmed

• 7) Mutin M, Dignat-George F, Sampol J:Immunologic phenotype of cultured endothelial cells:quantitative analysis of cell surface molecules. Tissue Antigens 50 (5):449-458, 1997.
  pubmed

• 8) Udani M, Rao N, Telen MJ:Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction. Transfusion 37 (9):904-909, 1997.

• 9) Bordin JO, Kelton JG, Wamer MN, Smith JW, Denomme GA, Warkentin TE, McGrath K, Minchinton R, Hayward CP:Maternal immunization to Gov system alloantigens on human platelets. Transfusion 37 (8):823-828, 1997.

• 10) Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Buhring HJ:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90 (1):111-125, 1997.
  pubmed

• 11) Singh J, Viswanathan PN, Gupta M, Devi S:Uptake and translocation of Cd109 by two aquatic ferns in relation to relative toxic response. Bull Environ Contam Toxicol 51 (6):914-919, 1993. (No abstract available)

• 12) Phillpotts CJ:The autoradiographic localization of retained orally administered cadmium tracer within Paneth cells of rat duodenum. Toxicology 33 (1):59-66, 1984.
  pubmed

• 13) Hunt DM, Clarke R:Metallothionein and the development of the mottled disorder in the mouse. Biochem Genet 21 (11-12):1175-1194, 1983.

• 14) Chowdhury P, Chang LW, Rayford PL:Catabolism and tissue distribution of Cd109 in rats. Bull Environ Contam Toxicol 31 (4):391-398, 1983. (No abstract available)

P.309 掲載の参考文献

• 1) Abe M, Suzuki K, Inagaki O, Sassa S, Shikama H:Anovel MPL point mutation resulting in thrombopoietin-independent activation. Leuleemia 16 (8):1500-1506, 2002.

• 2) Teofili L, Pierconti F, Di Febo A, Maggiano N, Vianelli N, Ascani S, Rossi E, Pileri S, Leone G, Larocca LM, De Stefano V:The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood 100 (2):714-717, 2002.
  pubmed

• 3) Mesa RA, Hanson CA, Li Cy, Yoon SY, Rajkumar SV, Schroeder G, Tefferi A:Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential throm-bocythemia. Blood 99 (11):4131-4137, 2002.

• 4) Scheding S, Bergmann M, Shimosaka A, Wolff P, Driessen C, Rathke G, Jaschonek K, Brugger W, Kanz L:Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo. Transfusion 42 (3):321-327, 2002.
  pubmed

• 5) Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V:Analysis of the throm-bopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87 (11):4678-4685, 1996.

• 6) Mignotte V, Vigon I, Boucher de Crevecoeur E, Romeo PH, Lemarchandel V, Chretien S:Structure and transcription of the human c-mpl gene (MPL). Genomics 20 (1):5-12, 1994.

• 7) Le Coniat M, Souyri M, Vigon I, Wendling F, Tambourin P, Berger R:The human homolog of the myeloproliferative virus maps to chromosome band 1p34. Hzam Genet 83 (2):194-196, 1989.

• 8) Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M:Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene:identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89 (12):5640-5644, 1992.

P.311 掲載の参考文献

• 1) Yoon M, Spear PG:Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry. J Virol 76 (14):7203-7208, 2002..

• 2) Cocchi F, Lopez M, Menotti L, Aoubala M, Dubreuil P, Campadelli-Fiume G:The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci USA 95 (26):15700-15705, 1998.

• 3) Cocchi F, Menotti L, Mirandola P, Lopez M, Campadelli-Fiume G:The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Viro172 (12):9992-10002, 1998.

• 4) Suzuki K, Bustos T, Spritz RA:Linkage disequilibrium mapping of the gene for Margarita Island ectodermal dysplasia (ED4) to 11q23. Am/Hum Genet 63 (4):1102-1107, 1998.
  pubmed

• 5) Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG:Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280 (5369):1618-1620, 1998.
  pubmed

• 6) Lopez M, Eberle F, Mattei MG, Gabert J, Birg F, Bardin F, Maroc C, Dubreuil P:Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene 155 (2):261-265, 1995.

• 7) Bustos T, Simosa V, Pinto-Cisternas J, Abramovits W, Jolay L, Rodriguez L, Fernandez L, Ramela M:Autosomal recessive ectodermal dysplasia:1. An undescribed dysplasia/malformation syndrome. Am J Med Genet 41 (4):398-404, 1991.

P.312 掲載の参考文献

• 1) Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG:The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol 73 (5):4493-4497, 1999.

• 2) Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear PG:Acell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246 (1):179-189, 1998.

• 3) Eberle F, Dubreuil P, Mattei MG, Devilard E, Lopez M:The human PRR2 gene, related to the human poliovirus receptor gene (PVR) , is the true homolog of the murine MPH gene. Gene 159 (2):267-272, 1995.

P.313 掲載の参考文献

• 1) Viprakasit V, Tachavanich K, Suwantol L, Pung-Amritt P, Chinchang W, Tanphaichitr VS:Allele related mutation specific-polymerase chain reaction for rapid diagnosis of Hb New York (beta 113 (G15) Val->Glu, beta (CD113 GTG->GAG). J Med Assoc Thai 85 (Suppl 2):S558-S563, 2002.

P.314 掲載の参考文献

• 1) Avalos BR:Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88:761, 1996.
  pubmed

• 2) Bernard T, Gale RE, Linch DC:Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. Br J Haematol 93:527, 1996.
  pubmed

• 3) Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, Aglietta M, Arese P, Mantovani A:Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337:471, 1989.
  pubmed

• 4) Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP:Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeioid leukemia preceded by severe congenital neutropenia. J Engl J Med 333:487, 1995.

• 5) Fukunaga R, Ishizaka-Ikeda E, Pan CX, Seto Y, Nagata S:Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 10:2855, 1991.
  pubmed

• 6) Fukunaga R, Seto Y, Mizushima S, Nagata S:Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA 87:8702, 1990.
  pubmed

• 7) Kasper B, Hadam MR, Welte K:Detection of normal G-CSF receptor-proteins in patients with severe congenital neutropenia. Blood 86 (Suppl 1):510a, 1995.

• 8) Nicholson SE, Oates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton JE:Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phospho-rylated after receptor activation. Proc Natl Acad Sci USA 91:2985, 1994.

• 9) Rauprich P, Kasper B, Tidow N, Welte K:The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 86:4500, 1995.
  pubmed

• 10) Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG:PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234, 1996.

• 11) Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, et al:Recombinant human granulocyte colony-stimulating factor:effects on normal and leukemic myeloid cells. Science 232:61, 1986.
  pubmed

• 12) Uzumaki H, Okabe T, Sasaki N, Hagiwara K, Takaku F, Tobita M, Yasukawa K, Ito S, Umezawa Y:Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA 86:9323, 1989.
  pubmed

• 13) Ziegler SF, Bird TA, Morella KK, Mosley B, Gearing DP, Baumann H:Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol Cell Biol 13:2384, 1993.
  pubmed

P.317 掲載の参考文献

• 1) Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG:Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 100 (3):998-1007, 2002.
  pubmed

• 2) Flick MB, Sapi E, Kacinski BM:Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element. J Cell Biochem 85 (1):10-23, 2002.

• 3) Jaju RJ, Boultwood J, Oliver FJ, Kostrzewa M, Fidler C, Parker N, McPherson JD, Morris SW, Muller U, Wainscoat JS, Kearney L:Molecular cytogenetic delineation of the critical deleted region in the 5q-syndrome. Genes Chromosomes Cancer 22 (3):251-256, 1998.
  pubmed

• 4) Andre C, Hampe A, Lachaume P, Martin E, Wang XP, Manus V, Hu WX, Galibert F:Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics 39 (2):216-226, 1997.
  pubmed

• 5) Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, Yeung YG:Biology and action of colony-stimulating factor-1. Mol Rep rod Dev 46 (1):4-10, 1997. (Review)

• 6) Gastier JM, Brody T, Pulido JC, Businga T, Sunden S, Hu X, Maitra S, Buetow KH, Murray JC, Sheffield VC, Boguski M, Duyk GM, Hudson TJ:Development of a screening set for new (CAG/CTG) ndynamic mutations. Genomics 32 (1):75-85, 1996.
  pubmed

• 7) Sapi E, Flick MB, Kacinski BM:The first intron of human c-fms proto-oncogene contains a processed pseudogene (RPL7P) for ribosomal protein L7. Genomics 22 (3):641-645, 1994.

• 8) Browning PJ, Bunn HF, Cline A, Shuman M, Nienhuis AW:"Replacement" of COOH-terminal trunca-tion of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci USA 83 (20):7800-7805, 1986.

• 9) Wheeler EF, Roussel MF, Hampe A, Walker MH, Fried VA, Look AT, Rettenmier CW, Sherr CJ:The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.JVirol 59 (2):224-233, 1986.

• 10) Xu DQ, Guilhot S, Galibert F:Restriction fragment length polymorphism of the human c-fms gene. Proc Natl Acad Sci USA 82 (9):2862-2865, 1985.

• 11) Roberts WM, Look AT, Roussel MF, Sherr CJ:Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes. Cell 55 (4):655-661, 1988.
  pubmed

• 12) Visvader J, Verma IM:Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Mol Cell Biol 9 (3):1336-1341, 1989.

• 13) Hampe A, Shamoon BM, Gobet M, Sherr CJ, Galibert F:Nucleotide sequence and structural organization of the human FMS proto-oncogene. Oncogene Res 4 (1):9-17, 1989.
  pubmed

• 14) Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A:Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320 (6059):277-280, 1986.
  pubmed

• 15) Boultwood J, Rack K, Kelly S, Madden J, Sakaguchi AY, Wang LM, Oscier DG, Buckle VJ, Wainscoat JS:Loss of both CSFIR (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc Natl Acad Sci USA 88 (14):6176-6180, 1991.

• 16) Galland F, Stefanova M, Lafage M, Birnbaum D:Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15-q23. Cytogenet Cell Genet 60 (2):114-116, 1992.
  pubmed

P.319 掲載の参考文献

• 1) Miyajima A, Mui AL, Ogorochi T, Sakamaki K:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960, 1993.
  pubmed

• 2) Crosier KE, Wong GG, Mathey-Prevot B, Nathan DG, Sieff CA:A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain. Proc Natl Acad Sci USA 88:7744, 1991.
  pubmed

• 3) Gearing DP, King JA, Gough NM, Nicola NA:Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 8:3667, 1989.
  pubmed

• 4) Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A:Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF):reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci US 187:9655, 1990.

• 5) Heaney ML, Vera JC, Raines MA, Golde DW:Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells. Proc Natl Acad Sci USA 92:2365, 1995.
  pubmed

• 6) Jubinsky PT, Laurie AS, Nathan DG, Yetz-Aldepe J, Sieff CA:Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit. Blood 84:4174, 1994.
  pubmed

• 7) Kitamura T, Hayashida K, Sakamaki K, Yokota T, Arai K, Miyajima A:Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF):evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc Natl Acad Sci USA 88:5082, 1991.
  pubmed

• 8) Nicola NA, Wycherley K, Boyd AW, Layton JE, Cary D, Metcalf D:Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain. Blood 82:1724, 1993.

• 9) Park LS, Martin U, Sorensen R, Luhr S, Morrissey PJ, Cosman D, Larsen A:Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc Natl Acad Sci USA 89:4295, 1992.
  pubmed

• 10) Ronco LV, Silverman SL, Wong SG, Slamon DJ, Park LS, Gasson JC:Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J Biol Chem 269:277, 1994.

• 11) Sakamaki K, Miyajima I, Kitamura T, Miyajima A:Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541, 1992.
  pubmed

P.321 掲載の参考文献

• 1) Buhring, H-J, Ashman LK, Gattei V, Kniep B, Larregina A, Pinto A, Valent P, van den Oord JJ:In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1882-1888, 1995.

• 2) Galli SJ, Zsebo KM, Geissler EN:The kit ligand, stem cell factor. Adv Immunol 55:1, 1994.
  pubmed

• 3) Adachi S, Ebi Y, Nishikawa S, Hayashi S, Yamazaki M, Kasugai T, Yamamura T, Nomura S, Kitamura Y:Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 79:650, 1992.

• 4) Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA:Expression of the YB5. B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30, 1991.
  pubmed

• 5) Besmer P, Murphy JE, George PC, Qiu FH, Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, Hardy WD:Anew acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415, 1986.

• 6) Blume-Jensen P, Wernstedt C, Heldin CH, Ronnstrand L:Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J Biol Chem 270:14192, 1995.

• 7) Buhring HJ, Ullrich A, Schaudt K, Muller CA, Busch FW:The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854, 1991.
  pubmed

• 8) Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE:Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82:1151, 1993.
  pubmed

• 9) Gadd SJ, Ashman LK:Amurine monoclonal antibody specific for a cell-surface antigen expressed by subgroup of human myeloid leukaemias. Leuk Res 9:1329, 1985.

• 10) Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T:Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6:2291, 1991.

• 11) Lerner NB, Nocka KH, Cole SR, Qiu FH, Strife A, Ashman LK, Besmer P:Monoclonal antibody YB5. B8 identifies the human c-kit protein product. Blood 77:1876, 1991.

• 12) Lev S, Givol D, Yarden Y:Aspecific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J 10:647, 1991.

• 13) Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD:Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14:257, 1995.
  pubmed

• 14) Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK:Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 65:241, 1987.
  pubmed

• 15) Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD:Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560, 1995.
  pubmed

• 16) Paulson RF, Vesely S, Siminovitch KA, Bernstein A:Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13:309, 1996.

• 17) Tang B, Mano H, Yi T, Ihle JN:Tec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor binding. Mol Cell Biol 14:8432, 1994.

• 18) Turner AM, Bennett LG, Lin NL, Wypych J, Bartley TD, Hunt RW, Atkins HL, Langley KE, Parker V, Martin F, et al:Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 85:2052, 1995.
  pubmed

• 19) Witte ON:Steel locus defines new multipotent growth factor. Cell 63:5, 1990.
  pubmed

• 20) Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A:Human proto-oncogene c-kit:a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987.

P.323 掲載の参考文献

• 1) Subramaniam PS, Johnson HM:Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1 alpha. J Immunol 169 (4):1959-1969, 2002.
  pubmed

• 2) Hostoffer RW:Interferon-gamma receptor defects. Clin Immunol 103 (2):210, 2002. (discussion 210)

• 3) Koch O, Awomoyi A, Usen S, Jallow M, Richardson A, Hull J, Pinder M, Newport M, Kwiatkowski D:IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis 185 (11):1684-1687, 2002.
  pubmed

• 4) Sasaki Y, Nomura A, Kusuhara K, Takada H, Ahmed S, Obinata K, Hamada K, Okimoto Y, Hara T:Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan:identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis 185 (5):706-709, 2002.
  pubmed

• 5) Losana G, Rigamonti L, Borghi I, Assenzio B, Ariotti S, Jouanguy E, Altare F, Forni G, Casanova JL, Novelli F:Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells. Eur J Immunol 32 (3):693-700, 2002.

• 6) Allende LM, Lopez-Goyanes A, Paz-Artal E, Corell A, Garcia-Perez MA, Varela P, Scarpellini A, Negreira S, Palenque E, Arnaiz-Villena A:A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol 8 (1):133-137, 2001.

• 7) Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M:A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335 (26):1941-1949, 1996.

• 8) Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA:Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 (5102):1739-1742, 1993.
  pubmed

• 9) Aguet M, Dembic Z, Merlin G:Molecular cloning and expression of the human interferon-gamma receptor. Cell 55 (2):273-280, 1988.
  pubmed

• 10) Novick D, Orchansky P, Revel M, Rubinstein M:The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies. J Biol Chem 262 (18):8483-8487, 1987.
  pubmed

• 11) Le Coniat M, Alcaide-Loridan C, Fellous M, Berger R:Human interferon gamma receptor 1 (IFNGR1) gene maps to chromosome region 6q23-6q24. Hum Genet 84 (1):92-94, 1989.
  pubmed

P.325 掲載の参考文献

• 1) Chen G, Goeddel DV:TNF-R1 signaling:a beautiful pathway. Science 296 (5573):1634-1635, 2002.
  pubmed

• 2) Dode C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J, Lecron JC, Reinert P, Cattan D, Piette JC, Szajnert MF, Delpech M, Grateau G:The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthtitis Rheum 46 (8):2181-2188, 2002.

• 3) Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen RP, Leivo I, Knuutila S:Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 81 (8):525-530, 2002.
  pubmed

• 4) Ciesielski CJ, Andreakos E, Foxwell BM, Feldmann M:TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappa B expression than lipopolysaccharides-induced macrophage chemokine secretion. Eur J Immunol 32 (7):2037-2045, 2002.
  pubmed

• 5) Eichholtz-Wirth H, Sagan D:Altered signaling of TNFalpha-TNFR1 and SODD/BAG4 is responsible for radioresistance in human HT-R15 cells. Anticancer Res 22 (1A):235-240, 2002.
  pubmed

• 6) Sugano M, Tsuchida K, Tomita H, Makino N:Increased proliferation of endothelial cells with overex-pression of soluble TNF-alpha receptor I gene. Atherosclerosis 162 (1):77-84, 2002.

• 7) Cottin V, Doan JE, Riches DW:Restricted localization of the TNF receptor CD120a to lipid rafts:a novel role for the death domain. J Immunol 168 (8):4095-4102, 2002.
  pubmed

• 8) Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ:The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem 277 (24):21730-21739, 2002.
  pubmed

• 9) Zaccone P, Fehervari Z, Blanchard L, Nicoletti F, Edwards CK 3rd, Cooke A:Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur J Immunol 32 (4):1021-1028, 2002.
  pubmed

• 10) Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Penarroja G, Broch M, Perez A, Richart C, Enge1 P, Ricart W:Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 282 (4):E952-959, 2002.
  pubmed

• 11) de Oliveira Pinto LM, Garcia S, Lecoeur H, Rapp C, Gougeon ML:Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)-and TNFR2-mediated apoptosis in HIV infection:relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 99 (5):1666-1675, 2002.
  pubmed

• 12) De Wilde G, Mertens N, Boone E, De Vreese B, Van Beeumen J, Fiers W, Haegeman G:Expression in Escherichia coli of the death domain of the human p55 tumor necrosis factor receptor. Protein Expr Purif 23 (2):226-232, 2001.
  pubmed

• 13) Amrani Y, Ammit AJ, Panettieri RA Jr:Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells:role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol 60 (4):646-655, 2001.

• 14) McDermott MF, Aksentilevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Kastner DL, et al:Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97 (1):133-144, 1999.
  pubmed

• 15) Castellino AM, Parker GJ, Boronenkov IV, Anderson RA, Chao MV:A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. JBiol Chem 272 (9):5861-5870, 1997.

• 16) Aggarwal BB, Eessalu TE, Hass PE:Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature 318 (6047):665-667, 1985-1986.

• 17) Stauber GB, Aiyer RA, Aggarwal BB:Human tumor necrosis factor-alpha receptor. Purification by immunoaffinity chromatography and initial characterization. J Biol Chem 263 (35):19098-19104, 1988.
  pubmed

• 18) Gray PW, Barrett K, Chantry D, Turner M, Feldmann M:Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci USA 87 (19):7380-7384, 1990.

• 19) Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, et al:Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61 (2):361-370, 1990.
  pubmed

• 20) Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W:Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61 (2):351-359, 1990.
  pubmed

P.329 掲載の参考文献

• 1) Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A:Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 61 (3):1079-1085, 2002.
  pubmed

• 2) Dale M, Nicklin MJ:Interleukin-1 receptor cluster:gene organization of ILIR2, ILIR1, ILIRL2 (IL-1Rrp2), ILIRL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57 (1):177-179, 1999.

• 3) Rameshwar P, Poddar A, Zhu G, Gascon P:Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibro-blasts. J Immunol 158 (7):3417-3424, 1997.

• 4) Chua AO, Gubler U:Sequence of the cDNA for the human fibroblast type interleukin-1 receptor. Nucleic Acids Res 17 (23):10114, 1989. (No abstract available)

• 5) Sims JE, Acres RB, Grubin CE, McMahan CJ, Wignall JM, March CJ, Dower SK:Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci US 4 86 (22):8946-8950, 1989.

• 6) McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, et al:A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10 (10):2821-2832, 1991.

• 7) Copeland NG, Silan CM, Kingsley DM, Jenkins NA, Cannizzaro LA, Croce CM, Huebner K, Sims JE:Chromosomal location of murine and human IL-1 receptor genes. Genomics 9 (1):44-50, 1991.
  pubmed

P.330 掲載の参考文献

• 1) Kharfi A, Boucher A, Akoum A:Abnormal interleukin-1 receptor type II gene expression in the endometrium of women with endometriosis. Biol Reprod 66 (2):401-406, 2002.
  pubmed

• 2) Dale M, Nicklin MJ:Interleukin-1 receptor cluster:gene organization of ILIR2, ILIRI, ILIRL2 (IL-1Rrp2), ILIRL1 (T1/ST2), and IL18R1 (1L-1Rrp) on human chromosome 2q. Genomics 57 (1):177-179, 1999.

• 3) Lovenberg TW, Crowe PD, Liu C, Chalmers DT, Liu XJ, Liaw C, Clevenger W, Oltersdorf T, De Souza EB, Maki RA:Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL IR-rp2). J Neuroimmunol 70 (2):113-122, 1996.

• 4) McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, et al:A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10 (10):2821-2832, 1991.

P.332 掲載の参考文献

• 1) Minami Y, Kono T, Miyazaki T, Taniguchi T:The IL-2 receptor complex:its structure, function, and target genes. Annuu Rev Immunol 11:245, 1993.
  pubmed

• 2) Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Nakamura M, Takeshita T:The common gamma-chain for multiple cytokine receptors. Adv Immunol 59:225, 1995.
  pubmed

• 3) Waldmann TA:The interleukin-2 receptor. J Biol Chem 266:2681, 1991.
  pubmed

• 4) Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T:Interleukin-2 receptor beta chain gene:generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science 244:551, 1989.
  pubmed

• 5) Sharon M, Klausner RD, Cullen BR, Chizzonite R, Leonard WJ:Novel interleukin-2 receptor subunit detected by cross-linking under. Science 234:859, 1986.
  pubmed

• 6) Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, et al:Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472, 1995.
  pubmed

• 7) Takeshita T, Goto Y, Tada K, Nagata K, Asao H, Sugamura K:Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med 169:1323, 1989.

• 8) Tsudo M, Kitamura F, Miyasaka M:Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc Natl Acad Sci USA 86:1982, 1989.
  pubmed

• 9) Tsudo M, Kozak RW, Goldman CK, Waldmann TA:Demonstration of a non-Tac peptide that binds interleukin 2:a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA 83:9694, 1986.

P.334 掲載の参考文献

• 1) Kosugi H, Nakagawa Y, Hotta T, Saito H, Miyajima A, Arai K, Yokota T:Structure of the gene encoding the alpha subunit of the human interleukin 3 receptor. Biochem Biophys Res Commun 208 (1):360-367, 1995.
  pubmed

• 2) Kitamura T, Sato N, Arai K, Miyaj ima A:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66 (6):1165-1174, 1991.

P.336 掲載の参考文献

• 1) Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE:Interleukin 4 receptor:signaling mechanisms. Immunol Today 15:423, 1994.
  pubmed

• 2) Harada N, Castle BE, Gorman DM, Itoh N, Schreurs J, Barrett RL, Howard M, Miyajima A:Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. Proc Natl Acad Sci USA 87:857, 1990.
  pubmed

• 3) Idzerda RL, March CJ, Mosley B, Lyman SD, Vanden Bos T, Gimpel SD, Din WS, Grabstein KH, Widmer MB, Park LS, et al:Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171:861, 1990.
  pubmed

• 4) Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, et al:The murine interleukin-4 receptor:molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335, 1989
  pubmed

P.337 掲載の参考文献

• 1) Takatsu K, Takaki S, Hitoshi Y:Interleukin-5 and its receptor system:implications in the immune system and inflammation. Adv Immunol 57:145, 1994.
  pubmed

• 2) Cornelis S, Plaetinck G, Devos R, Van der Heyden J, Tavernier J, Sanderson CJ, Guisez Y, Fiers W:Detailed analysis of the IL-5-IL-5R alpha interaction:characterization of crucial residues on the ligand and the receptor. EMBO J 14:3395, 1995.
  pubmed

• 3) Koike M, et al:In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998. (in preparation)

• 4) Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K:Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 175:341, 1992.
  pubmed

• 5) Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K:Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med 177:1523, 1993.
  pubmed

• 6) Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G:A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66:1175, 1991.

• 7) Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R:Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci USA 89:7041, 1992.
  pubmed

• 8) Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, Kanazawa H, Sunaga S, Kinashi T, Yoshimura K, Miyazaki J, Takaki S, Takatsu K:Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4:483, 1996.
  pubmed

P.339 掲載の参考文献

• 1) Rose-John S, Heinrich PC:Soluble receptors for cytokines and growth factors:generation and biological function. Biochem J 300:281, 1994.
  pubmed

• 2) Taga T, Kishimoto T:Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797, 1997.
  pubmed

• 3) Hirata Y, Taga T, Hibi M, Nakano N, Hirano T, Kishimoto T:Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J Immunol 143:2900, 1989.
  pubmed

• 4) Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S:Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 149:2021, 1992.
  pubmed

• 5) Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S:The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473, 1993.
  pubmed

• 6) Peters M, Jacobs S, Ehlers M, Vollmer P, Mullberg J, Wolf E, Brem G, Meyer zum Buschenfelde KH, Rose-John S:The function of the soluble interleukin 6 (IL-6) receptor in vivo:sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp J Med 183:1399, 1996.

• 7) Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Fattori E, Ciliberto G, Dienes HP, Meyer zum Buschenfelde KH, Rose-John S:Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med 185:755, 1997.
  pubmed

P.341 掲載の参考文献

• 1) Komschlies KL, Grzegorzewski KJ, Wiltrout RH:Diverse immunological and hematological effects of interleukin 7:implications for clinical application. J Leukoc Biol 58:623, 1995.
  pubmed

• 2) Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, Gimpel S, Cosman D, Dower SK, March CJ, Namen AE, et al:Cloning of the human and murine interleukin-7 receptors:demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941, 1990.
  pubmed

• 3) Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S:Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333:571, 1988.
  pubmed

• 4) Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, et al:Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955, 1994.
  pubmed

P.343 掲載の参考文献

• 1) Richardson RM, Pridgen BC, Haribabu B, Snyderman R:Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2. J Biol Chem 275 (13):9201-9208, 2000.
  pubmed

• 2) Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, Simmelink M, Locati M, Bernasconi S, Allavena P, Brandt E, Rossi F, Mantovani A, Sozzani S:Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164 (7):3862-3869, 2000.
  pubmed

• 3) Wuyts A, D, Haese A, Cremers V, Menten P, Lenaerts JP, De Loof A, Heremans H, Proost P, Van Damme J:NH2-and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. J Immunol 163 (11):6155-6163, 1999.
  pubmed

• 4) Mollereau C, Muscatelli F, Mattei MG, Vassart G, Parmentier M:The high-affinity interleukin 8 receptor gene (IL8RA) maps to the 2q33-q36 region of the human genome:cloning of a pseudogene (IL8RBP) for the low-affinity receptor. Genomics 16 (1):248-251, 1993.

• 5) Sebok K, Woodside D, al-Aoukaty A, Ho AD, Gluck S, Maghazachi AA:IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein. J Immunol 50 (4):1524-1534, 1993.

• 6) Sprenger H, Lloyd AR, Meyer RG, Johnston JA, Kel.vin DJ:Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J Immunol 153 (6):2524-2532, 1994.

• 7) Ahuja SK, Shetty A, Tiffany HL, Murphy PM:Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem 269 (42):26381-26389, 1994.

• 8) Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI:Structure and functional expression of a human interleukin-8 receptor. Science 253 (5025):1278-1280, 1991.
  pubmed

• 9) Morris SW, Nelson N, Valentine MB, Shapiro DN, Look AT, Kozlosky CJ, Beckmann MP, Cerretti DP:Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35. Genomics 14 (3):685-691, 1992.

• 10) Ahuja SK, Ozcelik T, Milatovitch A, Francke U, Murphy PM:Molecular evolution of the human interleukin-8 receptor gene cluster. Nat Genet 2 (1):31-36, 1992.
  pubmed

P.344 掲載の参考文献

• 1) Takamori H, Oades ZG, Hoch OC, Burger M, Schraufstatter IU:Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 21 (1):52-56, 2000.
  pubmed

• 2) Ludwig A, Ehlert JE, Flad HD, Brandt E:Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 291ycoforms in neutrophils:N-glycosylation is essential for maintenance of receptor surface expression. J Immunol 165 2):1044-1052, 2000.
  pubmed

• 3) Luu NT, Rainger GE, Nash GB:Differential ability of exogenous chemotactic agents to disrupt transen-dothelial migration of flowing neutrophils. J Immunol 164 (11):5961-5969, 2000.

• 4) Richardson RM, Pridgen BC, Haribabu B, Snyderman R:Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2. J Biol Chem 275 (13):9201-9208, 2000.
  pubmed

• 5) Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, Simmelink M, Locati M, Bernasconi S, Allavena P, Brandt E, Rossi F, Mantovani A, Sozzani S:Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164 (7):3862-3869, 2000.
  pubmed

• 6) Burger M, Burger JA, Hoch RC, Oades Z, Takamori H, Schraufstatter IU:Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J Immunol 163 (4):2017-2022, 1999.
  pubmed

• 7) Lippert U, Artuc M, Grutzkau A, Moller A, Kenderessy-Szabo A, Schadendorf D, Norgauer J, Hartmann K, Schweitzer-Stenner R, Zuberbier T, Henz BM, Kruger-Krasagakes S:Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 161 (5):2600-2608, 1998.
  pubmed

• 8) Mueller SG, White JR, Schraw WP, Lam V, Richmond A:Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J Biol Chem 272 (13):8207-8214, 1997.
  pubmed

• 9) Harada A, Kuno K, Nomura H, Mukaida N, Murakami S, Matsushima K:Cloning of a cDNA encoding a mouse homolog of the interleukin-8 receptor. Gene 142 (2):297-300, 1994.
  pubmed

• 10) Ahuja SK, Shetty A, Tiffany HL, Murphy PM:Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem 269 (42):26381-26389, 1994.

• 11) Sprenger H, Lloyd AR, Lautens LL, Bonner TI, Kelvin DJ:Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem 269 (15):11065-11072, 1994.

• 12) Murphy PM, Tiffany HL:Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253 (5025):1280-1283, 1991.
  pubmed

• 13) Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI:Structure and functional expression of a human interleukin-8 receptor. Science 253 (5025):1278-1280, 1991.
  pubmed

• 14) Morris SW, Nelson N, Valentine MB, Shapiro DN, Look AT, Kozlosky CJ, Beckmann MP, Cerretti DP:Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35. Genomics 14 (3):685-691, 1992.

P.345 掲載の参考文献

• 1) Tsukadaira A, Okubo Y, Koyama S, Sato E, Nagase H, Agematsu K, Nakazawa K:Human bronchial epithelium expresses interleukin-9 receptors and releases neutrophil chemotactic factor. Exp Lung Res 28 (2):123-139, 2002.
  pubmed

• 2) Harteveld CL, Giordano PC, Losekoot M, Heister JG, Batelaan D, van Delft P, Bruin MC, Bernini LF:Hb Utrecht [alpha 2129 (H12) Leu->Pro], a new unstable alpha 2-chain variant associated with a mild alpha-thalassaemic phenotype. Br J Haematol 94 (3):483-485, 1996.

P.347 掲載の参考文献

• 1) Taga T, Kishimoto T:Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797, 1997.
  pubmed

• 2) Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, et al:The IL-6 signal transducer, gp130:an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434, 1992.
  pubmed

• 3) Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T:Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149, 1990.

• 4) Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, et al:CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121, 1992.
  pubmed

• 5) Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI:Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 270:10915, 1995.

• 6) Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al:Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92, 1994.
  pubmed

• 7) Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD:Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349, 1995.
  pubmed

• 8) Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T:Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93:407, 1996.
  pubmed

P.349 掲載の参考文献

• 1) Miyajima A, Mui AL, Ogorochi T, Sakamaki K:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960, 1993.
  pubmed

• 2) Gorman DM, Itoh N, Kitamura T, Schreurs J, Yonehara S, Yahara I, Arai K, Miyajima A:Cloning and expression of a gene encoding an interleukin 3 receptor-like protein:identification of another member of the cytokine receptor gene family. Proc Natl Acad Sci USA 87:5459, 1990.
  pubmed

• 3) Hara T, Miyajima A:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3). EMBO J 11:1875, 1992.
  pubmed

• 4) Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A:Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF):reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655, 1990.
  pubmed

• 5) Itoh N, Yonehara S, Schreurs J, Gorman DM, Maruyama K, Ishii A, Yahara I, Arai K, Miyajima A:Cloning of an interleukin-3 receptor gene:amember of a distinct receptor gene family. Science 247:324, 1990.

• 6) Itoh T, Muto A, Watanabe S, Miyajima A, Yokota T, Arai K:Granulocyte-macrophage colony-stimulating factor provokes RAS activation and transcription of c-fos through different modes of signaling. J Biol Chem 271:7587, 1996.
  pubmed

• 7) Kitamura T, Sato N, Arai K, Miyajima A:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165, 1991.
  pubmed

• 8) Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD:Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14:257, 1995.
  pubmed

• 9) Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T, Azuma S, Yoshida S, Toyoda Y, Arai K, et al:Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 2:211, 1995.
  pubmed

• 10) Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN:JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994.

• 11) Sato N, Caux C, Kitamura T, Watanabe Y, Arai K, Banchereau J, Miyajima A:Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82:752, 1993.
  pubmed

• 12) Sato N, Sakamaki K, Terada N, Arai K, Miyajima A:Signal transduction by the high-affinity GM-CSF receptor:two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J 12:4181, 1993.
  pubmed

• 13) Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G:A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66:1175, 1991.

P.352 掲載の参考文献

• 1) Leonard WJ:The molecular basis of X-linked severe combined immunodeficiency:defective cytokine receptor signaling. Annu Rev Med 47:229, 1996.
  pubmed

• 2) Leonard WJ, Shores EW, Love PE:Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol Rev 148:97, 1995.
  pubmed

• 3) Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Nakamura M, Takeshita T:The common gamma-chain for multiple cytokine receptors. Adv Immunol 59:225, 1995.
  pubmed

• 4) Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K, Nakamura M, Takeshita T:The interleukin-2 receptor gamma chain:its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 14:179, 1996.

• 5) Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa S, Sugamura K:Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263:1453, 1994.
  pubmed

• 6) Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K:Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874, 1993.
  pubmed

• 7) Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ:Interleukin-2 receptor gamma chain:a functional component of the interleukin-7 receptor. Science 262:1877, 1993.
  pubmed

• 8) Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ:Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993.

• 9) Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leiand P, Friedmann MC, Miyajima A, Puri RK, Paul WE, et al:Interleukin-2 receptor gamma chain:a functional component of the interleukin-4 receptor. Science 262:1880, 1993.

• 10) Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K:Cloning of the gamma chain of the human IL-2 receptor. Science 257:379, 1992.
  pubmed

P.354 掲載の参考文献

• 1) Yu Y, Flint A, Dvorin EL, Bischoff J:AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 277 (23):20711-20716, 2002.
  pubmed

• 2) Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW:A novel five-transmembrane hematopoietic stem cell antigen:isolation, characterization, and molecular cloning. Blood 90 (12):5013-5021, 1997.
  pubmed

• 3) Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW:AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (12):5002-5012, 1997.
  pubmed

P.356 掲載の参考文献

• 1) Rogers PR, Song J, Gramaglia I, Killeen N, Croft M:OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15 (3):445-455, 2001.
  pubmed

• 2) Bansal-Pakala P, Jember AG, Croft M:Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 7 (8):907-912, 2001.
  pubmed

• 3) Pankow R, Durkop H, Latza U, Krause H, Kunzendorf U, Pohl T, Bulfone-Paus S:The HTLV-I tax protein transcriptionally modulates OX40 antigen expression. J Immunol 165 (1):263-270, 2000.
  pubmed

• 4) Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B, Odermatt B, Bachmann MF:OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11 (6):699-708, 1999.
  pubmed

• 5) Kawamata S, Hori T, Imura A, Takaori-Kondo A, Uchiyama T:Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2-and TRAF5-mediated NF-kappaB activation. J Biol Chem 273 (10):5808-5814, 1998.
  pubmed

• 6) Stuber E, Neurath M, Calderhead D, Fell HP, Strober W:Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2 (5):507-521, 1995.
  pubmed

• 7) Birkeland ML, Copeland NG, Gilbert DJ, Jenkins NA, Barclay AN:Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein. Eur J Immunol 25 (4):926-930, 1995.
  pubmed

• 8) Baum PR, Gayle RB 3rd, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Clifford KN, Grabstein K, Alderson MR, et al:Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. Circ Shock 44 (1):30-34, 1994. (No abstract available)

• 9) Latza U, Durkop H, Schnittger S, Ringeling J, Eitelbach F, Hummel M, Fonatsch C, Stein H:The human OX40 homolog:cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 24 (3):677-683, 1994.
  pubmed

• 10) Paterson DJ, Jefferies WA, Green JR, Brandon MR, Corthesy P, Puklavec M, Williams AF:Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 24 (12):1281-1290, 1987.
  pubmed

P.358 掲載の参考文献

• 1) Drexler HG:Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 10:588, 1996.
  pubmed

• 2) Lyman SD, Williams DE:Biology and potential clinical applications of flt3 ligand. Curr Opin Hematol 2:177-181, 1995.
  pubmed

• 3) Rosnet O, Buhring HJ, deLapeyriere O, Beslu N, Lavagna C, Marchetto S, Rappold I, Drexler HG, Birg F, Rottapel R, Hannum C, Dubreuil P, Birnbaum D:Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol 95:218, 1996.
  pubmed

• 4) Lavagna C, Marchetto S, Birnbaum D, Rosnet O:Identification and characterization of a functional murine FLT3 isoform produced by exon skipping. J Biol Chem 270:3165, 1995.
  pubmed

• 5) Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ:Cloning of the human homologue of the murine flt3 ligand:a growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994.

• 6) Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR:Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995.
  pubmed

• 7) Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR:A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991.
  pubmed

• 8) Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Buhring HJ:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90:111, 1997.
  pubmed

• 9) Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D:Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 10:238, 1996.
  pubmed

• 10) Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D:Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSFIR family. Oncogene 6:1641, 1991.

• 11) Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D:Human FLT3/FLK2 gene:cDNA cloning and expression in hematopoietic cells. Blood 82:1110, 1993.
  pubmed

• 12) Rusten LS, Lyman SD, Veiby OP, Jacobsen SE:The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+bone marrow progenitor cells in vitro. Blood 87:1317, 1996.
  pubmed

• 13) Shah AJ, Smogorzewska EM, Hannum C, Crooks GM:Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38-cells and maintains progenitor cells in vitro. Blood 87:3563, 1996.
  pubmed

• 14) Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, et al:STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994.
  pubmed

• 15) Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W:Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994.
  pubmed

P.360 掲載の参考文献

• 1) Collesi C, Santoro MM, Gaudino G, Comoglio PM:Asplicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol Cell Biol 16:5518, 1996.

• 2) Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM:The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11:2627, 1995.
  pubmed

• 3) Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ, Comoglio PM:RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 13:3524, 1994.
  pubmed

• 4) Han S, Stuart LA, Degen SJ:Characterization of the DNF15S2 locus on human chromosome 3:identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30:9768, 1991.
  pubmed

• 5) Iwama A, Okano K, Sudo T, Matsuda Y, Suda T:Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160, 1994.
  pubmed

• 6) Iwama A, Yamaguchi N, Suda T:STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J 15:5866, 1996.
  pubmed

• 7) Li BQ, Wang MH, Kung HF, Ronsin C, Breathnach R, Leonard EJ, Kamata T:Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor. Biochem Biophys Res Commun 216:110, 1995.
  pubmed

• 8) Medico E, Mongiovi AM, Huff J, Jelinek MA, Follenzi A, Gaudino G, Parsons JT, Comoglio PM:The tyrosine kinase receptors Ron and Sea control 'scattering' and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7:495, 1996.
  pubmed

• 9) Quantin B, Schuhbaur B, Gesnel MC, Doll'e P, Breathnach R:Restricted expression of the ron gene encoding the macrophage stimulating protein receptor during mouse development. Dev Dyn 204:383, 1995.
  pubmed

• 10) Ronsin C, Muscatelli F, Mattei MG, Breathnach R:A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8:1195, 1993.
  pubmed

• 11) Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E, Leonard EJ:Macrophage stimulating protein:purification, partial amino acid sequence, and cellular activity. J Exp Med 173:1227, 1991.
  pubmed

• 12) Wang MH, Cox GW, Yoshimura T, Sheffler LA, Skeel A, Leonard EJ:Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin-or cytokine-stimulated mouse macrophages. J Bio Chem 269:1402, 1994.
  pubmed

• 13) Wang MH, Dlugosz AA, Sun Y, Suda T, Skeel A, Leonard EJ:Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp Cell Res 226:39, 1996.
  pubmed

• 14) Wang MH, Gonias SL, Skeel A, Wolf BB, Yoshimura T, Leonard EJ:Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family. J Biol Chem 269:13806, 1994.
  pubmed

• 15) Wang MH, Iwama A, Skeel A, Suda T, Leonard EJ:The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc Natl Acad Sci USA 92:3933, 1995.
  pubmed

• 16) Wang MH, Montero-Julian FA, Dauny I, Leonard EJ:Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 13:2167, 1996.
  pubmed

• 17) Wang MH, Ronsin C, Gesnel MC, Coupey L, Skeel A, Leonard EJ, Breathnach R:Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266:117, 1994.
  pubmed

• 18) Wang MH, Skeel A, Leonard EJ:Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 97:720, 1996.
  pubmed

• 19) Wang MH, Yoshimura T, Skeel A, Leonard EJ:Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem 269:3436, 1994.
  pubmed

• 20) Yoshimura T, Yuhki N, Wang MH, Skeel A, Leonard EJ:Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 268:15461, 1993.
  pubmed

P.362 掲載の参考文献

• 1) Alderson MR, Smith CA, Tough TW, Davis-Smith T, Armitage RJ, Falk B, Roux E, Baker E, Sutherland GR, Din WS:Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 24:2219, 1994.
  pubmed

• 2) Garni-Wagner BA, Lee ZH, Kim YJ, Wilde C, Kang CY, Kwon BS:4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell Immunol 169:91, 1996.
  pubmed

• 3) Schwarz H, Blanco FJ, von Kempis J, Valbracht J, Lotz M:ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87:2839, 1996.

• 4) Schwarz H, Valbracht J, Tuckwell J, von Kempis J, Lotz M:ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85:1043, 1995.
  pubmed

• 5) Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, Kwon BS:Characterization of human homologue of 4-1BB and its ligand. Immunol Lett 45:67, 1995.
  pubmed

P.364 掲載の参考文献

• 1) Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, Sanderson RD:Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100 (2):610-617, 2002.
  pubmed

• 2) Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST:Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99 (4):1405-1410, 2002.
  pubmed

• 3) Bayer-Garner I, Dilday B, Sanderson R, Smoller B:Acantholysis and spongiosis are associated with loss of syndecan-1 expression. J Cutan Pathol 28 (3):135-139, 2001.
  pubmed

• 4) Spring J, Goldberger OA, Jenkins NA, Gilbert DJ, Copeland NG, Bernfield M:Mapping of the syndecan genes in the mouse:linkage with members of the myc gene family. Genomics 21 (3):597-601, 1994.
  pubmed

• 5) Mali M, Jaakkola P, Arvilommi AM, Jalkanen M:Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J Biol Chem 265 (12):6884-6889, 1990.
  pubmed

• 6) Lories V, Cassiman JJ, Van den Berghe H, David G:Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem 267 (2):1116-1122, 1992.
  pubmed

P.365 掲載の参考文献

• 1) Hadam MR:In Leukocyte Typing VI, section B35. (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.

• 2) Grotjahn C, Heuring A, Lohmeyer J, Hadam MR:In Leukocyte Typing VI, section B28. 4/642, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.

• 3) Hardie DL, Hill DS, Casamayor M, van Lier R, Johnson GD, Khan M, MacLennan I:In Leukocyte Typing VI, section B28.6/644, (eds Kishimoto T, et al), Garland Publishing Inc, New York, 1998.

P.367 掲載の参考文献

• 1) Andrae J, Molander C, Smits A, Funa K, Nister M:Platelet-derived growth factor-B and-C and active alpha-receptors in medulloblastoma cells. Biochem Biophys Res Commun 296 (3):604-611, 2002.

• 2) Ribom D, Andrae J, Frielingsdorf M, Hartman M, Nister M, Smits A:Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas. J Neurol Neurosurg Phychicatry 72 (6):782-787, 2002.

• 3) Joosten PH, Toepoel M, Mariman EC, Van Zoelen EJ:Promoter haplotype combinations of the platelet derived growth factor alpha-receptor gene predispose to human neural tube defects. Nat Genet 27 (2):215-217, 2001.
  pubmed

• 4) Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U:PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2 (5):302-309, 2000.
  pubmed

• 5) Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T:Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30 (2):224-232, 1995.
  pubmed

• 6) Mosselman S, Claesson-Welsh L, Kamphuis JS, van Zoelen EJ:Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer Res 54 (1):220-225, 1994.
  pubmed

• 7) Claesson-Welsh L, Eriksson A, Westermark B, Heldin CH:cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA 86 (13):4917-4921, 1989.

• 8) Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, Aaronson S:Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243 (4892):800-804, 1989.
  pubmed

• 9) Miki T, Matsui T, Heidaran MA, Aaronson SA:An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene 83 (1):137-146, 1989.
  pubmed

P.368 掲載の参考文献

• 1) Steer EJ, Cross NC:Myeloproliferative disorders with translocations of chromosome 5q31-35:role of the platelet-derived growth factor receptor beta. Acta Haematol 107 (2):113-122, 2002.
  pubmed

• 2) Dierov J, Xu Q, Dierova R, Carroll M:TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle. Blood 99 (5):1758-1765, 2002.
  pubmed

• 3) Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A:Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem 275 (21):16219-16226, 2000.
  pubmed

• 4) Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T:Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30 (2):224-232, 1995.
  pubmed

• 5) Francke U, Yang-Feng TL, Brissenden JE, Ullrich A:Chromosomal mapping of genes involved in growth control. Cold Spring Harb Symp Quant Biol 51 (Pt 2):855-866, 1986. (No abstract available)

• 6) Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin CH:cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8 (8):3476-3486, 1988.
  pubmed

• 7) Gronwald RG, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, Murray MJ:Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor:evidence for more than one receptor class. Proc Natl Acad Sci USA 85 (10):3435-3439, 1988.
  pubmed

• 8) Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, Aaronson S:Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243 (4892):800-804, 1989.
  pubmed

P.370 掲載の参考文献

• 1) Hafer-Macko CE, Ivey FM, Gyure KA, Sorkin JD, Macko RF:Reduced thrombomodulin in human peripheral nerve microvasculature. Muscle Nerve 26 (2):218-224, 2002.
  pubmed

• 2) Hafer-Macko CE, Ivey FM, Gyure KA, Sorkin JD, Macko RF:Thrombomodulin deficiency in human diabetic nerve microvasculature. Diabetes 51 (6):1957-1963, 2002.
  pubmed

• 3) Kunz G, Ohlin AK, Adami A, Zoller B, Svensson P, Lane DA:Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function. Blood 99 (10):3646-3653, 2002.
  pubmed

• 4) Jiang SJ, Lin TM, Wu HL, Han HS, Shi GY:Decrease of fibrinolytic activity in human endothelial cells by arsenite. Thromb Res 105 (1):55-62, 2002.
  pubmed

• 5) Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H:Increased levels of endothelial haemostatic markers in patients with coronary heart disease. Thromb Res 105 (1):25-31, 2002.
  pubmed

• 6) Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G:Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke. Thromb Haemost 87 (2):211-217, 2002.
  pubmed

• 7) Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY:Synergistic effect of thrombomodulin promoter-33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 87 (1):86-91, 2002.
  pubmed

• 8) Niimi S, Oshizawa T, Naotsuka M, Ohba S, Yokozawa A, Murata T, Hayakawa T:Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard. Biologicals 30 (1):69-76, 2002.
  pubmed

• 9) Acebo E, Val-Bernal JF, Gomez-Roman JJ:Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac myxoma. Histol Histopathol 16 (4):1031-1036, 2001.

• 10) Light DR, Glaser CB, Betts M, Blasko E, Campbell E, Clarke JH, McCaman M, McLean K, Nagashima M, Parkinson JF, Rumennik G, Young T, Morser J:The interaction of thrombomodulin with Ca2+. Eur J Biochem 262 (2):522-533, 1999.
  pubmed

• 11) van't Veer C, Kalafatis M, Bertina RM, Simioni P, Mann KG:Increased tissue factor-initiated pro-thrombin activation as a result of the Arg506->Gln mutation in factor VLEIDEN. J Biol Chem 272 (33):20721-20729, 1997.

• 12) Maglott DR, Feldblyum TV, Durkin AS, Nierman WC:Radiation hybrid mapping of SNAP, PCSK2, and THBD (human chromosome 20p). Mamm Genome 7 (5):400-401, 1996. (No abstract available)

• 13) Shirai T, Shiojiri S, Ito H, Yamamoto S, Kusumoto H, Deyashiki Y, Maruyama I, Suzuki K:Gene structure of human thrombomodulin, a cofactor for thrombin-catalyzed activation of protein C. J Biochem (Tokyo)103 (2):281-285, 1988.
  pubmed

• 14) Wen DZ, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE:Human thrombomodulin:complete cDNA sequence and chromosome localization of the gene. Biochemistry 26 (14):4350-4357, 1987.
  pubmed

• 15) Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S:Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 6 (7):1891-1897, 1987.
  pubmed

• 16) Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD:Human thrombomodulin gene is intron depleted:nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 84 (18):6425-6429, 1987.
  pubmed

P.372 掲載の参考文献

• 1) Carson SD, Brozna JP:The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis 4:281, 1993.
  pubmed

• 2) Mackman N:Regulation of the tissue factor gene. FASEB J 9:883, 1995.
  pubmed

• 3) Albrecht S, Luther T, Grossmann H, Flossel C, Kotzsch M, Muller M:An ELISA for tissue factor using monoclonal antibodies. Blood Coagul Fibrinolysis 3:263, 1992.
  pubmed

• 4) Carson SD, Ross SE, Bach R, Guha A:An inhibitory monoclonal antibody against human tissue factor. Blood 70:490, 1987.
  pubmed

• 5) Morrissey JH, Fair DS, Edgington TS:Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 52:247, 1988.
  pubmed

P.375 掲載の参考文献

• 1) Cambien F, Soubrier F:In Hypertension:Pathophysiology, Diagnosis, and Management, Second Edition, (eds Laragh JH, Brenner BM), Raven Press Ltd, New York, pp1667-1682, 1995.

• 2) Corvol P, Michaud A, Soubrier F, Williams TA:Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens Suppl 13:S3, 1995.
  pubmed

• 3) Skidgel RA, Erdos EG:In The Renin Angiotensin System, Vol.1, (eds Robertson JIS, Nichols MG), Gower Medical Publ, London, pp10.1-10.10, 1993.

• 4) Auerbach R, Alby L, Grieves J, Joseph J, Lindgren C, Morrissey LW, Sidky YA, Tu M, Watt SL:Monoclonal antibody against angiotensin-converting enzyme:its use as a marker for murine, bovine, and human endothelial cells. Proc Natl Acad Sci USA 79:7891, 1982.
  pubmed

• 5) Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F:Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J Biol Chem 269:26806, 1994.
  pubmed

• 6) Hauri HP, Sterchi EE, Bienz D, Fransen JA Marxer A:Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J Cell Biol 101:838, 1985.
  pubmed

• 7) Hubert C, Houot AM, Corvol P, Soubrier F:Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 266:15377, 1991.

• 8) Jaspard E, Wei L, Alhenc-Gelas F:Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 268:9496, 1993.
  pubmed

• 9) Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O:Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146, 1995.
  pubmed

• 10) Muzykantov VR, Atochina EN, Ischiropoulos H, Danilov SM, Fisher AB:Immunotargeting of anti-oxidant enzyme to the pulmonary endothelium. Proc Natl Acad Sci USA 93:5213, 1996.

• 11) Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P:Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386, 1988.
  pubmed

P.376 掲載の参考文献

• 1) Breier G, Breviario F, Caveda L, Berthier R, Schnurch H, Gotsch U, Vestweber D, Risau W, Dejana E:Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 87:630, 1996.
  pubmed

• 2) Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E:Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol 15:1229, 1995.
  pubmed

• 3) Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino D, Lampugnani MG, Dejana E:Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest 98:886, 1996.

• 4) Dejana E, Corada M, Lampugnani MG:Endothelial cell-to-cell junctions. FASEB J 9:910, 1995.
  pubmed

• 5) Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H, Vestweber D:VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 110:583, 1997.
  pubmed

• 6) Huber P, Dalmon J, Engiles J, Breviario F, Gory S, Siracusa LD, Buchberg AM, Dejana E:Genomic structure and chromosomal mapping of the mouse VE-cadherin gene (Cdh5). Genomics 32:21, 1996.
  pubmed

• 7) Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, Dejana E:The molecular organization of endothelial cell to cell junctions:differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129:203, 1995.
  pubmed

• 8) Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E:Anovel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118:1511, 1992.

• 9) Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E:Catenin-dependent and-independent functions of vascular endothelial cadherin. J Biol Chem 270:30965, 1995.
  pubmed

P.377 掲載の参考文献

• 1) Mutin M, Dignat-George F, Sampol J:Immunologic phenotype of cultured endothelial cells:quantitative analysis of cell surface molecules. Tissue Antigens 50 (5):449-458, 1997.
  pubmed

P.379 掲載の参考文献

• 1) Johnson JP, Rummel MM, Rothbacher U, Sers C:MUC18:A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr Top Microbiol Immunol 213:95, 1996.
  pubmed

• 2) Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V, Lesaule G, Sampol J:S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48:531, 1996.
  pubmed

• 3) George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D, Sampol J:Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82:2109, 1993.
  pubmed

• 4) George F, Mutin M, Laurent JC, Poncelet P, Sampol J:Antigenic densities defined by Workshop Endothelial Section mAb. In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, Oxford 1848, PP1798-1801, 1995.

• 5) Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G, Johnson JP:Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with amolecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:841, 1987.

• 6) Lehmann JM, Riethmuller G, Johnson JP:MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86:9891, 1989.

• 7) Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Fae I, Waclavicek M, Stockl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W:MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 158:2107, 1997.

• 8) Rummel MM, Sers C, Johnson JP:Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM. Cancer Res 56:2218, 1996.
  pubmed

• 9) Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP:Genomic organization of the melanoma-associated glycoprotein MUC18:implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA. 90:8514, 1993.
  pubmed

• 10) Shih IM, Elder DE, Hsu MY, Herlyn M:Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 145:837, 1994.
  pubmed

• 11) Shih IM, Kurman RJ:Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 75:377, 1996.
  pubmed

P.381 掲載の参考文献

• 1) Biswas C:Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 109:1026, 1982.
  pubmed

• 2) Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K:The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434, 1995.
  pubmed

• 3) Fadool JM, Linser PJ:5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 196:252, 1993.
  pubmed

• 4) Felzmann T, Gadd S, Majdic O, Maurer D, Petera P, Smolen J, Knapp W:Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J Clin Immunol 11:205, 1991.
  pubmed

• 5) Fossum S, Mallett S, Barclay AN:The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur J Immunol 21:671, 1991.
  pubmed

• 6) Kasinrerk W, Fiebiger E, Stefanova I, Baumruker T, Knapp W, Stockinger H:Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol 149:847, 1992.
  pubmed

• 7) Miyauchi T, Masuzawa Y, Muramatsu T:The basigin group of the immunoglobulin superfamily:complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen. J Biochem (Tokyo) 110:770, 1991.
  pubmed

• 8) Nehme CL, Cesario MM, Myles DG, Koppel DE, Bartles JR:Breaching the diffusion barrier that compartmentalizes the transmembrane glycoprotein CE9 to the posterior-tail plasma membrane domain of the rat spermatozoon. J Cell Biol 120:687, 1993.

• 9) Schiavone EM, Tortora V, Armetta I, Bontempo P, Mosti MR, Pezone L, Nola E, Puca, GA, Vacca C, Molinari AM:CD147 workshop:expression, modulation, and involvement in homotypic aggregation and adhesion to matrix of molecules recognized by monoclonal antibodies to CD147 on breast cancer cell lines. In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp764-765, 1997.

• 10) Schlosshauer B, Herzog KH:Neurothelin:an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons. J Cell Biol 110:1261, 1990.
  pubmed

• 11) Seulberger H, Lottspeich F, Risau W:The inducible blood-brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J 9:2151, 1990.
  pubmed

• 12) Stockinger H, Ebel T, Hansmann C, Koch C, Majdic O, Prager E, Patel DD, Fox DA, Horejsi V, Sagawa K, Shen D:CD147 (neurothelin/basigin) workshop panel report. In Leucocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp760-763, 1997.

P.382 掲載の参考文献

• 1) Fischer EH, Charbonneau H, Tonks NK:Protein tyrosine phosphatases:adiverse family of intracellular and transmembrane enzymes. Science 253:40, 1991.

• 2) Honda H, Inazawa J, Nishida J, Yazaki Y, Hirai H:Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta. Blood 84:4186, 1994.
  pubmed

• 3) Ostman A, Yang Q, Tonks NK:Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 91:9680, 1994.
  pubmed

P.385 掲載の参考文献

• 1) Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G:A novel receptor involved in T-cell activation. Nature 376:260-263, 1995.

• 2) Pinchouk VG, Sidorenko SP, Gluzman DF, Vetrova EP, Berdova AG, Schlapatskaya LN:Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens. Anticancer Res 8:1377-1380, 1988.

• 3) Polacino PS, Pinchuk LM, Sidorenko SP, Clark EA:Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J Med Primatol 25:201-209, 1996.

• 4) Punnonen J, Cocks BG, Carballido JM, Bennett B, Peterson D, Aversa G, de Vries JE:Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med 185:993-1004, 1997.

• 5) Sidorenko SP, Clark EA:Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J Immunol 151:4614-4624, 1993.

• 6) Sidorenko SP, Vetrova EP, Yurchenko OV, Berdova AG, Shlapatskaya LN, Gluzman DF:Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasma 39:3-9, 1992.
  pubmed

P.387 掲載の参考文献

• 1) Ashman LK, Aylett GW, Mehrabani PA, Bendall LJ, Niutta S, Cambareri AC, Cole SR, Berndt MC:The murine monoclonal antibody, 14A2. H1, identifies a novel platelet surface antigen. Br J Haematol 79:263, 1991.
  pubmed

• 2) Ashman LK, Fitter S, Sincock PM, Nguyen L, Cambareri AC:In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, this volume PL14, 1998.

• 3) Cole SR, Kriek GW, Ashman LK:In Leucocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp991-992, 1989.

• 4) Ferro LM, Fitter S, Tetaz TJ, Berndt MC, Ashman LK:In Leucocyte Typing V, (eds Schlossman SF, et al), Oxford University Press, pp1244-1245, 1995.

• 5) Fitter S, Tetaz TJ, Berndt MC, Ashman LK:Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 86:1348, 1995.
  pubmed

• 6) Hasegawa H, Utsunomiya Y, Kishimoto K, Yanagisawa K, Fujita S:SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily. J Virol 70:3258, 1996.

• 7) Sincock PM, Mayrhofer G, Ashman LK:Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues:comparison with CD9, CD63, and alpha 5 betal integrin. J Histochem Cytochem 45:515, 1997.

• 8) von dem Borne, Kr A E G:In Leucocyte Typing IV, (eds Knapp W, et al), Oxford University Press, pp1044-1045, 1989.

P.388 掲載の参考文献

• 1) Allison JP, Krummel MF:The Yin and Yang of T cell costimulation. Science 270:932, 1995.
  pubmed

• 2) Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P:A new member of the immunoglobulin superfamily-CTLA-4. Nature 328:267, 1987.
  pubmed

• 3) Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P:CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147:1037, 1991.
  pubmed

• 4) Krummel MF, Allison JP:CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182:459, 1995.
  pubmed

• 5) Leach DR, Krummel MF, Allison JP:Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734, 1996.
  pubmed

• 6) Linsley PS, Golstein P:Lymphocyte activation:T-cell regulation by CTLA-4. Curr Biol 6:398, 1996.
  pubmed

• 7) Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA:CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174:561, 1991.

• 8) Linsley PS:Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during Tcell activation? J Exp Med 182:289, 1995.

• 9) Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, Wang Y, Walunas T, Bluestone J, Listman J, et al:Regulation of CTLA-4 expression during T cell activation. J Immunol 156:4154, 1996.

• 10) Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH:Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541, 1995.
  pubmed

• 11) Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA:CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405, 1994.

• 12) Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW:Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985, 1995.
  pubmed

P.390 掲載の参考文献

• 1) Rossi FM, Degan M, Mazzocut-Zecchin L, Di Francia R, Aldinucci D, Pinto A, Gattei V:CD30L up-regulates CD30 and IL-4 expression by T cells. FEBS Lett 508 (3):418-422, 2001.

• 2) Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, Ely S, Casali P:Engagement of CD153 (CD30 ligand) by CD30+T cells inhibits class switch DNA recombination and antibody production in human IgD+IgM+B cells. J Immunol 165 (2):786-794, 2000.
  pubmed

• 3) Romagnani P, Annunziato F, Manetti R, Mavilia C, Lasagni L, Manuelli C, Vannelli GB, Vanini V, Maggi E, Pupilli C, Romagnani S:High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. Blood 91 (9):3323-3332, 1998.
  pubmed

• 4) Croager EJ, Abraham LJ:Characterisation of the human CD30 ligand gene structure. Biochim Biophys Acta 1353 (3):231-235, 1997.
  pubmed

• 5) Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, et al:CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 (7):1349-1360, 1993.

• 6) Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG:Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83 (8):2045-2056, 1994.
  pubmed

P.392 掲載の参考文献

• 1) Bussolati B, Russo S, Deambrosis I, Cantaluppi V, Volpe A, Ferrando U, Camussi G:Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. Int J Cancer 100 (6):654-661, 2002.
  pubmed

• 2) Larkin R, Benjamin CD, Hsu YM, Li Q, Zukowski L, Silver RF:CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes. Infect Immun 7 (8):4716-4720, 2002.
  pubmed

• 3) McDowell MA, Marovich M, Lira R, Braun M, Sacks D:Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun 70 (8):3994-4001, 2002.
  pubmed

• 4) van Rijen MM, Kuijf ML, Metselaar HJ, Tilanus HW, Bouma GJ, de Weger RA, Jonker M, Kwekkeboom J:CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. Transplantation 73 (10):1666-1672, 2002.
  pubmed

• 5) Grassme H, Bock J, Kun J, Gulbins E:Clustering of CD40 ligand is required to form a functional contact with CD40. J Biol Chem 277 (33):30289-30299, 2002.

• 6) Sipsas NV, Sfikakis PP, Kontos A, Kordossis T:Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4 (+) T-cell counts. Clin Diagn Lab Immunol 9 (3):558-561, 2002.
  pubmed

• 7) Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U:Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 277 (28):25032-25039, 2002.
  pubmed

• 8) Challa A, Eliopoulos AG, Holder MJ, Burguete AS, Pound JD, Chamba A, Grafton G, Armitage RJ, Gregory CD, Martinez-Valdez H, Young L, Gordon J:Population depletion activates autonomous CD154-dependent survival in biopsy like Burkitt lymphoma cells. Blood 99 (9):3411-3418, 2002.

• 9) Peng DQ, Zhao SP, Li YF, Li J, Zhou HN:Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta 319 (1):19-26, 2002.

• 10) Dai Y, Masterman T, Huang W, Hillert J:Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis. Eur J Immunogenet 29 (2):81-85, 2002.
  pubmed

• 11) Makino M, Utsunomiya A, Maeda Y, Shimokubo S, Izumo S, Baba M:Association of CD40 ligand expression on HTLV-1-infected T cells and maturation of dendritic cells. Scand J Immunol 54 (6):574-581, 2001.
  pubmed

• 12) Zupo S, Cutrona G, Mangiola M, Ferrarini M:Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. Blood 99 (6):2277-2278, 2002. (No abstract available)

• 13) Chu P, Deforce D, Pedersen IM, Kim Y, Kitada S, Reed JC, Kipps TJ:Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99 (6):3854-3859, 2002.
  pubmed

• 14) Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD:CD40L stabilizes arterial thrombi by a beta 3 integrin-dependent mechanism. Nat Med 8 (3):247-252, 2002.
  pubmed

• 15) Subauste CS:CD154 and type-1 cytokine response:from hyper IgM syndrome to human immunodeficiency virus infection. J Infect Dis 185 (Suppl 1):S83-89, 2002. (Review)

• 16) Cheng G, Schoenberger SP:CD40 signaling and autoimmunity. Curr Dir Autoimmun 5:51-61, 2002. (Review) (No abstract available)

• 17) Bhushan A, Covey LR:CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol Res 24 (3):311-324, 2001. (Review)

• 18) Lobo FM, Scholl PR, Fuleihan RL:CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability. J Immunol 168 (3):1473-1478, 2002.
  pubmed

• 19) Atamas SP, Luzina IG, Dai H, Wilt SG, White B:Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol 168 (3):1139-1145, 2002.
  pubmed

• 20) Bolacchi F, Carbone M, Capozzi M, Ventura L, Cepparulo M, Niutta P, Rocchi G, Bergamini A:Effect of different activation stimuli on the cytokine response of human macrophages to CD40L. Cytokine 16 (4):121-125, 2001.
  pubmed

P.394 掲載の参考文献

• 1) Solecki DJ, Gromeier M, Mueller S, Bernhardt G, Wimmer E:Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog. J Biol Chem 277 (28):25697-25702, 2002.
  pubmed

• 2) Mueller S, Cao X, Welker R, Wlmmer E:Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem 277 (10):7897-7904, 2002.

• 3) Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E:Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci USA 97 (12):6803-6808, 2000.
  pubmed

• 4) Mendelsohn CL, Wimmer E, Racaniello VR:Cellular receptor for poliovirus:molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56 (5):855-865, 1989.
  pubmed

• 5) Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, Takeuchi K, Takegami T, Nomoto A:The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 9 (10):3217-3224, 1990.

P.395 掲載の参考文献

• 1) Yamamoto S, Yoshiyama K, Kataoka M, Setoguchi M, Higuchi Y, Akizuki S:White Cell Differentiation Antigens. In Leucocyte Typing V, (eds Schlossman SF, et al) , Oxford University Press, pp1091-1093, 1995.

• 2) Yoshida S, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S:Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol 2:585, 1990.
  pubmed

• 3) Yoshiyama K, Higuchi Y, Kataoka M, Matsuura K, Yamamoto S:CD156 (human ADAM8):expression, primary amino acid sequence, and gene location. Genomics 41 (1):56-62, 1997.
  pubmed

P.397 掲載の参考文献

• 1) Black RA:Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 34 (1):1-5, 2002.
  pubmed

• 2) Lee MH, Verma V, Maskos K, Nath D, Knauper V, Dodds P, Amour A, Murphy G:Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme. Biochem J 364 (Pt 1):227-234, 2002.

• 3) Karkkainen I, Rybnikova E, Pelto-Huikko M, Huovila AP:Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 15 (6):547-560, 2000.
  pubmed

• 4) Nelson KK, Schlondorff J, Blobel CP:Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2 beta. Biochem J 343 (Pt 3):673-680, 1999.

• 5) Cerretti DP, Poindexter K, Castner BJ, Means G, Copeland NG, Gilbert DJ, Jenkins NA, Black RA, Nelson N:Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cytokine 11 (8):541-551, 1999.
  pubmed

• 6) Hirohata S, Seldin MF, Apte SS:Chromosomal assignment of two ADAM genes, TACE (ADAM17) and MLTNB (ADAM19), to human chromosomes 2 and 5, respectively, and of Mltnb to mouse chromosome 11. Genomics 54 (1):178-179, 1998. (No abstract available)

• 7) Patel IR, Attur MG, Patel RN, Stuchin SA, Abagyan RA, Abramson SB, Amin AR:TNF-alpha convertase enzyme from human arthritis-affected cartilage:isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol 160 (9):4570-4579, 1998.
  pubmed

• 8) Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD, et al:Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (6618):733-736, 1997.
  pubmed

• 9) Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP:Ametalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (6618):729-733, 1997.
  pubmed

P.399 掲載の参考文献

• 1) Dong C, Wang J, Neame P, Cooper MD:The murine BP-3 gene encodes a relative of the CD38/NAD glycohydrolase family. Int Immunol 6:1353, 1994.
  pubmed

• 2) Goldstein SC, Todd RF 3d:Structural and biosynthetic features of the Mo5 human myeloid differentiation antigen. Tissue Antigens 41:214, 1993.

• 3) Hirata Y, Kimura N, Sato K, Ohsugi Y, Takasawa S, Okamoto H, Ishikawa J, Kaisho T, Ishihara K, Hirano T:ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett 356:244, 1994.
  pubmed

• 4) Ishihara K, Kobune Y, Okuyama Y, Itoh M, Lee BO, Muraoka O, Hirano T:Stage-specific expression of mouse BST-1/BP-3 on the early B and T cell progenitors prior to gene rearrangement of antigen receptor. Int Immunol 8:1395, 11996.

• 5) Itoh M, Ishihara K, Tomizawa H, Tanaka H, Kobune Y, Ishikawa J, Kaisho T, Hirano T:Molecular cloning of murine BST-1 having homology with CD38 and Aplysia ADP-ribosyl cyclase. Biochem Biophys Res Commun 203:1309, 1994.
  pubmed

• 6) Kaisho T, Ishikawa J, Oritani K, Inazawa J, Tomizawa H, Muraoka O, Ochi T, Hirano T:BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc Natl Acad Sci USA 91:5325, 1994.

• 7) Lee BO, Ishihara K, Denno K, Kobune Y, Itoh M, Muraoka O, Kaisho T, Sasaki T, Ochi T, Hirano T:Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum 39:629, 1996.
  pubmed

• 8) McNagny KM, Bucy RP, Cooper MD:Reticular cells in peripheral lymphoid tissues express the phosphatidylinositol-linked BP-3 antigen. Eur J Immunol 21:509, 1991.
  pubmed

• 9) McNagny KM, Cazenave PA, Cooper MD:BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice. J Immunol 141:2551, 1988.

• 10) Okuyama Y, Ishihara K, Kimura N, Hirata Y, Sato K, Itoh M, Ok LB, Hirano T:Human BST-1 expressed on myeloid cells functions as a receptor molecule. Biochem Biophys Res Commun 228:838, 1996.
  pubmed

• 11) Todd RF 3d, Roach JA, Arnaout MA:The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen. Blood 65:964, 1985.

• 12) Vicari AP, Bean AG, Zlotnik A:Arole for BP-3/BST-1 antigen in early T cell development. Int Immunol 8:183, 1996.

P.403 掲載の参考文献

• 1) Lanier LL:NK cell receptors. Annu Rev Immunol 16:359, 1998.
  pubmed

• 2) Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L:Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619, 1996.
  pubmed

• 3) Parham P:NK cells, MHC class I antigens and missing self. Immunol Rev 155:5-221, 1997.

• 4) Baker E, D'Andrea A, Phillips JH, Sutherland GR, Lanier, LL:Natural killer cell receptor for HLA-B allotypes, NKB1:map position 19q13.4. Chromosome Res 3:511, 1995.

• 5) Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L:The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645, 1996.
  pubmed

• 6) Biassoni R, Pessino A, Malaspina A, Cantoni C, Bottino C, Sivori S, Moretta L, Moretta A:Role of amino acid position 70 in the binding affinity of p50. 1 and p58. 1receptors for HLA-Cw4 molecules. Eur J Immunol 27:3095, 1997.

• 7) Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG:Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813, 1998.

• 8) Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, Moretta L, Moretta A:Anovel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 26:1816, 1996.

• 9) Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ:HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795, 1998.

• 10) Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO:Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77, 1996.
  pubmed

• 11) Burshtyn DN, Yang W, Yi T, Long EO:Anovel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem 272:13066, 1997.

• 12) Cambiaggi A, Verthuy C, Naquet P, Romagne F, Ferrier P, Biassoni R, Moretta A, Moretta L, Vivier E:Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor. Proc Natl Acad Sci USA 94:8088, 1997.
  pubmed

• 13) Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M:Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 184:93, 1996.

• 14) Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R:p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 28:1980, 1998.

• 15) Carretero et al:In Leucocyte typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York &London, P294, 1998.

• 16) Castells MC, Wu X, Arm JP, Austen KF, Katz HR:Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J Biol Chem 269:8393, 1994.
  pubmed

• 17) Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M:Acommon inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809, 1997.

• 18) Colonna M, Samaridis J:Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405, 1995.
  pubmed

• 19) Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML:A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273, 1997.
  pubmed

• 20) D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL:Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 155:2306, 1995.
  pubmed

• 21) D'Andrea A, Chang C, Phillips JH, Lanier LL:Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med 184:789, 1996.

• 22) Dohring C, Samaridis J, Colonna M:Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 44:227, 1996.
  pubmed

• 23) Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M:A human killer inhibitory receptor specific for HLA-A1, 2. J Immunol 156:3098, 1996.

• 24) Fan QR, Mosyak L, Winter CC, Wagtmann N, Long EO, Wiley DC:Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389:96, 1997.
  pubmed

• 25) Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L:T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24:2294, 1994.
  pubmed

• 26) Fry AM, Lanier LL, Weiss A:Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 184:295, 1996.
  pubmed

• 27) George T, Yu YY, Liu J, Davenport C, Lemieux S, Stoneman E, Mathew PA, Kumar V, Bennett M:Allorecognition by murine natural killer cells:lysis of T-lymphoblasts and rejection of bone-marrow grafts. Immunol Rev 155:29, 1997.
  pubmed

• 28) Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D:Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J Exp Med 183:1817, 1996.

• 29) Hayami K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, Ohyama Y, Hikida M, Ohmori H, Takai T:Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem 272:7320, 1997.
  pubmed

• 30) Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG:Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199, 1997.

• 31) Kim J, Chwae YJ, Kim MY, Choi IH, Park JH, Kim SJ:Molecular basis of HLA-C recognition by P58 natural killer cell inhibitory receptors. J Immunol 159:3875, 1997.
  pubmed

• 32) Kubagawa H, Burrows PD, Cooper MD:Anovel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 94:5261, 1997.

• 33) Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH:Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703, 1998.
  pubmed

• 34) Lanier LL, Gumperz JE, Parham P, Melero I, Lopez-Botet M, Phillips JH:The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 154:3320, 1995.
  pubmed

• 35) Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH:Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741, 1996.
  pubmed

• 36) Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE:HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95:5199, 1998.

• 37) Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL:NKBI:anatural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180:537, 1994.

• 38) Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L:Expression cloning of a human Fc receptor for IgA. J Exp Med 172:1665, 1990.

• 39) Mandelboim O, Davis DM, Reyburn HT, Vales-Gomez M, Sheu EG, Pazmany L, Strominger JL:Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 274:2097, 1996.

• 40) Melero I, Salmeron A, Balboa MA, Aramburu J, Lopez-Botet M:Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J Immunol 152:1662, 1994.

• 41) Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH:LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7:283, 1997.

• 42) Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L:Human CD8+T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93:12433, 1996.
  pubmed

• 43) Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, et al:Identification of four subsets of human CD3-CD16+natural killer (NK) cells by the expression of clonally distributed functional surface molecules:correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 172:1589, 1990.
  pubmed

• 44) Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L:Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182:875, 1995.
  pubmed

• 45) Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, Pantaleo G, Moretta L:A novel surface antigen expressed by a subset of human CD3 CD16+natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 171:695, 1990.
  pubmed

• 46) Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L:P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178:597, 1993.

• 47) Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E:Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083, 1997.

• 48) Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E:Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531, 1996.
  pubmed

• 49) Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L:The natural killer cell receptor specific for HLA-A allotypes:anovel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Emp Med 184:505, 1996.

• 50) Rajagopalan S, Winter CC, Wagtmann N, Long EO:The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol 155:4143, 1995.

• 51) Samaridis J, Colonna M:Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells:structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660, 1997.
  pubmed

• 52) Selvakumar A, Steffens U, Dupont B:NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 48:285, 1996.
  pubmed

• 53) Selvakumar A, Steffens U, Dupont B:Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 155:183, 1997.
  pubmed

• 54) Selvakumar A, Steffens U, Palanisamy N, Chaganti RS, Dupont B:Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tissue Antigens 49:564, 1997.
  pubmed

• 55) Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P:Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739, 1997.

• 56) Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A:Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I:their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 93:1453, 1996.

• 57) Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO:Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 2:439, 1995.
  pubmed

• 58) Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO:Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:801, 1995.
  pubmed

• 59) Wagtmann N, Roj o S, Eichler E, Mohrenweiser H, Long EO:Anew human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7:615, 1997.

• 60) Wilson MJ, Torkar M, Trowsdale J:Genomic organization of a human killer cell inhibitory receptor gene. Tissue Antigens 49:574, 1997.
  pubmed

P.407 掲載の参考文献

• 1) Kabat J, Borrego F, Brooks A, Coligan JE:Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal.J Immunol 169 (4):1948-1958, 2002.
  pubmed

• 2) Plougastel B, Trowsdale J:Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes. Genomics 49 (2):193-199, 1998.
  pubmed

• 3) Renedo M, Arce I, Rodriguez A, Carretero M, Lanier LL, Lopez-Botet M, Fernandez-Ruiz E:The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 46 (4):307-311, 1997.
  pubmed

• 4) Plougastel B, Jones T, Trowsdale J:Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene. Immunogenetics 44 (4):286-291, 1996.
  pubmed

• 5) Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP:Amultigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37 (6):455-460, 1993.
  pubmed

• 6) Houchins JP, Yabe T, McSherry C, Bach FH:DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.J Exp Med 173 (4):1017-1020, 1991.
  pubmed

P.409 掲載の参考文献

• 1) Agrawal S, Marquet J, Freeman GJ, Tawab A, Bouteiller PL, Roth P, Bolton W, Ogg G, Boumsell L, Bensussan A:Cutting edge:MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 162 (3):1223-1226, 1999.

• 2) Anumanthan A, Bensussan A, Boumsell L, Christ AD, Blumberg RS, Voss SD, Patel AT, Robertson MJ, Nadler LM, Freeman GJ:Cloning of BY55, a novel lg superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161 (6):2780-2790, 1998.

P.410 掲載の参考文献

• 1) Lanier LL, Chang C, Phillips JH:Human NKR-PIA. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153:2417, 1994.

• 2) Poggi A, Costa P, Morelli L, Cantoni C, Pella N, Spada F, Biassoni R, Nanni L, Revello V, Tomasello E, Mingari MC, Moretta A, Moretta L:Expression of human NKRPIA by CD34+immature thymocytes:NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur J Immunol 26:1266, 1996.

P.412 掲載の参考文献

• 1) Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP:Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 118:445, 1992.
  pubmed

• 2) Norgard KE, Moore KL, Diaz S, Stults NL, Ushiyama S, McEver RP, Cummings RD, Varki A:Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides. J Biol Chem 268:12764, 1993.
  pubmed

• 3) Wilkins PP, Moore KL, McEver RP:Cummings RD:Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem 270:22677, 1995.

• 4) Pouyani T, Seed B:PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL1 amino terminus. Cell 83:333, 1995.
  pubmed

• 5) Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD:Asulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 83:323, 1995.

• 6) Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP:Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P-and E-selectin. J Biol Chem 271:3255, 1996.

• 7) Spertini O, Cordey AS, Monai N, Giuffre L, Schapira M:P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+hematopoietic progenitor cells. J Cell Biol 135:523, 1996.

• 8) Li F, Erickson HP, James JA, Moore KL, Cummings RD, McEver RP:Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem 271:6342, 1996.
  pubmed

• 9) Guyer DA, Moore KL, Lynam EB, Schammel CM, Rogelj S, McEver RP, Sklar LA:P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 88:2415, 1996.
  pubmed

• 10) Walcheck B, Moore KL, McEver RP, Kishimoto TK:Neutrophil-neutrophil interactions underhydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 98:1081, 1996.
  pubmed

• 11) Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL:P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 88:3010, 1996.
  pubmed

• 12) Tu L, Chen A, Delahunty MD, Moore KL, Watson SR, McEver RP, Tedder TF:L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes:interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity. J Immunol 157:3995, 1996.

P.413 掲載の参考文献

• 1) Biron C, Nguyen K, Pien GC, et al:Natural killer cells in antiviral defense:function and regulation by innate cytokines. Ann Rev Immunol 17:189-220, 1999.

• 2) Vivier E, Sorrell J, Ackerly M, et al:Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.J Exp Med 178:2023-2033, 1993.
  pubmed

• 3) Andre P, Spertini O, Guia S, et al:Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Pro Natl Aca Sci USA 97:3400-3405, 2000.

P.414 掲載の参考文献

• 1) Madsen M, Graversen JH, Moestrup SK:Haptoglobin and CD163:captor and receptor gating hemoglobin to macrophage lysosomes. Redox Rep 6 (6):386-388, 2001.
  pubmed

• 2) Hogger P, Sorg C:Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 288 (4):841-843, 2001.
  pubmed

• 3) Stover CM, Schleypen J, Gronlund J, Speicher MR, Schwaeble WJ, Holmskov U:Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis, Cytogenet Cell Genet 90 (3-4):246-247, 2000. (No abstract available)

• 4) Ritter M, Buechler C, Langmann T, Schmitz G:Genomic organization and chromosomal localization of the human CD163 (M130) gene:amember of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun 260 (2):466-474, 1999.

• 5) Law SK, Micklem KJ, Shaw JM, Zhang XP, Dong Y, Willis AC, Mason DY:Anew macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol 23 (9):2320-2325, 1993.

P.415 掲載の参考文献

• 1) Zannettino AC:CD164. J Biol Regzal Homeost Agents 15 (4):394-396, 2001.

• 2) Chan JY, Lee-Prudhoe JE, Jorgensen B, Ihrke G, Doyonnas R, Zannettino AC, Buckle VJ, Ward CJ, Simmons PJ, Watt SM:Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. J Biol Chem 276 (3):2139-2152, 2001.
  pubmed

• 3) Kurosawa N, Kanemitsu Y, Matsui T, Shimada K, Ishihama H, Muramatsu T:Genomic analysis of a murine cell-surface sialomucin, MGC-24/CD164. Eur J Biochem 265 (1):466-472, 1999.
  pubmed

• 4) Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA, Simmons PJ:The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 92 (8):2613-2628, 1998.
  pubmed

• 5) Watt SM, Buhring HJ, Rappold I, Chan JY, Lee-Prudhoe J, Jones T, Zannettino AC, Simmons PJ, Doyonnas R, Sheer D, Butler LH:CD164, a novel sialomucin on CD34 (+) and erythroid subsets, is located on human chromosome 6q21. Blood 92 (3):849-866, 1998.
  pubmed

• 6) Masuzawa Y, Miyauchi T, Hamanoue M, Ando S, Yoshida J, Takao S, Shimazu H, Adachi M, Muramatsu T:A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells:sequence analysis and examination of gene expression. J Biochem (Tokyo) 112 (5):609-615, 1992.
  pubmed

P.417 掲載の参考文献

• 1) Bruggers CS, Patel DD, Scearce RM, Whichard LP, Haynes BF, Singer KH:AD2, a human molecule involved in the interaction of T cells with epidermal keratinocytes and thymic epithelial cells. J Immunol 154:2012, 1995.
  pubmed

• 2) Seon BK, Negoro S, Barcos MP, Tebbi CK, Chervinsky D, Fukukawa T:Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein. J Immunol 132:2089, 1984.
  pubmed

• 3) Hara H, Seon BK:Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins:nude mouse models. Proc Natl Acad Sci USA 84:3390, 1987.
  pubmed

P.418 掲載の参考文献

• 1) Bowen MA, Bajorath J, Siadak AW, Modrell B, Malacko AR, Marquardt H, Nadler SG, Aruffo A:The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry. J Biol Chem 271:17390, 1996.

• 2) Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, et al:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181:2213, 1995.

• 3) Burns FR, von Kannen S, Guy L, Raper JA, Kamholz J, Chang S:DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7:209, 1991.
  pubmed

• 4) Corbel C, Pourquie O, Cormier F, Vaigot P, Le Douarin NM:BEN/SC1/DM-GRASP, a homophilic adhesion molecule, is required for in vitro myeloid colony formation by avian hemopoietic progenitors. Proc Natl Acad Sci USA 93:2844, 1996.
  pubmed

• 5) DeBernardo AP, Chang S:Heterophilic interactions of DM-GRASP:GRASP-NgCAM interactions involved in neurite extension.J Cell Biol 133:657, 1996.
  pubmed

• 6) Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A, Haynes BF:Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J Exp Med 181:1563, 1995.
  pubmed

• 7) Peduzzi JD, Irwin MH, Geisert EE Jr:Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat CNS. Brain Res 640:296, 1994.
  pubmed

• 8) Pesando JM, Hoffman P, Abed M:Antibody-induced antigenic modulation is antigen dependent:characterization of 22 proteins on a malignant human B cell line. J Immunol 137:3689, 1986.

• 9) Pourquie O, Corbel C, Le Caer JP, Rossier J, Le Douarin NM:BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci USA 89:5261, 1992.

• 10) Skonier JE, Bowen MA, Emswiler J, Aruffo A, Bajorath J:Recognition of diverse proteins by members of the immunoglobulin superfamily:delineation of the receptor binding site in the human CD6 ligand ALCAM. Biochemistry 35:12287, 1996.
  pubmed

• 11) Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland KC, Kohr B, Lee A, Phillips HS, Shelton DL:Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 7:535, 1991.
  pubmed

P.421 掲載の参考文献

• 1) Vogel W, Gish GD, Alves F, Pawson T:The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1 (1):13-23, 1997.
  pubmed

• 2) Sakuma S, Saya H, Tada M, Nakao M, Fuj iwara T, Roth JA, Sawamura Y, Shinohe Y, Abe H:Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Lett 398 (2-3):165-169, 1996.

• 3) Playford MP, Butler RJ, Wang XC, Katso RM, Cooke IE, Ganesan TS:The genomic structure of discoidin receptor tyrosine kinase. Genome Res 6 (7):620-627, 1996.
  pubmed

• 4) Valent A, Meddeb M, Danglot G, Duverger A, Nguyen VC, Bernheim A:Assignment of the NTRK4 (trkE) gene to chromosome 6p21. Hum Genet 98 (1):12-15, 1996.
  pubmed

• 5) Perez JL, Jing SQ, Wong TW:Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene 12 (7):1469-1477, 1996.
  pubmed

• 6) Johnson JD, Edman JC, Rutter WJ:A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proc Natl Acad Sci USA 90 (12):5677-5681, 1993.
  pubmed

• 7) Perez JL, Shen X, Finkernagel S, Sciorra L, Jenkins NA, Gilbert DJ, Copeland NG, Wong TW:Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene 9 (1):211-219, 1994.
  pubmed

• 8) Di Marco E, Cutuli N, Guerra L, Cancedda R, De Luca M:Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. J Biol Chem 268 (32):24290-24295, 1993.
  pubmed

• 9) Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS:Isolation and characterization ofan epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ 5 (11):1173-1183, 1994.

• 10) Shelling AN, Butler R, Jones T, Laval S, Boyle JM, Ganesan TS:Localization of an epithelial-specificreceptor kinase (EDDR1) to chromosome 6q16. Genomics 25 (2):584-587, 1995

• 11) Edelhoff S, Sweetser DA, Disteche CM:Mapping of the NEP receptor tyrosine kinase gene to humanchromosome 6p21.3 and mouse chromosome 17C. Genomics 25 (1):309-311, 1995.

P.422 掲載の参考文献

• 1) Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW:Insights into the pathobiology of hepatitis C virus-associated cirrhosis:analysis of intrahepatic differential gene expression. Am J Pathol 160 (2):641-654, 2002.
  pubmed

• 2) Doyle CT:The cytogenetics of 90 patients with idiopathic mental retardation/malformation syndromes and of 90 normal subjects. Hum Genet 33 (2):131-146, 1976.
  pubmed

P.423 掲載の参考文献

• 1) Akiyama Y, Jung S, Salhia B, Lee S, Hubbard S, Taylor M, Mainprize T, Akaishi K, van Furth W, Rutka JT:Hyaluronate receptors mediating glioma cell migration and proliferation. J Neurooncol 53 (2):115-127, 2001.
  pubmed

• 2) Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR:The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 111 (Pt 12):1685-1694, 1998.

• 3) Wang C, Entwistle J, Hou G, Li Q, Turley EA:The characterization of a human RHAMM cDNA:conservation of the hyaluronan-binding domains. Gene 174 (2):299-306, 1996.
  pubmed

• 4) Spicer AP, Roller ML, Camper SA, McPherson JD, Wasmuth JJ, Hakim S, Wang C, Turley EA, McDonald JA:The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2-qter and mouse chromosome 11. Genomics 30 (1):115-117, 1995.
  pubmed

P.426 掲載の参考文献

• 1) Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR:Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97 (1):288-296, 2001.
  pubmed

• 2) Nath D, Hartnell A, Happerfield L, Miles DW, Burchell J, Taylor-Papadimitriou J, Crocker PR:Macrophage-tumor cell interactions:identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin. Immunology 98 (2):213-219, 1999.
  pubmed

• 3) Mucklow S, Hartnell A, Mattei MG, Gordon S, Crocker PR:Sialoadhesin (Sn) maps to mouse chromo-some 2 and human chromosome 20 and is not linked to the other members of the sialoadhesin family, CD22, MAG, and CD33. Genomics 28 (2):344-346, 1995.

P.427 掲載の参考文献

• 1) Patel N, Brinkman-Van der Linden EC, Altmann SW, Gish K, Balasubramanian S, Timans JC, Peterson D, Bell MP, Bazan JF, Varki A, Kastelein RA:OB-BP1/Siglec-6. a leptin-and sialic acid-binding protein of the immunoglobulin superfamily.JBiol Chem 274 (32):22729-22738, 1999.

• 2) Kim HS:Assignment of the human OB binding protein-2 gene (CD33L2) to chromosome 19q13.3 by radiation hybrid mapping. Cytogenet Cell Genet 84 (1-2):96, 1999. (No abstract available)

• 3) Cornish AL, Freeman S, Forbes G, Ni J, Zhang M, Cepeda M, Gentz R, Augustus M, Carter KC, Crocker PR:Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 92 (6):2123-2132, 1998.
  pubmed

P.429 掲載の参考文献

• 1) Weller S, Gartner J:Genetic and clinical aspects of X-linked hydrocephalus (L1 disease):Mutations in the L1CAM gene. Hum Mutat 18 (1):H2, 2001.

• 2) Hofstra RM, Elfferich P, Osinga J, Verlind E, Fransen E, Lopez Pison J, de Die-Smulders CE, Stolte Dijkstra I, Buys CH:Hirschsprung disease and LICAM:is the disturbed sex ratio caused by LICAM mutations? J Med Genet 39 (3):E11, 2002.

• 3) Parisi MA, Kapur RP, Neilson I, Hofstra RM, Holloway LW, Michaelis RC, Leppig KA:Hydrocephalus and intestinal aganglionosis:is L1CAM a modifier gene in Hirschsprung disease? Am J Med Genet 108 (1):51-56, 2002.
  pubmed

• 4) Kamiguchi H, Lemmon V:Aneuronal form of the cell adhesion molecule L1 contains a tyrosine-based signal required for sorting to the axonal growth cone. J Neurosci 18 (10):3749-3756, 1998.

• 5) Coutelle O, Nyakatura G, Taudien S, Elgar G, Brenner S, Platzer M, Drescher B, Jouet M, Kenwrick S, Rosenthal A:The neural cell adhesion molecule L1:genomic organisation and differential splicing is conserved between man and the pufferfish Fugu. Gene 208 (1):7-15, 1998.
  pubmed

• 6) Brenner V, Nyakatura G, Rosentha1 A, Platzer M:Genomic organization of two novel genes on human Xq28:compact head to head arrangement of IDH gamma and TRAP delta is conserved in rat and mouse. Genomics 44 (1):8-14, 1997.
  pubmed

• 7) Vits L, Van Camp G, Coucke P, Fransen E, De Boulle K, Reyniers E, Korn B, Poustka A, Wilson G, Schrander-Stumpel C, et al:MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nat Genet 7 (3):408-413, 1994.
  pubmed

• 8) Jouet M, Rosenthal A, Armstrong G, MacFarlane J, Stevenson R, Paterson J, Metzenberg A, Ionasescu V, Temple K, Kenwrick S:X-linked spastic paraplegia (SPG1) , MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 7 (3):402-407, 1994.

• 9) Djabali M, Mattei MG, Nguyen C, Roux D, Demengeot J, Denizot F, Moos M, Schachner M, Goridis C, Jordan BR:The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics 7 (4):587-593, 1990.
  pubmed

• 10) Kobayashi M, Miura M, Asou H, Uyemura K:Molecular cloning of cell adhesion molecule L1 from human nervous tissue:acomparison of the primary sequences of L1 molecules of different origin. Biochim Biophys Acta 1090 (2):238-240, 1991.

• 11) Rosenthal A, MacKinnon RN, Jones DS:PCR walking from microdissection clone M54 identifies three exons from the human gene for the neural cell adhesion molecule L1 (CAM-L1). Nucleic Acids Res 19 (19):5395-5401, 1991.

• 12) Fryns Jp, Spaepen A, Cassiman JJ, van den Berghe H:Xlinked complicated spastic paraplegia, MASA syndrome, and X linked hydrocephalus owing to congenital stenosls of the aqueduct of Sylvius:variable expression of the same mutation at Xq28. J Med Genet 28 (6):429-431, 1991. (No abstract available)

• 13) Hlavin ML, Lemmon V:Molecular structure and functional testing of human LICAM:an interspecies comparison. Genomics 11 (2):416-423, 1991.

• 14) Reid RA, Hemperly JJ:Variants of human L1 cell adhesion molecule arise through alternate splicing of RNA.J Mol Neurosci 3 (3):127-135, 1992.
  pubmed

• 15) Rosenthal A, Jouet M, Kenwrick S:Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus. Nat Genet 2 (2):107-112, 1992.

P.432 掲載の参考文献

• 1) Vernon-Wilson EF, Kee WJ, Willis AC, Barclay AN, Simmons DL, Brown MH:CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRP alpha 1. Eur J Immunol 30 (18):2130-2137, 2000.

• 2) Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM:Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs). Oncogene 19 (35):3999-4010, 2000.

• 3) Sano S, Ohnishi H, Kubota M:Gene structure of mouse BIT/SHPS-1. Biochem/344 (Pt 3):667-675, 1999.

• 4) Seiffert M, Cant C, Chen Z, Rappold I, Brugger W, Kanz L, Brown EJ, Ullrich A, Buhring HJ:Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood 94 (11):3633-3643, 1999.

• 5) Ohnishi H, Yamada M, Kubota M, Hatanaka H, Sano S:Tyrosine phosphorylation and association of BIT with SHP-2 induced by neurotrophins. J Neurochem 72 (4):1402-1408, 1999.
  pubmed

• 6) Veillette A, Thibaudeau E, Latour S:High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-l in macrophages. J Biol Chem 273 (35):22719-22728, 1998.

• 7) Timms JF, Carlberg K, Gu H, Chen H, Kamatkar S, Nadler MJ, Rohrschneider LR, Neel BG:Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1in macrophages. Mol Cell Biol 18 (7):3838-3850, 1998.

• 8) Brooke GP, Parsons KR, Howard CJ:Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur J Immunol 28 (1):1-11, 1998.

• 9) Sano S, Ohnishi H, Omori A, Hasegawa J, Kubota M:BIT, an immune antigen receptor-like molecule in the brain. FEBS Lett 411 (2-3):327-334, 1997.

• 10) Yamao T, Matozaki T, Amano K, Matsuda Y, Takahashi N, Ochi F, Fujioka Y, Kasuga M:Mouse and human SHPS-1:molecular cloning of cDNAs and chromosomal localization of genes. Biochem Biophys Res Commun 231 (1):61-67, 1997.
  pubmed

• 11) Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A:Afamily of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386 (6621):181-186, 1997.

• 12) Ohnishi H, Kubota M, Ohtake A, Sato K, Sano S:Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule. J Biol Chem 271 (41):25569-25574, 1996.
  pubmed

• 13) Margolis RL, Breschel TS, Li SH, Kidwai AS, Antonarakis SE, Mclnnis MG, Ross CA:Characterization of cDNA clones containing CCA trinucleotide repeats derived from human brain. Somat Cell Mol Genet 21 (4):279-284, 1995.

P.434 掲載の参考文献

• 1) Cao Y, Merling A, Karsten U, Schwartz-Albiez R:The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 11 (8):677-683, 2001.

P.435 掲載の参考文献

• 1) Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H, Minami H:Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol 128 (5):257-264, 2002.
  pubmed

• 2) Li XW, Ding YQ, Cai JJ, Yang SQ, An LB, Qiao DF:Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma. World J Gastroenterol 7 (3):425-430, 2001.
  pubmed

• 3) Grahn A, Elmgren A, Aberg L, Svensson L, Jansson PA, Lonnroth P, Larson G:Determination of Lewis FUT3 gene mutations by PCR using sequence-specific primers enables efficient genotyping of clinical samples. Hum Mutat 18 (4):358-359, 2001.
  pubmed

• 4) Nishihara S, Yazawa S, Iwasaki H, Nakazato M, Kudo T, Ando T, Narimatsu H:Alpha (1, 3/1, 4) fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histoblood type negative individuals. Biochem Biophys Res Commun 196 (2):624-631, 1993.
  pubmed

• 5) Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I:Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 269 (46):29271-29278, 1994.
  pubmed

• 6) Cameron HS, Szczepaniak D, Weston BW:Expression of human chromosome 19p alpha (1, 3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J Biol Chem 270 (34):20112-20122, 1995.
  pubmed

• 7) Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB:A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha (1, 3/1, 4) fucosyltransferase. Genes Dev 4 (8):1288-1303, 1990.
  pubmed

• 8) Weston BW, Nair RP, Larsen RD, Lowe JB:Isolation of a novel human alpha (1, 3) fucosyltransferase gene and molecular comparison to the human Lewis blbod group alpha (1, 3/1, 4) fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem 267 (6):4152-4160, 1992.

P.436 掲載の参考文献

• 1) Doyle CT:The cytogenetics of 90 patients with idiopathic mental retardation/malformation syndromes and of 90 normal subjects. Hum Genet 33 (2):131-146, 1976.
  pubmed

P.437 掲載の参考文献

• 1) Doyle CT:The cytogenetics of 90 patients with idiopathic mental retardation/malformation syndromes and of 90 normal subjects. Hum Genet 33 (2):131-146, 1976.
  pubmed

P.438 掲載の参考文献

• 1) Cao Y, Karsten U, Liebrich W, Haensch R, Springer GF, Schlag P:Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation. Cancer 76:1700-1708, 1995.

• 2) Takanami I:Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol Rep 6:341-344, 1999.
  pubmed

• 3) Cao Y, Karsten U, Otto G, Bannasch P:Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2, 6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Vir Arch 434 (6):503-509, 1999.

• 4) Cao Y, Karsten U, Zerban H, Bannasch P:Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions. Vir Arch 436 (2):119-126, 2000.

• 5) Cao Y, Stosiek P, Springer GF, Karsten U:Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues:asystematic and comparative study. Histochem Cell Biol 106:197-207, 1996.

• 6) Nakada H, Inoue M, Tanaka N, Wakamiya N, Yamasita I:Expression of the T antigen on a T-lymphoid cell line, supT1. Glyco J 12 (3):356-359, 1995.

• 7) Agrawal B, Krantz MJ, Parker J, Longenecker B:Expression of MUC1 mucin on activated human T cells:implications for a role of MUC1 in normal immune regulation. Cancer Res 58:4079-4081, 1998.

P.439 掲載の参考文献

• 1) Stroncek D:Neutrophil alloantigens. Transfus Med Rev 16 (1):67-75, 2002.
  pubmed

• 2) Bux J:Granulocyte immunology. Wien Klin Wochenschr 113 (20-21):799-805, 2001.

• 3) Bux J:Molecular nature of antigens implicated in immune neutropenias. Int J Hematol 76 (Suppl 1):399-403, 2002.

• 4) Przygodzki RM, Hubbs AE, Zhao FQ, O'Leary TJ:Primary mediastinal seminomas:evidence of single and multiple KIT mutations. Lab Invest 82 (10):1369-1375, 2002.
  pubmed

• 5) Klippel S, Strunck E, Busse CE, Behringer D, Pahl HL:Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood 100 (7):2441-2448, 2002.
  pubmed

• 6) Kissel K, Scheffler S, Kerowgan M, Bux J:Molecular basis of N B1 (HNA-2a, CD177) deficiency. Blood 99 (11):4231-4233, 2002.

• 7) Bettinotti MP, Olsen A, Stroncek D:The use of bioinformatics to identify the genomic structure of the gene that encodes neutrophil antigen NBI, CD177. Clin Immunol 102 (2):138-144, 2002.

• 8) Bux J:Molecular nature of granulocyte antigens. Transfus Clin Biol 8 (3):242-247, 2001.
  pubmed

• 9) Kissel K, Santoso S, Hofmann C, Stroncek D, Bux J:Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol 31 (5):1301-1309, 2001.
  pubmed

P.442 掲載の参考文献

• 1) Selam B, Kayisli UA, Garcia-Velasco JA, Akbas GE, Arici A:Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 87 (8):3921-3927, 2002.
  pubmed

• 2) Tsubota K, Fujita H, Tadano K, Onoda N, Tsuzaka K, Takeuchi T:Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjogren's syndrome patients with enlarged exocrine glands. Clin Exp Immunol 129 (1):177-182, 2002.
  pubmed

• 3) Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S:Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195 (10):1303-1316, 2002.
  pubmed

• 4) Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, Mussi C, Ventura P, Olivieri F, Franceschi C, Salvioli G, Cossarizza A:Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity:studies on centenarians. Cell Death Differ 9 (4):431-438, 2002.
  pubmed

• 5) Roh CR, Lee JW, Kang BH, Yang SH, Kim BG, Bae DS, Kim JH, Lee JH:Differential expressions of Fas and Fas ligand in human placenta. J Korean Med Sci 17 (2):213-216, 2002.
  pubmed

• 6) Toillon RA, Descamps S, Adriaenssens E, Ricort JM, Bernard D, Boilly B, Le Bourhis X:Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling. Exp Cell Res 275 (1):31-43, 2002.
  pubmed

• 7) Yang Y, Dong B, Mittelstadt PR, Xiao H, Ashwell JD:HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem 277 (22):19482-19487, 2002.

• 8) Kim S, Ki JY, Lee TH, Suk K, Cha HS, Koh EM, Yagita H, Lee MS:Soluble Fas ligand-susceptible "memory" cells in mice but not in human:potential role of soluble Fas ligand in deletion of auto-reactive cells. Autoimmunity 35 (1):15-20, 2002.

• 9) Lee TB, Min YD, Lim SC, Kim KJ, Jeon HJ, Choi SM, Choi CH:Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells. J Gastroenterol Hepatol 17 (1):32-38, 2002.

• 10) Imanishi T, Han DK, Hofstra L, Hano T, Nishio I, Conrad Liles W, Gorden AM, Schwartz SM:Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 161 (1):143-151, 2002.

• 11) Lee MO, Kang HJ, Kim YM, Oum JH, Park J:Repression of FasL expression by retinoic acid involves anovel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Eur J Biochem 269 (4):1162-1170, 2002.

• 12) Nolsoe RL, Kristiansen OP, Larsen ZM, Johannesen J, Pociot F, Mandrup-Poulsen T:Complete mutation scan of the human Fas ligand gene:linkage studies in Type I diabetes mellitus families. Diabetologia 45 (1):134-139, 2002.
  pubmed

• 13) Silvestris F, Cafforio P, Tucci M, Dammacco F:Negative regulation of erythroblast maturation by Fas-L (+)/TRAIL (+) highly malignant plasma cells:amajor pathogenetic mechanism of anemia in multiple myeloma. Blood 99 (4):1305-1313, 2002.

• 14) van Landeghem FK, Felderhoff-Mueser U, Moysich A, Stadelmann C, Obladen M, Bruck W, Buhrer C:Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis. Pediatr Res 51 (2):129-135, 2002.
  pubmed

• 15) Cippitelli M, Fionda C, Di Bona D, Di Rosa F, Lupo A, Piccoli M, Frati L, Santoni A:Negative regulation of CD95ligand gene expression by vitamin D3 in T lymphocytes. J Immunol 168 (3):1154-1166, 2002.

• 16) Kase S, Osaki M, Adachi H, Kaibara N, Ito H:Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Int J Oncol 20 (2):291-297, 2002.
  pubmed

• 17) Chopin V, Toillon RA, Jouy N, Le Bourhis X:Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Phanuacol 135 (1):79-86, 2002.
  pubmed

• 18) Selam B, Kayisli UA, Garcia-Velasco JA, Arici A:Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod 66 (1):1-5, 2002.
  pubmed

• 19) Monleon I, Martinez-Lorenzo MJ, Monteagudo L, Lasierra P, Taules M, Iturralde M, Pineiro A, Larrad L, Alava MA, Naval J, Anel A:Differential secretion of Fas ligand-or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 167 (12):6736-6744, 2001.
  pubmed

• 20) Kasprzycka M, Klodos K, Nowaczyk M, Wyzgal J, Podobinska I, Durlik M, Gorski A:Expression of FasL gene in T cells of renal allograft recipients. Immunol Lett 80 (1):9-13, 2002.

P.444 掲載の参考文献

• 1) Gisler R, Sigvardsson M:The human V-pre B promoter is a target for coordinated activation by early B cell factor and E47. J Immunol 168 (10):5130-5138, 2002.

• 2) Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, Wang J, Shimizu N:One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 7 (3):250-261, 1997.
  pubmed

• 3) Guelpa-Fonlupt V, Bossy D, Alzari P, Fumoux F, Fougereau M, Schiff C:The human pre-B cell receptor:structural constraints for a tentative model of the pseudo-light (psi L) chain. Mol Immunol 31 (14):1099-1108, 1994.
  pubmed

• 4) Bauer SR, Kudo A, Melchers F:Structure and pre-B lymphocyte restricted expression of the Vpre B in humans and conservation of its structure in other mammalian species. EMBO J 7 (1):111-116, 1988.

• 5) Bauer SR, Huebner K, Budarf M, Finan J, Erikson J, Emanuel BS, Nowell PC, Croce CM, Melchers F:The human Vpre B gene is located on chromosome 22 near a cluster of V lambda gene segments. Immunogenetics 28 (5):328-333, 1988.

• 6) Tsubata T, Reth M:The products of pre-B cell-specific genes (lambda 5 and Vpre B) and the immunoglobulin mu chain form a complex that is transported onto the cell surface. J Exp Med 172 (3):973-976, 1990.

P.445 掲載の参考文献

• 1) Miyazaki T, Kato I, Takeshita S, Karasuyama H, Kudo A:Lambda 5 is required for rearrangement of the Ig kappa light chain gene in pro-B cell lines. Int Immunol 11 (8):1195-1202, 1999.

• 2) Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, Wang J, Shimizu N:One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 7 (3):250-261, 1997.
  pubmed

• 3) Donohoe ME, Blomberg BB:The 14.1surrogate light chain promoter has lineage-and stage-restricted activity. J Immunol 158 (4):1681-1691, 1997.
  pubmed

• 4) Bauer TR Jr, McDermid HE, Budarf ML, Van Keuren ML, Blomberg BB:Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2. Immuogenetics 38 (6):387-399, 1993.
  pubmed

• 5) Schiff C, Milili M, Fougereau M:Isolation of early immunoglobulin lambda-like gene transcripts in human fetal liver. Eur J Immunol 19 (10):1873-1878, 1989.

• 6) Hollis GF, Evans RJ, Stafford-Hollis JM, Korsmeyer SJ, McKearn Jp:Immunoglobulin lambda light-chain-related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin omega light-chain protein. Proc Natl Acad Sci USA 86 (14):5552-5556, 1989.
  pubmed

• 7) Mattei MG, Fumoux F, Roeckel N, Fougereau M, Schiff C:The human pre-B-specific lambda-like cluster is located in the 22q11.2-22q12.3region, distal to the IgC lambda locus. Genomics 9 (3):544-546, 1991.

• 8) Evans RJ, Hollis GF:Genomic structure of the human Ig lambda 1 gene suggests that it may be expressed as an Ig lambda 14.1-like protein or as a canonical B cell Ig lambda light chain:implications for Ig lambda gene evolution. J Exp Med 173 (2):305-311, 1991.
  pubmed

P.446 掲載の参考文献

• 1) Miura Y, Miyake K, Yamashita Y, Shimazu R, Copeland NG, Gilbert DJ, Jenkins NA, Inazawa J, Abe T, Kimoto M:Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RPIO5 genes (Ly64 and LY64). Genomics 38 (3):299-304, 1996.
  pubmed

P.449 掲載の参考文献

• 1) Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM:Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169 (2):1037-1049, 2002.
  pubmed

• 2) Kim CH, Johnston B, Butcher EC:Trafficking machinery of NKT cells:shared and differential chemokine receptor expression among V alpha 24 (+) Vbeta ll (+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100 (1):11-16, 2002.

• 3) Aust G, Sittig D, Steinert M, Lamesch P, Lohmann T:Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin Exp Immunol 127 (3):479-485, 2002.
  pubmed

• 4) Sauty A, Colvin RA, Wagner L, Rochat S, Spertini F, Luster AD:CXCR3 internalization following T cell-endothelial cell contact:preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J Immunol 167 (12):7084-7093, 2001.
  pubmed

• 5) Hensbergen PJ, van der Raaij-Helmer EM, Dijkman R, van der Schors RC, Werner-Felmayer G, Boorsma DM, Scheper RJ, Willemze R, Tensen CP:Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity. Eur J Biochem 268 (18):4992-4999, 2001.
  pubmed

• 6) Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, Jensen B, Madsen HO, Ryder LP, Svejgaard A, Malling HJ, Skov PS, Poulsen LK:CXC chemokine receptor 3 expression on CD34 (+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor:chemotax-is and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 96 (4):1230-1238, 2000.

• 7) Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB, Dissing S, Malling HJ, Skov PS, Poulsen LK:CXCR3 expression and activation of eosinophils:role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol 165 (3):1548-1556, 2000.

• 8) Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pita O, Puddu P, Girolomoni G:1L4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 165 (3):1395-1402, 2000.

• 9) Agace WW, Roberts AI, Wu L, Greineder C, Ebert EC, Parker CM:Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur J Immunol 30 (3):819-826, 2000.
  pubmed

• 10) Trentin L, Agostini C, Facco M, Piazza F, Perin A, Siviero M, Gurrieri C, Galvan S, Adami F, Zambello R, Semenzato G:The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest 104 (1):115-121, 1999.
  pubmed

• 11) Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B:Chemokine receptor specific for IP10 and mig:structure, function, and expression in activated T-lymphocytes. J Exp Med 184 (3):963-969, 1996.
  pubmed

• 12) Marchese A, Heiber M, Nguyen T, Heng HH, Saldivia VR, Cheng R, Murphy PM, Tsui LC, Shi X, Gregor P, et al:Cloning and chromosomal mapping of three novel genes, GPR9, GPRIO, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29 (2):335-344, 1995.
  pubmed

P.451 掲載の参考文献

• 1) Estes JD, Keele BF, Tenner-Racz K, Racz P, Redd MA, Thacker TC, Jiang Y, Lloyd MJ, Gartner S, Burton GF:Follicular dendritic cell-mediated up-regulation of CXCR4 expression on CD4 T cells and HIV pathogenesis. J Immunol 169 (5):2313-2322, 2002.
  pubmed

• 2) Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP:Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 99 (14):9410-9414, 2002.

• 3) Farzan M, Babcock GJ, Vasilieva N, Wright PL, Kiprilov E, Mirzabekov T, Choe H:The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J Biol Chem 277 (33):29484-29489, 2002.

• 4) Lu M, Grove EA, Miller RJ:Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99 (10):7090-7095, 2002.
  pubmed

• 5) Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J:CXCR44/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86 (8):1250-1256, 2002.

• 6) Nguyen DH, Taub D:CXCR4 function requires membrane cholesterol:implications for HIV infection. J Immunol 168 (8):4121-4126, 2002.
  pubmed

• 7) Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G:Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99 (8):2703-2711, 2002.
  pubmed

• 8) Juffermans NP, Weijer S, Verbon A, Speelman P, van der Poll T:Expression of human immunodeficiency virus coreceptors CXC chemokine receptor 4 and CC chemokine receptor 50n monocytes is down-regulated during human endotoxemia. J Infect Dis 185 (7):986-989, 2002.

• 9) Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK:Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62 (6):1832-1837, 2002.
  pubmed

• 10) Zhou N, Luo Z, Luo J, Fan X, Cayabyab M, Hiraoka M, Liu D, Han X, Pesavento J, Dong CZ, Wang Y, An J, Kaji H, Sodroski JG, Huang Z:Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines. J Biol Chem 277 (20):17476-17485, 2002.

• 11) Arthos J, Cicala C, Selig SM, White AA, Ravindranath HM, Van Ryk D, Steenbeke TD, Machado E, Khazanie P, Hanback MS, Hanback DB, Rabin RL, Fauci AS:The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. Virology 292 (1):98-106, 2002.
  pubmed

• 12) Zamarchi R, Allavena P, Borsetti A, Stievano L, Tosello V, Marcato N, Esposito G, Roni V, Paganin C, Bianchi G, Titti F, Verani P, Gerosa G, Amadori A:Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes. Clin Exp Immunol 127 (2):321-330, 2002.
  pubmed

• 13) Valenzuela-Fernandez A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini F, Virelizier JL, Chignard M, Pidard D, Arenzana-Seisdedos F:Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 277 (18):15677-15689, 2002.
  pubmed

• 14) Ferraro GA, Mello MA, Sutmoller F, Van Weyenbergh J, Shindo N, Galvao-Castro B, Bou-Habib DC:Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. Aids Res Hum Retroviruses 17 (13):1241-1247, 2001.
  pubmed

• 15) Ullrich CK, Groopman JE, Ganju RK:HIV-1 gp120-and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96 (4):1438-1442, 2000.
  pubmed

• 16) Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT:Active movement of T cells away from a chemokine. Nat Med 6 (5):543-548, 2000.
  pubmed

• 17) Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G:Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+T cells. J Immunol 164 (8):4018-4024, 2000.
  pubmed

• 18) Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, Cen B, Wu GX, Pei G:Beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4. J Biol Chem 275 (4):2479-2485, 2000.

• 19) Lalani AS, Masters J, Zeng W, Barrett J, Pannu R, Everett H, Arendt CW, McFadden G:Use of chemokine receptors by poxviruses. Science 286 (5446):1968-1971, 1999.
  pubmed

• 20) Sotsios Y, Whittaker GC, Westwick J, Ward SG:The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J Immunol 163 (11):5954-5963, 1999.

P.454 掲載の参考文献

• 1) Seibert C, Cadene M, Sanfiz A, Chait BT, Sakmar TP:Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci USA 99 (17):11031-11036, 2002.

• 2) Suzuki S, Miyagi T, Chuang LF, Yau PM, Doi RH, Chuang RY:Chemokine receptor CCR5:polymorphism at protein level Biochem Biophys Res Commun 296 (2):477-483, 2002.
  pubmed

• 3) Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP:Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 99 (14):9410-9414, 2002.

• 4) Lichterfeld M, Leifeld L, Nischalke HD, Rockstroh JK, Hess L, Sauerbruch T, Spengler U:Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 185 (12):1803-1807, 2002.

• 5) Kim CH, Johnston B, Butcher EC:Trafficking machinery of NKT cells:shared and differential chemokine receptor expression among V alpha 24 (+) Vbeta 11 (+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100 (1):11-16, 2002.

• 6) Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U:Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 122 (7):1721-1728, 2002.

• 7) Nguyen DH, Taub D:Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. Blood 99 (12):4298-4306, 2002.
  pubmed

• 8) Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D:Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes:strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells. J Immunol 168 (10):4920-4929, 2002.
  pubmed

• 9) Pashenkov M, Teleshova N, Kouwenhoven M, Kostulas V, Huang YM, Soderstrom M, Link H:Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clin Exp Immunol 127 (3):519-526, 2002.
  pubmed

• 10) Aust G, Sittig D, Steinert M, Lamesch P, Lohmann T:Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin Exp Immunol 127 (3):479-485, 2002.
  pubmed

• 11) Juffermans NP, Weijer S, Verbon A, Speelman P, van der Poll T:Expression of human immunodeficien-cy virus coreceptors CXC chemokine receptor 4 and CC chemokine receptor 50n monocytes is down-regulated during human endotoxemia. J Infect Z) is 185 (7):986-989, 2002.

• 12) Wang J, Crawford K, Yuan M, Wang H, Gorry PR, Gabuzda D:Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines. J Infect 1) is 185 (7):885-897, 2002.

• 13) Arthos J, Cicala C, Selig SM, White AA, Ravindranath HM, Van Ryk D, Steenbeke TD, Machado E, Khazanie P, Hanback MS, Hanback DB, Rabin RL, Fauci AS:The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. Virology 292 (1):98-106, 2002.
  pubmed

• 14) Zamarchi R, Allavena P, Borsetti A, Stievano L, Tosello V, Marcato N, Esposito G, Roni V, Paganin C, Bianchi G, Titti F, Verani P, Gerosa G, Amadori A:Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes. Clin Exp Immunol 127 (2):321-330, 2002.
  pubmed

• 15) Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP:HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype:acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr 29 (3):307-313, 2002. (Review)
  pubmed

• 16) Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, du Bois RM:CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. Immunol Lett 80 (3):189-193, 2002.
  pubmed

• 17) Tang J, Shelton B, Makhatadze NJ, Zhang Y, Schaen M, Louie LG, Goedert JJ, Seaberg EC, Margolick JB, Mellors J, Kaslow RA:Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J Virol 76 (2):662-672, 2002.
  pubmed

• 18) Ebert LM, McColl SR:Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+T lymphocytes. J Immunol 168 (1):65-72, 2002.
  pubmed

• 19) Nair MP, Mahajan S, Chadha KC, Nair NM, Hewitt RG, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA:Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. Adv Exp Med Biol 493:235-240, 2001. (No abstract available)

• 20) Lathey JL, Tierney C, Chang SY, D'Aquila RT, Bettendorf DM, Alexander HC, Santini CD, Hughes AM, Barroga CF, Spector SA, Landes JE, Hammer SM, Katzenstein DA:Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy. J Infect Dis 184 (11):1402-1411, 2001.

P.456 掲載の参考文献

• 1) Scandella E, Men Y, Gillessen S, Forster R, Groettrup M:Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100 (4):1354-1361, 2002..
  pubmed

• 2) Kim CH, Johnston B, Butcher EC:Trafficking machinery of NKT cells:shared and differential chemokine receptor expression among V alpha 24 (+) Vbeta 11 (+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100 (1):11-16, 2002.

• 3) Till KJ, Lin K, Zuzel M, Cawley JC:The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99 (8):2977-2984, 2002.
  pubmed

• 4) Hopken UE, Foss HD, Meyer D, Hinz M, Leder K, Stein H, Lipp M:Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99 (4):1109-1116, 2002.

• 5) Agace WW, Roberts AI, Wu L, Greineder C, Ebert EC, Parker CM:Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur J Immunol 30 (3):819-826, 2000.
  pubmed

• 6) Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O:Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272 (21):13803-13809, 1997.
  pubmed

• 7) Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E:Epstein-Barr virus-induced genes:first lymphocyte-specific G protein-coupled peptide receptors. J Virol 67 (4):2209-2220, 1993.
  pubmed

• 8) Schweickart VL, Raport CJ, Godiska R, Byers MG, Eddy RL Jr, Shows TB, Gray PW:Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. Genomics 23 (3):643-650, 1994.
  pubmed

• 9) Burgstahler R, Kempkes B, Steube K, Lipp M:Expression of the chemokine receptor BLR2/EBIl is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem Biophys Res Commun 215 (2):737-743, 1995.

P.458 掲載の参考文献

• 1) Gorczynski RM:Evidence for an immunoregulatory role of OX2 with its counter ligand (OX2L) in the regulation of transplant rejection, fetal loss, autoimmunity and tumor growth. Arch Immunol Ther Exp (Warsz) 49 (4):303-309, 2001.
  pubmed

• 2) Wright GJ, Jones M, Puklavec MJ, Brown MH, Barclay AN:The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102 (2):173-179, 2001.
  pubmed

• 3) Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD:Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (5497):1768-1771, 2000.
  pubmed

• 4) McCaughan GW, Clark MJ, Barclay AN:Characterization of the human homolog of the rat MRC OX-2membrane glycoprotein. Immunogenetics 25 (5):329-335, 1987.

• 5) Douglas J, Albertson DG, Barclay AN, Davis M, Rabbitts PH:RFLP and mapping of human MOX-1 gene on chromosome 3. Nucleic Acids Res 16 (18):9067, 1988.
  pubmed

P.459 掲載の参考文献

• 1) von Depka M, Czwalinna A, Eisert R, Wermes C, Scharrer I, Ganser A, Ehrenforth S:Prevalence of a 23bp insertion in exon 30f the endothelial cell protein C receptor gene in venous thrombophilia. Thromb Haemost 86 (6):1360-1362, 2001.

• 2) Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, Gu JM, Fetiveau R, Esmon CT, Mannucci PM, Faioni EM:A23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 86 (4):945-948, 2001.
  pubmed

• 3) Hayashi T, Nakamura H, Okada A, Takebayashi S, Wakita T, Yuasa H, Okumura K, Suzuki K:Organization and chromosomal localization of the human endothelial protein C receptor gene. Gene 238 (2):367-373, 1999.

• 4) Rothbarth K, Dabaghian AR, Stammer H, Werner D:One single mRNA encodes the centrosomal protein CCD41 and the endothelial cell protein C receptor (EPCR). FEBS Lett 458 (1):77-80, 1999.
  pubmed

• 5) Simmonds RE, Lane DA:Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene:comparison with the structure of CD1/major histocompatibility complex alphal and alpha 2 domains. Blood 94 (2):632-641, 1999.

• 6) Fukudome K, Esmon CT:Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269 (42):26486-26491, 1994.
  pubmed

P.461 掲載の参考文献

• 1) Hata K, Udagawa J, Fujiwaki R, Nakayama K, Otani H, Miyazaki K:Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. Oncology 62 (4):340-348, 2002.
  pubmed

• 2) Tsiamis AC, Morris PN, Marron MB, Brindle NP:Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 63 (2):149-158, 2002.
  pubmed

• 3) Hansbury MJ, Nicosia RF, Zhu WH, Holmes SJ, Winkler JD:Production and characterization of a Tie2 agonist monoclonal antibody. Angiogenesis 4 (1):29-36, 2001.
  pubmed

• 4) Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J:Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159 (6):2271-2280, 2001.
  pubmed

• 5) Kim I, Kim JH, Ryu YS, Jung SH, Nah JJ, Koh GY:Characterization and expression of a novel alternatively spliced human angiopoietin-2. J Biol Chem 275 (24):18550-18556, 2000.
  pubmed

• 6) Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM:Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83 (3):233-240, 1998.
  pubmed

• 7) Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM:Chemotactic properties of angiopoietin-1 and-2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273 (29):18514-18521, 1998.
  pubmed

• 8) Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR:Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 (7):1181-1190, 1996.
  pubmed

• 9) Ziegler SF, Bird TA, Schneringer JA, Schooley KA, Baum PR:Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8 (3):663-670, 1993.
  pubmed

• 10) Dumont DJ, Anderson L, Breitman ML, Duncan AM:Assignment of the endothelial-specific protein receptor tyrosine kinase gene (TEK) to human chromosome 9p21. Genomics 23 (2):512-513, 1994.
  pubmed

• 11) Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML:Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3 (9):1583-1587, 1994.
  pubmed

• 12) Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, Markel DS, Vikkula M, Mulliken JB, Warman ML, et al:A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 32 (3):197-199, 1995.

P.463 掲載の参考文献

• 1) Buhring HJ, Seiffert M, Giesert C, Marxer A, Kanz L, Valent P, Sano K:The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 97 (10):3303-3305, 2001.

• 2) Andoh K, Piao JH, Terashima K, Nakamura H, Sano K:Genomic structure and promoter analysis of the ecto-phosphodiesterase I gene (PDNP3) expressed in glial cells. Biochim Biophys Acta 1446 (3):213-224, 1999.
  pubmed

• 3) Jin-Hua P, Goding JW, Nakamura H, Sano K:Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes. Genomics 45 (2):412-415, 1997.
  pubmed

P.464 掲載の参考文献

• 1) Asaoka H, Matsumoto A, Itakura H, Kodama T:Structural and function of the human macrophage scavenger receptor. Nippon Rinsho 51 (6):1677-1683, 1993. Japanese.
  pubmed

• 2) Tomokiyo R, Jinnouchi K, Honda M, Wada Y, Hanada N, Hiraoka T, Suzuki H, Kodama T, Takahashi K, Takeya M:Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 161 (1):123-132, 2002.

• 3) Gough PJ, Greaves DR, Gordon S:Anaturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res 39 (3):531-543, 1998.

• 4) Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, Wada Y, Kanamori H, Yazaki Y, Takahashi E, Lepert M, et al:Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 268 (3):2120-2125, 1993.

• 5) Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H, et al:Human macrophage scavenger receptors:primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 87 (23):9133-9137, 1990.
  pubmed

P.465 掲載の参考文献

• 1) McKay PF, Imami N, Johns M, Taylor-Fishwick DA, Sedibane LM, Totty NF, Hsuan JJ, Palmer DB, George AJ, Foxwell BM, Ritter MA:The gp200-MR6 molecule which is functionally associated with the IL4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family. Eur J Immunol 28 (12):4071-4083, 1998.
  pubmed

• 2) Kato M, Neil TK, Clark GJ, Morris CM, Sorg RV, Hart DN:cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells. Immunogenetics 47 (6):442-450, 1998.
  pubmed

P.468 掲載の参考文献

• 1) Feinberg H, Park-Snyder S, Kolatkar AR, Heise CT, Taylor ME, Weis WI:Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor. JBiol Chem 275 (28):21539-21548, 2000.

• 2) Eichbaum Q, Clerc P, Bruns G, McKeon F, Ezekowitz RA:Assignment of the human macrophage mannose receptor gene (MRC1) to 10p13 by in situ hybridization and PCR-based somatic cell hybrid mapping. Genomics 22 (3):656-658, 1994. (No abstract available)

• 3) Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K:Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 265 (21):12156-12162, 1990.
  pubmed

• 4) Ezekowitz RA, Sastry K, Bailly P, Warner A:Molecular characterization of the human macrophage mannose receptor:demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172 (6):1785-1794, 1990.
  pubmed

• 5) Taylor ME, Bezouska K, Drickamer K:Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 267 (3):1719-1726, 1992.
  pubmed

• 6) Kim SJ, Ruiz N, Bezouska K, Drickamer K:Organization of the gene encoding the human macrophage mannose receptor (MRC1). Genomics 14 (3):721-727, 1992.
  pubmed

P.469 掲載の参考文献

• 1) Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D, Davoust J, Caux C, Lebecque S, Saeland S:Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (1):71-81, 2000.

• 2) [No authors listed]:Toward a complete human genome sequence. Genome Res 8 (11):1097-1108, 1998.

P.470 掲載の参考文献

• 1) de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S:A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9 (3):325-336, 1998.
  pubmed

• 2) Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y, Takahashi E, Nakamura Y:Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glyco-proteins 1 and 2:significantly increased expression in cancers of various tissues. Cancer Res 58 (16):3499-3503, 1998.

P.472 掲載の参考文献

• 1) Geijtenbeek TB, Engering A, Van Kooyk Y:DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol 71 (6):921-931, 2002.

• 2) Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R:C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76 (13):6841-6844, 2002.

• 3) Wu L, Martin TD, Vazeux R, Unutmaz D, KewalRamani VN:Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J Virol 76 (12):5905-5914, 2002.

• 4) Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N, Navarro J, Munoz-Fernandez MA, Sanchez--Mateos P, Corbi AL:DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 168 (6):2634-2643, 2002.
  pubmed

• 5) Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, Lanzavecchia A, Fransen J, Figdor CG, Piguet V, van Kooyk Y:The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168 (5):2118-2126, 2002.

• 6) Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Krieger E, Vriend G, Figdor CG, van Kooyk Y:Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J Biol Chem 277 (13):11314-11320, 2002.
  pubmed

• 7) Feinberg H, Mitchell DA, Drickamer K, Weis WI:Structural basis for selective recognition of oligosac-charides by DC-SIGN and DC-SIGNR. Science 294 (5549):2163-2166, 2001.

• 8) Mummidi S, Catano G, Lam L, Hoefle A, Telles V, Begum K, Jimenez F, Ahuja SS, Ahuja SK:Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts. J Biol Chem 276 (35):33196-33212, 2001.
  pubmed

• 9) Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Eilering JB, Martin MP, Wu L, Martin TD, Viebig N, Knolle PA, KewalRamani VN, van Kooyk Y, Carrington M:Adendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193 (6):671-678, 2001.

• 10) Soilleux EJ, Barten R, Trowsdale J:DC-SIGN;arelated gene, DC-SIGNR;and CD23 form a cluster on 19p13. J Immunol 165 (6):2937-2942, 2000.

• 11) Curtis BM, Scharnowske S, Watson AJ:Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 89 (17):8356-8360, 1992.
  pubmed

P.473 掲載の参考文献

• 1) Jones BC, Logsdon NJ, Josephson K, Cook J, Barry PA, Walter MR:Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci USA 99 (14):9404-9409, 2002.
  pubmed

• 2) Zhou JH, Broussard SR, Strle K, Freund GG, Johnson RW, Dantzer R, Kelley KW:1L-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3'-kinase. J Immunol 167 (8):4436-4442, 2001.

• 3) Crepaldi L, Gasperini S, Lapinet JA, Calzetti F, Pinardi C, Liu Y, Zurawski S, de Waal Malefyt R, Moore KW, Cassatella MA:Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J Immunol 167 (4):2312-2322, 2001.
  pubmed

• 4) Lai CF, Ripperger J, Morella KK, Jurlander J, Hawley TS, Carson WE, Kordula T, Caligiuri MA, Hawley RG, Fey GH, Baumann H:Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem 271 (24):13968-13975, 1996.
  pubmed

• 5) Tan JC, Indelicato SR, Narula SK, Zavodny PJ, Chou CC:Characterization of interleukin-10 receptors on human and mouse cells. J Biol Chem 268 (28):21053-21059, 1993.

• 6) Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW:Expression cloning and characterization of a human IL-10 receptor. J Immunol 152 (4):1821-1829, 1994.

• 7) Taniyama T, Takai S, Miyazaki E, Fukumura R, Sato J, Kobayashi Y, Hirakawa T, Moore KW, Yamada K:The human interleukin-10 receptor gene maps to chromosome 11q23.3. Hum Genet 95 (1):99-101, 1995.
  pubmed

• 8) Ho AS, Wei SH, Mui AL, Miyajima A, Moore KW:Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol Cell Biol 15 (9):5043-5053, 1995.
  pubmed

• 9) Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA:The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85 (12):3577-3585, 1995.
  pubmed

• 10) Dumoutier L, Van Roost E, Colau D, Renauld JC:Human interleukin-10-related T cell-derived inducible factor:molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97 (18):10144-10149, 2000. PMID:10954742[PubMed-indexed for MEDLINE]

• 11) Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK, Groner Y, Soeda E, Ohki M, Takagi T, Sakaki Y, Taudien S, Blechschmidt K, Polley A, Menze1 U, Delabar J, Kumpf K, Lehmann R, Patterson D, Reichwald K, Rump A, Schillhabel M, Schudy A, Zimmermann W, Rosenthal A, Kudoh J, Schibuya K, Kawasaki K, Asakawa S, Shintani A, Sasaki T, Nagamine K, Mitsuyama S, Antonarakis SE, Minoshima S, Shimizu N, Nordsiek G, Hornischer K, Brant P, Scharfe M, Schon O, Desario A, Reichelt J, Kauer G, Blocker H, Ramser J, Beck A, Klages S, Hennig S, Riesselmann L, Dagand E, Haaf T, Wehrmeyer S, Borzym K, Gardiner K, Nizetic D, Francis F, Lehrach H, Reinhardt R, Yaspo ML:The DNA sequence of human chromosome 21. Nature 405 (6784):311-319, 2000.

• 12) Reboul J, Gardiner K, Monneron D, Uze G, Lutfalla G:Comparative genomic analysis of the interferon/interleukin-10 receptor gene cluster. Genome Res 9 (3):242-250, 1999.
  pubmed

• 13) Spencer SD, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM, Sordat B, Gibbs VC, Aguet M:The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 187 (4):571-578, 1998.
  pubmed

• 14) Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S:Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16 (19):5894-5903, 1997.

• 15) Lutfalla G, Gardiner K, Uze G:Anew member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR. Genomics 16 (2):366-373, 1993.

• 16) Lutfalla G, McInnis MG, Antonarakis SE, Uze G:Structure of the human CRFB4 gene:comparison with its IFNAR neighbor. J Mol Evol 41 (3):338-344, 1995.

P.475 掲載の参考文献

• 1) Losana G, Rigamonti L, Borghi I, Assenzio B, Ariotti S, Jouanguy E, Altare F, Forni G, Casanova JL, Novelli F:Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells. Eur J Immunol 32 (3):693-700, 2002.

• 2) Altare F, Ensser A, Breiman A, Reichenbach J, Baghdadi JE, Fischer A, Emile JF, Gaillard JL, Meinl E, Casanova JL:Interleukin-12 receptor betal deficiency in a patient with abdominal tuberculosis. J Infect Dis 184 (2):231-236, 2001.

• 3) Kawashima T, Kawasaki H, Kitamura T, Nojima Y, Morimoto C:Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor beta 1 subunit. Cell Immunol 186 (1):39-44, 1998.
  pubmed

• 4) de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH:Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280 (5368):1435-1438, 1998.
  pubmed

• 5) Yamamoto K, Kobayashi H, Miura O, Hirosawa S, Miyasaka N:Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta 1 and beta 2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization.Cytogenet Cell Genet 77 (3-4):257-258, 1997. (No abstract available)

• 6) Gubler U, Presky DH:Molecular biology of interleukin-12 receptors. Ann N Y Acad Sci 795:36-40, 1996.
  pubmed

• 7) Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U:Afunctional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 93 (24):14002-14007, 1996.

• 8) Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, et al:Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 153 (1):128-136, 1994.
  pubmed

P.477 掲載の参考文献

• 1) Andrews AL, Holloway JW, Puddicombe SM, Holgate ST, Davies DE:Kinetic analysis of the interleukin-13 receptor complex. J Biol Chem 277 (48):46073-46078, 2002.
  pubmed

• 2) Roy B, Bhattacharjee A, Xu B, Ford D, Maizel AL, Cathcart MK:IL-13 signal transduction in human monocytes:phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats. J Leukoc Biol 72 (3):580-589, 2002.
  pubmed

• 3) Kawakami M, Leland P, Kawakami K, Puri RK:Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. Oncol Res 12 (11-12):459-467, 2000.

• 4) Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, Kuwano M, Nakajima K, Hamasaki N, Izuhara K:Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1:redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol 12 (11):1499-1509, 2000.
  pubmed

• 5) Osawa M, Miyoshi S, Copeland NG, Gilbert DJ, Jenkins NA, Hiroyama T, Motohashi T, Nakamura Y, Iwama A, Nakauchi H:Characterization of the mouse interleukin-13 receptor alphal gene. Immunogenetics 51 (11):974-981, 2000.

• 6) Zhang JG, Hilton DJ, Willson TA, McFarlane C, Roberts BA, Moritz RL, Simpson RJ, Alexander WS, Metcalf D, Nicola NA:Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J Biol Chem 272 (14):9474-9480, 1997.
  pubmed

• 7) Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P:Cloning of the human IL-13R alpha 1 chain and reconstitution with the IL-4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 401 (2-3):163-166, 1997.

• 8) Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ:cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271 (46):29265-29270, 1996.

P.479 掲載の参考文献

• 1) Daines MO, Hershey GK:Anovel mechanism by which interferorgamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J Biol Chem 277 (12):10387-10393, 2002.

• 2) Kawakami K, Takeshita F, Puri RK:Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain. J Biol Chem 276 (27):25114-25120, 2001.

• 3) Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM Jr, Beier DR, Turner KJ, Wood CR, Collins M:The murine IL-13 receptor alpha 2:molecular cloning, characteriza-tion, and comparison with murine IL-13 receptor alpha 1. J Immunol 161 (5):2317-2324, 1998.

• 4) Guo J, Apiou F, Mellerin MP, Lebeau B, Jacques Y, Minvielle S:Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 42 (1):141-145, 1997.
  pubmed

• 5) Zhang JG, Hilton DJ, Willson TA, McFarlane C, Roberts BA, Moritz RL, Simpson RJ, Alexander WS, Metcalf D, Nicola NA:Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J Biol Chem 272 (14):9474-9480, 1997.
  pubmed

• 6) Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P:Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.J Biol Chem 271 (28):16921-16926, 1996.

P.480 掲載の参考文献

• 1) Kehlen A, Thiele K, Riemann D, Langner J:Expression, modulation and signalling of IL17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol 127 (3):539-546, 2002.
  pubmed

• 2) Footz TK, Brinkman-Mills P, Banting GS, Maier SA, Riazi MA, Bridgland L, Hu S, Birren B, Minoshima S, Shimizu N, Pan H, Nguyen T, Fang F, Fu Y, Ray L, Wu H, Shaull S, Phan S, Yao Z, Chen F, Huan A, Hu P, Wang Q, Loh P, Qi S, Roe BA, McDermid HE:Analysis of the cat eye syndrome critical region in humans and the region of conserved synteny in mice:asearch for candidate genes at or near the human chromosome 22 pericentromere. Genome Res 11 (6):1053-1070, 2001.
  pubmed

• 3) Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida Jp, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al:The DNA sequence of human chromosome 22. Nature 402 (6761):489-495, 1999.

• 4) Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, Zappone JD, Painter SL, Armitage RJ:Molecular characterization of the human interleukin (IL)-17 receptor. Cytoleine 9 (11):794-800, 1997.
  pubmed

P.482 掲載の参考文献

• 1) Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, Conover CA:Functional insulin receptors on human epithelial ovarian carcinoma cells:implications for IGF-H mitogenic signaling. Endocrinology 143 (9):3259-3267, 2002.
  pubmed

• 2) Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA:Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 (6):1884-1888, 2002.
  pubmed

• 3) Surinya KH, Molina L, Soos MA, Brandt J, Kristensen C, Siddle K:Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. J Biol Chem 277 (19):16718-16725, 2002.

• 4) Xu B, Hua QX, Nakagawa SH, Jia W, Chu YC, Katsoyannis PG, Weiss MA:Chiral mutagenesis of insulin's hidden receptor-binding surface:structure of an allo-isoleucine (A2) analogue. J Mol Biol 316 (3):435-441, 2002.

• 5) Krieger-Brauer HI, Medda PK, Kather H:Insulin-induced activation of NADPH-dependent H202 generation in human adipocyte plasma membranes is mediated by Galphai 2. J Biol Chem 272 (15):10135-10143, 1997.

• 6) Cama A, Sierra ML, Kadowaki T, Kadowaki H, Quon MJ, Rudiger HW, Dreyer M, Taylor SI:Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance:a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. Hum Genet 95 (2):174-182, 1995.

• 7) Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI:Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 5 (1):71-73, 1993.
  pubmed

• 8) Roth RA, Cassell DJ:Insulin receptor:evidence that it is a protein kinase. Science 219 (4582):299-301, 1983.
  pubmed

• 9) Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, et al:Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313 (6005):756-761, 1985.

• 10) Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, et al:The human insulin receptor cDNA:the structural basis for hormone-activated transmembrane signalling. Cell 40 (4):747-758, 1985.
  pubmed

• 11) Taira M, Hashimoto N, Shimada F, Suzuki Y, Kanatsuka A, Nakamura F, Ebina Y, Tatibana M, Makino H, et al:Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science 245 (4913):63-66, 1989.
  pubmed

• 12) Seino S, Seino M, Bell GI:Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes 39 (1):123-128, 1990.
  pubmed

• 13) Christiansen K, Tranum-Jensen J, Carlsen J, Vinten J:Amodel for the quaternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl Acad Sci USA 88 (1):249-252, 1991.

• 14) Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F, et al:NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 41 (4):521-526, 1992.
  pubmed

P.484 掲載の参考文献

• 1) Watanabe H, Yu D, Sasaki T, Shibuya H, Hosoi Y, Asada M, Komatsu K, Miura M:Insulin-like growth factor I receptor is expressed at normal levels in Nijmegen breakage syndrome cells. Biochenz Biophys Res Commun 296 (1):62-66, 2002.
  pubmed

• 2) Aro AL, Savikko J, Pulkkinen V, von Willebrand E:Expression of insulin-like growth factors IGF-I and IGF-II, and their receptors during the growth and megakaryocytic differentiation of K562 cells. Leuk Res 26 (9):831-837, 2002.
  pubmed

• 3) Wang HS, Wasa M, Okada A:Amino acid transport in a human neuroblastoma cell line is regulated by the type I insulin-like growth factor receptor. Life Sci 71 (2):127-137, 2002.

• 4) de Mello Coelho V, Villa-Verde DM, Farias-de-Oliveira DA, de Brito JM, Dardenne M, Savino W:Functional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human and murine thymic epithelial cells. Neuroendocrinology 75 (2):139-150, 2002.
  pubmed

• 5) Chakravarti A, Loeffler JS, Dyson NJ:Insulin-like growth factor receptor 1 mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62 (1):200-207, 2002.
  pubmed

• 6) Favelyukis S, Till JH, Hubbard SR, Miller WT:Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol 8 (12):1058-1063, 2001.
  pubmed

• 7) Fasshauer M, Klein J, Ueki K, Kriauciunas KM, Benito M, White MF, Kahn CR:Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 275 (33):25494-25501, 2000.
  pubmed

• 8) Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C:Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275 (24):18447-18453, 2000.
  pubmed

• 9) Grant ES, Ross MB, Ballard S, Naylor A, Habib FK:The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells. J Clin Endocrinoly Metab 83 (9):3252-3257, 1998.

• 10) Werner H, Karnieli E, Rauscher FJ, LeRoith D:Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 93 (16):8318-8323, 1996.
  pubmed

• 11) Francke U, Yang-Feng TL, Brissenden JE, Ullrich A:Chromosomal mapping of genes involved in growth control. Cold Spring Harb Symp Quant Biol 51 (Pt 2):855-866, 1986.

• 12) Flier JS, Usher P, Moses AC:Monoclonal antibody to the type I insulin-like growth factor (IGF-1) receptor blocks IGF-I receptor-mediated DNA synthesis:clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83 (3):664-668, 1986.

• 13) Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et al:Insulin-like growth factor I receptor primary structure:comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5 (10):2503-2512, 1986.
  pubmed

• 14) Cooke DW, Bankert LA, Roberts CT Jr, LeRoith D, Casella SJ:Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem Biophys Res Commun 177 (3):1113-1120, 1991.
  pubmed

• 15) Abbott AM, Bueno R, Pedrini MT, Murray JM, Smith RJ:Insulin-like growth factor I receptor gene structure. J Biol Chem 267 (15):10759-10763, 1992.
  pubmed

P.486 掲載の参考文献

• 1) Chen Z, Ge Y, Landman N, Kang JX:Decreased expression of the mannose 6-phosphate/insulin-like growth factor-ll receptor promotes growth of human breast cancer cells. BMC Cancer 2 (1):18, 2002.

• 2) Aro AL, Savikko J, Pulkkinen V, von Willebrand E:Expression of insulin-like growth factors IGF-1 and IGF-ll, and their receptors during the growth and megakaryocytic differentiation of K562 cells. Leule Res 26 (9):831-837.2002

• 3) Zhou G, Roizman B:Cation-independent mannose 6-phosphate receptor blocks apoptosis induced by herpes simplex virus 1 mutants lacking glycoprotein D and is likely the target of antiapoptotic activity of the glycoprotein. J Virol 76 (12):6197-6204, 2002.
  pubmed

• 4) Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB, Jones EY:Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur. EMBO J 21 (5):1054-1062, 2002.
  pubmed

• 5) Forbe BE, McNeil KA, Scott CD, Surinya KH, Cosgrove LJ, Wallace JC:Contribution of residues A54 and L550f the human insulin-like growth factor-ll (IGF-H) Adomain to Type 21GF receptor binding specificity. Growth Facto rs 19 (3):163-173, 2001.

• 6) Killian JK, Oka Y, Jang HS, Fu X, Waterland RA, Sohda T, Sakaguchi S, Jirtle RL:Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat 18 (1):25-31, 2001.
  pubmed

• 7) Sandholzer U, von Figura K, Pohlmann R:Function and properties of chimeric MPR 46-MPR 300 mannose 6-phosphate receptors. J Biol Chem 275 (19):14132-14138, 2000.

• 8) Killian JK, Jirtle RL:Genomic structure of the human M6P/IGF2 receptor. Mamm Genome 10 (1):74-77, 1999. (No abstract available)

• 9) Rao PH, Murty VV, Gaidano G, Hauptschein R, Dalla-Favera R, Chaganti RS:Subregional mapping of 8 single copy loci to chromosome 6 by fluorescence in situ hybridization. Cytogenet Cell Genet 66 (4):272-273, 1994.
  pubmed

• 10) De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL:Frequent loss of heter-ozygosity on 6q at the mannose 6-hosphate/insulin-like growth factor ll receptor locus in human hepatocellular tumors. Oncogene 10 (9):1725-1729, 1995.

• 11) Oshima A, Nolan CM, Kyle JW, Grubb JH, Sly WS:The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells. J Biol Chem 263 (5):2553-2562, 1988.
  pubmed

• 12) Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ:Insulin-like growth factor H receptor as a multifunctional binding protein. Nature 329 (6137):301-307, 1987.

P.488 掲載の参考文献

• 1) Andreae S, Piras F, Burdin N, Triebel F:Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 168 (8):3874-3880, 2002.
  pubmed

• 2) Bruniquel D, Borie N, Hannier S, Triebel F:Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II. Immunogenetics 48 (2):116-124, 1998.
  pubmed

• 3) Bruniquel D, Borie N, Triebel F:Genomic organization of the human LAG-3/CD410cus. Immunogenetics 47 (1):96-98, 1997. (No abstract available)

• 4) Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E, Hercend T:LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171 (5):1393-1405, 1990.
  pubmed

P.489 掲載の参考文献

• 1) Chikhi N, Holic N, Guellaen G, Laperche Y:Gamma-glutamyl transpeptidase gene organization and expression:acomparative analysis in rat, mouse, pig and human species. Comp Biochem Physiol B Biochem Mol Biol 122 (4):367-380, 1999. (Review)

• 2) Leh H, Chikhi N, Ichino K, Guellaen G, Wellman M, Siest G, Visvikis A:An intronic promoter controls the expression of truncated human gamma-glutamyltransferase mRNAs. EEBS Lett 434 (1-2):51-56, 1998.

• 3) Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, Wang J, Shimizu N:One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 7 (3):250-261, 1997.
  pubmed

• 4) Diederich M, Wellman M, Visvikis A, Puga A, Siest G:The 5' untranslated region of the human gamma-glutamyl transferase mRNA contains a tissue-specific active translational enhancer. FEBS Lett 332 (1-2):88-92, 1993.

• 5) Courtay C, Heisterkamp N, Siest G, Groffen J:Expression of multiple gamma-glutamyltransferase genes in man. Biochem J 297 (Pt 3):503-508, 1994.

• 6) Wetmore LA, Gerard C, Drazen JM:Human lung expresses unique gamma-glutamyl transpeptidase transcripts. Proc Natl Acad Sci USA 90 (16):7461-7465, 1993.
  pubmed

• 7) Sakamuro D, Yamazoe M, Matsuda Y, Kangawa K, Taniguchi N, Matsuo H, Yoshikawa H, Ogasawara N:The primary structure of human gamma-glutamyl transpeptidase. Gene 73 (1):1-9, 1988.
  pubmed

• 8) Rajpert-De Meyts E, Heisterkamp N, Groffen J:Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. Proc Natl Acad Sci USA 85 (23):8840-8844, 1988.
  pubmed

• 9) Bulle F, Mattei MG, Siegrist S, Pawlak A, Passage E, Chobert MN, Laperche Y, Guellaen G:Assignment of the human gamma-glutamyl transferase gene to the long arm of chromosome 22. Hum Genet 76 (3):283-286, 1987.

• 10) Goodspeed DC, Dunn TJ, Miller CD, Pitot HC:Human gamma-glutamyl transpeptidase cDNA:comparison of hepatoma and kidney mRNA in the human and rat. Gene 76 (1):1-9, 1989.
  pubmed

• 11) Pawlak A, Cohen EH, Octave JN, Schweickhardt R, Wu SJ, Bulle F, Chikhi N, Baik JH, Siegrist S, Guellaen G:An alternatively processed mRNA specific for gamma-glutamyl transpeptidase in human tissues. J Biol Chem 265 (6):3256-3262, 1990.
  pubmed

• 12) Courtay C, Oster T, Michelet F, Visvikis A, Diederich M, Wellman M, Siest G:Gamma-glutamyltrans-ferase:nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Biochem Pharmacol 43 (12):2527-2533, 1992.

P.492 掲載の参考文献

• 1) Deblandre GA, Marinx OP, Evans SS, Majjaj S, Leo O, Caput D, Huez GA, Wathelet MG:Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem 270 (40):23860-23866, 1995.
  pubmed

• 2) Kelly JM, Gilbert CS, Stark GR, Kerr IM:Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha-and gamma-interferons. Eur J Biochem 153 (2):367-371, 1985.

• 3) Reid LE, Brasnett AH, Gilbert CS, Porter AC, Gewert DR, Stark GR, Kerr IM:Asingle DNA response element can confer inducibility by both alpha-and gamma-interferons. Proc Natl Acad Sci USA 86 (3):840-844, 1989.

P.493 掲載の参考文献

• 1) Shibuya A, Campbell D, Hanmum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier LL, Phillips JH:Related Articles, Links:DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4 (6):573-581, 1996.

P.495 掲載の参考文献

• 1) Peterson JA, Scallan CD, Ceriani RL, Hamosh M:Structural and functional aspects of three major glycoproteins of the human milk fat globule membrane. Adv Exp Med Biol 501:179-187, 2001.
  pubmed

• 2) Vinall LE, King M, Novelli M, Green CA, Daniels G, Hilkens J, Sarner M, Swallow DM:Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123 (1):41-49, 2002.
  pubmed

• 3) Ciborowski P, Finn OJ:Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro:potential role in metastasis. Clin Exp Metastasis 19 (4):339-345, 2002.

• 4) Porowska H, Paszkiewicz-Gadek A, Wolczynski S, Gindzienski A:MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation. Neoplasma 49 (2):104-109, 2002.
  pubmed

• 5) Julian J, Carson DD:Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun 293 (4):1183-1190, 2002.
  pubmed

• 6) Muller S, Hanisch FG:Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. J Biol Chem 277 (29):26103-26112, 2002.
  pubmed

• 7) Shiraga T, Smith D, Nuthall HN, Hollingsworth MA, Harris A:Identification of two novel elements involved in human MUC1 gene expression in vivo. Mol Med 8 (1):33-41, 2002.
  pubmed

• 8) Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M:Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 94 (6):1770-1776, 2002.
  pubmed

• 9) Ren J, Li Y, Kufe D:Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J Biol Chem 277 (20):17616-17622, 2002.

• 10) Gonzaez-Guerrico AM, Cafferata EG, Radrizzani M, Marcucci F, Gruenert D, Pivetta OH, Favaloro RR, Laguens R, Perrone SV, Gallo GC, Santa-Coloma TA:Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J Biol Chem 277 (19):17239-17247, 2002.

• 11) Zimmerman RL, Burke M, Young NA, Solomides CC, Bibbo M:Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration. Cancer 96 (1):53-57, 2002.
  pubmed

• 12) Baldus SE, Hanisch FG, Putz C, Flucke U, Monig SP, Schneider PM, Thiele J, Holscher AH, Dienes HP:Immunoreactivity of Lewis blood group and mucin peptide core antigens:correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence. Histol Histopathol 17 (1):191-198, 2002.
  pubmed

• 13) Oosterkamp HM, Scheiner L, Stefanova MC, Lloyd KO, Finstad CL:Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z). Int J Cancer 72 (1):87-94, 1997.
  pubmed

• 14) Pratt WS, Islam I, Swallow DM:Two additional polymorphisms within the hypervariable MUC1 gene:association of alleles either side of the VNTR region. Ann Hum Genet 60 (Pt 1):21-28, 1996.

• 15) Zrihan-Licht S, Vos HL, Baruch A, Elroy-Stein O, Sagiv D, Keydar I, Hilkens J, Wreschner DH:Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue. Eur J Biochem 224 (2):787-795, 1994.
  pubmed

• 16) Middleton-Price H, Gendler S, Malcolm S:Close linkage of PUM and SPTA within chromosome band 1q21. Ann Hum Genet 52 (Pt 4):273-278, 1988.

• 17) Lan MS, Batra SK, Qi WN, Metzgar RS, Hollingsworth MA:Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 265 (25):15294-15299, 1990.
  pubmed

• 18) Wreschner DH, Hareuveni M, Tsarfaty I, Smorodinsky N, Horev J, Zaretsky J, Kotkes P, Weiss M, Lathe R, Dion A, et al:Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem 189 (3):463-473, 1990.
  pubmed

• 19) Lancaster CA, Peat N, Duhig T, Wilson D, Taylor-Papadimitriou J, Gendler SJ:Structure and expression of the human polymorphic epithelial mucin gene:an expressed VNTR unit. Biochem Biophys Res Commun 173 (3):1019-1029, 1990.
  pubmed

• 20) Hareuveni M, Tsarfaty I, Zaretsky J, Kotkes P, Horev J, Zrihan S, Weiss M, Green S, Lathe R, Keydar I, et al:Atranscribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue. Eur J Biochem 189 (3):475-486, 1990.
  pubmed

P.497 掲載の参考文献

• 1) Sekyere E, Food MR, Richardson DR:Asecond melanotransferrin gene (MTf2) and a novel protein isoform:explanation for the membrane-bound and soluble forms of melanotransferrin? FEBS Lett 512 (1-3):350-352, 2002. (No abstract available)

• 2) Richardson DR:The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur J Biochem 267 (5):1290-1298, 2000.
  pubmed

• 3) Le Beau MM, Diaz MO, Plowman GD, Brown JP, Rowley JD:Chromosomal sublocalization of the human p97 melanoma antigen. Hum Genet 72 (4):294-296, 1986.
  pubmed

• 4) Seligman PA, Butler CD, Massey EJ, Kaur JA, Brown Jp, Plowman GD, Miller Y, Jones C:The p97 antigen is mapped to the q24-qter region of chromosome 3;the same region as the transferrin receptor. Am J Hum Genet 38 (4):540-548, 1986

• 5) Rose TM, Plowman GD, Teplow DB, Dreyer WJ, Hellstrom KE, Brown JP:Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci USA 83 (5):1261-1265, 1986.
  pubmed

P.498 掲載の参考文献

• 1) Tovar V, de la Fuente MA, Pizcueta P, Bosch J, Engel P:Gene structure of the mouse leukocyte cell surface molecule Ly9. Immunogenetics 51 (10):788-793, 2000.
  pubmed

• 2) Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA:Large-scale concatenation cDNA sequencing. Genome Res 7 (4):353-358, 1997.

• 3) Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA:A "double adaptor" method for improved shotgun library construction. Anal Biochem 236 (1):107-113, 1996.
  pubmed

• 4) Sandrin MS, Henning MM, Lo MF, Baker E, Sutherland GR, McKenzie IF:Isolation and characterization of cDNA clones for Humly 9:the human homologue of mouse Ly9. Immunogenetics 43 (1-2):13-19, 1996.

• 5) Kingsmore SF, Souryal CA, Watson ML, Patel DD, Seldin MF:Physical and genetic linkage of the genes encoding Ly-9 and CD480n mouse and human chromosomes 1. Immunogenetics 42 (1):59-62, 1995.
  pubmed

P.500 掲載の参考文献

• 1) Dagvadorj A, Petersen RB, Lee HS, Cervenakova L, Shatunov A, Budka H, Brown P, Gambetti P, Goldfarb LG:Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy. Ann Neurol 52 (3):355-359, 2002.
  pubmed

• 2) Barclay GR, Houston EF, Halliday SI, Farquhar CF, Turner ML:Comparative analysis of normal prion protein expression on human, rodent, and ruminant blood cells by using a panel of prion antibodies. Transfusion 42 (5):517-526, 2002.
  pubmed

• 3) Holada K, Simak J, Risitano AM, Maciejewski J, Young NS, Vostal JG:Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein. Blood 100 (1):341-343, 2002.
  pubmed

• 4) McCormack JE, Baybutt HN, Everington D, Will RG, Ironside JW, Manson JC:PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob disease. Gene 288 (1-2):139-146, 2002.

• 5) Rybner C, Hillion J, Sahraoui T, Lanotte M, Botti J:All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation. Leukemia 16 (5):940-948, 2002.
  pubmed

• 6) Simak J, Holada K, D'Agnillo F, Janota J, Vostal JG:Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 42 (3):334-342, 2002.
  pubmed

• 7) Rybner C, Finel-Szermanski S, Felin M, Sahraoui T, Rousseau C, Fournier JG, Seve AP, Botti J:The cellular prion protein:a new partner of the lectin CBP70 in the nucleus of NB4 human promyelocytic leukemia cells. J Cell Biochem 84 (2):408-419, 2002.

• 8) el-Bastawissy E, Knaggs MH, Gilbert IH:Molecular dynamics simulations of wild-type and point mutation human prion protein at normal and elevated temperature. J Mol Graph Model 20 (2):145-154, 2001.
  pubmed

• 9) Lorenz H, Windl O, Kretzschmar HA:Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277 (10):8508-8516, 2002.
  pubmed

• 10) Mead S, Mahal SP, Beck J, Campbell T, Farrall M, Fisher E, Collinge J:Sporadic-but not variant-Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet 69 (6):1225-1235, 2001.

• 11) Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edstrom L, Anvret M, Prusiner SB:Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 69 (6):1385-1388, 2001.
  pubmed

• 12) Zou WQ, Yang DS, Fraser PE, Cashman NR, Chakrabartty A:All or none fibrillogenesis of a prion peptide. Eur J Biochem 268 (18):4885-4891, 2001.
  pubmed

• 13) Lee IY, Westaway D, Smit AF, Wang K, Seto J, Chen L, Acharya C, Ankener M, Baskin D, Cooper C, Yao H, Prusiner SB, Hood LE:Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res 8 (10):1022-1037, 1998.
  pubmed

• 14) Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ:Molecular cloning of a human prion protein cDNA. DNA 5 (4):315-324, 1986.
  pubmed

• 15) Liao YC, Lebo RV, Clawson GA, Smuckler EA:Human prion protein cDNA:molecular cloning, chromosomal mapping, and biological implications. Science 233 (4761):364-367, 1986.
  pubmed

• 16) Palmer MS, Dryden AJ, Hughes JT, Collinge J:Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 (6333):340-342, 1991.
  pubmed

• 17) Diedrich JF, Knopman DS, List JF, Olson K, Frey WH 2nd, Emory CR, Sung JH, Haase AT:Deletion in the prion protein gene in a demented patient. Hum Mol Genet 1 (6):443-444, 1992. (No abstract available)

• 18) Giaccone G, Verga L, Bugiani O, Frangione B, Serban D, Prusiner SB, Farlow MR, Ghetti B, Tagliavini F:Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci USA 89 (19):9349-9353, 1992.

P.501 掲載の参考文献

• 1) Berditchevski F:Complexes of tetraspanins with integrins:more than meets the eye. J Cell Sci 114 (Pt 23):4143-4151, 2001.

• 2) Castellvi-Bel S, Mila M:Genes responsible for nonspecific mental retardation. Mol Genet Metab 72 (2):104-108, 2001.
  pubmed

• 3) Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrie A, Billuart P, McDonell N, Couvert P, Francis F, Chafey P, Fauchereau F, Friocourt G, Portes V, Cardona A, Frints S, Meindl A, Brandau O, Ronce N, Moraine C, Bokhoven H, Ropers HH, Sudbrak R, Kahn A, Fryns JP, Beldjord C, et al:A new gene involved in X-linked mental retardation identified by analysis of an X ;2balanced translocation. Nat Genet 24 (2):167-170, 2000.

• 4) Hosokawa Y, Ueyama E, Morikawa Y, Maeda Y, Seto M, Senba E:Molecular cloning of a cDNA encoding mouse A15, a member of the transmembrane 4 superfamily, and its preferential expression in brain neurons. Neurosci Res 35 (4):281-290, 1999.
  pubmed

• 5) Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, Boucheix C, Rubinstein E:Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 340 (Pt 1):103-111, 1999.

• 6) Emi N, Kitaori K, Seto M, Ueda R, Saito H, Takahashi T:Isolation of a novel cDNA clone showing marked similarity to ME491/CD63 superfamily. Immunogenetics 37 (3):193-198, 1993.
  pubmed

• 7) Li SH, McInnis MG, Margolis RL, Antonarakis SE, Ross CA:Novel triplet repeat containing genes in human brain:cloning, expression, and length polymorphisms. Genomics 16 (3):572-579, 1993.
  pubmed

• 8) Virtaneva KI, Emi N, Marken JS, Aruffo A, Jones C, Spurr NK, Schroder Jp:Chromosomal localization of three human genes coding for A15, L6, and S5.7 (TAPAI):all members of the transmembrane 4 superfamily of proteins. Immunogenetics 39 (5):329-334, 1994.

• 9) Takagi S, Fujikawa K, Imai T, Fukuhara N, Fukudome K, Minegishi M, Tsuchiya S, Konno T, Hinuma Y, Yoshie O:Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int/Cancer 61 (5):706-715, 1995.
  pubmed

P.503 掲載の参考文献

• 1) Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, Tessier-Lavigne M, Comoglio PM:Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99 (1):71-80, 1999.

• 2) Comeau MR, Johnson R, DuBose RF, Petersen M, Gearing P, VandenBos T, Park L, Farrah T, Buller RM, Cohen JI, Strockbine LD, Rauch C, Spriggs MK:Apoxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8 (4):473-482, 1998.
  pubmed

P.505 掲載の参考文献

• 1) Tanner MJ:Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 9 (2):133-139, 2002.
  pubmed

• 2) Inaba M:Band 3:expanding knowledge on its functions. Seikagaku 73 (12):1431-1435, 2001. (Japanese)
  pubmed

• 3) Tanner MJ:Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol 30 (1):34-57, 1993.
  pubmed

• 4) Knauf PA, Law FY, Leung TW, Gehret AU, Perez ML:Substrate-dependent reversal of anion transport site orientation in the human red blood cell anion-exchange protein, AE1. Proc Natl Acad Sci USA 99 (16):10861-10864, 2002.
  pubmed

• 5) Galtieri A, Tellone E, Romano L, Misiti F, Bellocco E, Ficarra S, Russo A, Di Rosa D, Castagnola M, Giardina B, Messana I:Band-3 protein function in human erythrocytes:effect of oxygenation-deox-ygenation. Biochim Biophys Acta 1564 (1):214-218, 2002.

• 6) Yenchitsomanus PT, Vasuvattakul S, Kirdpon S, Wasanawatana S, Susaengrat W, Sreethiphayawan S, Chuawatana D, Mingkum S, Sawasdee N, Thuwajit P, Wilairat P, Malasit P, Nimmannit S:Autosomal recessive distal renal tubular acidosis caused by G701D mutation of anion exchanger 1 gene. Am J Kidney Dis 40 (1):21-29, 2002.
  pubmed

• 7) Bordin L, Brunati AM, Donella-Deana A, Baggio B, Toninello A, Clari G:Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood 100 (1):276-282, 2002.

• 8) Sterling D, Alvarez BV, Casey JR:The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE1 C1-/HCO3-exchanger binds carbonic anhydrase IV. J Biol Chem 277 (28):25239-25246, 2002.

• 9) Quilty JA, Li J, Reithmeier RA:Impaired trafficking of distal renal tubular acidosis mutants of the human kidney anion exchanger kAE1. Am J Physiol Renal Physiol 282 (5):F810-820.
  pubmed

• 10) Kuma H, Shinde AA, Howren TR, Jennings ML:Topology of the anion exchange protein AE1:the controversial sidedness of lysine 743. Biochemistry 41 (10):3380-3388, 2002.
  pubmed

• 11) Southgate CD, Chishti AH, Mitchell B, Yi SJ, Palek J:Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 14 (2):227-230, 1996.
  pubmed

• 12) Zelinski T, Coghlan G, White L, Philipps S:The Diego blood group locus is located on chromosome 17q. Genomics 17 (3):665-666, 1993.
  pubmed

• 13) Hsu L, Morrison M:Anew variant of the anion transport protein in human erythrocytes. Biochemistry 24 (13):3086-3090, 1985.

• 14) Tanner MJ, Martin PG, High S:The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem J 256 (3):703-712, 1988.
  pubmed

• 15) Lux SE, John KM, Kopito RR, Lodish HF:Cloning and characterization of band 3, the human eryth-rocyte anion-exchange protein (AE1). Proc Natl Acad Sci USA 86 (23):9089-9093.

• 16) Spring FA, Bruce LJ, Anstee DJ, Tanner MJ:Ared cell band 3 variant with altered stilbene disul-phonate binding is associated with the Diego (Dia) blood group antigen. Biochem J 288 (Pt 3):713-716, 1992.

P.507 掲載の参考文献

• 1) Hamblin MT, Thompson EE, Di Rienzo A:Complex signatures of natural selection at the Duffy blood group locus. Am J Hum Genet 70 (2):369-383, 2002.
  pubmed

• 2) Woolley IJ, Kalayjian R, Valdez H, Hamza N, Jacobs G, Lederman MM, Zimmerman PA:HIV nephropathy and the Duffy antigen/receptor for Chemokines in African Americans. J Nephrol 14 (5):384-387, 2001.
  pubmed

• 3) Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC:Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158 (6):2882-2890, 1997.

• 4) Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO:Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 90 (22):10793-10797, 1993.
  pubmed

• 5) Iwamoto S, Omi T, Kajii E, Ikemoto S:Genomic organization of the glycoprotein D gene:Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85 (3):622-626, 1995.
  pubmed

• 6) Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH:Areceptor for the malarial parasite Plasmodium vivax:the erythrocyte chemokine receptor. Science 261 (5125):1182-1184, 1993.

• 7) Tournamille C, Colin Y, Cartron JP, Le Van Kim C:Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10 (2):224-228, 1995.
  pubmed

P.509 掲載の参考文献

• 1) Johnson ST, McFarland JG, Kelly KJ, Casper JT, Gottschall JL:Transf

• 2) Blumenfeld OO, Huang CH:Molecular genetics of glycophorin MNS variants. Transfus Clin Biol 4 (4):357-365, 1997.
  pubmed

• 3) Blumenfeld OO, Huang CH:Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups:multiple gene rearrangements and modulation of splice site usage result in extensive diversification. Hum Mutat 6 (3):199-209, 1995.
  pubmed

• 4) Baum J, Ward RH, Conway DJ:Natural selection on the erythrocyte surface. Mol Biol Evol 19 (3):223-229, 2002.

• 5) MacKenzie KR, Prestegard JH, Engelman DM:Atransmembrane helix dimer:structure and implications. Science 276 (5309):131-133, 1997.

• 6) Huang CH, Reid ME, Blumenfeld OO:Exon skipping caused by DNA recombination that introduces a defective donor splice site into the human glycophorin A gene. J Biol Chem 268 (7):4945-4952, 1993.

• 7) Huang CH, Reid M, Daniels G, Blumenfeld OO:Alteration of splice site selection by an exon mutation in the human glycophorin A gene. J Biol Chem 268 (34):25902-25908, 1993.

• 8) Kudo S, Onda M, Fukuda M:Characterization of glycophorin A transcripts:control by the common erythroid-specific promoter and alternative usage of different polyadenylation signals. J Biochem (Tokyo) 116 (1):183-192, 1994.
  pubmed

• 9) Onda M, Fukuda M:Detailed physical mapping of the genes encoding glycophorins A, B and E, as revealed by P1 plasmids containing human genomic DNA. Gene 159 (2):225-230, 1995.

• 10) Pasvol G, Wainscoat JS, Weatherall DJ:Erythrocytes deficiency in glycophorin resist invasion by the malarial parasite Plasmodium falciparum. Nature 297 (5861):64-66, 1982.
  pubmed

• 11) Siebert PD, Fukuda M:Molecular cloning of a human glycophorin B cDNA:nucleotide sequence and genomic relationship to glycophorin A. Proc Natl Acad Sci USA 84 (19):6735-6739, 1987.

• 12) Siebert PD, Fukuda M:Isolation and characterization of human glycophorin A cDNA clones by a synthetic oligonucleotide approach:nucleotide sequence and mRNA structure. Proc Natl Acad Sci USA 83 (6):1665-1669, 1986.
  pubmed

• 13) Huang CH, Puglia KV, Bigbee WL, Guizzo ML, Hoffman M, Blumenfeld OO:A family study of multiple mutations of alpha and delta glycophorins (glycophorins A and B). Hum Genet 81 (1):26-30, 1988.

• 14) Tate CG, Tanner MJ:Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta. Biochem J 254 (3):743-750, 1988.
  pubmed

• 15) Kudo S, Fukuda M:Structural organization of glycophorin A and B genes:glycophorin B gene evolved by homologous recombination at Alu repeat sequences. Proc Natl Acad Sci USA 86 (12):4619-4623, 1989.

• 16) Hamid J, Burness AT:The mechanism of production of multiple mRNAs for human glycophorin A. Nucleic Acids Res 18 (19):5829-5836, 1990.

• 17) Huang CH, Blumenfeld OO:Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification. J Biol Chem 266 (11):7248-7255, 1991.
  pubmed

• 18) Huang CH, Blumenfeld OO:Identification of recombination events resulting in three hybrid genes encoding human MiV, MiV (J L) , and Sta glycophorins. Blood 77 (8):1813-1820, 1991.

• 19) Barton P, Collins A, Hoogenraad N:Avariant of glycophorin A resulting from the deletion of exon 4. Biochim Biophys Acta 1090 (2):265-266, 1991.

P.510 掲載の参考文献

• 1) Blumenfeld OO, Huang CH:Molecular genetics of glycophorin MNS variants. Transfus Clin Biol 4 (4):357-365, 1997.
  pubmed

• 2) Blumenfeld OO, Huang CH:Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups:multiple gene rearrangements and modulation of splice site usage result in extensive diversification. Hum Mutat 6 (3):199-209, 1995.
  pubmed

• 3) Huang CH, Reid ME, Blumenfeld OO:Exon skipping caused by DNA recombination that introduces a defective donor splice site into the human glycophorin A gene. J Biol Chem 268 (7):4945-4952, 1993.

• 4) Huang CH, Reid ME, Blumenfeld OO:Remodeling of the transmembrane segment in human glycophorin by aberrant RNA splicing. J Biol Chem 269 (14):10804-10812, 1994.
  pubmed

• 5) Onda M, Fukuda M:Detailed physical mapping of the genes encoding glycophorins A, B and E, as revealed by P1 plasmids containing human genomic DNA. Gene 159 (2):225-230, 1995.

• 6) Siebert PD, Fukuda M:Molecular cloning of a human glycophorin B cDNA:nucleotide sequence and genomic relationship to glycophorin A. Proc Natl Acad Sci USA 84 (19):6735-6739, 1987.

• 7) Tate CG, Tanner MJ:Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta. Biochem J 254 (3):743-750, 1988.
  pubmed

• 8) Kudo S, Fukuda M:Structural organization of glycophorin A and B genes:glycophorin B gene evolved by homologous recombination at Alu repeat sequences. Proc Natl Acad Sci USA 86 (12):4619-4623, 1989.

• 9) Kudo S, Fukuda M:ldentification of a novel human glycophorin, glycophorin E, by isolation of genomic clones and complementary DNA clones utilizing polymerase chain reaction. J Biol Chem 265 (2):1102-1110, 1990.

• 10) Huang CH, Blumenfeld OO:Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversifica-tion. J Biol Chem 266 (11):7248-7255, 1991.

• 11) Huang CH, Blumenfeld OO:Identification of recombination events resulting in three hybrid genes encoding human MiV, MiV (J. L), and Sta glycophorins. Blood 77 (8):1813-1820.

• 12) Rearden A, Phan H, Dubnicoff T, Kudo S, Fukuda M:ldentification of the crossing-over point of a hybrid gene encoding human glycophorin variant Sta. Similarity to the crossing-over point in haptoglobin-related genes. J Biol Chem 265 (16):9259-9263, 1990.

P.513 掲載の参考文献

• 1) Cartron JP, Le Van Kim C, Colin Y:Glycophorin C and related glycoproteins:structure, function, and regulation. Semin Hematol 30:152-168, 1993.
  pubmed

• 2) Le Van Kim C, Colin Y, Mitjavila MT, Clerget M, Dubart A, et al:Structure of the promoter region and tissue specificity of the human glycophorin C gene. J Biol Chem 264:20407-20414, 1989.

• 3) Winardi R, Reid M, Conboy J, Mohandas N:Molecular analysis of glycophorin C deficiency in human erythrocytes. Blood 81:2799-2803, 1933.

• 4) Chishti AH, Palek J, Fisher D, Maalouf GJ, Liu SC:Reduced invasion and growth of Plasmodium falciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and P55. Blood 87:3462-3469, 1996.
  pubmed

P.514 掲載の参考文献

• 1) Cartron JP, Colin Y, Le Van Kim C, Rahuel C, Blanchard D, Bloy C, London J:Structure of human erythrocyte glycophorin C deduced from cDNA analysis. Rev Fr Transfus immunohematol 29 (4):267-285, 1986.
  pubmed

• 2) Jaskiewicz E, Czerwinski M, Colin Y, Lisowska E:Recombinant forms of Gerbich blood group antigens:expression and purification. Transfus Clin Biol 9 (2):121-129, 2002.
  pubmed

• 3) Daniels G, King MJ, Avent ND, Khalid G, Reid M, Mallinson G, Symthe J, Cedergren B:A point mutation in the GYPC gene results in the expression of the blood group Ana antigen on glycophorin D but not on glycophorin C:further evidence that glycophorin D is a product of the GYPC gene. Blood 82 (10):3198-3203, 1993.

• 4) Winardi R, Reid M, Conboy J, Mohandas N:Molecular analysis of glycophorin C deficiency in human erythrocytes. Blood 81 (10):2799-2803, 1993.
  pubmed

• 5) Anstee DJ, Parsons SF, Ridgwell K, Tanner MJ, Merry AH, Thomson EE, Judson PA, Johnson P, Bates S, Fraser ID:Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J 218 (2):615-619, 1984.
  pubmed

• 6) Mattei MG, Colin Y, Le Van Kim C, Mattei JF, Cartron JP:Localization of the gene for human erythrocyte glycophorin C to chromosome 2, q14-q21. Hum Genet 74 (4):420-422, 1986.
  pubmed

• 7) High S, Tanner MJ:Human erythrocyte membrane sialoglycoprotein beta. The cDNA sequence suggests the absence of a cleaved N-terminal signal sequence. Biochem J 243 (1):277-280, 1987.
  pubmed

• 8) Le Van Kim C, Colin Y, Blanchard D, Dahr W, London J, Cartron JP:Gerbich blood group deficiency of the Ge:-1,-2,-3 and Ge:-1,-2,3 types. Immunochemical study and genomic analysis with cDNA probes. Eur J Biochem 165 (3):571-579, 1987.
  pubmed

• 9) Colin Y, Le Van Kim C, Tsapis A, Clerget M, d'Auriol L, London J, Galibert F, Cartron JP:Human erythrocyte glycophorin C. Gene structure and rearrangement in genetic variants. J Biol Chem 264 (7):3773-3780, 1989.
  pubmed

• 10) High S, Tanner MJ, Macdonald EB, Anstee DJ:Rearrangements of the red-cell membrane glycophorin C (sialoglycoprotein beta) gene. A further study of alterations in the glycophorin C gene. Biochem J 262 (1):47-54, 1989.
  pubmed

• 11) Le Van Kim C, Colin Y, Mitjavila MT, Clerget M, Dubart A, Nakazawa M, Vainchenker W, Cartron JP:Structure of the promoter region and tissue specificity of the human glycophorin C gene. J Biol Chem 264 (34):20407-20414, 1989.

• 12) Colin Y, Rahuel C, London J, Romeo PH, d'Auriol L, Galibert F, Cartron JP:Isolation of cDNA clones and complete amino acid sequence of human erythrocyte glycophorin C. J Biol Chem 261 (1):229-233, 1986.
  pubmed

• 13) Le Van Kim C, Mitjavila MT, Clerget M, Cartron JP, Colin Y:An ubiquitous isoform of glycophorin C is produced by alternative splicing. Nucleic Acids Res 18 (10):3076, 1990.
  pubmed

• 14) Chang S, Reid ME, Conboy J, Kan YW, Mohandas N:Molecular characterization of erythrocyte glycophorin C variants. Blood 77 (3):644-648, 1991.
  pubmed

P.516 掲載の参考文献

• 1) Lee S, Wu X, Reid M, Zelinski T, Redman C:Molecular basis of the Kell (K1) phenotype. Blood 85 (4):912-916, 1995

• 2) Lee S, Zambas ED, Marsh WL, Redman CM:The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 81 (10):2804-2809, 1993.
  pubmed

• 3) Lee S, Wu X, Reid M, Redman C:Molecular basis of the K:6,-7[Js (a+b-)]phenotype in the Kell blood group system. Transfusion 35 (10):822-825, 1995.

• 4) Lee S, Zambas ED, Marsh WL, Redman CM:Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 88 (14):6353-6357, 1991.
  pubmed

P.517 掲載の参考文献

• 1) Parsons SF, Mallinson G, Daniels GL, Green CA, Smythe JS, Anstee DJ:Use of domain-deletion mutants to locate Lutheran blood group antigens to each of the five immunoglobulin superfamily domains of the Lutheran glycoprotein:elucidation of the molecular basis of the Lu (a)/Lu (b) and the Au (a)/Au (b) polymorphisms. Blood 89 (11):4219-4225, 1997.

• 2) Campbell IG, Foulkes WD, Senger G, Trowsdale J, Garin-Chesa P, Rettig WJ:Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers:a novel member of the immunoglobulin super-family. Cancer Res 54 (22):5761-5765, 1994.

• 3) Parsons SF, Mallinson G, Holmes CH, Houlihan JM, Simpson KL, Mawby WJ, Spurr NK, Warne D, Barclay AN, Anstee DJ:The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 92 (12):5496-5500, 1995.
  pubmed

P.518 掲載の参考文献

• 1) Flegel WA, Wagner FF:Molecular genetics of RH. Vox Sang 78 (Suppl 2):109-115, 2000.

• 2) Avent ND, Reid ME:The Rh blood group system:areview. Blood 95 (2):375-387, 2000.

• 3) Tax MG, van der Schoot CE, van Doorn R, Douglas-Berger L, van Rhenen DJ, Maaskant-vanWijk PA:RHC and RHc genotyping in different ethnic groups. Transfusion 42 (5):634-644, 2002.
  pubmed

• 4) Noizat-Pirenne F, Le Pennec PY, Mouro I, Rouzaud AM, Juszczak G, Roussel M, Lauroua P, Krause C, Rouger P, Cartron JP, Ansart-Pirenne H:Molecular backgroud of D (C) (e) haplotypes within the white population. Transfusion 42 (5):627-633, 2002.

• 5) Wagner FF, Flegel WA:RHCE represents the ancestral RH position, while RHD is the duplicated gene. Blood 99 (6):2272-2273, 2002.
  pubmed

• 6) Westhoff CM, Ferreri-Jacobia M, Mak DO, Foskett JK:Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J Biol Chem 277 (15):12499-12502, 2002.
  pubmed

• 7) Okuda H, Suganuma H, Kamesaki T, Kumada M, Tsudo N, Omi T, Iwamoto S, Kajii E:The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun 274 (3):670-683, 2000.
  pubmed

• 8) Huang CH, Chen Y, Reid ME, Seidl C:Rhnull disease:the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood 92 (2):664-671, 1998.

• 9) Huang CH, Chen Y, Reid M, Ghosh S:Genetic recombination at the human RH locus:afamily study of the red-cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene. Am J Hum Genet 59 (4):825-833, 1996.

• 10) Mouro I, Colin Y, Cherif-Zahar B, Cartron JP, Le Van Kim C:Molecular genetic basis of the human Rhesus blood group system. Nat Genet 5 (1):62-65, 1993.
  pubmed

• 11) Cherif-Zahar B, Le Van Kim C, Rouillac C, Raynal V, Cartron JP, Colin Y:Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region. Genomics 19 (1):68-74, 1994.

• 12) Kajii E, Umenishi F, Iwamoto S, Ikemoto S:Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. Hum Genet 91 (2):157-162, 1993.

• 13) Avent ND, Ridgwell K, Tanner MJ, Anstee DJ:cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J 271 (3):821-825, 1990.
  pubmed

• 14) Cherif-Zahar B, Bloy C, Le Van Kim C, Blanchard D, Bailly P, Hermand P, Salmon C, Cartron JP, Colin Y:Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci USA 87 (16):6243-6247, 1990.
  pubmed

• 15) Le van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y:Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci USA 89 (22):10925-10929, 1992.
  pubmed

• 16) Le Van Kim C, Cherif-Zahar B, Raynal V, Mouro I, Lopez M, Cartron JP, Colin Y:Multiple Rh messenger RNA isoforms are produced by alternative splicing. Blood 80 (4):1074-1078, 1992.
  pubmed

P.520 掲載の参考文献

• 1) Avent ND, Reid ME:The Rh blood group system:areview. Blood 95 (2):375-387, 2000.

• 2) Cartron JP:Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Rev 8 (4):199-212, 1994.
  pubmed

• 3) Mouro-Chanteloup I, D'Ambrosio AM, Gane P, Le Van Kim C, Raynal V, Dhermy D, Cartron JP, Colin Y:Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood 100 (3):1038-1047, 2002.
  pubmed

• 4) Matheson KA, Denomme GA:Novel 3' Rhesus box sequences confound RHD zygosity assignment. Transfusion 42 (5):645-650, 2002.
  pubmed

• 5) Noizat-Pirenne F, Le Pennec PY, Mouro I, Rouzaud AM, Juszczak G, Roussel M, Lauroua P, Krause C, Rouger P, Cartron JP, Ansart-Pirenne H:Molecular background of D (C) (e) haplotypes within the white population. Transfusion 42 (5):627-633, 2002.

• 6) Wagner FF, Ladewig B, Angert KS, Heymann GA, Eicher NI, Flegel WA:The DAU allele cluster of the RHD gene. Blood 100 (1):306-311, 2002.
  pubmed

• 7) Wagner FF, Flegel WA:RHCE represents the ancestral RH position, while RHD is the duplicated gene. Blood 99 (6):2272-2273, 2002.
  pubmed

• 8) Nickerson L, Wiersma EJ:Epitope mapping of four monoclonal antibodies specific for the human RhD antigen. Immunol Lett 80 (1):33-39, 2002.
  pubmed

• 9) Okuda H, Suganuma H, Kamesaki T, Kumada M, Tsudo N, Omi T, Iwamoto S, Kajii E:The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun 274 (3):670-683, 2000.
  pubmed

• 10) Wagner FF, Flegel WA:RHD gene deletion occurred in the Rhesus box. Blood 95 (12):3662-3668, 2000.
  pubmed

• 11) Liu W, Avent ND, Jones JW, Scott ML, Voak D:Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh .constructs in K562 erythroleukemia cells. Blood 94 (12):3986-3996, 1999.
  pubmed

• 12) Omi T, Takahashi J, Tsudo N, Okuda H, Iwamoto S, Tanaka M, Seno T, Tani Y, Kajii E:The genomic organization of the partial D category DVa:the presence of a new partial D associated with the DVa phenotype. Biochem Biophys Res Commun 254 (3):786-794.
  pubmed

• 13) Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA:Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 91 (6):2157-2168, 1998.
  pubmed

• 14) Huang CH, Chen Y, Reid M:Human D (IIIa) erythrocytes:RhD protein is associated with multiple dispersed amino acid variations. Am J Hematol 55 (3):139-145, 1997.

• 15) Smythe JS, Avent ND, Judson PA, Parsons SF, Martin PG, Anstee DJ:Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood 87 (7):2968-2973, 1996.
  pubmed

• 16) Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM:Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 82 (2):651-655, 1993.

• 17) Mouro I, Colin Y, Cherif-Zahar B, Cartron JP, Le Van Kim C:Molecular genetic basis of the human Rhesus blood group system. Nat Genet 5 (1):62-65, 1993.
  pubmed

• 18) Suyama K, Lunn R, Haller S, Goldstein J:Rh (D) antigen expression and isolation of a new Rh (D) cDNA isoform in human erythroleukemic K562 cells. Blood 84 (6):1975-1981, 1994.

• 19) Le van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y:Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci USA 89 (22):10925-10929, 1992.
  pubmed

P.522 掲載の参考文献

• 1) Mouro-Chanteloup I, D'Ambrosio AM, Gane P, Le Van Kim C, Raynal V, Dhermy D, Cartron JP, Colin Y:Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood 100 (3):1038-1047, 2002.
  pubmed

• 2) Westhoff CM, Ferreri-Jacobia M, Mak DO, Foskett JK:Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J Biol Chem 277 (15):12499-12502, 2002.
  pubmed

• 3) Huang C, Cheng GJ, Reid ME, Chen Y:Rhmod syndrome:afamily study of the translation-initiator mutation in the Rh50 glycoprotein gene. Am J Hum Genet 64 (1):108-117, 1999.

• 4) Huang CH, Liu Z, Cheng G, Chen Y:Rh50 glycoprotein gene and rhnull disease:asilent splice donor is trans to a Gly279->Glu missense mutation in the conserved transmembrane segment. Blood 92 (5):1776-1784, 1998.

• 5) Matassi G, Cherif-Zahar B, Raynal V, Rouger P, Cartron JP:Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family. Genomics 47 (2):286-293, 1998.
  pubmed

• 6) Huang CH:The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh (null) disease. J Biol Chem 273 (4):2207-2213, 1998.
  pubmed

• 7) Cherif-Zahar B, Raynal V, Gane P, Mattei MG, Bailly P, Gibbs B, Colin Y, Cartron JP:Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nat Genet 12 (2):168-173, 1996.
  pubmed

• 8) Ridgwell K, Spurr NK, Laguda B, MacGeoch C, Avent ND, Tanner MJ:Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochem J 287 (Pt1):223-228, 1992.

P.524 掲載の参考文献

• 1) Hayflick JS, Kilgannon P, Gallatin WM:The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol Res 17 (3):313-327, 1998.
  pubmed

• 2) Hermand P, Le Pennec PY, Rouger P, Cartron JP, Bailly P:Characterization of the gene encoding the human LW blood group protein in LW+and LW-phenotypes. Blood 87 (7):2962-2967, 1996.
  pubmed

• 3) Bailly P, Tontti E, Hermand P, Cartron JP, Gahmberg CG:The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD181eukocyte integrins. Eur J Immunol 25 (12):3316-3320, 1995.
  pubmed

• 4) Bailly P, Hermand P, Callebaut I, Sonneborn HH, Khamlichi S, Mornon JP, Cartron JP:The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA 91 (12):5306-5310, 1994.
  pubmed

• 5) Hermand P, Gane P, Mattei MG, Sistonen P, Cartron JP, Bailly P:Molecular basis and expression of the LWa/LWb blood group polymorphism. Blood 86 (4):1590-1594, 1995.
  pubmed

• 6) Sistonen P:Linkage of the LW blood group locus with the complement C3 and Lutheran blood group loci. Ann Hum Genet 48 (Pt 3):239-242, 1984.

P.525 掲載の参考文献

• 1) Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schakel U, Ehninger G, Schaich M:MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 62 (17):4955-4962, 2002.
  pubmed

• 2) Hsia TC, Lin CC, Wang JJ, Ho ST, Kao A:Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression. Lung 180 (3):173-179, 2002.
  pubmed

• 3) Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Dionysiou-Asteriou D, Skarlos D, Gonos E:Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients. Anticancer Res 22 (4):2275-2280, 2002.

• 4) Wilkes DM, Wang C, Aristimuno PC, Castro AF, Altenberg GA:Nucleotide triphosphatase activity of the N-terminal nucleotide-binding domains of the multidrug resistance proteins P-glycoprotein and MRP1. Biochem Biophys Res Commun 296 (2):388-394, 2002.

• 5) Garrigues A, Escargueil AE, Orlowski S:The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci USA 99 (16):10347-10352, 2002.
  pubmed

• 6) Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, Mecucci C, Tedeschi A, Fioritoni G, Ferrara F, Di Raimondo F, Gallo E, Liso V, Fabbiano F, Cascavilla N, Pizzolo G, Camera A, Pane F, Lanza F, Cilloni D, Annino L, Vitale A, Vegna ML, Vignetti M, Foa R, Mandelli F:MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 100 (3):974-981, 2002.
  pubmed

• 7) Chen GK, Lacayo NJ, Duran GE, Wang Y, Bangs CD, Rea S, Kovacs M, Cherry AM, Brown JM, Sikic BI:Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma. Genes Chromosomes Cancer 34 (4):372-383, 2002.

• 8) Guimond M, Balassy A, Barrette M, Brochu S, Perreault C, Roy DC:P-glycoprotein targeting:aunique strategy to selectively eliminate immunoreactive T cells. Blood 100 (2):375-382, 2002.

• 9) Hegedus T, Orfi L, Seprodi A, Varadi A, Sarkadi B, Keri G:Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1. Biochim Biophys Acta 1587 (2-3):318-325, 2002. (Review.)

• 10) Soni S, Pande P, Shukla NK, Ralhan R:Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis. J Cancer Res Clin Oncol 128 (6):336-342, 2002.

• 11) Loo TW, Bartlett MC, Clarke DM:Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments. J Biol Chem 277 (31):27585-27588, 2002.

• 12) Kimchi-Sarfaty C, Gribar JJ, Gottesman MM:Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol 62 (1):1-6, 2002.
  pubmed

• 13) Nuti SL, Rao US:Proteolytic Cleavage of the Linker Region of the Human P-glycoprotein Modulates Its ATPase Function. J Biol Chem 277 (33):29417-29423, 2002.

• 14) Potocnik U, Ravnik-Glavac M, Golouh R, Glavac D:Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene:correlation with microsatellite instability and lymphoid infiltration in colorectal cancers. J Med Genet 39 (5):340-346, 2002.
  pubmed

• 15) van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P:Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia 16 (5):833-839, 2002.
  pubmed

• 16) Potocnik U, Ravnik-Glavac M, Glavac D:Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability. Cell Mol Biol Lett 7 (1):92-95, 2002.
  pubmed

• 17) Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K:Induction of multidrug resistance in MOLT-4cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Cancer Chemother Pharmacol 49 (5):391-397, 2002.

• 18) Kuo MT, Liu Z, Wei Y, Lin-Lee YC, Tatebe S, Mills GB, Unate H:Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 21 (13):1945-1954, 2002.

• 19) Kucerova H, Sumerauer D, Drahokoupilova E, Piskova M, Bedrnicek J, Eckschlager T:Significance of P-glycoprotein expression in childhood malignant tumors. Neoplasma 48 (6):472-478, 2001.
  pubmed

• 20) Hooiveld GJ, Heegsma J, van Montfoort JE, Jansen PL, Meijer DK, Muller M:Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins. Br J Pharmacol 135 (7):1685-1694, 2002.
  pubmed

P.527 掲載の参考文献

• 1) Costello RT, Sivori S, Mallet F, Sainty D, Arnoulet C, Reviron D, Gastaut JA, Moretta A, Olive D:A novel mechanism of antitumor response involving the expansion of CD3+/CD56+large granular lymphocytes triggered by a tumor-expressed activating ligand. Leukemia 16 (5):855-860, 2002.

• 2) Bottino C, Parolini S, Biassoni R, Falco M, Notarangelo L, Moretta A:X-linked lymphoproliferative disease:the dark side of 2b4 function. Adv Exp Med Biol 495:63-67, 2001.
  pubmed

• 3) Chuang SS, Kumaresan PR, Mathew PA:2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways. J Immunol 167 (11):6210-6216, 2001.
  pubmed

• 4) Speiser DE, Colonna M, Ayyoub M, Cella M, Pittet MJ, Batard P, Valmori D, Guillaume P, Lienard D, Cerottini JC, Romero P:The activatory receptor 2B4 is expressed in vivo by human CD8+effector alpha beta T cells. J Immunol 167 (11):6165-6170, 2001.

• 5) Boles KS, Nakajima H, Colonna M, Chuang SS, Stepp SE, Bennett M, Kumar V, Mathew PA:Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens 54 (1):27-34, 1999.
  pubmed

• 6) Nakajima H, Cella M, Langen H, Friedlein A, Colonna M:Activating interactions in human NK cell recognition:the role of 2B4-CD48. Eur J Immunol 29 (5):1676-1683, 1999.
  pubmed

• 7) Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH:Cutting edge:human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 162 (12):6981-6985, 1999.

• 8) Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN:2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 188 (11):2083-2090, 1998.

• 9) Siu G, Strauss EC, Lai E, Hood LE:Analysis of a human V beta gene subfamily.JExp Med 164 (5):1600-1614, 1986.

P.529 掲載の参考文献

• 1) Okumura K, Kato K, Kobata T:T-cell antigens:section report. In Leukocyte Typing VI, (eds Kishimoto T, et al), Garland Publishing Inc, New York, pp23-32, 1998.

P.530 掲載の参考文献

• 1) Miyake I, Hakomori Y, Shinohara A, Gamou T, Saito M, Iwamatsu A, Sakai R:Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines. Oncogene 21 (38):5823-5834, 2002.
  pubmed

• 2) Dirks WG, Fahnrich S, Lis Y, Becker E, MacLeod RA, Drexler HG:Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines. Int J Cancer 100 (1):49-56, 2002.
  pubmed

• 3) Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P:Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 34 (4):354-362, 2002.
  pubmed

• 4) ten Berge RL, Meijer CJ, Dukers DF, Kummer JA, Bladergroen BA, Vos W, Hack CE, Ossenkoppele GJ, Oudejans JJ:Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 99 (12):4540-4546, 2002.
  pubmed

• 5) Passoni L, Scardino A, Bertazzoli C, Gallo B, Coluccia AM, Lemonnier FA, Kosmatopoulos K, Gambacorti-Passerini C:ALK as a novel lymphoma-associated tumor antigen:identification of 2 HLA-A2.1-restricted CD8+T-cell epitopes. Blood 99 (6):2100-2106, 2002.
  pubmed

• 6) Powers C, Aigner A, Stoica GE, McDonnell K, Wellstein A:Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J Biol Chem 277 (16):14153-14158, 2002.
  pubmed

• 7) Bai RY, Dieter P, Peschel C, Morris SW, Duyster J:Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 18 (12):6951-6961, 1998.
  pubmed

• 8) Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G:ALK-positive lymphoma:a single disease with a broad spectrum of morphology. Blood 91 (6):2076-2084, 1998. (Review)
  pubmed

• 9) Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP:ALK, the chromosome 2 gene locus altered by the t (2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14 (18):2175-2188, 1997.

• 10)Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T:Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14 (4):439-449, 1997.
  pubmed

• 11)Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T:Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t (2;5). Proc Natl Acad Sci USA 93 (9):4181-4186, 1996.

• 12)Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT:Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 (5151):1281-1284, 1994
  pubmed

P.532 掲載の参考文献

• 1) Dumont C, Blanchard N, Di Bartolo V, Lezot N, Dufour E, Jauliac S, Hivroz C:TCR/CD3 down-modulation and zeta degradation are regulated by ZAP-70. J Immunol 169 (4):1705-1712, 2002.
  pubmed

• 2) Pang M, Setoyama Y, Tsuzaka K, Yoshimoto K, Amano K, Abe T, Takeuchi T:Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients. Clin Exp Immunol 129 (1):160-168, 2002.

• 3) Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC:Regulation of T cell receptor CD3 zeta chain expression by L-arginine. J Biol Chem 277 (24):21123-21129, 2002.
  pubmed

• 4) Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Higashi H, lwashige H, Aridome K, Hokita S, Aikou T:CD3-zetachain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients. Cancer 94 (5):1437-1442, 2002.

• 5) Cemerski S, Cantagrel A, Van Meerwijk JP, Romagnoli P:Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem 277 (22):19585-19593, 2002.
  pubmed

• 6) Torres J, Briggs JA, Arkin IT:Convergence of experimental, computational and evolutionary approaches predicts the presence of a tetrameric form for CD3-zeta. J Mol Biol 316 (2):375-384, 2002.
  pubmed

• 7) Hombach A, Wieczarkowiecz A, Marquardt T, Heuser C, Usai L, Pohl C, Seliger B, Abken H:Tumorspecific T cell activation by recombinant immunoreceptors:CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. J Immunol 167 (11):6123-6131, 2001.
  pubmed

• 8) Sturm RA, Eyre HJ, Baker E, Sutherland GR:The human OTF1 locus which overlaps the CD35 gene is located at 1q22->q23. Cytogenet Cell Genet 68 (3-4):231-232, 1995.

• 9) Weissman AM, Samelson LE, Klausner RD:Anew subunit of the human T-cell antigen receptor complex. Nature 324 (6096):480-482, 1986.

• 10) Gold DP, Clevers H, Alarcon B, Dunlap S, Novotny J, Williams AF, Terhorst C:Evolutionary relationship between the T3 chains of the T-cell receptor complex and the immunoglobulin supergene family. Proc Natl Acad Sci USA 84 (21):7649-7653, 1987.

• 11) Weissman AM, Hou D, Orloff DG, Modi WS, Seuanez H, O'Brien SJ, Klausner RD:Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain:distinction from the molecular CD3 complex. Proc Natl Acad Sci USA 85 (24):9709-9713, 1988.

• 12) Jensen JP, Hou D, Ramsburg M, Taylor A, Dean M, Weissman AM:Organization of the human T cell receptor zeta/eta gene and its genetic linkage to the Fc gamma RII-Fc gamma RIII gene cluster. J Immuunol 148 (8):2563-2571, 1992.